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Abstract
Glutathione synthetase (GS) catalyses the final step of glutathione (GSH) synthesis. GSH 
is an important antioxidant, involved in detoxifying free radicals and maintaining the 
cellular redox balance. Oxidative stress is thought to be one of the causes of cellular 
senescence and organismal aging. The broad scope of this work is the analysis of oxidative 
stress resistance in Drosophila melanogaster, in relation to ageing, and specifically, this 
project aims to characterise GS in D. melanogaster.
The gene encoding GS in D. melanogaster (DmGS) is 8Kb long, and consists of up to 10 
exons. Nine distinct potential transcripts, which differ due to alternative splicing, have 
been identified. In this study, cDNAs obtained from adult flies and S2 cells were 
sequenced, and confirmed the presence of six transcripts in vivo. Functional 
complementation in yeast corroborated the bioinformatic approach used to identify the two 
transcripts which are likely to produce an active GS protein.
A tandem duplication of GS in certain strains of D. melanogaster was identified using PCR 
techniques and southern blotting. Analysis of a small subset of sibling species indicated the 
duplication was not present in these closely related sibling species, or in any wild type D. 
melanogaster strains tested.
The effect of GS overexpression on oxidative stress resistance in adult flies was 
investigated, and the overall contribution of the protein to GSH production in relation to 
GCLC was also analysed. Increased levels of transcription of both genes raised GSH levels 
in adult flies, and also increased oxidative stress resistance.
After attempting to create a GS null mutant fly, GS knockdown in Drosophila S2 cells 
was studied using RNAi. GS RNAi was not found to have an effect on GSH levels, 
although in combination with GCLC knockdown, it did have a cumulative effect on 
lowering cellular GSH concentrations. Knockdown of either GSH synthesis genes did not 
have an effect on cellular viability, although upon exposure to DEM, GS and GCLC RNAi 
both significantly decreased cellular survival.
Publications
Conference abstracts
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ROS Reactive oxygen species
rpm Revolutions per minute
RT-PCR Reverse transcriptase PCR
S2 Drosophila Schneider 2 cells
SDS Sodium Dodecyl Sulphate
SEM Standard error of the mean
SFM Serum free medium
SOC Super optimised catabolite media
SOD Superoxide dismutase
SSA Sulphosalycylic acid
SSC Sodium citrate buffer
TAE Tris acetate buffer
Taq Taq polymerase enzyme
TBE Tris borate buffer
TCA Trichloroacetic acid
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TE Tris-EDTA buffer
TNB 5-thio-2-nitrobenzoic acid
TNF-a Tumor necrosis factor a
Trx Thioredoxin
TrxR Thioredoxin reductase
U Unit
}xg microgram
jil microlitre
UAS Upstream activating sequence
X-Gal 5-Bromo-4-chloro-3-indolyl P-D-galactoside
YE Yeast extract media
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1 Chapter 1: Introduction
Aerobic organisms produce toxic reactive oxygen species (ROS) during normal metabolism as 
a result of the incomplete reduction of O2 . The free radical theory of ageing proposes that the 
cumulative damage caused by endogenous and exogenous ROS results in cellular senescence 
and ultimately death, and is supported by a well documented correlation between oxidative 
stress resistance and longevity. Cellular antioxidant defences have therefore been studied as a 
means to increase the oxidative stress resistance, and thereby the lifespan of organisms. The 
tripeptide y-glutamylcysteinylglycine, commonly known as glutathione, is one of the most 
abundant intracellular thiols and is part of an integrated antioxidant system that protects cells 
from oxidative damage. Glutathione (GSH) is synthesised in a two-step reaction, with the first 
step catalysed by glutamate-cysteine ligase (GCL) and the second step catalysed by 
glutathione synthetase (GS). This chapter presents ah overview of the reactive oxygen species 
which cause oxidative stress, and the cellular response to those stresses, with a particular focus 
on the antioxidant glutathione. In addition, the review provides an overview of the oxidative 
stress in ageing which links the damage caused by ROS to the rate at which organisms age. 
Finally, the use of Drosophila as a model organism will be discussed in relation to the 
manipulation of expression of antioxidant genes with a view to extending lifespan.
1.1 Oxidative stress
Oxidative stress is the situation where there is a serious imbalance between the rate of ROS 
production and the antioxidant defence system. This may arise from a reduced level of 
antioxidants, or from an increased production of ROS (Halliwell and Gutteridge, 1999; 
Abdollahi et al., 2004; Girardot et al., 2004). Free radicals are molecules or atoms containing 
unpaired electrons, therefore seeking stability by attacking molecules nearby to obtain another
electron, and resulting in damage to the structure and function of the oxidised molecule 
(Abdollahi et al., 2004). Antioxidants are substances which delay or inhibit oxidative damage 
to a target molecule by donating electrons to free radicals (Abdollahi et al., 2004).
Exposure to low levels of oxidative stress can lead to an adaptive response in a cell, where 
transcription of genes involved in response to oxidative stress is upregulated (Halliwell and 
Gutteridge, 1999). Excessive oxidative stress can lead to cell injury, and eventually death 
through apoptosis or necrosis (Girardot et al., 2004). High levels of ROS production are 
associated with cancer, artherosclerosis, neurodegerative diseases (Bains and Shaw, 1997; 
Droge, 2002), and they also play a role in ageing (Harman, 1956; Phillips et al., 1989; Cho et 
al., 2003), as listed in Table 1.1.
Table 1.1: Diseases in which oxidative stress is involved in the pathophysiology (Phillips et al., 1989; 
Abdollahi et al., 2004; Dugan and Quick, 2005; Reliene and Schiestl, 2005)______________________
Disease Category Diseases
Autoimmune Rheumatoid arthritis, inflammatory bowel diseases
Eye Cataract, age-related macular degeneration, retinopathy, cystic 
macular degeneration
GI tract Hepatitis, pancreatitis, colitis
Kidney Renal failure, renal interstitial fibrosis, neuropathy
Lung Bronchial asthma, cystic fibrosis, pneumonia, pulmonary fibrosis, 
Chronic obstructive pulmonary disease
Neurodegenerative Parkinson’s, Huntington’s, amyotrophic lateral sclerosis, 
Alzheimer’s, multiple sclerosis, dementia, neuronal lipofuscinosis
Red blood cells Sickle cell disease, anaemia, neonatal hypoxia, thalassaemia, 
malaria infection
Skin Contact dermatitis, atopic dermatitis, psoriasis, vitiligo
Vascular Atherosclerosis, myocardial infarction, stroke
Systemic Cancer
1.1.1 The chemistry of free radicals
Atoms usually exist in the state where electrons are matched, or paired in terms of spin, the 
quantum number describing the two possible orientations of the magnetic moment generated 
by an electron as a result of rotation on its own axis (Cowan, 1981). This means that the outer
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orbital of an atom will have two electrons, one with a spin value of !4, and the other with a 
value of -V2 (Cowan, 1981).
A free radical is any species capable of independent existence that contains one or more 
unpaired electrons in the outer orbital (Figure 1.1), and they are usually highly reactive 
because they readily give up or accept an electron to stabilise the unpaired electron (Halliwell 
and Gutteridge, 1999). This leads to a chain of radical reactions, which can be quenched by a 
molecule that is stabilised by the addition of a free radical (Halliwell and Gutteridge, 1999).
•  •
SOTO* Dioxygen 
•  •  •  •
▼
•  •  oZ O Z  O Z  su peroxide 
•  •  •  •
Figure 1.1: Schematic representation of the gain of electrons to create a free radical. The Lewis electron 
configuration of molecular dioxygen is shown, as well as the structure of free radical superoxide with the 
extra electron, which gives superoxide the negative charge.
The free radical status of a molecule is indicated by a dot, for example O2’, which can exist 
with a positive, negative or neutral charge. The reactions in which free radicals are involved 
are oxidative, where there is either a gain in oxygen, e.g. C+O2 = CO2 , or a loss of electrons, 
e.g. Na = Na+ + e', or 02*’ = O2 + e' (Halliwell and Gutteridge, 1999). Because there are 
examples of reactive species in biological systems which are not radicals, for example 
peroxide, the term ‘reactive oxygen species’ (ROS) is more widely used to incorporate oxygen 
radicals (O2*" and 0H ‘) and some non-radical derivatives of oxygen, including H2O2 , 
hypochlorous acid (H0C1) and O3, which are involved in oxidative damage of the 
biomolecules (Halliwell and Gutteridge, 1999).
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1.1.2 Sources of reactive oxygen species in vivo
ROS are an inevitable consequence of normal aerobic metabolism, and are produced during 
aerobic respiration when electrons are transferred along the mitochondrial respiratory chain to 
generate ATP (Sampayo et al., 2003), as illustrated in Figure 1.2.
' 2H* 2  H* 2 H* ' X
/  6H 4
'  cyt b
cy tc ,
2  H*
2 H*
KADH + H’
3 ATP
NAD*
NADH dehydrogenase Cytochrome b - c .  Cytochrome ATP
complex complex oxidase complex synthase
Figure 1.2: A cartoon of the components of the electron transport chain, with the movement of the electron 
shown with a pink arrow, and the proton pump shown with grey arrows. FMN = flavoprotein, 
Q=ubiquinone, cyt = cytochrome. (Becker et al., 2000)
The respiratory chain is not, however, a perfect system, and electrons are able to Teak’ out and 
form ROS (superoxide, hydrogen peroxide or hydroxyl molecules) when electrons are donated 
inappropriately, usually to ubiquinone (Phillips et al., 1989; Sampayo et al., 2003). It has been 
estimated that approximately 2-4% of total oxygen consumed during electron transport is 
converted to ROS in aerobic organisms (Nygren et al., 2005). ROS are also formed during 
peroxisomal fatty acid metabolism and cytochrome P450 reactions (Seto et al., 1990; Hekimi 
and Guarente, 2003). Cellular ROS, particularly the hydroxyl radical, are highly reactive and 
cause damage to lipids, proteins, carbohydrates and nucleic acids (Phillips et al., 1989; Seto et 
al., 1990). Biological systems also produce ROS by interaction with ionising and UV 
radiation, and by the redox cycling of cellular components such as quinines, thiols and flavins
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(Phillips et al., 2000). The three major endogenous ROS species are discussed in the following 
sections.
1.1.2.1 Superoxide radical O2’’
Superoxide is produced by the reaction: O2 + e' = O2*’, and has one unpaired electron 
(Halliwell and Gutteridge, 1999). Sources of superoxide in aerobic organisms include the 
mitochondrial electron transport chain, the cytochrome P450 system in the endoplasmic 
reticulum and auto-oxidation reactions (Hekimi and Guarente, 2003; Nygren et al., 2005). Of 
these sources of superoxide, the mitochondrial electron transport chain in the inner membrane 
of the mitochondrion, illustrated in Figure 1.2, is the most important source of O2*" in vivo.
1.1.2.2 Peroxide ion O22"
Peroxide is produced mainly in the mitochondrial outer membrane by the reaction: O2*’ + e" = 
O22" (Cadenas and Davies, 2000). Peroxide is not technically a radical, as it has no unpaired 
electrons, but the strength of the O2 bond decreases with added electrons, therefore the 
addition of two electrons to create peroxide readily leads to the formation of the radical O2 *’ 
(Halliwell and Gutteridge, 1999).
1.1.2.3 Hydroxyl radicals OH’
The extremely unstable hydroxyl radicals are generated by different pathways in the cell,
94- •including Fenton chemistry, where Fe reacts with H2O2 to form OH and OH'; UV-induced 
homeolytic fission of the 0 -0  bond in H2 O2 ; and ionising radiation, which can produce 
hydroxyl radicals from water (Phillips et al., 1989). The highly reactive hydroxyl radicals are 
responsible for most of the oxygen-derived cytotoxicity.
30
1.1.3 Cellular responses to oxidative stress
The cellular consequences of exposure to highly reactive radicals are summarised in Figure 
1.3. In order to combat the deleterious effects of ROS, cells have antioxidant defences 
available to them which vary between cell and tissue types. Within biological systems, an 
antioxidant is defined as a substance which delays or prevents oxidation of an oxidisable 
substrate, when present at levels lower than the substrate (Halliwell and Gutteridge, 1999). 
The antioxidant defences available to cells include ROS scavenging chemicals, enzymatic 
systems, and proteins such as heat shock proteins (Orr and Sohal, 2003; Sampayo and 
Lithgow, 2004; Nygren et al., 2005).
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Cytoskeletal damage
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Figure 1.3: The effects of oxidative stress on cellular processes, including DNA damage, protein damage 
and lipid peroxidation. GSH is depleted directly and indirectly by exposure to oxidative stress. Reduction 
in GSH has further consequences which increase the cellular damage (Modified from Halliwell and 
Gutteridge, 2001).
1.1.3.1 Glutathione
The cell has a wide variety of non-enzymatic antioxidant molecules available which have the 
ability to remove reactive oxygen species, thus minimising damage caused by ROS to 
membranes, DNA and proteins. The water-soluble tripeptide glutathione (GSH) is the most 
abundant non-enzymatic antioxidant (Meister, 1994; Rebrin et al., 2004), and is supported by 
other ROS scavenging molecules including thioredoxin (Kanzok et al., 2001), selenoproteins 
(Morey et al., 2003) and antioxidants from the diet such as Vitamins C and E (Halliwell and 
Gutteridge, 1999). The functional redundancy and cooperation between the antioxidant 
detoxification pathways shows the importance of cellular defence against ROS. GSH is of 
interest in ageing studies due to its antioxidant properties, and because the levels of GSH 
decrease with age in various species and tissue types (Kanzok et al., 2001; Rebrin et al., 2003;
Zhu et al., 2006). Depletion of GSH has been shown to activate the apoptotic pathway, 
resulting in cell death (Hancock et al., 2001; Cristofanon et al., 2006). In a recent study, it was 
shown that human blood GSH levels correlated positively with good health in all age groups 
(Lang et al., 2002). Cellular redox status is maintained mainly by preserving the balance 
between reduced GSH and its oxidized form, GSSG (Figure 1.4). The GSH:GSSG redox 
couple is the most important of the redox couples because the GSH concentration is about 
500-1000 fold higher than thioredoxin (section 1.1.3.2) or NADPH redox systems (Filomeni et 
al., 2002). Oxidation-reduction and thiol-disulfide exchange reactions during exposure to 
oxidative stress can result in a change in the GSH:GSSG ratio, with a shift in the ratio in 
favour of GSSG reflecting an oxidized cellular redox status (Aw, 2003).
SH
o  h -
2
NH
GLUTATHIONE (G SH )
OXIDATION
n h 2
O H-
GLUTATHIONE DISULFIDE 
(GSSG)
NH-
Figure 1.4: The chemical structures of reduced glutathione (GSH) and oxidised glutathione (GSSG).
Glutathione is the major non-protein thiol in many organisms, and is widely distributed in 
most cells. The high concentrations of GSH in most tissues, ranging from 1-1 OmM, as well as 
its high electron-donating ability make GSH a powerful cellular antioxidant (Schafer and
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Buettner, 2001; Nygren et al., 2005). GSH is also one of the major determinants of cellular , 
redox potential (Bauer et al., 2002; Cristofanon et al., 2006). The potent reducing power of 
GSH is the basis for its involvement in a variety of other cellular actions including 
detoxification, prevention of protein cross-linking, DNA synthesis, cell cycle regulation, 
signal transduction activity, telomerase regulation, neurotransmission, and its action as a co­
factor for antioxidant enzymes (Kehrer and Lund, 1994; Meister, 1994; Halliwell and 
Gutteridge, 1999; Janaky et al., 1999; Polekhina et al., 1999; Meierjohann et al., 2002; Kim et 
al., 2003a; Borras et al., 2004; Forman et al., 2004).
The reducing properties of GSH are due to the sulfhydryl (-SH) group, also known as a thiol 
group, on the cysteine residue. The -SH group is the sulphur analogue of the hydroxyl group 
(Forman et al., 2004). The thiol exchange reactions which GSH can take part in are rapid and 
reversible, and are able to control redox sensitive protein functions (Cho et al., 2003). As an 
antioxidant, reduced glutathione is an electron donor in the neutralisation of H2O2 to H2O, 
producing oxidised glutathione (GSSG) in a reaction catalysed by glutathione peroxidase 
(GPx) (Inoue et al., 1998). GPx is present in most animal tissues, but is not found in insects 
(Radyuk et al., 2001). To compensate for the lack of this enzyme, Drosophila rely on catalase, 
thioredoxins and peroxidases to remove peroxides (Radyuk et al., 2001), with GSH providing 
reducing equivalents in reactions involving peroxidases. GSH also displays antioxidant 
properties by reacting directly with the hydroxyl radical (OH*), reducing it to H2 O. GSH 
reacts directly with free radicals, but also chemically restores damage to macromolecules by 
donating a hydrogen atom (Nygren et al., 2005).
In an oxidation reaction, GSH is oxidised to GSSG, with the differences in structure illustrated 
in Figure 1.4. In healthy cells, GSSG is usually less than 10 percent of the total amount of 
glutathione present, and the decreased ratio of reduced to oxidised glutathione can be used as a
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measure of cellular oxidative stress, redox flux and ageing (Frosali et al., 2004; Njalsson and 
Norgren, 2005).
A further protective role of GSH is its involvement in detoxification of electrophilic 
xenobiotics in a conjugation reaction catalysed by the glutathione S-transferases (Halliwell 
and Gutteridge, 1999; Kim et al., 2003a). GSH conjugation represents an important 
detoxification reaction because electrophiles are potentially toxic species that can bind to 
critical nucleophiles, such as proteins and nucleic acids. All the enzymes involved in 
xenobiotic transformation have the potential to generate reactive intermediates, most of which 
are detoxified to some extent by conjugation to GSH (Parkinson, 2001). GSH is also involved 
in organic peroxide detoxification through glutathione peroxidase (Forman et al., 2004; Zhu et 
al., 2006).
In mammalian cells glutathione is maintained in its reduced state by glutathione reductase 
(GR). This enzyme is absent in Drosophila, where thioredoxin (Trx) is substituted for the GR 
system in order to support reduction of GSSG (Kanzok et al., 2001), as illustrated in Figure 
1.5. Thioredoxin reductase (TRxR) catalyses the reduction of oxidised thioredoxin to 
Trx(SH)2 , which is then involved in the reduction of other proteins such as thioredoxin 
peroxidase, and ribonucleotide reductase, as well as the reduction of GSSG (Kanzok et al., 
2001). The thioredoxin system has been found to be capable of maintaining sufficiently high 
levels of GSH in Drosophila necessary to counteract the high concentrations of ROS present 
in insects (Kanzok et al., 2001; Morey et al., 2003). GSH is also exported through the cell 
membrane to be metabolised by y-glutamyltransferase (GGT), a membrane bound enzyme 
that cleaves GSH into its component amino acids cysteine, glycine, and glutamine, which are 
ultimately recycled for use in gluthathione synthesis in the cytosol (Rahman et al., 2005), as 
shown in Figure 1.5 overleaf.
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Figure 1.5: Glutathione cycle in Drosophila. Glutathione is synthesised in the cytosol from its component 
amino acids in a two-step reaction shown in red arrows, catalysed by GCL and GS. GSH is transported 
out of the cell by a GSH transporter, and leads to the formation of y-glutamyl amino acids and 
cysteinylglycine, which is cleaved to form glycine and cysteine. Glutathione is used to detoxify xenobiotics 
and electrophiles present in the cell by conjugation reactions catalysed by GST (glutathione-S-transferase). 
Glutathione is also used inside the cell to protect the cell against reactive oxygen species, such as H20 2. 
Most eukaryotic cells utilise the GPx (glutathione peroxidase) system to detoxify peroxide, but since this 
enzyme is not present in Drosophila, flies rely on the presence of the peroxiredoxin system, as well as 
cataiase to remove peroxides. Oxidised glutathione (GSSG) is replenished by the thioredoxin system in 
Drosophila, since flies lack the glutathione reductase (GR) enzyme. All enzymes are labelled in dark blue.
Despite the efficient renewal of GSH by GR/Trx, GSH is lost from the cell through 
detoxification and free radical scavenging reactions, thus necessitating de novo synthesis of 
GSH, as illustrated in Figure 1.5, and in more detail in Figure 1.6. In the first step, glutamate- 
cysteine ligase (GCL; EC 6.3.2.2, formerly known as y-glutamylcysteine synthetase) catalyses 
the rate-limiting reaction, where cysteine is bound to the y-carboxyl group of glutamate using 
ATP, resulting in the formation of and the release of ADP and P; (Janowiak and Griffith,
2005). The formation of the gamma bond protects y-glutamylcysteine from hydrolysis by 
peptidases. Availability of cysteine, produced from methionine, is usually the rate-limiting 
factor in this step (Meister and Larsson, 1995). GCL is a holoenzyme composed of a catalytic
(GCLC) and a modifier subunit (GCLM), which are separated under oxidising conditions 
(Seelig et al., 1984). D. melanogaster GCLC has been cloned and characterised (Saunders and 
McLellan, 2000; Fraser et al., 2002), and is regulated in a manner similar to mammalian 
GCLC, as described in 1.1.4.
In the second step of the glutathione synthesis reaction, y-glutamylcysteine is combined with 
glycine by the enzyme glutathione synthetase (GS; EC 6.3.2.3) to form glutathione (Gushima 
et al., 1983; Meister, 1985; Huang et al., 1995). In this reaction, the transfer of the phosphate 
group of ATP to the carboxylate of y-glutamylcysteine results in the formation of an unstable 
acylphosphate intermediate. A nucleophilic attack of this intermediate by glycine leads to the 
formation of glutathione, with the release of ADP and Pi (Polekhina et al., 1999; Jez and 
Cahoon, 2004).
Mitochondrial concentrations of GSH are similar to those in the cytosol (Cristofanon et al., 
2006). GSH is transported into the mitochondria from the cytosol by dicarboxylate carrier 
proteins and 2-oxoglutarate carrier protein, using energy from the concentration gradient of 
dicarboxylic acids (Meister, 1995; Shen et al., 2005). GSH synthesis is regulated by the 
concentration of GSH through feedback inhibition on GCL, as well as by the intracellular 
level of y-GC and the availability of its substrates; glutamate, cysteine and glycine (Meister, 
1995; Meister and Larsson, 1995; Njalsson and Norgren, 2005).
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Figure 1.6: The glutathione biosynthesis pathway. The first step is catalysed by GCL, and the second step 
is catalysed by GS. Both steps require a molecule of ATP.
The mechanism whereby GSH regulates GCL involves the reduction of the disulphide bond 
between the two GCL subunits by GSH, causing a conformational change of the active site 
(Zhu et al., 2006). This conformational change makes the binding of GSH easier, thereby 
inhibiting substrate (glutamate) binding. The mechanism of glutathione biosynthesis 
regulation is complex (Njalsson and Norgren, 2005), and is discussed further in section 1.1.4.
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1.1.3.2 Thioredoxin (Trx) and Peroxiredoxin (Prx)
Thioredoxins and peroxiredoxins are cellular reducing agents, which reduce disulphide bonds 
in a manner similar to glutathione (Carmel-Harel and Storz, 2000; Kanzok et al., 2001). 
Oxidised thioredoxin (Trx) is replenished by thioredoxin reductase (TrxR) (Missirlis et al.,
2001). In Drosophila TrxR plays an important role in glutathione recycling, owing to the 
absence of glutathione reductase within Drosophila (Radyuk et al., 2003). Thioredoxins are 
also specific electron donors to peroxiredoxins (Filomeni et al., 2002).
Peroxiredoxins (Prx) are small proteins which have peroxidase activity in the presence of GSH 
or Trx (Radyuk et al., 2001). Both cytosolic as well as mitochondrial peroxiredoxins detoxify 
hydrogen peroxide, thereby protecting enzymes susceptible to oxidative damage. Five Prx 
members have been identified in Drosophila, two of which are members of the 1-Cys 
peroxiredoxins, which reduce H2O2 in the presence of glutathione, and three which have 
peroxide reductase activity in the presence of thioredoxin, and are known as thioredoxin 
peroxidases (Radyuk et al., 2001).
1.1.3.3 Antioxidant enzymes
One of the major cellular responses to oxidative stress is the use of enzymes which detoxify 
ROS. The main antioxidant enzymes in Drosophila are SOD and cataiase (Mackay and 
Bewley, 1989; Radyuk et al., 2001; Mockett et al., 2003). Studies on transgenic animals which 
overexpress antioxidant enzymes, or knockout mutants which do not express a functional copy 
of a particular antioxidant enzyme, will be discussed later in this chapter.
Superoxide dismutase
Superoxide dismutase (SOD) is a ubiquitous enzyme that exists in two forms, encoded by two 
separate genes. Cu/ZnSOD, which has a copper and zinc atom in the active site of the enzyme, 
is present in the cytosol, while MnSOD contains manganese in the active site and is found in
the mitochondria of virtually all eukaryotic cells (Phillips et al., 1989; Orr and Sohal, 1993; 
Halliwell and Gutteridge, 1999). MnSOD and Cu/ZnSOD both catalyse the dismutation of O2’" 
to hydrogen peroxide and oxygen, as shown in the reaction below, thereby preventing the 
formation of the highly cytotoxic hydroxyl radical.
O2 + O2 +2H+ —> H2 O2 + O2
MnSOD and glutathione peroxidase 1 (GPxl) are the primary antioxidant defences in 
mitochondria (Van Remmen et al., 2004). GPx scavenges the H2O2 produced by SOD and 
converts it to water and oxygen (Van Remmen et al., 2004). Drosophila has been found to be 
well protected against the toxic effects of oxygen by SOD and cataiase, which detoxifies 
H2O2 , as discussed below (Seto et al., 1990). The levels of SOD are not, however, sufficient to 
completely eliminate superoxide molecules (Phillips et al., 2000).
Cataiase
Hydrogen peroxide is formed by the dismutation of superoxide, as well as other cellular 
oxidation reactions, and is removed directly by catalases, while peroxidases use H2O2 to 
oxidise a reduced substrate (Mockett et al., 2003). Cataiase, present in organelles called 
peroxisomes in most eukaryotic cells, prevents free radical reformation by breaking down 
H2O2 into water and oxygen, as illustrated in the following reaction (Halliwell and Gutteridge, 
1999):
2 H20 2 ^  2 H20  + 0 2
There is only one functional cataiase gene in Drosophila, and low levels of the protein are 
sufficient to minimise the cytotoxic effects of peroxide (Mackay and Bewley, 1989).
1.1.4 Transcriptional regulation of antioxidants
One of the mechanisms whereby oxidative stress regulates the expression of antioxidant genes 
is through a cis-acting enhancer sequence known as an antioxidant response element (ARE)
(Nguyen et al., 2003). The expression of a range of antioxidant genes, including glutathione 
biosynthesis genes (GCLC, GCLM and GS) as well as genes encoding redox proteins, e.g. 
thioredoxins (Yang et al., 2002; Kim et al., 2004; Rahman et al., 2005), is mediated by the 
presence of one or more ARE elements in the 5' flanking region of the gene. The focus of this 
section is the regulation of the glutathione biosynthesis genes (Figure 1.7).
GCLC and GS are regulated in a coordinated manner, with the synthesis of GSH 
transcriptionally mediated by the presence of ROS (Shi et al., 1994), lipid peroxidation 
products (Dickinson et al., 2004), heat shock (Kondo et al., 1993), a change in the GSH:GSSG 
ratio (Huang et al., 2000), and by the tumor necrosis factor-a (TNF-a ) signalling pathway 
(Yang et al., 2005b). Exposure to oxidants, such as H2 O2 , causes an initial depletion of GSH, 
followed by a rebound increase in GSH after approximately 24 hours, and is accompanied by 
an increase in GCL and/or GS transcription (Rahman et al., 2005). The regulation of GCL and 
GS transcription is a complex process, with a simplified schematic diagram involving some of 
the regulatory pathways shown in Figure 1.7.
ARE enhancer sites are present in the promoters of the genes encoding both human GCL 
subunits, while the gene encoding the GCLC subunit also contains an activator protein 1 (AP- 
1) and nuclear factor kB (NFkB) binding sites (Yang et al., 2002). The GS promoter is 
regulated primarily by the presence of numerous AP-1 binding sites (Yang et al., 2002), and 
increased AP-1 transactivation has been found to be the major underlying mechanism for the 
upregulation of GS and GCLC (Yang et al., 2005b).
AP-1 and NFkB are redox-sensitive families of transcription factors (Rahman et al., 2005) 
Both AP-1 and NFkB are activated by oxidative stress, as well as a shift in the GSH:GSSG 
ratio. The presence of AP-1 is essential for GS and GCL basal expression (Yang et al., 2002). 
AP-1 is composed of Jun and Fos proteins, and is induced by ROS via the c-Jun N-terminal 
protein kinase (JNK) signal transduction pathway (Rahman et al., 2005). NFkB  is activated
when the depletion of GSH causes a rapid phosphorylation and degradation of the inhibitor of 
N F k B  (Ik B ), illustrated in Figure 1.7 (Rahman et al., 2005).
IkB inactivation
t NFkB* T Nrf1/2 |— Keapl
t c-Jun/AP-1
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Figure 1.7: Schematic representation of the proposed mechanisms of stress-induced glutathione 
biosynthesis gene activation. The interactions between Nrf 1/2, NFkB, AP-1 and glutathione levels are 
shown in relation to ROS. The upstream enhancer elements present in the 5' region of GCLC, GS and 
GCLM are shown, as well as the transcription factors acting on each of the elements.
Both ROS themselves and the end products of ROS-mediated lipid peroxidation upregulate the 
expression of nuclear factor related factors 1 and 2 (Nrfl and Nrf2), transcription factors 
which are members of the cap’n ’collar leucine zipper proteins (lies and Liu, 2005). Nrfl and 
Nrf2 are ubiquitously expressed, although expression patterns are not identical, and it is 
thought that Nrf2 plays a greater role in ARE-driven gene expression than Nrfl (Mathers et 
al., 2004). The actin binding protein Keapl negatively regulates N rf by controlling its cellular 
localisation, as well as stability. Under reducing conditions, including DEM treatment, Keapl 
is complexed with Nrf, thereby inhibiting translocation of the transcription factor into the 
nucleus (Itoh et al., 1999). On exposure to oxidative stress, Keapl disassociates from N rfl/2, 
allowing Nrfl/2 to move into the nucleus. Nrfl/2 transactivate ARE in the GCLC promoter,
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and activate GCLM and GS expression by modulating AP-1 and NFkB expression (Yang et 
al., 2005a), as shown in Figure 1.7. In addition to ROS, GCL and GS are both induced by 
TNF-a, which acts through both AP-1 and NFkB (Yang et al., 2005b).
The transcriptional regulation of GSH biosynthesis is complex and encompasses many 
different signalling pathways. It was recently found that GCL is reversibly activated under 
dephosphorylating conditions, and in the presence of NADPH, and both processes may be 
used to regulate GSH production as a primary response to oxidative stress (Orr et al., 2005). 
The mammalian Nrf2 pathway is evolutionarily conserved amongst different genera, including 
zebrafish (Kobayashi et al., 2002) and nematodes (An and Blackwell, 2003). Evidence from 
bioinformatic studies suggests that Drosophila possess regulatory elements with functions 
analagous to the mammalian Nrf2 and Keapl, although the biological function of the 
hypothetical genes encoding Keapl and the cap’n’collar proteins have not been 
experimentally determined (Mathers et al., 2004). In addition to these proposed orthologous 
genes, the ability of Drosophila to induce antioxidant gene expression, including GCL, on 
exposure to an oxidative challenge provides further evidence of the presence of an antioxidant 
regulatory system in Drosophila (Zou et al., 2000; Girardot et al., 2004; Mathers et al., 2004)
1.2 The Free Radical Theory of Ageing
The process of ageing, whereby organisms senesce and eventually die is a characteristic of all 
multicellular organisms. Ageing has been defined as ‘the progressive loss of function 
accompanied by decreasing fertility and increasing mortality with advancing age’ (Kirkwood 
and Austad, 2000). In Drosophila ageing is characterised by a decline in locomotor ability, 
geotaxis, learning, immune function and cardiac function (Bier and Bodmer, 2004; Johnson et 
al., 2006; Lesser et al., 2006; Simon et al., 2006), while mitochondria produce more ROS, and 
the GSH:GSSG ratio declines significantly (Sohal et al., 1995; Rebrin et al., 2004). Male
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germline stem cell cycle activity also decreases with age in Drosophila, as do stem cells that 
maintain the gut (Wallenfang et al., 2006).
Ageing is an extremely complex, multifactorial process determined by genetic, epigenetic and 
environmental factors, and this, as well as the great diversity in lifespan among different 
species, has led to a variety of theories of ageing. Here the focus is on the free radical theory 
of ageing, which is presently the most widely accepted theory on ageing, and it underlies the 
work on the antioxidant glutathione undertaken in this study.
The free radical theory of ageing, first proposed by Harman in 1956, is still considered one of 
the most important ageing theories (Harman, 1956; Masoro, 1993; Orr and Sohal, 1993; Finkel 
and Holbrook, 2000; Knight, 2000; Phillips et al., 2000; Biesalski, 2002; Sohal, 2002;
Harman, 2006). In the last 50 years, the free radical theory of ageing has been transformed 
into a more general theory which highlights the importance of ROS in ageing as a result of the 
gradual accrual of unrepaired oxidative damage leading to the progressive dysfunction and 
death of cells (Harman, 1981; Phillips et al., 2000; Sohal et al., 2002; Sampayo et al., 2003; 
Harman, 2006). The basic tenet of the free radical theory of ageing is that although there is a 
balance between ROS and antioxidant systems in healthy organisms, there will always be a 
small number of ROS that escape due to slightly inefficient antioxidant systems, and cause 
cumulative damage to biomolecules, which in turn leads to a gradual functional decline, 
ageing and eventually death if left unrepaired.
As discussed in section 1.1.2, normal cellular metabolism (principally mitochondrial 
metabolism) produces highly reactive species of oxygen, which cause damage to cellular 
structures unless inactivated by antioxidants. ROS cause damage to each of the four classes of 
macromolecules: nucleic acids, lipids, carbohydrates, and protein, and in keeping with the 
hypothesis of the free radical theory of ageing, damaged products of each class accumulate in 
ageing organisms, including Drosophila (Landis and Tower, 2005; Magwere et al., 2006a).
One of the most widely reported manifestations of oxidative damage to DNA is base 
modification, for example the formation of 8-hydroxy-2’-deoxyguanosine (8-oxo-dG) 
(Nygren et al., 2005). ROS also cause single strand DNA breaks, double strand DNA breaks, 
and interstrand crosslinks which could disrupt transcription and translation, resulting in 
possible cell death or cancer (Hasty et al., 2003; Kim, 2004). The estimated 10 000 oxidative 
DNA lesions per cell each day (Ames et al., 1993; Cardozo-Pelaez et al., 2002) highlights the 
scale of the potential damage to the organism.
Lipids and proteins are particularly vulnerable to oxidative damage, and membranes with a 
high lipid content are easily peroxidised because of the degree of unsaturation of the fatty 
acids making up membranes (Yu et al., 1982; Sohal and Weindruch, 1996). Biological 
membranes, particularly of the mitochondria and endoplasmic reticulum, are also the major 
site of free radical production within the cell, making the vulnerable membranes more likely 
targets for oxidative damage.
Proteins are particularly susceptible to ageing, owing to their structural flexibility and reactive 
amino acid residues (Stadtman and Levine, 2003). ‘Abnormal’ proteins, and protein carbonyls 
caused by oxidative damage accumulate with age (Sohal et al., 1995; Finkel and Holbrook, 
2000; Stadtman, 2002), and age-related protein damage is exacerbated by reduced 
mitochondrial activity which results in lowered protein turnover rate causing increased protein 
half-life and damage to proteins (Landis and Tower, 2005).
1.2.1 Support for the Free Radical Theory of Ageing
In order to determine whether the damage cause by ROS to macromolecules is indeed a cause 
of ageing, evidence supporting the three main predictions of the free radical theory of ageing 
is required. The first prediction of the theory is that oxidative damage accumulates with age, 
the second is that treatments which lower the rate of oxidative damage result in a longer
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lifespan, and the third is that interventions which increase longevity should also reduce 
oxidative damage (Ames et al., 1993).
Oxidative damage to proteins, lipids and DNA has been shown to accumulate with age in a 
variety of different tissues in Drosophila, worms and mice (Ames, 1989; Ames et al., 1993; 
Sohal et al., 1995; Sohal et al., 2002). A simultaneous increase in the rate of mitochondrial 
superoxide and H2O2 generation has also been seen in ageing insects and mammals, 
accompanied by a decline in antioxidant defences with age (Wei et al., 2001; Sampayo et al., 
2003; Melvin and Ballard, 2006). In a recent paper, the rate of mitochondrial ROS production 
was correlated with lifespan potential in flies (Magwere et al., 2006a). Oxidised GSH also 
increases with age by up to 500% in the mitochondria of ageing rats and mice (de la Asuncion 
et al., 1996). In addition to these observations, microarray studies have shown an increase in 
heatshock proteins in ageing flies (Pletcher et al., 2002), and a downregulation of genes 
involved in mitochondrial metabolism (Girardot et al., 2006), suggesting an increase in the 
presence of damaged proteins, and mitochondrial dysfunction with age. Comparisons of 
ageing and oxidative stress profiles in Drosophila microarray studies reveal similar patterns of 
gene expression, including upregulation of heatshock proteins, immune response, and 
antioxidant genes (Zou et al., 2000; Seroude et al., 2002; Landis et al., 2004; McElwee et al., 
2004; Park and Prolla, 2005; Girardot et al., 2006). Zou et al. compared gene expression 
profiles of old and oxidatively stressed flies, and found that 42 genes were co-regulated with 
age and oxidative stress, comprising 33% of all age-regulated genes and 18% of all oxidative 
stress regulated genes (Zou et al., 2000). These data strongly suggest that free radicals play a 
major role in regulating transcription in ageing. It must however be noted that in that particular 
study, 60% of age-related genes were not altered in response to oxidative stress, implying that 
free radicals are not the only causal factor in ageing.
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The second hypothesis of the free radical theory of ageing is that lowering the rate of oxidative 
damage should increase longevity. This can be tested either by assessing the effect of 
antioxidants in the diet on lifespan, or by genetic interventions which raise antioxidant levels 
or reduce ROS levels. A recent study in which a meta-analysis was performed of dietary 
antioxidant supplement studies in humans found that although almost half of the studies 
showed no correlation, there was an overall significant effect of antioxidant ingestion resulting 
in lower DNA damage measured in white blood cells and urine (Moller and Loft, 2006). 
Antioxidant administration has also been shown to reverse mtDNA damage and GSH 
oxidation rates in mice (de la Asuncion et al., 1996; Lenton et al., 2000; Alvarado et al., 2006), 
as well as in C. elegans (Sampayo et al., 2003). Feeding Drosophila with antioxidant 
chemicals has been shown to increase lifespan in some cases (Brack et al., 1997; Bonilla et al., 
2002; Kang et al., 2002), although there are criticisms of these regarding the strains used in 
some studies, and comparability of nutritional regimes (Sohal et al., 2002). The lifespan- 
extending properties of SOD mimetics have been controversial. Melov et al. reported that 
treatment with synthetic SOD compounds significantly extended lifespan in C. elegans, 
although subsequent studies have failed to replicate these data (Melov et al., 2000; Keaney et 
al., 2004) A recent study resolved some of the issues by feeding SOD mimetics to 
Drosophila, and found that the antioxidants had life-shortening effects on wild type flies and 
did not increase resistance to oxidative stress, although when SOD null mutants were fed the 
supplements, their extreme sensitivity to oxidative stress and their shortened lifespan were 
significantly improved (Magwere et al., 2006b). The effects of antioxidant supplementation 
remain controversial, and to date, no single antioxidant has produced lifespan extension in a 
range of long-lived strains from multiple species (Magwere et al., 2006b), although there have 
been many studies where antioxidant supplements do result in an extension of lifespan.
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To remove the problems associated with feeding of antioxidants, including control of 
ingestion rate, a more widespread technique of raising antioxidant levels is the use of genetic 
interventions which raise endogenous antioxidant levels. Transgenic overexpression of 
antioxidant genes, for example SOD, has resulted in increased lifespan in mice (Harman,
2006) and flies, although the effect was only credible in flies when the genes were over­
expressed in neural tissues (Parkes et al., 1998; Morrow et al., 2004), or ectopically (Orr et al.,
2003), as discussed in detail in section 1.3.4.1, and Table 1.2. Overexpression of genes which 
reduce the level of oxidative stress have also resulted in an extension of lifespan in flies 
(Fridell et al., 2005), while mutations which compromise antioxidant gene function show 
reduced lifespans (Phillips et al., 1989).
The third prediction of the free radical theory, that there is a decrease in oxidative stress in 
interventions which increase longevity, is also supported by evidence from the literature. A 
strong correlation between increased oxidative stress resistance and longevity has been 
established in diverse organisms including C. elegans, Drosophila, and mammals (Lin et al., 
1998; Finkel and Holbrook, 2000; Feng et al., 2001; Sohal et al., 2002; Holzenberger et al., 
2003; Wang et al., 2004; Bauer et al., 2005; Berry et al., 2006). The early discovery of lifespan 
extension when genes such as daf-2 and methuselah are mutant (in C. elegans and Drosophila 
respectively) provided support for the theory because correlations between oxidative stress 
resistance and lifespan extension were noted in the mutants (Kenyon et al., 1993; Lin et al., 
1998; Pennisi, 1998), and since then the correlation has continued to be observed.
The manner in which the free radical theory can be used to encompass or explain many 
existing ageing theories lends additional support. The mitochondrial theory of ageing proposes 
that oxidative damage to mitochondria can lead to an escalating effect where damaged 
mitochondria release more ROS, thereby compounding rates of oxidative damage, and 
eventually leading to defective mitochondria in a positive feedback mechanism (Harman,
1972; Van Remmen and Richardson, 2001). Mitochondria are particularly vulnerable to 
oxidative damage because of the constant production of superoxide as electrons escaping the 
electron transport chain combine with oxygen (Van Remmen et al., 2004). Damaged 
mitochondria exhibit reduced energy production, leading to compromised cell function (Van 
Remmen and Richardson, 2001; Sohal et al., 2002), and eventually a decline in organismal 
physiological function. Mitochondrial DNA is particularly susceptible to oxidative damage 
because ROS formed by aerobic respiration are in close proximity to mitochondrial DNA 
(mtDNA), and mtDNA is not protected by histones, leaving it sensitive to attack by oxidants 
(Cadendas and Davies, 2002). Membrane lipid peroxidation and protein degradation also leads 
to a loss of function, and possible increased ROS production (Van Remmen and Richardson, 
2001).
The ‘error catastrophe’ theory which proposed that ageing is caused by translational errors that 
give rise to defective proteins, including proofreading enzymes involved in checking the 
integrity of proteins, thereby leading to an accumulation of defective proteins (Kirkwood, 
1977), has recently been revisited by relating it to the mitochondrial theory of ageing (Wei et 
al., 2001). This revised error catastrophe theory feeds into the free radical theory of ageing 
which also proposes that the increased production of ROS and the result of subsequent cellular 
damage is a cause of ageing.
The rate of living theory is based on the inverse relationship between metabolic rate and 
lifespan in poikilotherms, including Drosophila (Pearl, 1928; Lints, 1989; Masoro, 1993). A 
recent study measuring the metabolic rate of Drosophila with age detracts from the original 
rate of living theory because in the study oxygen consumption did not correlate with lifespan 
(Hulbert et al., 2004). The initial claim of the rate of living theory that a temperature-induced 
increased metabolic rate would reduce the lifespan of poikilothermic animals is, however,
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supported by evidence that an increased metabolic rate results in greater production of ROS, 
which could cause cellular damage and reduced longevity (Lints, 1989; Sohal et al., 2002). 
Evolutionary theories of ageing state that a reduction in the force of natural selection acting on 
older individuals causes ageing by allowing each generation to inherit mutations which have 
deleterious effects in old age (Kirkwood, 1977; Rose, 1999; Kirkwood and Austad, 2000;
Rose and Long, 2002). This ties in with the free radical theory of ageing because ROS levels 
increase with age, as does oxidative damage of DNA, both of which are a likely cause of the 
mutations which accumulate in older individuals (Orr and Sohal, 1994; Sohal, 2002; Sun et al., 
2002; Landis and Tower, 2005).
Caloric restriction (CR), or more specifically, dietary restriction (DR) is the only intervention 
to date that causes lifespan extension in all model systems tested (Masoro, 2005), including 
yeast (Lin et al., 2000), worms (Hosono et al., 1989), flies (Clancy et al., 2002; Pletcher et al.,
2002) and rodents (Kubo et al., 1984; Masoro, 2005). Furthermore, according to preliminary 
data, DR has positive effects on primate longevity (Mattison et al., 2003) . Drosophila is a 
complicated case because limiting amino acids, and not calories, extends lifespan (Mair et al., 
2005; Min and Tatar, 2006). DR is thought to increase the lifespan of animals by reducing the 
metabolic rate (Sohal and Weindruch, 1996). DR is associated with decreased rates of 
mitochondrial H2 O2 and superoxide production, and lower amounts of oxidative damage 
(Sohal and Weindruch, 1996; Gredilla and Barja, 2005), while antioxidants such as GSH are 
upregulated (Cho et al., 2003). DR also has the effect of reducing fertility, therefore it may 
represent a response which evolved to allow animals to survive periods of food scarcity by 
shutting down reproduction and diverting all energy to survival of the animal (Droge, 2005; 
Gredilla and Barja, 2005; Min and Tatar, 2006). The effects of caloric restriction can be 
interpreted in terms of the free radical theory because of the observed increased antioxidant 
defences, or reduced free radical production rates during dietary restriction regimes (Harman,
1981; Sohal and Weindruch, 1996; Van Remmen and Richardson, 2001; Droge, 2005; 
Harman, 2006; Sanz et al., 2006).
1.2.2 Criticisms of the Free Radicai Theory of Ageing
Despite their potential for causing cellular damage, ROS are important biological molecules, 
and are thought to play a role in gene regulation by interacting with gene regulatory elements 
and transcription factors, or by mediating developmental processes controlled by incremental 
increases in cellular oxidation (Allen, 1993; Linnane and Eastwood, 2006). Under 
physiological conditions ROS are specific signalling molecules, and at low levels are essential 
to maintaining homeostasis (Finkel and Holbrook, 2000), acting as molecular messengers, 
directly regulating the transcription of certain genes, e.g. NF-k-B, oxyR, and the collagen gene 
(Allen, 1993).
Although co-expression and altered spatial/temporal expression of SOD has resulted in 
lifespan extension (Orr and Sohal, 1994; Parkes et al., 1998), not all studies where 
antioxidants are overexpressed achieve increased longevity, as discussed further in section 
1.3.4.1. An example is the simultaneous overexpression of MnSOD and catalase in the 
mitochondria of Drosophila, which significantly reduced lifespan, although the antioxidant 
overexpression resulted in reduced H2 O2 production and increased oxidative stress resistance 
(Bayne et al., 2005). The simultaneous overexpression of both subunits of GCL in a 
ubiquitous pattern and at high level has also recently been shown to be lethal in Drosophila 
(Orr et al., 1995; Kotecki et al., manuscript in preparation). The deleterious effects resulting 
from the overexpression of certain antioxidants may be explained by the theory that a baseline 
level of ROS is necessary for cellular signalling, and if ROS are reduced below that level by 
overexpression of antioxidants the reduced rate of ageing benefits from removing ROS are 
outweighed by the detrimental effects of interfering with cell signalling.
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Another criticism of the free radical theory of ageing is that lifespan extension by 
overexpression of an antioxidant gene has not been seen in mammals (Dugan and Quick, 
2005). A recent paper reported on the overexpression of catalase in mice causing lifespan 
extension. Unfortunately the effect was reduced in later generations, and is possibly a result of 
founder line genes (Schriner et al., 2005). This lack of effect in mice may be because complex 
redox regulation of cell signalling is adversely affected in transgenic lines. It is important to 
note at this stage that all lifespan extension studies performed on laboratory animals are 
conducted in an unstressed pathogen-free environment. This lack of stress is not natural, and 
may minimise the effect that overexpression of antioxidant genes has on survival.
1.2.3 Summary of the Free Radical Theory
On balance of all the evidence presented in the preceding section, it seems that the free radical 
theory of ageing is important, but may have more relevance in organisms living under 
conditions of oxidative stress, as would be encountered in non-laboratory natural habitats. 
Under stressful conditions, the production of ROS increases, and the improvement of 
antioxidant systems would be beneficial for the rapid removal of the toxic species. Under 
normal physiological conditions or laboratory conditions where ROS production rates are 
relatively slow, however, the increase in antioxidants may not have any additional effect on 
ROS removal. It may also be detrimental to increase the levels of antioxidants far in excess of 
their physiological concentrations, as ROS are required in the cellular processes. Artificially 
decreasing the levels of ROS could even shorten lifespan by interfering with signal 
transduction pathways, or gene regulation, thereby masking any beneficial effects on the rate 
of ageing. The implications for this study are that it is likely that an increase in GS expression 
would probably only be noticeable under conditions of raised oxidative stress.
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1.3 Genes implicated in altering lifespan
Extensive research has been carried out on the molecular mechanisms of ageing, as well as the 
role of genetics in ageing. The heritability of lifespan is estimated to be in the range of 10-30% 
(Wilson et al., 2006), with natural variation, spontaneous mutations and environmental factors 
also playing a role in lifespan. Microarray studies have revealed that genes implicated in 
lifespan are diverse, with influences on processes including insulin metabolism, 
developmental regulation, behavioural timing, chromosomal packaging, reproduction, signal 
transmission and antioxidant processes (Zou et al., 2000; Seroude et al., 2002; McCarroll et 
al., 2004; Melov and Hubbard, 2004; Park and Prolla, 2005; Girardot et al., 2006). The main 
prediction of the oxidative stress theory of ageing is that ageing cannot be slowed without the 
corresponding reduction of oxidative stress, and one mechanism to achieve this is to increase 
the cellular antioxidant concentration. The focus of this review will be on genes that have a 
link to altering oxidative stress and longevity, with a particular emphasis on Drosophila.
1.3.1 D. melanogaster as a model system for research into ageing
There have been a wide range of genes described in the literature which can affect lifespan in 
a variety of model organisms. Each of these organisms has specific advantages and 
disadvantages as experimental models. Possibly the most successful models in oxidative stress 
and ageing research are the invertebrates Drosophila melanogaster and Caenorhabditis 
elegans (Hemdon et al., 2002; Kirkwood and Finch, 2002; Barger et al., 2003; Masoro, 2005), 
followed by rodents, and the yeast Saccharomyces cerevisiae (Guarente and Kenyon, 2000). 
Drosophila is a very useful model organism to use in the study of ageing, with an extensive 
array of molecular tools available for genetic manipulation, as well as a long research history. 
The 180Mb genome was sequenced in 2000 (Adams et al., 2000) and encodes approximately 
13600 genes. The annotated sequence greatly facilitates in-depth genetic analyses (Bernards
53
and Hariharan, 2001; Adams and Sekelsky, 2002; Misra et al., 2002; Drysdale and Crosby, 
2005), and has been subject to several revisions since the first release in 2000. Over 70% of 
genes implicated in human disease were found to have orthologues in Drosophila, making it a 
useful tool for studying the molecular and genetic basis of human diseases (Reiter et al.,
2001).
Drosophila has also been useful in ageing studies because of their relatively short lifespan of 
~80 days, their ease of culture, and the availability of stocks with a wide range of genetic 
mutations (Helfand and Rogina, 2003b). When undertaking lifespan experiments, the large 
numbers of genetically homogeneous populations that can be produced are useful for 
statistical analyses. The rate of living theory originated from experiments on the effect of 
temperature on longevity in flies, and most theories since have been tested in Drosophila. 
Drosophila is useful specifically in ageing studies as most cells in the organism, except in the 
gonads and parts of the gastro-intestinal tract, are post-mitotic, and therefore senescent 
changes are not diluted by successive cell divisions (Helfand and Rogina, 2003b; Rebrin et al.,
2004).
One of the major drawbacks of using Drosophila in ageing research is the variation in lifespan 
between different strains. The genetic background of the strains used for transgenic 
experiments has been shown to influence the results of overexpression studies, as discussed 
later in this chapter. Drosophila laboratory strains may have assumed short lifespans by 
adaptation to laboratory culture conditions over many decades: this lifespan reduction may be 
a result of selecting for high fecundity, as well as the lack of selection to remove mutations 
that have deleterious effects past an age of 7 days (Sgro and Partridge, 1999; Spencer et al.,
2003). Genes being tested for beneficial effects on longevity may therefore only be restoring 
longevity in laboratory strains to the original time period (Spencer et al., 2003).
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1.3.2 Genetic techniques to study ageing in Drosophila
In order to discuss the genes implicated in lifespan extension through oxidative stress 
resistance in Drosophila, it is necessary to have an understanding of the genetic techniques 
employed in the experiments, and the merits of each technique. To test a proposed mechanism 
of ageing, transgenic animals can be used to alter the genotype of an organism and then test 
the resultant effect on ageing (Tower, 2000). Because ageing phenotypes are difficult to study 
in small organisms such as Drosophila, lifespan is used as a measurement of the rate of 
ageing. Using a decrease in lifespan is not as informative as an increase in lifespan, because 
genetic changes that cause decreased longevity could be doing so through a wide range of 
mechanisms, including new pathologies which do not normally have an influence on lifespan 
(Tower, 2000). Mutations that increase lifespan, however, are more likely to do so via a 
mechanism that is directly involved in ageing. Maximum lifespan as a measure of ‘ageing’ in 
Drosophila has been shown to correlate with decline in physical and mental abilities 
associated with ageing in a recent study where a long-lived mutant also showed decreased 
rates of locomotor, geotaxis and learning decline (Simon et al., 2006). For this reason, this 
review focuses on studies which have identified genes that cause an increase in lifespan.
There are a variety of techniques available to create mutants, thus enabling research into 
ageing in Drosophila. These include more traditional genetic approaches, as well as new 
molecular techniques such as RNAi, as summarised in the following sections.
1.3.2.1 P-elements
P-elements are transposable elements with inverted terminal repeats, as illustrated in the 
general P-element structure in Figure 1.8. The elements are present in the Drosophila 
melanogaster genome and have a variety of functions in genetic manipulations of the fly, 
including identifying genes of interest, mutating genes, and inserting specific genes back into
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the fly genome. P-elements are manipulated in M cytotype strains which lack functional P- 
elements. Many laboratory strains are M cytotype due to the fact that the rapid spread of P- 
elements in natural Drosophila populations occurred after most Drosophila strains were 
collected (Spencer et al., 2003).
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Figure 1.8: Structure of a complete P-element (Engels, 1996). The terminal repeats are indicated by 
arrows on either end of the structure. In the case of non-autonomous P-elements which lack their own 
transposase, a region between exon 1 and 3 is deleted.
Engineered P-elements that lack their own source of transposase are commonly used in 
genetic experiments (Ryder and Russell, 2003; Castro and Carareto, 2004) since their 
transposition is dependent on an external source of transposase.
When P-elements are mobilised, they often cause mutations due to insertions into genes, or as 
a result of imprecise excision causing deletions of the surrounding sequence. P element 
mobilisation occurs throughout germline development, mostly pre-meiotically, allowing the 
recovery of the mutations in the next generation (Engels, 1996).
1.3.2.2 Transgenes with native or heterologous promoters
In this system, the entire gene including 5' and 3' regulatory elements is cloned into a P- 
element transformation vector to produce transgenic lines. The theoretical advantage of this 
system is that normal regulation of expression of the gene is maintained, but the approach has
56
been problematic (Seto et al., 1990; Orr and Sohal, 1992; Orr W. C. and Sohal R. S., 1993; 
Mockett et al., 1999b), and it has recently been found that lifespan extensions are more 
successful when antioxidant genes are expressed using heterologous promoters (Parkes et al., 
1998; Orr et al., 2003; Orr and Sohal, 2003; Orr et al., 2005). Using a heterologous promoter, 
transgene expression can be expressed at varying amounts and in a variety of different tissues 
at different lifestages. An example of a commonly used heterologous promoter is the Actin5C 
promoter, used for high level ubiquitous and constitutive gene expression.
1.3.2.3 The GAL4/UAS system
This system is a binary system, where the promoter activity is dependent on the presence of an 
activator molecule (GAL4) binding an upstream activating sequence (UAS) (Brand and 
Perrimon, 1993). The pUAST vector is one of the more commonly used plasmids for cloning a 
gene of interest in the GAL4/UAS system (Hammond, 2003), and is constructed to include a 
Drosophila promoter linked to UAS enhancer repeats. The responder strain carrying a single 
P-element with a transgene under UAS transcriptional control is crossed to a strain bearing a 
driver P-element expressing GAL4. Progeny that contain both elements will express the 
transgene in those cells expressing GAL4, as illustrated in Figure 1.9 (Osterwalder et al.,
2001). The spatiotemporal pattern of transgene expression is dictated by the expression pattern 
of the GAL4 driver (Duffy, 2002). The advantage of this system is that with the wide range of 
GAL4 drivers available, the expression of the gene of interest can be studied in many tissue 
types, and toxic effects in other tissues can be avoided. It is important to note that the presence 
of GAL4 does not have any deleterious effects in Drosophila (Duffy, 2002).
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Figure 1.9: The GAL4/UAS system. The enhancer trap consisting of a P-element with a weak promoter 
driving Gal4 expression is present in the driver line. The UAS construct containing a promoter containing 
the UAS which drives expression of the gene of interest is present in the second parental stock. GAL4 is 
expressed and can bind to the UAS sequence in the progeny of the two lines, allowing tissue-specific 
expression of the gene of interest.
1.3.2.4 RU486 inducible GAL4
A tighter control of transgene expression may be achieved by using a GAL4-progesterone- 
receptor fusion protein (GeneSwitch) which is activated by RU486, a mammalian 
antiprogestin also known as mifepristone (Osterwalder et al., 2001; Roman et al., 2001). The 
GeneSwitch fusion protein is only able to bind to the UAS sequence of the responder line in 
the presence of the RU486 molecule, allowing the study of genes in adult systems which 
would be lethal if  overexpressed during development. RU486 is easily administered to adult 
flies or larvae by adding the chemical to regular fly food, allowing easy control of the onset of 
gene expression. No adverse effects on fly lifespan or physiology have been reported for the 
RU486 (Roman et al., 2001; Poirier and Seroude, 2005). This system, illustrated in Figure 
1.10, is favoured because the genetic background of the control flies is identical to the treated 
flies (which differ by the administration of RU486), and the system uses the large collection of 
UAS fly lines from the GAL4/UAS system, which are already characterised.
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Figure 1.10: The GeneSwitch/UAS expression system in Drosophila. Flies expressing the tissue-specific 
transcriptional activator GeneSwitch are crossed to UAS reporter lines. The progeny express the 
GeneSwitch protein which is unable to bind to the UAS elements in the absence of RU486. In the presence 
of RU486, the GeneSwitch protein binds to the UAS sequence, allowing expression of the gene of interest 
(modified from Osterwalder et al, 2001).
1.3.2.5 FLP-out
One of the earlier inducible expression systems is the FLP/FRT binary system, which consists 
of one element expressing the yeast FLP recombinase under the control of the hsp70 promoter 
and a target element in which a stop codon upstream of the transgene ORF is flanked by FLP 
target sequences (FRTs) (Sun and Tower, 1999; Sun et al., 2002). Expression of FLP 
recombinase then excises the stop codon between the FRT sequences, resulting in the fusion 
of the promoter and the transgene, driving expression, as illustrated in Figure 1.11.
Although this system has the advantage of removing genetic background differences from 
control lines, the problem with using this system in ageing studies is the requirement of the 
heat shock, since the heat shock itself can activate a host of stress response genes, possibly 
confounding the phenotype obtained from overexpression of the target gene (Sun and Tower, 
1999; Sun et al., 2002).
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Figure 1.11 : The FLP-out system. The FLP construct consisting of yeast FLP recombinase controlled by 
the heat-inducible hsp70 is present in one of the parental stocks. The reporter construct is present in the 
second parental stock. The reporter construct contains the actin5c promoter which could constitutively 
drive expression of the gene of interest downstream of actin5c, but is interrupted by a transcriptional stop 
sequence flanked by FRTs. Upon heat shock induced expression of FLP, the FRT flanked stop sequence is 
excised, and the gene of interest is constitutively expressed.
1.3.2.6 RNA interference (RNAi)
RNAi is a new technique available to interfere with normal gene expression in both cell 
culture systems as well as in whole organisms (Clemens et al., 2000; Hammond, 2003; Lee 
and Carthew, 2003; Lum et al., 2003; Yang et al., 2005c). The cellular RNAi machinery can 
be triggered by experimentally introduced double stranded RNAs (dsRNAs). RNAi is a 
reverse genetic technique that degrades endogenous mRNA using specific dsRNAs. RNAi is 
an efficient approach to loss-of-function phenotype analyses (Boutros et al., 2004; Sledz and 
Williams, 2005).
RNAi is a two step process: first, an exogenous dsRNA corresponding to the target mRNA is 
processed by the recipient cell into 21-23bp fragments known as short interfering RNA 
(siRNA); this is done by the Dicer protein which functions in a similar manner to RNase III 
(Hannon, 2002; Amarzguioui et al., 2005). In the second step, siRNAs are incorporated into 
the RISC (RNA-induced silencing complex) which results in the sequence-specific
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degradation of mRNA molecules from the corresponding endogenous gene, as illustrated in 
Figure 1.12.
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Figure 1.12: Cartoon of the mechanism of RNA interference. Synthetic double stranded RNA is shown in 
black, and the endogenous single stranded mRNA of interest is shown in pink.
Dicer is a member of the ribonuclease III family which contains a RNA helicase domain, a 
domain of unknown function, a PAZ (PiwilArgonaute/Zwille) domain, two ribonuclease 
domains and a dsRNA binding domain (Hammond, 2005). Dicer acts on the dsRNA, cleaving 
it into 21-23nt small RNAs, and plays a role in delivering the siRNAs to the RISC complex 
(Kavi et al., 2005). Drosophila has two Dicers; dcr-1, which processes endogenously 
expressed microRNAs (miRNAs), and dcr-2, which is involved in siRNA production. The 
Dicer complex stabilises the siRNA before unwinding it, identifying the guide strand with the 
5TO 4 and degrading the passenger strand that does not enter the RISC complex (Hammond, 
2005; Kavi et al., 2005; Sledz and Williams, 2005).
The argonaute proteins (Ago) form part of the RISC complex, and have the characteristic PAZ 
and PIWI domains, which interact with Dicer and bind to the guide siRNA respectively
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(Hammond, 2005). In Drosophila there are 5 genes encoding argonaute proteins: piwi, 
aubergine, argonaute-1, argonaute-2, and argonaute-3 (Kavi et al., 2005). The RISC multi­
protein components assemble the active RISC complex, into which the single stranded guide 
siRNA is loaded (Kavi et al., 2005). The active siRNA/RISC complex locates mRNA targets 
by Watson-Crick base pairing, leading to cleavage of the mRNA target by the RNase H 
enzyme Sheer, whose activity is contained within Ago2 (Hammond, 2005; Sledz and 
Williams, 2005).
1.3.3 Genetic background problems in Drosophila
It is important to control for genetic variation and its effect on lifespan very thoroughly. In 
addition to spontaneous mutations that accumulate in all fly lines, genetic variation is also 
introduced through the ‘positional effect’ of the random P-element insertion. Some insertion 
sites are close to enhancers that could have significant effects on the levels of transgene 
expression (Tower, 2002). P-element insertions could also disrupt a random gene unrelated to 
the study, causing a wide range of unforeseen effects in the animal. The use of inducible 
transgene constructs such as GeneSwitch, has bypassed this position effect by ensuring that 
control and experimental lines carry the same P-element insertion, and differ only in RU486 
administration (Osterwalder et al., 2001).
It has recently been noted that there is a negative correlation between the control lifespan and 
the increase in lifespan of flies that overexpress a variety of antioxidant enzymes (Orr et al., 
2003), as illustrated in Figure 1.13. The reason for this phenomenon is thought to be due to 
lack of genetic robustness in the short lived flies which is rescued by the overexpression of 
antioxidant enzymes. Overexpression of the same antioxidants has been shown to have a much 
milder, or no effect, on longevity in wild type long lived strains which are genetically robust 
(Spencer et al., 2003). This highlights the importance of using a long lived control fly when 
determining a gene’s effect on longevity.
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Figure 1.13: A significant correlation between lifespan extension and control lifespan in Drosophila 
melanogaster was found using data obtained from published studies featuring overexpression of 
antioxidant enzymes in transgenic Drosophila up to 2003 [ (1) Sun and Tower, 1999; (2) Parkes et al.,1998; 
(3) Reveillaud et al., 1991; (4) Orr and Sohal 1994; (5) Seto et al., 1990; (6) Orr and Sohal, 1993; (7) Orr 
and Sohal, 1992; (8) Mockett et al., 1999 (MnSOD); (9) Mockett et al., 1999 (thioredoxin reductase)). The 
figure was obtained from Orr and Sohal (2003).
1.3.4 Genetic interventions which increase longevity in Drosophila
Interventions which have been shown to increase Drosophila lifespan are antioxidant 
overexpression, reduction in egg laying , reduction in temperature, and dietary restriction 
(Maynard Smith, 1962; Rose and Charlesworth, 1981; Mair et al., 2003). This review will 
concentrate on genetic interventions which cause an increase in longevity, specifically 
overexpression of antioxidant genes, since the free radical theory can be tested by determining 
whether normal lifespan may be extended by increasing antioxidant levels to a point where 
they minimise damage caused by ROS. Mutations which result in a decrease in lifespan do not 
necessarily point to genes involved in ageing; the lowered fitness could be a result of 
decreased fitness due to the disruption of any number of biological pathways.
1.3.4.1 Overexpression of antioxidant enzymes
The four main antioxidant enzymes in Drosophila are Cu/ZnSOD, MnSOD, catalase and 
thioredoxin reductase. The free radical theory of ageing predicts that a decrease in oxidative 
stress would inhibit the accumulation of oxidative damage, thus increasing the lifespan of the
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animal (Helfand and Rogina, 2003a; Orr and Sohal, 2003). Expectations of the free radical 
theory are that an addition of antioxidants to the diet would alter the balance of oxidants and 
antioxidants, which would lead to increased longevity. The addition of antioxidants to food is 
problematic as the amounts ingested cannot be quantified, and lethality at high doses may be 
due to starvation as the animals reject their food (Le Bourg, 2001).
Another proposed method to test the free radical theory of ageing would be to increase the 
activity of antioxidant enzymes and determine the effects on lifespan. The over-expression of 
antioxidant enzymes in vivo, including catalase, Cu/Zn SOD and MnSOD is discussed in 
detail below.
1.3.4.2 Overexpression of Cu/ZnSOD and MnSOD
Both Cu/Zn SOD, expressed in the cytosol and outer mitochondrial space, and MnSOD, 
expressed in the inner mitochondrial space reduce superoxide anion to hydrogen peroxide. A 
deficiency in SOD leads to increased oxidative stress (Orr and Sohal, 1993), and results in a 
reduced lifespan and oxidative stress sensitivity in SOD null adult flies (Phillips et al., 1989). 
The insertion of extra copies of Drosophila Cu/Zn SOD under native promoter control into the 
fly genome has no effect on lifespan (Seto et al., 1990; Orr and Sohal, 1993; Orr and Sohal, 
1994). These studies used a P-element mediated approach to introduce the coding sequence of 
Cu/Zn SOD into the genome, and it is possible that this method could have influenced results 
due to the ‘positional effect’, although multiple insertion lines were used to control for this 
effect (Orr and Sohal, 2003).
Sun and Tower used an inducible FLP-out binary system to overexpress Cu/ZnSOD under the
control of a constitutive promoter (Sun and Tower, 1999). This approach did not increase
lifespan significantly in most of the female lines, although male lines had an increase in
lifespan of up to 48%. The lifespan increase, however, was found to be dependent on genetic
background, with higher levels of enzyme overexpression needed to observe an increase in
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lifespan in long-lived strains compared to short-lived strains (Sun and Tower, 1999; Tower,
2002). Muscle tissue-specific overexpression of Drosophila Cu/Zn SOD had no effect on 
lifespan (Phillips et al., 2000).
The two most successful studies of Cu/Zn SOD overexpression in Drosophila have used 
transgenic expression of bovine or human SOD, and in both studies virtually isogenic strains 
could be compared (Reveillaud et al., 1991; Parkes et al., 1998). Overexpression of bovine 
Cu/ZnSOD resulted in a moderate lifespan increase of 10% (Reveillaud et al., 1991). The 
study using the GAL4-UAS binary system to overexpress human Cu/Zn SOD (hSOD) 
specifically in motomeurons showed increases in lifespan of up to 41%, although the controls 
were once again short-lived flies (Parkes et al., 1998; Phillips et al., 2000). Criticisms of this 
work that should be noted are firstly that the motomeuron ‘specific’ D42-GAL4 driver used 
also expresses GAL4 in salivary gland tissue in our laboratory (R. Saunders, pers. comm.). 
Secondly, the D42-GAL4 driver used has been shown to have an exceptionally long lifespan 
(C.Kotecki, pers. comm.), and these data were not included in the Parkes publication.
The overexpression of human SOD, using the same transgene construct as Parkes et al (1998), 
in wild caught long-lived flies showed that of ten lines tested, one showed extended lifespan in 
males, while 6  showed extended lifespan in females (Spencer et al., 2003). These results 
highlighted the importance of genetic background in lifespan experiments, and also pointed to 
an interesting sex-specific variation. On average, however, the increase in SOD expression in 
motomeurons increased lifespan in many genetic backgrounds, including long-lived flies 
(Spencer et al., 2003).
In addition to an effect on longevity, human or bovine Cu/Zn SOD overexpression resulted in 
increased oxidative stress resistance (Reveillaud et al., 1991; Parkes et al., 1998), although this 
trend was not seen when native Drosophila SOD was overexpressed (Seto et al., 1990; Orr 
and Sohal, 1993). An interesting trait noted by Orr and Sohal (1993) was that SOD
overexpression at moderate levels led to increased oxidative stress resistance; however, a 
severalfold increase in expression caused cells to became sensitised to paraquat induced 
oxidative stress, probably due to the enhanced rate of peroxide generation (Orr and Sohal,
1993). This is an important point to note when overexpressing specific antioxidants, as the 
raised level of one antioxidant may interfere with the delicate balance between antioxidant 
systems, for example, between SOD and catalase in this instance.
MnSOD over-expression under the control of a native promoter led to a 5% lower lifespan, 
and no increased resistance to stress (Mockett et al., 1999a), while the targeted overexpression 
of MnSOD in motor neurons extended lifespan by 30% (Phillips et al., 2000). The induced 
overexpression of MnSOD under the control of actin5C promoter in adult flies also extended 
lifespan by 16-33% (Sun et al., 2002).
It is possible that optimal levels of SOD are present in adult flies, and overexpressing native 
SOD has no effect in an already long-lived genetic background. Under conditions of oxidative 
stress, however, the optimal level of SOD is raised, and an increased level of antioxidant has a 
beneficial effect. In contrast to this, the results of overexpressing SOD using non-native 
promoters show that SOD does limit Drosophila lifespan. This may be caused by new 
expression patterns and significantly higher levels of the antioxidant in particularly vulnerable 
tissues, such as motomeurons. The positive results achieved with heterologous promoters may 
also be the result of detrimental effects of overexpression during development when using a 
native promoter (Sun et al., 2002).
On balance, it would seem that overexpression of SOD extends lifespan, however only when 
expressed in specific tissues.
1.3.4.3 Overexpression of catalase
Catalase mutants with a 50% reduction in catalase activity show no increased susceptibility to
hydrogen peroxide stress, although mutants with 5% of wild type catalase activity are sensitive
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to hydrogen peroxide stress (Mackay and Bewley, 1989). The over-expression of catalase 
under the control of a native promoter (Orr and Sohal, 1992), as well as a transgene under the 
control of an inducible actin5C promoter (Sun and Tower, 1999; Sun et al., 2002), had no 
effect on lifespan, although resistance to H2 O2 induced stress was slightly increased. 
Overexpression of catalase targeted ectopically to the mitochondria increased resistance to 
oxidative stress, however, the increased levels of mitochondrial catalase did not have any 
effect on Drosophila lifespan (Mockett et al., 2003). Similarly, catalase overexpressed in 
motomeurons had no effect on lifespan (Phillips et al., 2000). Overexpression of catalase in 
Drosophila therefore can increase resistance to oxidative stress, although there are no 
beneficial effects on ageing or lifespan. The work done on catalase in Drosophila to date 
suggests that there is a threshold level of catalase activity above which viability is not affected. 
It was recently suggested that ectopic overexpression of catalase in mouse mitochondria 
extended lifespan, however the results are not conclusive because the mice used in the study 
were not backcrossed, and later generations did not display the lifespan extension (Dugan and 
Quick, 2005; Schriner et al., 2005).
1.3.4.4 Combined SOD/catalase overexpression studies
The overexpression of Cu/Zn SOD in conjunction with catalase has been found to increase 
Drosophila lifespan, although only when overexpressed in particular tissues and under the 
control of non-native promoters (Orr and Sohal, 1994; Sun and Tower, 1999). The first study 
where native SOD and catalase were co-expressed found 8  transgenic lines which had an 
increased lifespan (14-34%), while 1 line had decreased lifespan, and another 6  lines remained 
unchanged (Orr and Sohal, 1994). Genetic background in this study was a problem as the 
mean lifespan of control flies was 55 days, approximately 2 0 % less than average lifespan, as 
illustrated by point 4 in Figure 1.13 (Orr and Sohal, 1994). In the study by Sun and Tower, the
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FLP expression system used was later found to be leaky, confounding results obtained for 
control flies (Sohal et al., 2002).
In order to clarify the effects of antioxidant co-expression on lifespan in a long-lived genetic 
background, different combinations of transgenic antioxidants with normal spatial and 
temporal expression were simultaneously overexpressed, including Cu/Zn SOD and catalase; 
and Cu/Zn SOD, MnSOD, catalase (Orr et al., 2003). Overexpression of any of the 
combinations of these and other homologously expressed antioxidant enzymes had no effect 
on longevity in relatively long-lived genetic backgrounds. Further studies revealed that 
MnSOD overexpressed with Cu/ZnSOD had moderately additive effects (Sun et al., 2004), 
and confirmed that the overexpression of catalase along with Cu/ZnSOD (Orr and Sohal,
1994) or MnSOD (Sun et al., 2002) had no additional beneficial effect on lifespan extension. 
In fact, when catalase was simultaneously overexpressed with Cu/ZnSOD in motomeurons, 
the life extending effect of Cu/ZnSOD overexpression was abrogated (Parkes et al., 1998). 
Further, although the co-expression of MnSOD and catalase in mitochondria showed an 
increased resistance to oxidative stress, the simultaneous overexpression of MnSOD and 
catalase caused a significant reduction in lifespan via an unknown mechanism (Bayne et al., 
2005).
These studies on the effect of antioxidant enzyme overexpression suggest that increasing the 
levels of antioxidants is only beneficial when a new antioxidant is introduced into a region of 
the cell or organism where it is not normally expressed, rather than increasing the activity of 
an enzyme that is normally present (Mockett et al., 2003). Moreover, it is likely that ROS can 
be removed to a baseline level with beneficial effects as a result of reduced oxidative damage, 
however the further reduction of ROS then has detrimental effects on lifespan due to 
dismption of the important cell signalling role of ROS (Bayne et al., 2005).
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1.3.4.5 Other genetic interventions that increase Drosophila lifespan
In the previous two decades ageing research was shaped by the discovery of long-lived 
mutants of C. elegans (Friedman and Johnson, 1988; Kenyon et al., 1993; Yanase et al., 2002) 
and Drosophila (Lin et al., 1998; Rogina et al., 2000; Clancy et al., 2001). These early studies 
pose problems in the search for the underlying mechanism of ageing because of the multitude 
of trade-offs for the increased longevity, including sterility and dwarfism (Sohal et al., 2002; 
Spencer et al., 2003; Mockett and Sohal, 2006). The control lifespans were also short, and the 
lifespan extension reported for the Drosophila mutant Chico, for example, was significantly 
reduced in strains with a genetic background conferring increased longevity (Spencer et al.,
2003). The search for a single gene that could control the rate of ageing has since been 
replaced by the understanding that ageing is a multi-gene phenomenon that is influenced by 
environmental factors. In addition to oxidative stress, a major focus in ageing research is the 
insulin signalling pathway. Down-regulation of this pathway has been shown to extend the 
lifespan in worms, flies and mice, although there is usually a reduction in fertility, and an 
associated dwarf phenotype (Liang et al., 2003; Tatar et al., 2003; Holzenberger et al., 2004; 
Baumeister et al., 2006). Another problem with pursuing this pathway is that in humans a 
decrease in insulin signalling is associated with diabetes, which is linked to pathologies which 
decrease lifespan (Rincon et al., 2004). A summary of the genes involved in the insulin 
signalling pathway, along with other genetic interventions which could not be discussed due to 
the constraints of this review, are presented in Table 1.2.
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Table 1.2: Review of genetic interventions which have increased lifespan in Drosophila melanogaster, 
excluding the antioxidant gene overexpression discussed in the previous section.__________________
Gene_______Function____________ Intervention Effect on lifespan______ Reference
methuselah
(met)
Transmembrane 
protein involved in 
stress response 
pathway.
P-element 
insertional 
disruption of 
gene
Up to 35% increase in 
lifespan. This large 
extension in lifespan 
has since been refuted, 
and the effect shown to 
be temperature 
sensitive (Mockett and 
Sohal, 2006).
(Lin et al., 
1998)
chico Insulin receptor 
substrate
Heterozygous 
or homozygous 
null mutations
48% mean lifespan 
extension in 
homozygous females, 
13% in heterozygous 
males, but homozygous 
male lifespans were 
reduced.- Sterility in 
mutants. Short-lived 
controls.
(Clancy et 
al., 2 0 0 1 )
Indy Exchanger of 
dicarboxylic and 
tricarboxylic Krebs 
cycle intermediates.
Heterozygous 
null mutation
50% increase in 
maximum lifespan. 
Recently refuted, with 
only 15% increase in 
long lived background 
(Spencer et al., 2003)
(Rogina et 
al., 2 0 0 0 )
Drosophila
Insulin
Like
Peptides
(Dilp)
Signalling molecule 
in the insulin 
signalling pathway.
Ablation of 
neurosecretory 
cells where 
DILPs are 
produced
Reduction in insulin 
signalling results in up 
to 35% increase in 
maximum lifespan. 
Short-lived controls.
(Broughton 
et al., 2005)
InR Insulin Receptor 
homologous to C. 
elegans daf-2
Hypomorphic
mutants
Up to 85% increase in 
lifespan, but with 
reduced fertility and 
dwarf phenotype. 
Short-lived controls.
(Tatar et al., 
2 0 0 1 )
dFOXO Forkhead
transcription factor, 
negatively regulated 
by the insulin 
signalling pathway.
Overexpression 
in adult fat 
body
70
20-50% increase in 
median lifespan, and 
19% increase in 
maximum lifespan. 
Reduction in fecundity.
(Giannakou 
et al., 2004; 
Hwangbo et 
al., 2004)
Gene Function Intervention Effect on lifespan Reference
dSir2
Rpd3
puckered
(puc)
dPOSH
hep
Gclc
Gclm
MsrA
Histone deacetylase, 
involved in gene 
silencing, particulary 
in the insulin 
signalling pathway.
Histone deacetylase
JNK-specific 
phosphatase that 
downregulates the 
JNK pathway.
Unknown function, 
involved in JNK 
signalling.
JNK kinase causing 
activation of JNK 
(JNK is involved in 
the stress signalling 
pathway. JNK is a 
kinase that 
phosphorylates a 
variety of
transcription factors).
Catalytic subunit of 
GCL, the rate limiting 
enzyme in glutathione 
biosynthesis.
Modifier subunit of 
GCL, the rate limiting 
enzyme in glutathione 
biosynthesis.
Methionine sulfoxide 
reductase A is 
involved in repair of 
damaged proteins by 
reducing methionine 
sulfoxide to 
methionine.
Ubiquitous and Up to 57% increase in
neuronal median lifespan and
overexpression 25% increase in
maximal lifespan.
Heterozygous Up to 50% increase in 
loss of function median lifespan, 
mutants
Heterozygous Significant increases in
loss of function mean and maximal 
mutants lifespan.
Overexpression 14% increase in mean 
in neurons lifespan.
Overexpression 50% increase in mean 
in neurons lifespan, 25% increase
in maximum lifespan.
Overexpression Up to 50% increase in
in neurons mean and maximum
lifespan.
Ubiquitous 24% increase in mean
overexpression lifespan.
Overexpression Up to 70% increase in 
in neurons median lifespan.
(Rogina and
Helfand,
2004)
(Rogina et 
al., 2 0 0 2 )
(Wang et 
al., 2005)
(Seong et 
a l, 2 0 0 1 )
(Wang et 
a l, 2003)
(Orr et a l, 
2005)
(Orr et a l,
2005)
(Ruan et a l, 
2002)
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Gene Function Intervention Effect on lifespan Reference
heat shock 
proteins 
0 hsp)
Removal of damaged 
proteins usually 
caused by heat or 
oxidative stress.
Overexpression 
of hsp2 2  in 
motomeurons
Overexpression 
of hsp26, hsp27 
and hsp6 8  
using
hsGAL4/UAS
constmct
30% increase in mean 
lifespan.
30% increase in mean 
lifespan.
(Morrow et 
al., 2004)
(Wang et 
a l, 2004)
Dm£>53 Transcription factor 
regulating cell cycle, 
with tumor suppressor 
function.
Dominant 
negative 
expression in 
adult neurons
Maximum lifespan 
increased by 15%.
(Lee et a l, 
2003)
uncoupling
proteins
(UCP)
Mitochondrial carrier 
proteins which cause 
uncoupling of the 
mitochondrial 
electron transport 
chain.
Overexpression 
in neurons
Up to 28% increase in 
median lifespan.
(Fridell et 
al, 2005)
Ecdysone
receptor
Steroid hormone Knockout
mutation
Up to 40% increase in 
median lifespan.
(Simon et 
al, 2003)
1.3.4.6 Is antioxidant overexpression beneficial?
While the overexpression of a single, cytosolic antioxidant under the control of a native 
promoter has not yet been shown to increase lifespan, co-expression of antioxidants and 
altered spatial/temporal expression has yielded lifespan extension (Orr and Sohal, 1994;
Parkes et al., 1998). Motomeurons have been implicated as a vital tissue for lifespan extension 
in Drosophila (Parkes et al., 1998; Ruan et al., 2002; Morrow et al., 2004; Bauer et al., 2005), 
with the implication that motomeurons are particularly sensitive to oxidative stress and 
ageing.
A large proportion of the antioxidant overexpression studies published to date have involved 
SOD, and it has been suggested that the mixed results obtained are due to optimal levels of
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SOD present already in wild type flies (Mockett et al., 1999a; Magwere et al., 2006b), and 
raising the levels of SOD would have no further effect on lifespan. On the other hand, 
beneficial effects are observed when flies overexpressing antioxidants are exposed to 
oxidative stress (Orr and Sohal, 1994; Parkes et al., 1998). This limits the potential of raised 
antioxidant levels to increase lifespan, although in an environment of high stress organisms 
may benefit from the raised antioxidant levels. A recent example is the overexpression of 
hsp70 preserving muscle function in old mice without increasing lifespan (Broome et al.,
2006), which implies the extension of lifespan ‘quality’, without an increase in ‘quantity’ of 
life. This idea of increasing lifespan quality has recently been extended to Drosophila, where 
the lag before the mortality rate increases is an indication of increased quality of life measured 
by maintenance of body weight, physical activity and reproduction later into the flies lives 
(Ruan et al., 2002).
The final point to note is that a dramatic reduction in ROS as a result of overexpressing 
antioxidants at a high level could have detrimental effects by interfering with cell signalling. 
On balance, it would appear that a moderate increase in antioxidant levels in tissues where 
they are limited may have a beneficial effect on the quality of lifespan, even if  the actual 
maximum lifespan is not altered. This is interesting with respect to human health where we are 
constantly exposed to oxidative stress via diet and an increasingly polluted environment.
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1.4 Characterisation of GS
As described in section 1.1.3.1, glutathione (GSH) is synthesised in a two step process 
involving two separate enzymes. The first step, which in vertebrates is the rate limiting step, is 
the ligation of glutamate and cysteine, catalysed by y-glutamylcysteine synthetase (GCL) and 
the second step involves the addition of glycine to the dipeptide y-glutamyl-cysteine to form 
GSH.
GCL is feedback inhibited by GSH and is not saturated at normal levels of cysteine, therefore 
increased levels of cysteine can promote GSH synthesis under certain conditions.
GSH depletion has been associated with a range of human diseases including Parkinson’s 
disease, Alzheimer’s disease, liver damage, amyotrophic lateral sclerosis, cystic fibrosis and 
ageing (Anderson, 1998; Schulz et al., 2000; Townsend et al., 2003). There is substantial 
evidence for the importance of GSH and GSH-metabolising enzymes in vivo. Firstly, a 
decrease in cellular GSH through the use of chemical GSH depletors, e.g. buthionine-S- 
sulfoximine (BSO) or diethyl maleate (DEM), causes an increase in the number of 
intracellular ROS, and severe depletion of GSH causes widespread mitochondrial damage, 
and results in lethal organ damage in newborn animals (Meister, 1995; Armstrong and Jones, 
2002; Njalsson, 2005; Hong et al., 2006). Loss of glutathione is also thought to lead to 
apoptotic signalling events (Schulz et al., 2000; Shen et al., 2005), eventually causing cell 
death. Secondly, evidence for GSH importance is shown by defects in GSH metabolism. 
Humans with the rare condition of GCL deficiency, and the less rare deficiency in GS, have 
symptoms that include neurological defects and haemolysis, as discussed further in section 
1.4.5.
GSH levels decrease with age in many organisms, including fruit flies, mice, rats and humans 
(Sohal and Weindruch, 1996; Schulz et al., 2000). Ageing Drosophila exhibit an exponential 
decline in the GSHrGSSG ratio, which is regulated by the temperature at which the flies are
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grown, suggesting that the ratio and cellular redox state is a determinant of the physiological 
age of flies, and thus may be involved in determining the rate of ageing (Rebrin et al., 2004).
In ageing rat brains, GSH has been shown to decrease by up to 25%, with a corresponding 
decrease in the GSH/GSSG ratio (Zhu et al., 2006). There is also a significant pro-oxidising 
shift in the glutathione redox state in ageing mice, which is thought to be a result of increased 
mitochondrial ROS production (Rebrin et al., 2003). The mechanisms of age-related decline of 
GSH are not understood, but may be due to increased demand from higher levels of ROS, or 
from a decrease in de novo synthesis. In rats there is no age-related decline in GR activity, 
while there is a decrease in GCL and GS with age, suggesting that the decrease in GSH is only 
due to a decrease in de novo GSH synthesis (Liu et al., 2004). A recent study of rat brains 
contradicts the GS findings, and reported no change in GS activity with age, although there 
was a drop in GCL activity (Zhu et al., 2006). This discrepancy in results deserves further 
study.
GS is moderately conserved between different organisms, however a small number of cysteine 
residues that form polar interactions with ATP, Mg2+ and GSH are highly conserved between 
all eukaryotic GS sequences (Polekhina et al., 1999; Rogina et al., 2000), and will be 
discussed further in Chapter 5. Because of the role of GSH in cellular metabolism, and the 
potential role in decreasing oxidative stress, the enzymes involved in its synthesis have been 
the subject of many studies, albeit with the focus on GCL. GS has received less attention in 
the literature because it is widely accepted that GCL catalyses the rate limiting step in GSH 
synthesis. A recent study has shown the importance of GS over-expression in achieving high 
levels of GSH production in E. coli, and GS is also vital to human life (Njalsson and Norgren, 
2005; Liao et al., 2006).
In most eukaryotic organisms GS is a 104-112 kDa homodimer consisting of two identical 52- 
56 kDa subunits. Despite the lack of sequence homology and different molecular masses of
GS in different eukaryotic and prokaryotic species, they all share a common three dimensional 
fold and are members of the ATP grasp family (Polekhina et al., 1999). GS has been 
characterised in a variety of animal models, including yeast, Plasmodium, rodents and 
primates, reviewed below, but there have not been any studies on GS in Drosophila thus far.
1.4.1 E. coli
The E. coli GS enzyme is a tetramer of four identical 306-residue subunits (Gushima et al., 
1983; Gushima et al., 1984). GS deficient is. coli are sensitive to diamide, which creates 
oxidative stress by oxidising GSH (Carmel-Harel and Storz, 2000). Elevated expression of GS 
in E. coli did not significantly increase GSH content (Gushima et al., 1983; Liao et al., 2006).
1.4.2 Yeast
S. cerevisiae GS exists as a dimer of 492 amino acids (Inoue et al., 1998). Yeast cells with a 
null mutation in GS did not have increased sensitivity to oxidative stress, however the cells did 
exhibit poor growth on minimal medium, suggesting that in S. cerevisiae GS may be required 
to produce GSH for the detoxification of harmful metabolic intermediates (Grant et al., 1997). 
Overexpression of GS had no effect on GSH concentration (Grant et al., 1997). The capacity 
for yeast to survive with low levels of GSH could be because y-glutamylcysteine can act as a 
substitute in yeast, while this does not appear to be possible in mammalian cells (Meierjohann 
et al., 2 0 0 2 ).
S. pombe GS is a tetramer of 491aa subunits (Kim et al., 2003b). Overexpression of GS in S. 
pombe is reported to lead to a 1.4-fold increase in GSH, and to protect the cells against heavy 
metals, as well as oxidative stresses (Kim et al., 2003b). GS deficient S. pombe grow slower in 
media without GSH supplements, and are sensitive to cadmium-induced oxidative stress 
(Mutoh and Hayashi, 1988; Carmel-Harel and Storz, 2000).
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1.4.3 Plasmodium
Plasmodium falciparum GS, encoded by a gene with no introns, is a 655 amino acid 
polypeptide which is active as a homodimer (Meierjohann et al., 2002).
1.4.4 Rodents
In the rat kidney, GS is composed of two identical subunits of 474 amino acid residues 
(Meister, 1985). The enzyme has been shown to be upregulated by glutathione depletion using 
DEM or BSO (Huang et al., 2000). Six different mRNAs were identified in the mouse from a 
single copy GS gene that encoded a 474aa protein (Shi et al., 1996). The transcripts differed at 
the 5' region, with only 3 of the transcripts producing active enzymes. The authors speculate 
that the apparently non-functional transcripts are involved in GSH regulation in different 
organs.
1.4.5 Primates
The human GS gene is ~32kb, consisting of 13 exons, 12 of which are in the coding region, 
and there is no evidence of alternative splicing (Whitbread et al., 1998). The GS protein is a 
homodimer consisting of two 52 kDa subunits (Polekhina et al., 1999).
GS deficiency causes a lack of feedback inhibition of GCL because no GSH is produced, 
resulting in an accumulation ofy-glutamylcysteine (y-GC), a good substrate of y-glutamyl 
cotransferase, which then overproduces 5-oxoproline (Figure 1.14), leading to a life- 
threatening acidosis (Gali and Board, 1997). The GS activity levels in patients with the 
condition are 1-30% of control values, and GSH levels are typically 5-20% of the controls 
(Njalsson and Norgren, 2005). GS deficiency has been described in 70 patients worldwide 
who have been divided into three groups based on the clinical manifestation (Njalsson, 2005). 
GS mutations are autosomal recessive, and all GS deficient patients have some level of GS 
activity, suggesting that a complete loss of GS would be lethal (Gali and Board, 1997). The
mild phenotype is caused by mutations only affecting enzyme stability, resulting in haemolytic 
anaemia because GSH is essential for cell membrane integrity and enucleated erythrocytes 
cannot produce more GS as it degrades. The moderately affected group develop metabolic 
acidosis, while the severely affected patients develop CNS dysfunction including mental 
retardation, and increased susceptibility to infection (Njalsson, 2005). There is, however, no 
clear link between the genotype and phenotype, and patients with the same mutation do not 
exhibit the same symptoms, possibly due to unique environmental and/or genetic conditions in 
each individual (Ristoff and Larsson, 2002).
GS activity decreased logarithmically with age in the lenses of five species of primate 
including Old World higher primates and prosimians (Rathbun and Holleschau, 1992)
GCL is the enzyme glutamyl-cysteine ligase, GS is glutathione synthetase, and GCT is glutamyl- 
cyclotransferase. In the case of a GS deficiency, y-glutamyl cysteine (y-GC) accumulates, which is then 
broken down into cysteine and 5-oxoproline by y-GCT. (Whitbread et al., 1998)
1.4.6 Drosophila
A review of the published literature suggests that no work has been done on the 
characterisation of GS in Drosophila by other groups. The work described in this thesis is the 
first report describing the molecular structure of Drosophila GS, as well as the effects of 
altering GS expression in Drosophila.
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Figure 1.14: A schematic representation of 5-oxoproline synthesis within the glutathione synthesis cycle.
1.5 Summary
The link between oxidative stress and longevity has been established experimentally with the 
extension of lifespan by mutations in genes that also decrease oxidative stress. Glutathione is a 
low molecular weight molecule found in most cells, and plays an important role in reducing 
cellular oxidative stress by detoxifying hydrogen peroxide, hydroxyl ions and xenobiotics. y- 
glutamyl-cysteine-ligase (GCL) catalyses the first step of the two-step reaction to produce 
GSH, and the final step is catalysed by glutathione synthetase (GS). GCL is widely accepted 
to be the rate limiting step of the reaction, but it is thought that altering levels of GS may also 
impact on the amount of GSH produced, and simultaneously affect oxidative stress resistance. 
To date little attention has been paid to GS characterisation because it is not thought to be rate 
limiting. It has, however, been shown that increasing GS expression in rat liver cells raised the 
levels of GSH, with the authors concluding that GS may be as important as GCL in 
determining the rate of GSH synthesis in certain cells types (Huang et al., 2000). In E. coli and 
yeast, GS is non-essential to survival, however the absence of GS in humans is thought to be 
lethal. Patients with very low levels of GS have low levels of GSH, and display severe 
phenotypes, including mental retardation and death. A decrease in GS activity post surgery in 
humans was also shown to decrease GSH in skeletal muscle despite GCL activity levels 
remaining constant (Luo et al., 1998). Reports of GCL being the rate-limiting enzyme are 
concerned with hepatic systems, and it is possible that in other tissues GS may be the rate 
limiting step, as was the case in skeletal muscles post surgery (Yang et al., 2002). The 
upregulation of GS by thioacetamide in a human liver cell line also resulted in a significant 
increase in GSH, despite no change in GCL expression (Huang et al., 2000), while Tat mice 
exhibit decreased GSH correlated to downregulation of GS, with no change in GCL (Choi et 
al., 2000), again suggesting that GS plays a more prominent role than previously thought. The 
role of GS may therefore have been overlooked, and it possibly plays a role as important as
GCL in de novo GSH synthesis capacity, thus warranting further studies on the enzyme. The 
role of GS in GSH production and oxidative stress resistance in Drosophila is also of interest 
because the glutathione cycle in insects has noticeable differences compared to other species, 
in particular, the absence of glutathione reductase and glutathione peroxidase, thus making 
general assumptions of gene functions based on other species less reliable.
The broad aims of this study are to characterise the gene encoding GS in Drosophila 
melanogaster, and to determine whether resistance to oxidative stress can be manipulated by 
altering transcription levels of the gene encoding GS. The specific objectives include 
determining the structure of the gene encoding GS using molecular techniques; analysing the 
multiple transcripts produced by the gene through cloning and sequencing of the transcript 
cDNAs; determining the effect of overexpression of GS on adult fly resistance to oxidative 
stress; and finally elucidating the role of GS in S2 cell oxidative stress resistance and viability 
using RNAi.
80
2 Chapter 2: Methods and materials
2.1 Standard media
All concentrations of reagents described in this chapter refer to the final concentration.
Fly Media
The medium described was used for the routine maintenance of all fly stocks. 300g 
oatmeal, 200g molasses sugar, 48g agar and 33.6 g Bakers yeast were combined in 4L of 
dH20 . The mixture was boiled in a microwave oven for 15 minutes. After stirring, 13.6g p- 
hydroxymethyl benzoic ester in 80ml ethanol was added to the media. The mixture was 
then poured into plastic fly bottles or vials, and stopped with cotton wool bungs.
Fly injection plates
The following medium was used to collect embryos following egg laying by adult female 
flies. 50g molasses sugar, 12g agar and 8.4g Bakers yeast were combined, and made up to 
1L with dH20 . The mixture was heated in a microwave oven for 10 minutes, stirred and 
allowed to cool before adding 3.4g p-hydroxymethyl benzoic ester in 20ml ethanol. The 
mixture was then poured into Petri dishes and stored at 4°C for further use.
LB
1% tryptone, 0.5%Bacto yeast extract and 1% NaCl in dH20 , adjusted to pH 7.2. For LB 
plates, agar to a final concentration of 1.5% was added to the solution before autoclaving 
for 2 0  minutes.
SOC media
2% tryptone, 0.5% yeast extract, 1% 1M NaCl, and 0.25% 1M KC1 in dH20  is autoclaved 
for 20 minutes. After cooling, add 1% 2M filter-sterilized glucose solution, and 1% 2M 
filter-sterilized Mg solution (10.15g MgCl2 andl2.35g MgSCL in 50ml dH2 0). Before use 
the entire media was filter-sterilized using a 0 .2 2 pm filter.
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Yeast EMM media
EMM medium containing full supplements, except for leucine, was made up to the 
manufacturer’s instructions: 32.5g powdered EMM medium in 1L dH20 . The solution was 
autoclaved for 20 minutes. If required, 1.5% agar was added to the solution prior to 
autoclaving for solid media.
Yeast Extract (YE) media
0.5% yeast extract, 3% glucose and 2% agar were combined in dH20 , and autoclaved for 
15 minutes. It was necessary to ensure the glucose was completely dissolved before 
autoclaving to prevent caramelisation of the media.
2.2 Standard Solutions and Buffers 
SSC 20X
3M NaCl and 0.3M Tri-sodium citrate in dH20 , and autoclaved for 20 minutes before use. 
Church’s Buffer
0.35M Na2HP04 (pH7), 0.15M NaH2P 04 (pH7) and 1.4% SDS are combined in dH20 , 
before adding ImM EDTA.
SOX Denhardt’s solution
1% Ficoll 400, 1% polyvinylpyrrolidone andl% BSA are dissolved in dH20  over a mild 
heat, followed by centrifugation at 2000rpm for 5 minutes. The solution is filter sterilised 
with a 0.45pm syringe filter.
1M Phosphate buffer
0.18M NaH2P 04 and 1.55M Na2HP04 in dH20 , adjusted to pH 7.5.
10x Phosphate buffered saline (PBS)
1.37M NaCl, 26.8mM KCl, 0.1M Na2HP04, 16.9mM KH2P 04 dissolved in dH20 , adjusted 
to pH 7.4.
50XDTT
20% dithiothreitol (DTT) dissolved in dH20.
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1M Na-EDTA
372.25g Na-EDTA dissolved in 1L dH20 .
50XTAE buffer
2M Trizma base and 0.05M Na-EDTA in dH20 , adjusted to pH8.0 with glacial acetic acid. 
TE buffer
0.01M Trizma base, adjusted to pH 8.0 with HC1, combined with ImM Na-EDTA in 
dH20.
10X MOPS buffer
0.2M MOPS, 0.13M Sodium acetate and ImM Na-EDTA dissolved in nuclease free dH20. 
pH is adjusted to 7.0 with NaOH prepared in nuclease free dH20.
X-Gal
5% X-Gal (5-Bromo-4-chloro-3-indolyl p-D-galactoside) was dissolved in N,N- 
dimethylformamide
Deithly pyrocarbonate (DEPC) water
0.1% DEPC was added to 1L dH20  and stirred overnight using a magnetic stirrer, 
followed by autoclaving for 20 minutes.
Antibiotic solutions 
Ampicillin
Ampicillin stock solution was made up in dH20  at a concentration of 50mg/ml, to be used 
at a final concentration of 50pg/ml.
Chloramphenicol
Chloramphenicol stock solution was made up in ethanol at a concentration of 50mg/ml, to 
be used at a final concentration of 25pg/ml.
Tetracyclin
Tetracyclin stock solution was made up in dH20  at a concentration of 5mg/ml, to be used 
at a final concentration of lOpg/ml.
83
2.3 Enzymes
Restriction enzymes
Restriction enzymes were purchased from Amersham, Roche and New England Biolabs. 
Reaction conditions recommended by the manufacturer were used. For genomic DNA 
~5U/pg DNA was used in the reaction, and for plasmid DNA, 2U/pg DNA was used in 
order to complete the digest. The reactions were typically incubated at 37°C for 3 hours, 
unless otherwise specified. Inactivation of restriction enzymes was performed as per the 
manufacturer’s instructions, either by heat inactivation, or by DNA precipitation if 
necessary.
Ligase
Ligations were carried using a 3:1 insert to vector ratio, starting with approximately 50ng 
vector, to which 0.2pl (0.2 units) T4 ligase was added. The reactions were incubated at 
16°C overnight.
A second Quick Ligation Kit was also used, where the ligation reaction was performed in 5 
minutes compared to 16 hours using T4 DNA ligase. 50 ng vector was added to a 3 fold 
excess of insert, along with lOpl 2X buffer and lpl Quick T4 DNA Ligase. The reaction 
was incubated at 25°C for 5 minutes.
Calf intestinal alkaline phosphatase (CIP)
10 units of the enzyme was used to dephosphorylate 0.5pg digested vector at 37°C for one 
hour. The CIP was then inactivated by gel purification or phenol extraction.
Antarctic Phosphatase
Antarctic phosphatase was used as an alternative to CIP, using the same protocol as CIP, 
however the reaction time was 30 minutes rather than 1 hour, and the enzyme was heat- 
inactivated by exposure to 65°C for 5 minutes.
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2.4 Nucleic acid extraction
Extraction of genomic DNA from adult Drosophila
The method used was obtained from FlyBase (http://flybase.bio.indiana.edu/).
Approximately 30 flies were collected into an eppendorf tube and frozen at -80°C, before 
homogenising them in 200pl Buffer A (lOOmM Tris-HCl, pH7.5; lOOmM EDTA; lOOmM 
NaCl; 0.5% SDS) with a disposable pellet pestle. An additional 200pl Buffer A was added, 
and the mixture was incubated at 65°C for 30 minutes. 800pl of Buffer B (5M potassium 
acetate, 6M Lithium chloride) was added to the homogenised flies, incubated on ice for 20 
minutes, then microfuged at 13000xg for 15 minutes. 1ml of the supernatant was 
transferred to a clean eppendorf to precipitate the DNA with 600pl isopropanol. After 
centrifugation, the pellet was washed in ethanol, and resuspended in 150pl TE buffer.
Extraction of total RNA from Drosophila samples and S2 cells
The method used was obtained from FlyChip (http://www.flychip.org.uk/). RNA samples
were only handled with RNase-free pipette tips and eppendorf tubes, and DEPC-treated 
equipment. 200pl TRIzol was added to -15 adult flies, -lOOpl larvae, -50 pi embryos or 
~ lx l0 6 S2 cells, which were then homogenised for 30-60 seconds using a disposable pellet 
pestle. A further 800pl TRIzol was added before centrifugation at 13 OOOxg for 5 minutes 
at 4°C. 200pl chloroform was then added to the supernatant, and incubated at room 
temperature for 3 minutes before centrifuging at 13 OOOxg for 5 minutes at 4°C. The 
supernatant was removed, and 0.3 volumes isopropanol was added to the pellet. After 5 
minutes incubation at room temperature the sample was spun at 13OOOxg for 5 minutes. 
The resulting pellet was washed in 70% ethanol, and spun for 10 minutes. The pellet was 
air dried, and resuspended in approximately lOOpl DEPC-dFLO.
2.4.1 Plasmid purification 
Maxipreps
Large scale plasmid purifications (for purification of ~500ug plasmid DNA) were 
performed according to the instructions for the Qiagen Plasmid Maxi Kit. In this protocol,
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E. coli clones were grown overnight in 2L flasks containing 500ml media at 37°C in a 
shaking incubator. The following day, cells were centrifuged, resuspended, and lysed in an 
alkaline lysis solution. Proteins, genomic DNA and cellular debris were precipitated, and 
then removed by centrifugation. The cleared lysate was then placed on an ion exchange 
resin to facilitate plasmid DNA binding. A medium salt wash which removed the 
remaining RNA, proteins and other impurities, was followed by a high salt elution of 
plasmid DNA. Isopropanol precipitation resulted in a concentrated and desalted plasmid 
DNA pellet, which typically yielded approximately 160pg/L cells.
Minipreps
The miniprep kit used was the Wizard Plus S V Minipreps DNA Purification System. The 
protocol followed is detailed in the manual; briefly: a 5ml overnight culture of an E.coli 
clone was pelleted by centrifugation and resuspended. A lysis solution was added to the 
cell solution, as well as an alkaline protease solution, resulting in lysis of the cells, and 
inactivation of cellular endonucleases. The reaction was neutralised, and the solution was 
centrifuged to remove the cellular debris. The cleared lysate was then added to the spin 
column, where the DNA was bound onto a membrane during centrifugation of the lysate. 
After an ethanol wash, the plasmid DNA was eluted with lOOpl dP^O, typically at a 
concentration of 100-200ng/pl.
2.4.2 DNA extraction from an agarose gel
The DNA sample of interest was run on a low percentage (0.8%) agarose gel, and cut from 
the gel using a sterile blade while visualised on a UV transilluminator. DNA was then 
extracted from the gel fragment using a SpinPrep gel DNA kit, following the 
manufacturer’s instructions. Briefly, the gel fragment was added to the supplied gel melt 
solution and heated until the agarose was dissolved. The DNA was then bound to a silica 
membrane in the spin tube though a series of centrifugations. The bound DNA was then 
washed with an ethanol solution to remove protein and salts. Elution was performed with 
the supplied elution solution, or with dt^O.
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2.5 Nucleic acid purification
2.5.1 Ethanol precipitation
Ethanol precipitation was performed to remove salts from nucleic acid preparations. In the 
case of RNA, all reagents were made up using DEPC-treated dH20 .
0.5 volumes 0.3M sodium acetate (pH5.2) was added to the DNA/RNA solution along with 
2 volumes ice cold ethanol. The mixture was incubated on ice for 20 minutes, then 
centrifuged at maximum speed in a benchtop microfuge fori 5 minutes. The supernatant 
was discarded, and the pellet was washed with 70% ethanol, before being allowed to air 
dry. Once dry, the pellet was resuspended in dH20  or TE buffer.
2.5.2 Phenol-ch/oroform precipitation
Phenol-chloroform precipitation was used to remove protein from DNA extractions, and to 
inactivate restriction enzymes that could not be heat inactivated. A mixture of 
phenol:chloroform:isoamyl alcohol at a ratio of 25:24:1 was used instead of the standard 
phenol:chloroform mixture because the addition of isoamyl alcohol ensures the 
deactivation of RNases.
An equal volume of phenol:chloroform:isoamyl alcohol was added to the DNA solution, 
and mixed to form an emulsion before centrifuging at 12 OOOxg for 15 seconds in a 
microfuge. The upper aqueous layer was transferred to a fresh tube and the process was 
repeated until no white protein precipitate was visible at the aqueous-organic interface. An 
equal volume of chloroform was then mixed with the aqueous layer, followed by 
centrifugation at 12 OOOxg for 15 seconds. The aqueous layer was transferred to a new 
tube, and the nucleic acid was recovered by ethanol precipitation.
2.6 Spectrophotometric nucleic acid quantification
The amount of DNA or RNA in solution was determined by a spectrophometric 
measurement. The OD of a volume of DNA or RNA in TE buffer was determined at 
260nm, and to calculate the concentration of the nucleic acid, the OD was multipled by the
dilution factor, and by 50 (in the case of DNA) or 40 (in the case of RNA), because an OD 
of 1 corresponds to 50pg/ml dsDNA and 40pg/ml ssRNA.
To estimate the purity of the sample, the OD of the sample was read at 260nm as well as 
280nm, because the ratio between the OD at 260nm and 280nm gave an indication of the 
purity of the sample. An OD260/OD280 value of 1.8-2 indicates a pure nucleic acid 
preparation, and a value of 1.5 or less indicates protein or phenol contamination of the 
sample.
2.7 Gel electrophoresis
2.7A Agarose gels
The gels were made and run in IX TAE buffer. The concentration of the agarose ranged 
from 0.5-1.5%, depending on the size of fragment to be separated. 0.5 pg/ml ethidium 
bromide was added to the gels in order to visulaise DNA under UV light. Samples were 
loaded into the gel in IX loading dye (6X loading dye contained 0.25g bromophenol blue, 
0.25g xylene cyanol and 15g Ficoll in 100ml dH20), alongside the 1Kb plus molecular 
weight marker, or Hyperladderll molecular weight marker. Gels were generally run at 
100 V for 1-2 hours.
Isolation of DNA from agarose gels was performed using the SpinPrep Gel DNA kit, as 
described in section 2.4.2 .
2 . 7 .2  Denaturing gel electrophoresis of RNA
Before starting, the gel tanks, trays and combs were soaked in 3% hydrogen peroxide and 
rinsed with DEPC-water. RNA samples were only handled with RNase-free pipette tips 
and eppendorf tubes. Agarose was dissolved in IX MOPS, and cooled before adding 18% 
formamide. IX MOPS was used as a running buffer to run the denatured RNA samples. 
The samples were denatured in a denaturing buffer (345pi formamide, 20pl formaldehyde, 
35pl 10X MOPS, 3pi ethidium bromide) by heating to 65°C. The loading buffer consisted 
of 50% glycerol, 40mM DEPC-treated EDTA, 0.2% xylene cyanol and 0.2% bromophenol
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blue. Samples were loaded alongside an RNA size ladder, and electrophoresed for 
approximately 1 hour at 100V.
2.8 Subcloning DNA fragments
This technique was used when the gene of interest could not be amplified by PCR, or when 
the TOPO cloning vector did not contain the appropriate cloning sites (Ausubel et al., 
1987).
The starting DNA molecule (in the form of a genomic DNA, a B AC or a plasmid) was 
digested with one or two restriction enzymes, depending on the sequence of the target 
DNA, and on the restriction sites available in the cloning vector. Both the insert DNA and 
the vector the insert would be cloned into were digested with restriction enzymes. The 
reaction was usually performed on 5-10pg DNA containing the insert of interest, in a 
volume of 20pl. The digested vector and DNA insert were then run on a low percentage 
agarose gel, and relevant DNA bands were cut from the gel and purified.
After gel purification, the 5' phosphates on the digested vector DNA were removed by CIP, 
or alkaline phosphatase digestion, followed by an ethanol precipitation of the digested 
insert DNA and the dephosphorylated vector. The vector and insert DNA were then ligated 
using T4 DNA ligase at a vectoriinsert ratio of 3:1. The ligated vector was then 
transformed into electrocompetent E. coli cells, followed by colony screening to detect 
positive clones.
2.9 TOPO cloning
When cloning PCR products with TOPO vector, the TOPO TA cloning Kit version K2 was 
used. Top 10 chemically competent cells with blue/white screening were transformed with 
linearised plasmid vector. The TOPO vector system has thymidine overhangs with 
topoisomerase bound to the vector. Since Taq polymerase adds an adenosine to the 3' ends 
of PCR products, they can ligate to the thymidine overhanging residue in the vector. The 
topoisomerase binds linear ends of the vector, protecting them from digestion and prevents
religation. Ligation of the topoisomerase-activated vector to PCR products, which lack 5' 
phosphates, occurs with the release of topoisomerase enzyme. Ligation of the 200ng PCR 
product and 2.5ng plasmid was carried out at room temperature for 30 minutes (for >5kb 
fragments), then added to 50pi Top 10 cells. The reaction was incubated on ice for 15 
minutes, followed by a 30 second 42°C heat shock. 250pl SOC was added to the cells, 
which were incubated at 37°C for an hour before plating them out on LB-Amp plates 
coated with 40pl 40mg/ml X-gal. 10 white colonies (indicating disruption of the lacZ gene, 
and therefore a positive cloning result) were picked and tested for the presence of the DNA 
insert of interest.
2.10 Bacterial transformation
Transformation was performed on electrocompetent XL1 Blue E. coli cells, or on One Shot 
ToplO electrocompetent E. coli cells. Transformation was carried out using a Stratagene 
apparatus set at 1800V. ~100ng of plasmid DNA was added to 50pl electrocompetent 
cells, mixed, and then added to a chilled cuvette. The cells were pulsed at 1800V before 
the immediate addition of lOOpl SOC medium. After transferring the cells to an eppendorf 
tube, they were incubated at 37°C for 1 hour before plating out onto LB plates containing 
an antibiotic appropriate to the plasmid. In the case of plasmids carrying the lacZ gene 
which allows for blue/white colony screening, X-Gal was spread on the plates before 
addition of cells. Both XL Blue and ToplO cells are sensitive to ampicillin.
2 .10.1 Creation of electrocompetent cells
Electrocompetent cells were prepared by first inoculating a colony of XL1 Blue E.coli into 
50ml LB, and incubating at 37°C for 5-8 hours. This starter culture was used to inoculate 
500ml LB which was incubated at 37°C with shaking to an OD600 of 0.5-0.7. The cells 
were then chilled in an ice-water bath for 15 minutes, before centrifuging at 4200rpm for 
20 minutes at 2°C in a Beckman U2-21 centrifuge. The pellet was resuspended in 5ml ice- 
cold water, then mixed with 500ml ice cold water and centrifuged as before. The pellet
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was resuspended, and washed again, and resuspended finally in a 10% glycerol solution 
before storing the cells in lOOpl aliquots at -80°C.
The transformation efficiency of each batch of electrocompetent cells created was tested by 
transforming a lOOpl aliquot of cells with lng pUC18 DNA. Volumes of lpl, lOpl and 
50 pi of the transformation were plated onto LB+Amp plates, and incubated overnight at 
37°C. The number of colonies on each plate was counted the following day, and the 
transformation efficiency was calculated as the number of colonies per pg plasmid. This 
calculation involved multiplying the number of colonies counted by the dilution factor, and 
by 1000 to convert the value from ng of DNA transformed to pg. An efficiency of over 1 x
a
10 transformants per pg plasmid in a lOOpl reaction was usually obtained, but if the 
number was lower than 1 x 107, the cells were discarded.
2.10.2 Colony screening
Clones were screened in a two-stage process, first the colonies were picked and screened 
via PCR, after which positive clones were confirmed by restriction digest
PCR colony screening
This initial screening technique was used to detect possible positive colonies. 
Approximately 50 colonies, or 10 white colonies in the presence of blue/white screening, 
were picked using an individual sterile pipette tip for each colony. The pipette tip from 
each colony was dipped in 5 pi dfLO in a lOpl eppendorf tube, and then streaked on an LB 
plate to be incubated at 37°C overnight and stored at 4°C for further analysis. The 
eppendorf tube containing the E. coli cell solution was heated to 95°C for 10 minutes to 
lyse the cells. The solution was then centrifuged at 8000xg in an Eppendorf microfuge for 
10 minutes to pellet the cell debris, and 3 pi of the supernatant was used in a PCR reaction 
to test for the presence of the insert of interest. In the case of a positive PCR result, the 
colony was screened by restriction digest to confirm the result using the colony streak 
made on the LB plate.
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Restriction enzyme digest colony screening
Clones with a positive result from PCR were picked using a sterile pipette tip which was 
placed in a 15ml sterile centrifuge tube containing 5ml LB plus the appropriate antibiotic. 
The culture was incubated in a shaking incubator overnight at 37°C. The following day, 
plasmid DNA was extracted from the culture using the miniprep procedure. Plasmid DNA 
was then digested using a restriction enzyme that had a recognition site within the insert 
DNA, resulting in a banding pattern specific to the positive clones when the digests were 
run on an agarose gel.
2.11 Yeast transformation
For a single transformation, 10ml EMM in a 50ml sterile tube was inoculated with a single 
S. pombe colony. The cells were grown in a shaking incubator at 25°C. The following day 
the OD of the solution was monitored, and when the media reached an OD of 0.4, the cells 
were centrifuged at 1500g for 5 minutes, and the pellet was washed in 1ml sterile dtLO. 
The cells were then washed in 200pl of a 0.1M lithium acetate solution (adjusted to pH 4.9 
with acetic acid). Following centrifugation, the pellet was resuspended in 50pl 0.1M 
lithium acetate. 600ng of plasmid DNA was added to the cells, along with 300pl of a 
lithium acetate/PEG solution (0.1M lithium acetate, 50% w/v PEG 4000). The cells were 
incubated at 30°C for 30 minutes, and heat shocked at 42°C for 15 minutes. The cells were 
centrifuged at 1500g for 5 minutes, and the pellet was resuspended in 200pl TE buffer. The 
total transformation was plated onto EMM -Leu plates which selected for the pNMTl 
vector which carried the Leu2 gene.
2.12 Bacterial and yeast culture storage
E. coli bacterial cells were stored on LB plates containing the appropriate antibiotic, and S. 
pombe yeast cells were maintained on YE agar plates. The plates were sealed with 
Parafilm and could be stored at 4°C for the duration of a month. For long-term storage, 
glycerol stocks were made by mixing 850pl of a culture grown to an OD of -0.3 with
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150(0.1 sterile glycerol. The mixture was then frozen in a dry ice bath (ethanol poured onto 
dry ice), and stored in a -80°C freezer indefinitely.
2.13 Vectors
The pBluescript SK+ vector was used to clone restriction enzyme digested fragments.
The TopoTA Vector 2.1 was used to clone PCR products. Cloned sequences were 
sequenced from this vector using the universal M13 primers.
The pNMT TopoTA expression vector was used to clone and express PCR amplified 
DmGS cDNAs in S. pombe. The vector contains a nmtl promoter which results in 
thiamine-regulated gene expression in S. pombe cells. It has been found, however, that the 
nmtl promoter does allow gene expression in the presence of thiamine in some cases, and 
the ability to ‘shut o ff completely seems to be gene dependent (Forsburg, 1993). For this 
reason the thiamine control was not used in this experiment.
The pUAST vector was used to clone restriction enzyme digested fragments for expression 
within the Drosophila adults using the GAL4/UAS system (Brand and Perrimon, 1993). 
All the vectors used in this thesis are summarised below in Table 2.1.
Table 2.1; Vectors used for cloning DNA fragments. The uses and properties of each vector are listed. 
Vector Use Size Antibiotic Promoter Source/
_____________________________ (kb) resistance_________________  Reference
pBluescript
SK+
Cloning restriction 
enzyme digested 
genomic 
fragments
3.4 Chlor­
amphenicol
lac promoter Stratagene
TopoTA
2.1
TA overhangs 
allows cloning of 
PCR products. 
Sequencing of 
cloned products 
using M13 
primers
3.9 Kanamycin
Ampicillin
lacZ promoter Invitrogen
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Vector Use Size
(kb)
Antibiotic
resistance
Promoter Source/
Reference
pNMT
TopoTA
pUAST
Clone and express 
PCR amplified 
cDNAs in S. 
pombe.
Clone and express 
restriction enzyme 
digested 
fragments in 
Drosophila. The 
construct is 
flanked with P- 
element sequences 
to allow for 
transgene genome 
integration. 
Expression of the 
white gene allows 
for transgenic fly 
identification.
6.1 Ampicillin
9.1 Ampicillin
nmtl promoter 
which results in 
thiamine-regulated 
gene expression in 
S. pombe cells. It 
has been found, 
however, that the 
nmtl promoter 
does allow gene 
expression in the 
presence of 
thiamine in some 
cases, and the 
ability to ‘shut o ff 
completely seems 
to be gene 
dependent 
(Forsburg, 1993). 
For this reason the 
thiamine control 
was not used.
UAS promoter 
which is activated 
in the presence of 
GAL4
Invitrogen
Brand and
Perrimon
(1993)
2.14Nucleic acid hybridisation assays
2 .14.1 Radiolabelling DNA probes
DNA probes of PCR or enzyme digest origin were labelled by a 32P dCTP incorporation, 
using the Megaprime DNA labelling system. This system uses random sequence 
hexanucleotides to prime DNA synthesis along the DNA segment. Klenow DNA 
polymerase 1 uses the primer-template complex as a substrate for DNA synthesis, 
incorporating a 32P dCTP instead of an unlabelled nucleotide. The labelled probes are
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released from the template by denaturation, and added directly to the hybridisation 
reaction.
The Megaprime reaction is started by denaturing a 50pl solution of 50ng DNA and 5 pi 
primers at 95°C for 5 minutes. This is followed by the addition of lOpl labelling buffer, 5pi 
labelled dCTP and 2ul Klenow polymerase enzyme. The reaction is incubated at 37°C for 
30 minutes before being denatured by heating to 95°C for 5 minutes, followed by a cooling 
on ice.
2.14.2 Southern blots
DNA was separated by electrophoresis on a 1% agarose gel at a low voltage overnight.
The gel was then depurinated by soaking in 0.125M HC1 for 10 minutes, followed by 
submerging in 0.4M NaOH for approximately 30 minutes. A capillary blotting apparatus 
was set up by placing a paper wick on a platform supported above a tank of 0.4M NaOH. 
The treated gel was placed on the wick, covered by a Hybond N+ nylon membrane then 
three sheets of 0.4M NaOH saturated 3MM paper. The gel and membrane were finally 
covered by a 20cm stack of absorbent paper towel and a weight on top of the paper stack. 
The blotting apparatus is illustrated in Figure 2.1. After the overnight transfer, the 
membrane was washed in 2X SSC buffer, and stored for the hybridisation procedure.
/ \
\  / \  /
weight
glass plate 
absorbent towel
3 sheets 3MM paper
Hybond N+ 
gel
paper wick
-  plastic tray 
filled with 0.4M NaOH
Figure 2.1: Diagrammatic representation of a capillary blotting apparatus
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Probe hybridisation
Hybridisation was carried out in a Hybaid Micro4 rotating hybridisation incubator. The 
nylon membrane containing bound DNA was pre-hybridised with Church’s buffer for 30- 
60 minutes. The labelled probes were then added to the Church’s buffer and hybridised to 
the membrane in the rotating incubator overnight at 65°C. The following day the 
membrane was washed with 3X SSC containing 0.5% SDS at 65°C, followed by two 
washes with IX SSC containing 0.5% SDS at 65°C. The membranes were then exposed to 
X-ray film at -80°C, and developed 1-5 days later.
2.14.3 Northern blots
All procedures for Northern blotting were done with care to avoid nuclease contamination, 
including rinsing apparatus in 3% H2O2 , and making up solutions with DEPC water. RNA 
samples were run on a 1% denaturing agarose gel at a low voltage overnight. The gel was 
set up in the same manner as the Southern blot (Figure 2.1), although instead of using 
0.4M NaOH, a 20X SSC solution was used to moisten the paper wicks, and to fill the 
lower tank. The second difference between the Northern and Southern blot set up was the 
use of an uncharged Hybond N nylon membrane for transfer of the RNA. After the 
overnight transfer, RNA was fixed to the nylon membrane using UV light in a Hoefer 
UVC500 UV Crosslinker.
Probe hybridisation
Northern hybridisation was carried out in a Hybaid Micro4 rotating hybridisation 
incubator. The nylon membrane containing bound RNA was washed in prehybridisation 
solution (50% deionised formamide, 5X Denhardt’s solution, 1% SDS, 6X SSC) for 2 
hours at 42°C. The labelled probes were then added to the pre-hybridisation solution and 
hybridised to the membrane in the rotating incubator overnight at 42°C. The following day 
the membrane was washed twice with 3X SSC containing 0.5% SDS, followed by a wash 
with IX SSC containing 0.5% SDS. Both washes were performed at 55°C. The 
membranes were then exposed to X-ray film at -80°C, and developed 1-5 days later.
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2.15 Polymerase chain reaction
The Opticon2 thermocycler was used for routine PCR as well as for RT-PCR. Thin-walled
low profile PCR tubes were used in the machine. Reactions were usually carried out in
20jil volumes, containing IX PCR buffer with Mg2+, 0.2mM dNTP, 100-200ng target
DNA, 0.5pM of each primer, and 1U Taq. The following PCR thermal cycling program
was followed, and adjusted depending on the annealing temperature of the primers:
95°C___________ 3 minutes_______
95°C 30 seconds
Annealing temp 45 seconds 30 cycles
72°C___________ 1-3 minutes______
72°C 5 minutes
Primers were designed to have an annealing temperature of 55-60°C, and care was taken to 
ensure that the sequences would not cause hairpin structures through complementary 
annealing. Primers were ordered from Invitrogen through the online ordering service at 
www.invitrogen.com, and the lyophilized primers were made up to a stock concentration 
of lOOpM with dfbO. The various primers used are listed in Table 2.2.
Table 2.2: List of PCR primers. GS distal copy on BAC=24700-33850, GS proximal copy = 34840-
41280____________________________________________________ __________________________________
Primer name Sequence from 5 'to 3' Position on
BACR29H04
GS-L1 teg ttg aga geg cag cag ta 24970/35130
GS-L2 cag ccg ttt aac ggt gtc ca 24870 / 35030
GS-L3 gta tat ege ccg get ggt at 24740/34910
GS-R1 ctg ctg ctg gta tct ggg at 25190/35350
GS-R2 ggc ata ate ctt ggc ctt gg 25310/35470
GS-R3 ata cga gcc etc act age ga 25410/35570
GS-L4 cca ggc gga gat caa aag ca 23780 / 33940
GS-R4 atg gat teg cct ctg tgc tg 26320 / 36470
GS-R5 geg atg aga tga gat gag tg 27280 / 37440
GS-R6 tgt tat ege aca ege etc ga 28330/38480
GS-L5 age gag etc tgc aac caa tc 22810/32440
GS-L6 gag gga cgt cga tat gtg ac 21874
GS-R7 get cat cct cgt cat ege ta 33670/41090
GS-R8 cca gac tga ggc aac agg tg 33740/41160
Exonl-F ggt gga aca ggt gga gca c 24910/35060
Intronl-F ggc gaa caa eta aca ac 25130/35280
5' of297-F cag ctt gta gtc ata teg g 28660/38820
GS-upstream-F gga cca eta gtt cac gac 22940
GS-upstream-R gaa cat geg aac tgt gcc 23413
GS-copy2_R get tta gcc cca att cca g 41284
GS_copy2_notI-F gac taa age ggc ege aca aca acg att gga cct 24520 / 34680
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Primer name Sequence from 5' to 3 f Position on 
BACR29H04
GS copy2 notl R gaa tea age ggc ege ate cag ttt gca tat tga 33850/41280
Ex4-F ege aag gag ttc gaa aa 25740/35890
Exon4-R cgt cgt cgt gat gaa etc c 25810/35970
Ex5-F geg ate tga tgc tgg agt c 26850 / 37005
Ex5-R get tcc acg age agt aag 27087 / 37242
Ex6-F ttt ggc cac ttg gga cca g 27134/37289
Ex7-F gcc tag agt ttt cat ttg ctg ac 27695 / 37850
Ex7-R ggt gtc ggt tgg cag gtg c 27798 / 37952
Ex8-F gca ggt cga gat caa cac g 31830/39250
ExlO-F tea ttc tgt tea tea teg ag 32693/40114
Exl2-F gac caa ggg eta tat ggt g 33450 / 40870
Exl2-R eta ctt ctg etc ate etc gt 33680/41100
First-exon F cga tea tgt cca geg acg c 25223 / 35378
Placl cac cca agg etc tgc tcc cac aat 234 on EP-element
Pry4 caa tea tat ege tgt etc act ca 7856 on EP-element
Actin5C-F tta ttc cag tea ttc ctt tea
Actin5C-R ttc gag ate cac ate tgc tg
NMT pombe ttt caa tct cat tct cac ttt ctg a pNMT TOPO vector
forward
URA4 pombe aca agg cat cga ctt ttt caa ta pNMT TOPO vector
reverse
pUAST F seq age gca get gaa caa get aaa c sequencing
pUAST R seq ttt gtc caa tta tgt cac acc aca sequencing
M13 F sequencing gta aaa cga egg cca g sequencing
M l3 R sequencing cag gaa aca get atg ac sequencing
GFP-forward geg taa tac gac tea eta tag gga gaa tgg ctagc GFP for RNAi
GFP-reverse geg taa tac gac tea eta tag gga gat tga agt 
tea
GFP for RNAi
GS-RNAi-F tct gat tea tcc gcc get gac caa g GS for RNAi
GS-RNAi-R ege tat cga tea gat atg gac tgt c GS for RNAi
GCLC-RNAi-F ggg tct act gag cga ggg GCLC for RNAi
GCLC-RNAi-R ccg tgc ggc aat cca cc GCLC for RNAi
2.16 rt-PCR
RT-PCR was performed on RNA extracted from Drosophila embryos, larvae, adult flies, 
and S2 cell cultures. In the case of embryos and larvae, approximately lOOpl embryos were 
collected for RNA extraction, and in the case of adult flies, 10-15 flies were collected for 
each RNA extraction. For S2 cell culture, approximately 106 cells were pelleted for RNA 
extraction. Gene-specific primers were used to quantify the GS or GCLC mRNA in each 
sample after RT-PCR, using actin5C as an internal control for quantifying RNA.
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2.16.1 First strand cDNA synthesis
cDNA was created from RNA using Superscript II Reverse Transcriptase kit from 
Invitrogen. 2pg RNA was added to 500ng oligo(dT)i2-i8 primer and lpl lOmM dNTP 
solution in a total volume of 12pi. This mixture was heated to 65°C for 5 minutes then 
chilled on ice. After a quick spin, 5pl 5X First strand buffer, 2pl 0.1M DTT, and 200U 
Superscript IIRT was added to make up a final volume of 20pl. The reaction was 
incubated at 42°C for 50 minutes, then inactivated by heating to 70°C for 15 minutes.
2.16.2 PCR reaction
PCR from the cDNA template was optimised carefully so that the final PCR product made 
was still in the linear phase of the reaction. The number of cycles of the PCR reaction was 
decreased to the point where the reaction just became visible when visualised on an 
agarose gel. The concentration of primers used was tested on a gradient system, ensuring 
they were not in excess, which allowed for greater control of the linear phase of the 
reaction. The standard amount of cDNA used in each 20pl PCR reaction was 1 pi. The 
primer concentrations and cycle numbers for each gene specific reaction are listed below: 
Table 2.3: Primer concentrations and cycle numbers of specific RT-PCRs___________
Primer set Primer concentration Number of cycles
GS First ex F + Exl2R 0.4pM (fly cDNA) or 24
0.5pM (S2 cell DNA) -
GCLC F + GCLC R 0.4pM 24
Actin5C F Actin5C R 0.4pM 21
2.17 The typhoon 9410 variable mode imager & Imagequant 
software
The Typhoon imager was used to scan ethidium bromide stained DNA on agarose gels, as 
well as peroxidase labelled western blot membranes. The ImageQuant software was used 
to digitally measure the density of bands on the gel or membrane, thereby allowing 
comparison of band intensities.
2.17.1 Measuring the intensity of DNA bands on an agarose gel
The Typhoon scanner software was used to select the size of the gel. The fluorescence
acquisition mode was selected, and the pixel size was set to 200pm. After the scan was
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complete, the saved image file was opened with ImageQuant software, which was used to 
analyse DNA band intensity on the gel. Manual analysis was performed on the gel instead 
of the automatic analysis to allow greater sensitivity when choosing dimensions of the 
bands. In manual mode, the lanes were defined, and the bands to be analysed were 
demarcated. The software finally subtracted the background intensity, giving values (in 
arbitrary units) for the volume of each band indicated on the gel. This allowed for 
comparison of the intensity of different bands on the same gel, eg, a comparison of GS and 
actin5C intensities was used to determine relative expression levels in different samples.
2.17.2 Capturing the chemiluminescent signal from a peroxidase treated 
western blot
The Typhoon scanner software was used to select the size of the membrane. The 
chemiluminescent mode was selected, with medium sensitivity set. Pixel size was set to 
500pm, and the image was scanned. No further analysis of the image was performed. The 
scanner was used as an alternative to X-ray film to visualise the chemiluminescent 
reaction.
2.18 Sequencing
Samples for direct nucleotide sequencing were sent to Macrogen (www.macrogen.com). 
15pl of purified plasmid (lOOng/pl) or purified plasmid (50ng/pl) along with lOpl of the 
relevant primer (5mM) was sent to the sequencing service in Korea. The service utilised 
the BigDye Terminator sequencing kit from ABI, and the reactions were run on an ABI 
3730XL automatic sequencer. The results were sent back in the form of .abi files. These 
files were then viewed and analysed using BioEdit sequence alignment editor, version 
7.0.4.1 (Hall, 1999).
2.19 Glutathione determination
The principle of this assay is based on an enzymatic recycling reaction where glutathione 
reductase is used to quantify the amount of GSH in a sample (Tietze, 1969). 5 ,5 -dithio-
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bis-2-nitrobenzoic acid (DTNB) is reduced by GSH in the presence of NADPH2 to the 
yellow coloured 5-thio-2-nitrobenzoic acid (TNB) which is measured at 405nm. The mixed 
disulfide, GSTNB (between GSH and TNB) that is produced in this reaction, as well as 
GSSG, is reduced by glutathione reductase to recycle the GSH and produce more TNB.
The rate of TNB production is proportional to this GSH recycling reaction, which is then 
directly proportional to the concentration of GSH in the sample. The reaction is started, 
then the colour change is monitored over 4 minutes to determine the total amount of GSH 
present in the samples based on the standard curve produced. The full protocol used is 
detailed below:
Samples were prepared by homogenizing flies or S2 cells in ice cold 10% sulphosalycylic 
acid (SSA), followed by centrifugation at 3000g for 10 minutes. The aqueous layer was 
collected and used for the assay. A standard curve was prepared using GSH in SSA 
ranging in concentration from 1 -  lOOpM.
50pl of each of the samples and standards were aliquoted in triplicate into wells of a 96- 
well plate. 50pl of 4mM DTNB (prepared in a 200mM phosphate buffer pH 7.5, lOmM 
EDTA) was added to each of the samples, followed by an addition of 0.1U glutathione 
reductase in phosphate buffer to each of the wells. The plates were then incubated at room 
temperature for 10 minutes. 50pl of 1.36mM NADPH was added to each of the samples to 
start the reaction, and the first reading at 405nm on a spectrophotometric multiplate reader 
was taken immediately. After 4 minutes, the second reading was taken.
To calculate the amount of GSH present in each of the samples, the mean rate of the 
reaction was calculated using the equation: Mean V = (OD at 4 min -  OD at 0 min)/4 
The standard curve was plotted with mean rate against GSH concentration. The total GSH 
concentration can then be calculated from the standard curve with the rate of colour change 
(mean V) proportional to the GSH standard concentrations.
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2.20 Protein techniques
Protein Extraction
Extraction from yeast cells
Six millilitres of a starter culture of S. pombe cells was grown to an OD of 0.5. The cells 
were spun at 1500xg for 5 minutes, and the pellet was washed in 5ml dH20. The resulting 
pellet was resuspended in 300pl 1.85M NaOH with 7% P-mercaptoethanol. After 
vortexing for 1 minute, 150pl of 100% cold trichloroacetic acid (TCA) was added. The 
mixture was then incubated on ice, followed by a 10 minute centrifugation at 4°C. The 
pellet was washed in 500pl 1M Tris base, and resuspended in 150pl of an 8M urea 
solution. The protein sample was then stored at -20°C until required.
Extraction from adult flies
15 flies were homogenised in 150pl lysis buffer (50mM Tris-HCl, pH7.2; 20mM 
Na2HP0 3 ,pH7 ; 150mM NaCl; 1% Triton X-100, O.lmM benzamidine; O.lmM PMSF, 
0.5mM EDTA), spun in a microfuge at top speed for 3 minutes. The supernatant 
containing the protein was collected and stored at -20°C for further use.
Protein Determination
Protein was quantified using the BioRad DC protein assay. This assay is based on the 
Bradford method where Coomassie brilliant blue dye is added to a protein sample and the 
change in absorbance is read at 595nm. The absorbance maximum of the dye changes from 
465nm to 595nm on binding to protein. Comparison of samples to the standard curve gives 
a relative measurement of protein concentration. The kit was used according to the 
manufacturer’s instructions, as detailed below.
BSA protein standards were made from 0-1.4 mg/ml. The standards were treated in the 
same manner as the samples. 5pl of samples and standards were pipetted into individual 
wells of a 96-well microtitre plate. 20pl Reagent S was added to 1ml Reagent A, and 25pl 
of this mixture was added to each well, followed by 200pl of Reagent B. After a fifteen 
minute incubation, the samples were placed onto a plate reader to measure the absorbance
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at 595nm. Using the BSA standard curve results, the protein concentration in each sample 
could be calculated.
SDS-PAGE
Protein samples were reduced prior to loading on a SDS-PAGE gel by the addition of a 
final concentration of IX dithiothreitol (DTT), and boiled at 95°C for 15 minutes with 1% 
bromophenol blue. Approximately 20pg protein was separated on a 10% SDS-PAGE gel 
with a 5% stacking gel, alongside a rainbow molecular weight marker. The mini- 
PROTEANII gel pouring and electrophoresis apparatus was used for the protein gels. 
Samples were electrophoresed in running buffer (25mM Tris, 192mM glycine, 0.1% SDS) 
at 100V for approximately 1 hour.
The SDS-PAGE gel consisted of two portions; the lower ‘running gel’ (50% Protogel 
acrylamide [30% acrylamide and 0.8% bis-acrylamide]; 0.15% SDS; 0.56M Tris-HCl, pH 
8.8; 0.25% TEMED; 0.15% APS) which made up the majority of the gel, and a ‘stacking 
gel’ (1.67% Protogel acrylamide; 0.1% SDS; 0.125M Tris-HCl, pH 6.8; 0.1% TEMED; 
0.5% APS) which covered the running gel and held the comb.
Staining of proteins on a PAGE gel with Coomassie Blue
All reagents were prepared on the day of use. After electrophoresis, the acrylamide gel was 
soaked in a gel-fixing solution for 1 hour (50% ethanol and 10% acetic acid in dHiO). The 
solution was then aspirated from the gel using a pipette, and enough gel-washing solution 
(50% methanol, 10% acetic acid in dH20) was added to cover the gel completely. The gel 
was incubated in the gel-washing solution for 4 hours on a rotating incubator. Following 
the incubation, the gel-washing solution was aspirated from the gel, and the gel was 
covered with 400ml Coomassie stain (0.1% (w/v) Coomassie blue R350, 20% (v/v) 
methanol, and 10% (v/v) acetic acid) and stained with gentle agitation for 3hours, after 
which time the stain was removed by aspiration. The gel was then covered with 300ml 
destain solution (50% methanol, 10% acetic acid in dH20), and incubated with gentle 
agitation. The extent of destaining was monitored throughout the incubation period, and
the destain solution was changed every 30 minutes. Once the protein bands could be seen 
without a strong background staining, the gel was equilibrated in 5% acetic acid for at least 
1 hour.
Transfer of protein to a nitrocellulose membrane (Western blot)
After electrophoresis, or after Coomassie staining, proteins were transferred from the
acrylamide gel to a soaked Protran nitrocellulose membrane using a Trans-Blot 
electrophoretic transfer cell. The membrane and gel were submerged in blotting buffer 
(25mM Tris and 192mM glycine in 20% ethanol) and blotted overnight at 150mA at 4°C.
Blocking the membrane and binding of antibodies
After transfer of proteins, the membrane was blocked in blocking buffer (0.2% Tween20 
and 2% Marvel milk powder in PBS) for 2 hours, followed by a 2 hour incubation with a 
primary antibody (1:1000 dilution). The milk protein from the blocking buffer prevented 
non-specific binding of the primary antibody to the membrane. The primary antibody used 
was a sheep-anti-Drosophila-GS polyclonal antibody, received as a gift from Lesley 
McLellan (Dundee University). After incubation with the primary antibody, the membrane 
was washed four times for 10 minutes in blocking buffer. The membrane was then 
incubated with the secondary antibody (1:15000 dilution) for 1 hour, after which time the 
membrane was washed in blocking buffer three times for 10 minutes, followed by a final 
wash in PBS for 10 minutes. The secondary antibody used was a donkey anti- sheep 
peroxidase conjugated antibody.
Enhanced chemiluminescence (ECL) detection
The Western Lightning Chemiluminescence Reagent was used to visualise the peroxidase 
label on the secondary antibody. Peroxidase catalyses the chemiluminescent reaction 
where light is emitted from the oxidation of luminol. 5ml of the oxidising reagent and 5ml 
of luminol reagent are added together immediately before addition to the washed 
membrane. The membrane was incubated in this mixture for exactly 2 minutes before 
blotting it dry, and visualising on the Typhoon scanner in Chemiluminescence mode.
2.21 S2 cell culture
Drosophila Schneider2 (S2) cells (Schneider, 1972) were obtained as a gift from Carol 
Midgley (Open University). All work with the cells was performed in a laminar flow hood 
using sterile technique.
Preparation of SFM
Serum-Free Medium (SFM) was supplemented with 18mM L-glutamine, 50U/ml penicillin 
and 50ug/ml streptomycin. Once the supplements were added to the SFM, the media was 
stored at 4°C.
Thawing S2 cells from a frozen stock
A frozen stock of S2 cells was kept in liquid nitrogen storage. When required, a 1ml vial of 
cells was thawed, and then resuspended in 5ml SFM. The cells were centrifuged at lOOOg, 
and the medium containing DMSO from the frozen cells was discarded. The pellet was 
resuspended in 10ml fresh SFM, and grown in a 75cm2 tissue culture flask at 27°C in a 
normal atmosphere until the cells reached a density o f-10 x 106 cells/ml.
Routine maintenance of S2 cells
Cells were maintained by splitting at a 1:10 dilution into SFM every 5-7 days, retaining 
1/10 of the conditioned media. The cells were maintained in 75cm2 flasks at 27°C in a 
normal atmosphere. S2 cells grow both in suspension and attach lightly to the flask, so in 
order to remove cells attached to the flask, the flask was tapped, and growth media was 
aspirated over the attached cells to dislodge them. Most cells would be in suspension after 
this treatment, and could be used immediately for centrifugation or dilution.
2.22 Cell viability assay and cell counting
Viability of cells was determined by staining with 0.4% Trypan Blue and counting the 
viable cells using an improved Neubauer haemocytometer. Trypan blue stains dead cells 
blue, while viable cells exclude the dye and remain clear. To count the number of cells in a 
solution, an equal volume of cells was added to Trypan blue solution in an eppendorf tube,
and mixed by gently pipetting up and down. lOpl of this solution was then immediately 
added under the coverslip placed on the haemocytometer, using capillary action, making 
sure that both sides of the counting chamber were not over-filled or under-filled. After 1 
minute, cells were counted by counting the number of cells in the four outer 1mm2 grids 
using an inverted microscope. At least 100 cells were counted in each grid. Living and 
dead cells were counted separately to allow for the calculation of percentage viability.
The number of cells/ml was calculated by multiplying the average number of cells counted 
in each 1mm2 grid by the dilution factor multiplied by 104, ie:
Cells/ml = (total number of cells counted in four 1mm2 blocks)/4 x 2 x 104
Viability was determined as the ratio of the percentage of live cells to the total number of
cells.
2.23 Double stranded RNA for RNAi
Double stranded RNA (dsRNA) was made using a Ambion’s MEGAscript RNAi kit. A 
primary DNA template containing opposing T7 RNA polymerase binding sites 
(GAATTAATACGACTCACTATAGGGAGA) at each end was made by PCR using 
primers specific to GS, GCLC or GFP, obtained from the MRC’s Geneservice RNAi 
construct library (http://www.geneservice.co.uk/products/mai/Dros_RNAi.jsp) in the case 
of GS, or designed from the cDNA sequence in the case of GCLC and GFP. Geneservice 
is a collection of RNAi constmcts which can be purchased. The constmcts were created by 
amplifying Drosophila genomic/cDNA fragments using gene-specific primers with dual 
T7 promoter sequences, and re-amplifying the PCR products to produce DNA templates 
which are used to synthesise dsRNA.
The primary PCR products were purified using QIAquick PCR purification kit, and 
quantified using OD.
Using the MEGAscript RNAi kit, two complementary RNA transcripts were synthesised 
from the DNA template by T7 RNA polymerase and were hybridised together to form a
106
dsRNA product. DNA and single-stranded RNA was then digested by nucleases before 
performing the final dsRNA purification with a solid-phase absorption system. The 
Ambion protocol was followed for a 20pi reaction: lpg of the appropriate PCR product, 
2pl 10X T7 reaction buffer, 2pl of each of the dNTP solutions and 2pl T7 enzyme mix 
was incubated together at 37°C overnight. The mixture was then incubated at 75°C for 10 
minutes, followed by a slow cooling to room temperature to allow the formation of RNA 
duplexes.
DNA and ssRNA were then removed by nuclease digestion as follows: 20pl of the dsRNA 
from previous step was added to 5pl digestion buffer, 2pl DNase I and 2pl RNase in a 50pl 
reaction and incubated at 37°C for 1 hour. After the nuclease digestion, the remaining 
dsRNA was purified from proteins, free nucleotides, and nucleic acid degradation products 
in a filter column system. The amount of dsRNA recovered was usually ~l-2pg RNA/pi.
2.24 RNAi in S2 cells
S2 cells were diluted to a density of 3 x 106 cells/ml in SFM. The cells were assayed using 
Trypan Blue to ensure >90% were alive before continuing. The cells were transfected with 
dsRNA and GeneJuice, a cationic lipid transfection agent, using an adaptation of the 
manufacturer’s protocol:
lml of a cell suspension at a density of 3 x 106 cells was plated per well of a 6-well cell 
suspension culture dish and the cells were allowed to settle overnight. The following day 
2pg dsRNA in lOOpl SFM was complexed with lOpl transfection agent in lOOpl SFM.
This complex was incubated at room temperature for 15 minutes and then added to cells in 
the wells. The plates were swirled vigorously, followed by a 4 hour incubation at room 
temperature in the laminar flow hood. A second addition of dsRNA with the transfection 
agent, along with a further 1.5ml SFM, was pipetted into the the cell/lipoplex mixture in 
the wells, to bring the total volume in each well to 3ml. The cells were then incubated for
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24 hours at 27°C to allow for turnover of the target protein. After the 24 hour incubation, 
cells were ready for use in further experiments.
2.25 Experimentally induced stress and S2 cell viability
S2 cells treated with RNAi and control cells treated with the lipid transfection agent only 
were grown at 27°C in SFM for 24 hours, as described above. The following day cells were 
exposed to DEM or H2O2 .
2.25.1 DEM treatment
Two concentrations of DEM were tested on cells: a low dose of 0.25mM, and a high dose 
of 0.5mM. A stock solution of 300mM was created by adding 10pl of a 6M stock to 190pl 
DMSO. Either 5pl or 2.5pl of this stock solution was added to the 3ml of cells in each 
well, depending on whether the high dose or low dose of DEM was required. After 
addition of the DEM, the plates containing the cells and DEM were swirled gently to mix, 
followed by a 24 hour incubation at 27°C. Following the incubation, cells could be assayed 
at the first time point of Day 1. Day 0 was used to indicate samples taken directly after 
DEM addition.
2.25.2 H2 O2 treatment
Two concentrations of H2 O2 were tested on cells: a low dose of lOmM, and a high dose of 
30mM. A stock solution of 30% H2O2 was purchased from Sigma. Either 10.2pl or 3.4pl of 
this stock solution was added to the 3ml of cells in each well, depending on whether the 
high dose or low dose of H2O2 was required. After addition of the H2 O2 , the plates 
containing the cells and DEM were swirled gently to allow for mixing. TO indicated the 
samples taken directly after the addition of H2O2 . The assay used for testing cell viability, 
and consequently GS and GCLC expression levels in cells exposed to H2O2 required 
samples to be taken every 2 hours over a total assay period of 8 hours. The assay was 
modified from the peroxide viability assay on S2 cells from Radyuk et al (2003).
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2.26 Comet assay
The comet assay, also known as the single cell gel assay, is used for evaluating DNA 
damage in cells. Denatured, damaged DNA will migrate out of a cell under an electric field 
while undamaged, intact DNA remains in the nucleus and migrates much slower under 
electrophoresis. The shape and migration pattern of the ‘comet tail’ is used to assess the 
amount of DNA damage. The protocol used in this study is a combination of various 
techniques, which follow the same principle. Cells were embedded in low melting point 
agarose on a glass slide, then lysed and treated with an alkaline solution to denature the 
DNA and hydrolyse sites of damage. The cells were then electrophoresed and stained with 
SYBR green dye. The samples were then visualised by epiflourescence microscopy on an 
Olympus BX61 microscope using the FITC filter. Analysis was carried out using 
CometScore version 1.5 Freeware, available from http://autocomet.com, using 100 
randomly selected images. The full protocol and reagents used are detailed below:
105 cells were added to 75pi 0.5% low melting point agar solution made up in PBS, and 
warmed to 37°C. This mixture was spread over a frosted glass microscope slide in 
duplicates and left to cool at 4°C for 10 minutes. The slide was then placed in pre-chilled 
lysis solution (2.5M NaCl, lOOmM EDTA, lOmM Trizma base) at 4°C for 1 hour. After 3 
washes in a 0.4M Tris pH 7.5 solution, the slides were placed in an alkaline solution 
(300mM NaOH, ImM EDTA, pH12) for 30 minutes. Samples were rinsed in IX TBE 
three times, and then transferred to a horizontal electrophoresis apparatus and covered with 
IX TBE. Power was set to IV per cm, and voltage was applied for 10 minutes. Slides were 
then dipped in 70% ethanol for 5 minutes, followed by air drying. At this stage, slides 
could either be stored with desiccant for later use, or stained immediately with 50pl diluted 
SYBR Green solution (lpl 10 000X SYBR Green in 10ml TE buffer). Analysis of the 
images is described in Chapter 7.
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2.27 Embryo micro-injection to produce transgenic flies
Human-GS (hGS) cloned into pUAST vector was injected into Drosophila embryos in an 
attempt to create a transgenic fly which could over-express hGS. The embryos used were 
from a fly strain that expressed a transposase, allowing chromosomal integration of the 
transgene flanked with a P-element sequence (Spradling and Rubin, 1982). Mobilisation of 
the transgene from the plasmid onto a chromosome allowed for transgene integration into 
the germline.
DNA used for injecting into embryos was purified by ethanol precipitation to remove any 
salts and impurities. The DNA was resuspended in IX injection buffer (10X buffer: 0.1M 
Sodium Phosphate Buffer pH 6.8, 5mM KC1, filter through 0.22pm syringe filters) to give 
a final concentration of lpg/pl. Prior to loading the DNA into the injection needle, the 
DNA solution was centrifuged at 13 OOOrpm in a microfuge for 5 minutes to pellet any 
undissolved DNA.
In order to collect embryos at a developmental stage prior to blastoderm cellularisation, 
fertilised female flies were allowed to lay eggs in a laying cage on agar plates overnight in 
a 25°C incubator. In the morning, a fresh injection plate was placed into the cage for 1 
hour. After this time period, eggs were collected from the plate, and the procedure of 
putting in fresh plates and collecting embryos was repeated throughout the day at hourly 
intervals. The pre-blastoderm stage required for injection occurs approximately 40 minutes 
after egg laying.
The embryos were dechorionated by rolling them carefully on double sided sticky tape 
until the outer shell has been removed. Between 20 and 50 dechorionated embryos were 
lined up on double-sided sticky tape on the edge of a glass slide with the posterior end of 
the embryo facing the closest edge of the slide, in a process not exceeding 15 minutes. The 
embryos were placed in a desiccator for 5 minutes before being covered with Halocarbon 
oil to prevent further desiccation. Eggs were typically collected every 30-60 minutes at
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25°C and injected within 30 minutes of collection to attempt to prevent an abundance of 
embryos which had passed Bownes stage 2, after which cellularisation occurs.
A glass micro-injection needle was used to inject purified DNA into the embryos which 
had not yet passed to Bownes stage 2 (pre-blastoderm). 2pi of the centrifuged DNA 
solution (lpg/pl) was pipetted into the needle. The needle was then attached to the 
injection apparatus, which consisted of an inverted microscope (Leica), a 
micromanipulator, and an air-pressure injecting device connected to a needle holder (Micro 
Instruments). The slide containing the lined-up embryos with the posterior sides facing the 
needle was placed on the microscope stage, and the needle containing the purified plasmid 
was brought into the same focal plane as the embryos. The needle was brought down 
slowly into the oil, and gently pressed further to break the tip of the needle. The jagged 
edge of the needle facilitates penetration of the embryo. The needle was brought close to 
the posterior side of the first embryo, and the injection button attached to the needle was 
pressed slowly to allow the release of a just-visible amount of DNA into the cell. The 
procedure was repeated for the whole row of embryos.
After injection, the embryos were carefully placed into a shallow hollow made in standard 
fly food in a vial. The embryos were then allowed to develop at 25°C, keeping a close 
check on the developmental stage. At the pupal stage, each pupa was moved to a separate 
vial and allowed to develop to hatching. The resultant white eyed adults (Fo) were crossed 
to w1118 adults. Orange eyed Fi progeny in a w1118 background indicated the presence of the 
transgene marked with w+. The transgenic flies were then collected and crossed to make 
homozygous stocks.
2.28 Oxidative stress tests on flies
Two to three day old flies were collected for the oxidative stress assay, and placed in a 
transparent polyethylene tub with a lid (Figure 2.2) at a density of approximately 75 flies 
per tub. After a 48 hour aging period with access to regular fly food (Figure 2.2A), flies
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were starved for 4 hours before the addition of a 10% sucrose solution containing either 
5mM Paraquat or 6mM DEM to absorbent cotton wool in the fly tub (Figure 2.2B). The 
DEM or Paraquat solution was added to the cotton wool every second day, allowing a 
constant supply of the chemical stressor. The experiment was run at 25°C in the dark, 
because Paraquat is light sensitive (Wang et al., 2000). Dead flies were counted every day, 
and the data were analysed using the SPSS statistical software application (2004, vl3.0). 
Each experiment was completed at least in duplicate, and usually in triplicate. The data 
from all three experiments were pooled to increase the power of the statistical tests. Mean 
and maximal survival was calculated using the Kaplan-Meier analysis. The Mann-Whitney 
non-parametric test was used to determine if there was a significant difference between 
two groups.
A
Vial contain ing  
regular fly food  
m ed ia
*  <3)Cotton w ool - 
plug allow ing  
ventilation
C otton w oo l ball 
s o a k e d  with 
su c r o se  solution
Figure 2.2: Survival tubs used for oxidative stress experiments. Panel A shows the tub during the 2 day 
ageing period where flies are fed on regular fly food. Panel B shows the tub during the administration 
of chemical oxidative stress. The vial containing food is removed, and cotton wool soaked in a sucrose 
solution containing the appropriate chemical stressor is introduced to the tub.
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2.29 RU486 administration with the geneswitch system
The Geneswitch system present in the P{ELAV-Geneswitch}stock (Osterwalder et al., 
2001; Roman et al., 2001) uses a GAL4-RU486 receptor fusion protein to allow 
conditional GAL4 expression in specific tissues controlled by the presence or absence of 
the progesterone chemical RU486 (Mifepristone). In the Geneswitch system, GAL4 is 
expressed in a tissue-specific manner through the use of a specific promoter, as in standard 
GAL4/UAS systems, however the GAL4 molecule is biologically inactive until it is bound 
to RU486. The GAL4-RU486 compound is then able to bind to a UAS receptor and 
thereby activate transcription of the downstream gene.
A 20mM stock solution of RU486 made in 80% ethanol was added to standard fly media to 
a final concentration of 0.5mM. Flies or larvae were then added to the media containing 
the RU486 depending on when transcriptional activation of the target gene was required. 
Transcription is thought to be activated 3 hours after ingestion of RU486, and reaches a 
maximum level 24hours after ingestion (Roman et al., 2001), therefore flies were tested for 
gene expression levels at least 24 hours after being transferred to the RU486 containing 
medium. RU486 has not been found to have any effect on longevity, fecundity or 
behaviour in Drosophila (Roman et al., 2001; Poirier and Seroude, 2005).
2.30 Fly stocks
Table 2.4: Fly stocks used. All stocks are available from Bloomingtons stock centre, with the exception
of the first two stocks which were marked in our laboratory.______________________________________
Genotype Stock name Comments
(if different to
 .________________________ genotype)
w sn3 EP1322 EP1322
w,1IS sn EP0970 EP0970
w!,,s 
CantonS
winscy; dpovl; rhoveA; svspa'po!
Df(l) C128/FM6
C (l)D X yf/F M 6 FM6
1(1) 7Edl /FM7a FM7
w sn3 
y  sn3 v
P-element in the 5' end of copyl of 
GS
P-element downstream of GS 
Our lab reference strain 
Wild type strain 
X-balancer, viable 
X-balancer chromosome 
X-balancer chromosome 
X-balancer chromosome 
GS single copy reference strain 
GS double copy reference strain
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Genotype Stock name 
(if different to 
genotype)
Comments
w m f
f
y2 m74F wy74t sd1 oss 
Drosophila mauritiana Cl 64.1 
Drosophila simulans Oxnard 
Drosophila simulans Ethiopie 
225.1
Drosophila simulans Cl 67.4 
Drosophila sechellia Jallons 
Drosophila sechellia Cousin 
Drosophila melanogaster VAGI 
Drosophila melanogaster BER1 
Drosophila melanogaster RC1 
Drosophila melanogaster BS1 
Drosophila melanogaster PRY2 
Drosophila melanogaster Wild 
10D
Drosophila melanogaster CA1 
w sn3 l(l)8.3/FM6 l(l)8.3/FM6
w ;  ry506 Sb‘ P99B/TM6B, Tb‘ A2-3
w,ns; CyO/Bl; TM6,Tb/TM2,Ubx
P{ELA V- Geneswitch} Elav_GS_GAL4
or GeneSwitch
y ‘ w*; P{w+mC=Act5C- Actin(2)-GAL4
GAL4}25FO!/CyO, y +
y ‘ w*; P{w+mC=Act5C- 
GAL4}17bF01/TM6B, Tb1
w~; P {w \ GAL4}-D42
y  vv"; P{w+mC~tubP- 
GAL4}LL 7/TM3, Sb‘ 
w';P{w+mc=UAS-GFP.565T}T2
w ;P {w mc=UAS-GFP.565T}T2
w';P{w+mC=GAL4- 
Hsp70.PB}2/CyO 
w,l,s; pUAST-GcIc
w " '8; pUAST-Gclc, pUAST- 
Gclm
w1118; hGS-pUAST (A)
Actin(3)-GAL4
D42-GAL4
Tubulin-GAL4
GAL4-HS
UAS-Gc/c
Gclc/Gclm-
pUAST
X chromosome marker stock 
Sibling species 
Sibling species 
Sibling species
Sibling species 
Sibling species 
Sibling species 
Wild type strain 
Wild type strain 
Wild type strain 
Wild type strain 
Wild type strain 
Wild type strain
Wild type strain 
GS lethal mutation created by 
imprecise mutagenesis 
Source of transposase
RU486 dependent GAL4 driver - 
Neuronal expression 
GAL4 driver -  ubiquitous 
expression
GAL4 driver -  ubiquitous 
expression
GAL4 driver -  motomeuron 
expression
GAL4 driver -  ubiquitous 
expression
Ubiquitous UAS-GFP transgene 
used to test GAL4 drivers (2nd 
chromosome)
Nuclear localised UAS-GFP 
transgene used to test GAL4 
drivers (2nd chromosome)
GAL4 fused to a leaky heat shock 
promoter
Contains Drosophila GCLC 
transgene in pUAST vector 
Contains both GCL subunits in 
pUAST vectors
Contains human GS transgene in 
pUAST vector inserted onto the 
second chromosome
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Genotype Stock name Comments 
(if different to
genotype)_________________
Dp(l; Y) W73, ynd B 'f f  /  C(I)Dx 
y ‘f / y '  b a ^ mEH171
Marker stock used to map 1(1)8.3 
lethality
2.31 Statistical tests
Standard statistical tests including the independent t-test and calculation of the standard 
error of the means (SEM) were carried out using the Microsoft Office Excel spreadsheet 
software package (2003, v5.1.2600). Before performing a t-test, the data were tested for 
normal distribution using the ‘descriptive statistics’ option on the SPSS statistical software 
application (2004, vl3.0). The t-test was used to compare the means of two different 
groups of parametric data to determine whether there was a significant difference between 
the groups or not. Statistical significance was defined as significant when p<0.05 (*), and 
highly significant when p<0.01 (**) or p<0.001 (***). SEM measures the standard error 
of the sampling distribution of the means, ie, SEM determines whether the sample mean is 
a true reflection of the population mean. The equation used to calculate SEM was to divide 
the standard deviation of the mean by the square root of the number of observations.
In the case of non-parametric data (non-normal distribution), such as fly survival data, the 
Mann-Whitney U test was used to test for differences between two groups using the SPSS 
software application. The significance level (labelled ‘Asymp.Sig.’ by SPSS) indicated 
whether there was a statistically significant difference between groups or not, where values 
less than 0.05 (*) defined a statistically significant difference, and values less than 0.01 
(**) or less than 0.001 (***) were highly significant.
2.32 Details of Suppliers and Catalogue number of routinely used 
reagents
Reagent Supplier Catalogue number
1Kb plus DNA ladder
Agar
Agarose
Invitrogen
Sigma
Invitrogen
10787-018
A5054
15510-027
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Reagent Supplier Catalogue number
Agarose (low melting point) 
Ammonium persulphate 
(APS)
Ampicillin
Anti-sheep peroxidase
conjugated antibody
p-mercaptoethanol
Benzamidine
Bovine serum albumin
(BSA)
Bromophenol blue
Chloramphenicol
Chloroform
Coomassie Blue solution
dCTP-32P
dNTP solution set
DEM (diethyl maleate)
DEPC
N,N-dimethylformamide 
Disodium hydrogen 
phosphate
Dithiothreitol (DTT) 
Drosophila Serum Free 
Medium (SFM)
DTNB
EDTA (sodium salt) 
Electroblotting buffer 
(western blots)
EMM -Leu medium 
Ethidium bromide 
Ficoll 400 
Formamide 
Glacial acetic acid 
Glucose
L-Glutamine 100X 
Glutathione (reduced) 
Glycerol 
Glycine
Halocarbon oil 700 
Hydrochloric acid 
Hydrogen peroxide (30%) 
Hyperladder II molecular 
weight marker 
Isopropanol 
Insect GeneJuice 
Lithium chloride 
Magnesium chloride 
Magnesium sulphate 
Mifepristone (RU486) 
MOPS 
NADPH
01igo(dt)i2-i8 Primer
Sigma A9414-5G
Biorad 161-0700
Sigma A9393
Sigma A3415
Sigma M7154
Sigma 12072
Sigma A2153
Sigma B0126
Sigma 23275
Sigma C2432
BioRad 161-0436
Perkin Elmer BLU013H
NEBiolabs N0446S
Sigma D97703
Sigma D5758
Sigma D4551
Sigma S3264
Sigma D0632
Invitrogen 10797-017
Sigma D8130
Sigma E6760
National EC880
diagnostics
Formedium PDM0810
Sigma E1510
Sigma F2637
Sigma PS2031
Sigma 537020
Sigma D8066
Invitrogen 25030-024
Sigma G6529
Sigma G5516
Sigma G8898
Sigma H8898
Fluka (Sigma) 08256
Sigma H1009
Bioline BIO-33039
Sigma 19516
Novagen 71259-3
Sigma L4158
Sigma M8266
Sigma M2643
Sigma M8046
Sigma Ml 294
Sigma N1630
Invitrogen 18418-012
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Reagent Supplier Catalogue number
Parafilm M
Paraquat (methyl viologen) 
PEG 4000
Penicillin/Streptomycin
100X
Phenol - chloroform - 
isoamyl alcohol (25:24:1) 
PMSF
Polyvinylpyrrolidone 
p-hydroxymethyl benzoic 
ester
Potassium acetate 
Potassium chloride 
Protogel acrylamide 
Rainbow molecular weight 
marker
RNA ladder, 0.24 -9kb 
Running buffer 10X (SDS- 
PAGE gels)
Sodium chloride 
Sodium dihydrogen 
phosphate
Sodium dodecyl sulphate 
(SDS - 20%)
Sodium hydroxide
Sodium phosphate bibasic
pentahydrate
Sulphosalycyclic acid
SYBR green
TEMED (N,N,N',N'-
T etramethylethylenediamine)
Trichloroacetic acid (TCA)
Tri-sodium citrate
Trizma base
TRIzol
Tris-HCl
Triton X-100
Trypan Blue
Tryptone
Tween20
Urea
Water (tissue culture grade) 
X-gal
Xylene cyanol 
Yeast extract
Sigma P7793
Sigma M2254
BDH Laboratory 29576
supplies
Invitrogen 15070-063
Sigma 77617
Sigma P7626
Sigma P5288
Sigma H6654
Sigma P5708
Sigma P9541
Geneflow A2-0074
Amersham RPN756
Gibco-BRL 15620-016
National EC870
diagnostics
Sigma S3014
Sigma S3139
Sigma 05030
Sigma 480879
Sigma 04283 .
Sigma S0640
Sigma S9430
Sigma 87689
Fluka (Sigma) 91228
Sigma SI 894
Sigma T1503
GibcoBRL 15596-018
Sigma T3253
Sigma 234729
Sigma T8154
Sigma T9410
Sigma P7949
Sigma U5378
Sigma W3500
Sigma B6024
Sigma 335940
BD 288620
Kit & enzymes & vectors Supplier______ Catalogue number
Antarctic phosphatase NEBiolabs M0289S
BioRad DC protein assay 
Calf Intestinal Phosphatase 
Glutathione reductase 
Megaprime DNA labelling 
system
MEGAscript RNAi kit 
One Shot Top 10 
chemically competent cells 
Pfu ultra Taq 
Plasmid Maxi Kit 
pNMTl-TOPO 
SpinPrep gel DNA kit 
Superscript II Reverse 
Transcriptase 
T4 DNA Ligase 
Taq DNA Polymerase with 
1 OX buffer
TOPO TA cloning kit 
QIAquick PCR purification 
kit
Quick ligation kit 
Western Lightning 
Chemiluminescence 
Reagent plus
Wizard Plus SV Minipreps 
DNA purification system 
XL1 Blue E.coli cells
BioRad 500-0116
NEBiolabs M0290S
Sigma G3664
Amersham RPN1606
Ambion 1626
Invitrogen C4040-10
Stratagene 600380
Qiagen 12163
Invitrogen K181-01
Novagen 70958-3
Invitrogen 18064-022
Invitrogen 15224-017
Sigma D1806
Invitrogen K4500-01
Qiagen 28104
NEBiolabs M2200S
Perkin Elmer NEL103
Promega A1330
Stratagene 200130
Equipment/consumables Supplier_____________Catalogue number
0.22 micron syringe filters Sigma F8148
0.45 micron syringe filters Sigma F8273
3MM blotting paper Whatman 3030-866
6-well cell suspension tissue Greiner 657-185
culture dish
DNA Engine Opticon2 MJ Research n/a
thermocycler
Disposable pellet pestle Sigma Z35-9947
Electroporator Stratagene n/a
Electroporation cuvette Flowgen C24182
Fly bottles Scientific Laboratory INC 9002
Fly vials Sarstedt Ltd 58-490
Haemocytometer Scientific Laboratory HAE2112
Hybond N+ nylon membrane
Supplies
Amersham RPN203B
Hybond N nylon membrane Amersham RPN203N
Low profile 0.2ml PCR MJ Research TLS-0801
tubes
Flat caps for 0.2ml PCR MJ Research TCS-0803
tubes
Microfuge Fisher Scientific CFA-105-01 OH
mini-PROTEAN II system Biorad 165-2944
Non-absorbent cotton wool Richardsons Cl 690
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Equipment/consumables Supplier Catalogue number
Orbital shaker Stuart Scientific 
model SOI
n/a
Petri dishes (90mm) Greiner 633185
Pipette tips l-10pl Starlabs SI 11-3700
Pipette tips l-200pl Starlabs S i l l 0-1800
Pipette tips lOO-lOOOpl Starlabs S I111-2721
Pipette tips (filtered) Starlabs SI 120-1810
l-20pl
Pipette tips (filtered) Starlabs S I120-8810
l-200pl
Pipette tips (filtered) Starlabs S I126-7810
lOO-lOOOpl
Plate reader Labsystems Multiscan 
Plus
n/a
Polyethylene tubs and lids Medfor Products Ltd PN92
for fly survival experiments
Protran nitrocellulose Schleicher & Schuell BA83
membrane
Rotating hybridisation Hybaid Micro4 n/a
incubator
Sterile falcon tubes Greiner 188271
Sterile centrifuge tubes Greiner 227270
(50ml)
Sterile pipette, single wrap Greiner 606180
(5 ml)
Sterile pipette, single wrap Greiner 607180
(10ml)
Sterile pipette, single wrap Greiner 760180
(25ml)
Tissue culture flask - 75cm2 Greiner 685-190
Trans-Blot cell Biorad 170-3939
Typhoon 9410 variable Amersham 63-0055-80
mode imager & ImageQuant biosciences
software
UV cross linker Hoeffer UCV500 n/a
X-Ray film Scientific Laboratory MOL 7016
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3 Chapter 3: Genomic organisation of GS in Drosophila 
melanogaster
3.1 Introduction
Glutathione synthetase (GS) which catalyses the second step of the two step glutathione 
synthesis reaction is a member of the ATP-grasp family of enzymes (Galperin and Koonin, 
1997). This superfamily is characterised by the presence of phosphate binding loop and an 
ATP binding cleft formed by two structural elements, each composed of two P-sheets and a 
loop (Murzin, 1996; Galperin and Koonin, 1997). GS catalyses the addition of glycine to 
y-glutamylcysteine by phosphorylating the C-terminal carboxylate of y-glutamylcysteine, 
which forms an acyl phosphate intermediate. This intermediate is bound by glycine, 
resulting in the formation of glutathione, ADP and an inorganic phosphate (Jez and 
Cahoon, 2004).
GS is conserved between species that are evolutionarily diverse, and although the sequence 
homology can vary to a great degree, there are specific residues which are highly 
conserved. Characterisation of GS has been undertaken in humans (Webb et al., 1995), 
mice (Shi et al., 1996), rats (Huang et al., 1995), S. cerevisiae (Inoue et al., 1998), S. 
pombe (Kim et al., 2003), Arabidopsis (Rawlins et al., 1995), Legumes (Frendo et al.,
2001) and E. coli (Gushima et al., 1984), while in Drosophila there has been no published 
work on GS.
The mechanism of action of glutathione synthetase in different organisms is conserved 
despite the lack of extensive sequence homology (Figure 3.1) and differences in molecular 
masses (Jez and Cahoon, 2004). Studying GS in Drosophila should therefore give us 
information on the functioning of GS that will be broadly relevant. Because glutathione is 
one of the major cellular antioxidants, understanding the gene structure of GS in 
Drosophila (referred to DmGS in this thesis) is important to start dissecting the role of GS
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and glutathione in the oxidative stress response and, ultimately, ageing.
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Figure 3.1: Alignment of GS protein sequences from six representative eukaryotic species. Active site 
residues which form specific binding sites in human GS are labelled in yellow (glutathione binding 
site), red (ATP binding site) and blue (magnesium binding site). The alignment was created using a 
Blast search of conserved domains (Marchler-Bauer and Bryant, 2004).
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This chapter describes work aimed at characterising the molecular structure of the DmGS 
locus. The findings present an interesting result with the gene structure of DmGS appearing 
to be a duplication. The distribution of this duplication within strains of Drosophila 
melanogaster, as well as in sibling species of Drosophila, was studied. Finally, the two 
gene copies were compared and the differences discussed.
3.2 Results
3.2.1 Molecular characterisation o f the GS locus in Drosophila 
melanogaster
At the outset of the work described in this thesis, the genomic region of the X-chromosome 
containing DmGS had not yet been completely sequenced, making it difficult to establish 
the structure of the locus using molecular techniques. Preliminary work, discussed further 
in Chapter 4, was aimed at generating DmGS mutants by imprecise excision of an EP- 
element inserted in the 5' end of DmGS (Kansagra and Saunders, pers. comm.). The 
reported insertion site was verified by PCR using primers complementary to the 5' end of 
the P-element paired with primers complementary to positions downstream of the 3' end of 
the P-element, as well as primers pairs complementary to the 3' end of the P-element and 
the region upstream of the 5' end of the P-element (Figure 3.2a). Sequencing the PCR 
products from primer pairs Placl and L3, as well as the product from Pry4 and R l, mapped 
the P-element to the 5'end of DmGS (Kansagra, pers comm.). This corresponds to position 
25010 on BACR29H04 (Appendix A), a Bacterial Artificial Chromosome which contains 
the entire Drosophila GS gene region.
Contradictory results were obtained from further PCR analysis of the P insertion in strain 
EP1322. The primer pairs L3 and Placl, which correspond to the region upstream of the P- 
element, and to the 5' end of the P-element respectively, gave a PCR product of the 
expected size (500bp), and the primer pairs R l and Pry4, which correspond to the region 
downstream of the P-element and the 3' end of the P-element respectively, also resulted in
a PCR product of the expected size (300bp). An anomaly was noted, however, when 
primers L3 and R l, which flank the P-element insertion site, yielded a product 
characteristic of wild type GS from EP1322 genomic DNA (Figure 3.2), even though that 
region of the gene should have been disrupted by the 8kb P-element insertion whose 
position had already been confirmed.
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Figure 3.2: Determining the position of the P-element with the DmGS locus in strain EP1322. Panel A is 
a schematic representation of the hypothetical placement of the 8KB P-element in DmGS, with the 
positions of the various primers along DmGS shown as arrows ‘Left 1-4’ and ‘Right 1-4’. Primers on 
the 3' and 5' ends of the P-element, Placl and Pry4, are shown in pink. Panel B is an agarose gel with 
PCR samples loaded. PCR was performed on DNA from male as well as female EP1322 flies. The first 
two lanes are PCR products from the primer pair L3 on DmGS and Placl on the P-element. The 
middle two lanes are PCR products from the primer pair Pry4 on the P-element and R l on DmGS. The 
last two lanes are PCR products from the primer pair L3 and R l.
L3-Plac1 ' Pry4-R1 L3-R1
a  9  cr 9  0 9
One of the possible explanations for this unexpected result was the presence o f a second 
copy of the DmGS gene which did not contain a P-element. Southern blotting of EP1322 
genomic DNA confirmed the presence of a duplication of DmGS in strain EP1322, and 
was strongly suggestive of a tandem duplication. This was corroborated by the then newly 
published version 3 of the Drosophila sequence release (Celniker et al., 2002). After 
verifying the existence of a DmGS duplication, the presence of the DmGS duplication in 
other strains of D. melanogaster was tested by PCR.
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3.2.1.1 Southern Blot of EP1322 genomic DNA reveals presence of a DmGS 
duplication
A Southern blot was performed on EP1322 genomic DNA to determine whether a 
duplication of DmGS was present in this strain. By digesting the region of the genome 
containing DmGS with the restriction enzyme Haell, which has recognition sites within as 
well as flanking the P-element, a unique digestion pattern would be expected for each copy 
of the DmGS gene provided there was a gene duplication. Strains EP0970 and wIns, which 
did not contain a P-element within DmGS, were used as controls.
The probe used in the Southern blot was amplified by PCR from BACR29H04 DNA using 
the primers L3 and R4, which are complementary to the region spanning positions 24740- 
26320 on the BAC (Appendix A). The 1580bp probe corresponds to a genomic region 
extending over the insertion site of the P-element in strain EP1322.
As illustrated in Figure 3.3 A, in the presence of the P-element, the probe was expected to 
bind to 3 fragments of DNA after digestion with Haell; A (2392bp), B (705bp) and C 
(116bp). In the absence of the P-element, the probe should bind to two fragments of DNA; 
D (108 lbp) and C (the identical fragment produced in the presence of EP1322).
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Figure 3.3; Panel A: Schematic representation of the DmGS genomic region (green bar) digested with 
H aell and probed with L3-R4 probe (red bar). The positions of H aell restriction sites are marked 
with blue bars, numbering starts at 0 at the first H aell site. The position of the probe is also shown 
underneath the probe on the diagram. Genomic DNA from EP1322 and control male flies was digested 
with H aell and in a Southern blot was probed with a PCR fragment spanning the region of the P- 
element insertion. Panel AI illustrates the standard 5' DmGS genomic region: Fragments D and C 
(yellow bars) were expected after digestion. Panel AH shows the position of the P-element in the 5' end 
of DmGS, along with the H aell restriction sites. Panel AIII illustrates the expected fragment sizes in 
the case where the P-element is present in the 5' end of DmGS: Fragments A, B and C (yellow bars) 
were expected after H aell digestion.
Panel B: Southern Blot results of H aell digestion of EP1322 genomic DNA from adult males, with 
control strains EP0970 and w 1118, probed with fragment L3-R4. EP1322 DNA has four bands: 
Fragments C and D expected in the absence of the P-element EP1322, as well as the additional two 
fragments (A and B) expected only in the presence of P-element EP1322. Bands of 705bp (fragment B), 
2392bp (fragment A) and 1116bp (fragment C) correspond to the sizes expected in the presence of the 
P-element, and the fragments of 1116bp (fragment C) and 1081bp (fragment D) correspond to the 
sizes expected in the absence of the P-element. The control DNAs had 2 fragments of 1116bp and 
1081 bp (fragments C and D), which was expected of the genomic region probed after digestion with 
Haell.
125
The Southern blot of EP1322 genomic DNA resulted in bands corresponding to sizes 
expected in the presence, as well as the absence of the P-element, thus providing proof of 
two distinct copies of DmGS in this strain (Figure 3.3B). The blot results for the controls 
w,m  and EP0970 gave the expected results of two bands of 1081bp and 1116bp as there 
was no P-element present in DmGS in these strains. The two bands of 108 lbp and 1116bp 
in EP1322 and EP0970 are not clearly resolved in this blot since there is only a 35bp 
difference in size between the two bands. A shorter exposure time would have shown the 
presence of the two separate bands more distinctly.
3.2.1.2 Bioinformatic evidence of a DmGS duplication
Further evidence of the presence of a DmGS gene duplication was obtained with release 3 
of the Drosophila genome sequence, in which sequencing of the region including DmGS 
was completed. A map of the DmGS region reveals a tandem duplication of DmGS (Figure 
3.4 A). There is an internally deleted 297 element inserted into the middle of the distal copy 
of the DmGS gene (CG6835). Full length 297 elements are 6.9kb (Dominguez and 
Albomoz, 1999): the 297 element within CG6835 has an internal deletion of 4.26kb. The 
function of CG6835 is annotated as glutathione synthetase on FlyBase. Its gene structure 
appeared very similar to the neighbouring gene CG32495. A sequence alignment of those 
two genes revealed them to be identical, other than the presence of the internally deleted 
297 element within the large intron of CG6835. The presence of a DmGS gene duplication 
has since been confirmed in the latest release (version 4.2.1, September 2005) of the 
annotated Drosophila sequence, which assigned a glutathione synthetase function to 
GC32495, the proximal (to the centromere) copy of DmGS (Drysdale and Crosby, 2005), 
as shown in Figure 3.4B.
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Figure 3.4: Schematic representation of DmGS gene structure as illustrated on FlyBase. Panel A is the 
original version 3 release that was available after the start of this project (Celniker et al., 2002). The 
green rectangles represent cDNA ESTs, the blue rectangles represent exons of genes, and the turquoise 
inverted triangles represent P-element insertions. The gene highlighted in red (CG6835) is DmGS distal 
copy, and CG32495 is the proximal copy of DmGS. Panel B is the current gene model of the DmGS 
locus from Release 4.2.1 (September 2005) of the annotated sequence on FlyBase (Drysdale and 
Crosby, 2005). The 297 element insertion site is circled, as is the position of EP1322.
3.2.2 Determination o f the presence o f the GS duplication within 
Drosophila strains.
In order to determine how widespread the GS duplication is within D. melanogaster and its 
sibling species, a PCR test was carried out on a number of strains. The primer pair 
GS_Exl2F and G S R 4  was designed in order to amplify a fragment between the last exon 
of the distal copy to the first exon of the proximal copy of DmGS, a specific amplification 
product of the region between the two DmGS copies (Figure 3.5). This PCR reaction 
allowed a rapid means of detecting the presence or absence of the duplication.
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Figure 3.5: The DmGS duplication PCR test. Panel A shows a schematic representation of the primers 
used to amplify the region between the two copies of DmGS. Primer E xl2F  was designed to anneal to 
the 3' end of the distal copy of DmGS, and to form a product with the primer GS-R4, which was 
designed to correspond to the 5' region of the proximal copy of DmGS. The size fragment expected 
from an amplification of the region between the two copies of DmGS was 3020bp. A control PCR 
reaction was performed to test DNA integrity using primers Exl2F and Exl2R, which amplifies a 
230bp region of the 3' end of DmGS, regardless of the duplication status. Panel B is a photograph of an 
agarose gel with PCR products. DNA was extracted from male flies of each strain tested, and a PCR 
reaction was performed to amplify the region between the two copies of DmGS with primers Ex-12F 
and DmGS-R4. CantonS was used as a positive control for the presence of the duplication in all PCR 
reactions. PCR cycling conditions used were as described previously, with an annealing temperature of 
52°C and an extension time of 2 minutes. Lane 1= 1Kb plus DNA marker, lanes 2-6 contain PCR 
products from primers 12F-R4 for w1118, CantonS, EP0970, EP1322 and BACR29H04. Lanes 7-11 are 
the positive controls for the previous six PCR samples amplified with primers Exl2F-12R.
An agarose gel with an example of the PCR reaction using strains with the duplication is 
shown in Figure 3.5B. It is interesting to note that not all strains of D. melanogaster tested 
contained the DmGS duplication (Table 3.1). None of the sibling species tested 
{Drosophila mauritiana C l64.1, Drosophila simulans Oxnard, Drosophila simulans
128
Ethiopie 225.1, Drosophila simulans C l67.4, Drosophila sechellia Jallons, and Drosophila 
sechellia Cousin) contained the duplication (Table 3.2), so it is suspected the duplication is 
present only in specific strains of Drosophila melanogaster.
Table 3.1: Results of the PCR test for the presence of the DmGS duplication in a range of D. 
melanogaster laboratory strains________________
D. melanogaster strain Duplication status
winscy One copy
1(1)8.3/FM6 One copy
FM 6/C(l)DXyf One copy
FM7 One copy
w sn3 One copy
f One copy
w m f One copy
FM6/Df(1)C128 Two copies
y  sn3 v Two copies
y2 m74F wy74x sd1 oss Two copies
CantonS Two copies
w sn3 EP1322 Two copies
w1118 snEP0970 Two copies
S2 cells Two copies
w1118 Two copies
Table 3.2: Results of the PCR test for the presence of the GS duplication in a range of Drosophila 
sibling species_____________________________________________
Drosophila species Duplication status
Drosophila mauritiana C l64.1 One copy
Drosophila simulans Oxnard One copy
Drosophila simulans Ethiopie 225.1 One copy
Drosophila simulans C l67.4 One copy
Drosophila sechellia Jallons One copy
Drosophila sechellia Cousin One copy
CantonS, a widely used wild type strain, does have two copies of the gene, while a variety 
of strains held in our laboratory, including the balancers winscy, FM6, FM7, and strains 
marked with w sn , f  and w m f  only had one copy of DmGS. The commonly used 
Drosophila S2 cell line had two copies o f DmGS. A selection of wild type Drosophila 
melanogaster strains from different geographical regions and collection dates were also 
tested for the duplication. All of the wild caught strains possess the DmGS duplication 
(Table 3.3).
Table 3.3: Results of the PCR test for the presence of the DmGS duplication in a range of Drosophila 
melanogaster wild type strains______________________________________________________________
Drosophila melanogaster 
strain
Country of collection Date of 
collection
Duplication status
VAGI Athens, Greece 1965 Two copies
BER1 Bermuda 1954 Two copies
RC1 California, USA 1954 Two copies
BS1 Barcelona, Spain 1954 Two copies
PYR2 Pyrenees, Spain 1965 Two copies
Wild 10D South Carolina, USA 1966 Two copies
CA1 Cape Town, South Africa 1954 Two copies
3.2.3 Resolution o f the position o f the 297 element in the DmGS gene 
duplication
A partial 297 element with a 4.26kb internal deletion is assigned to the distal copy of 
DmGS (CG6835) in FlyBase, but because the sequences of the distal and proximal copy 
are identical, it was unclear how the sequence assembly process had assigned this element 
specifically to the distal copy. Direct PCR amplification of the 297 element was not used 
as a strategy because of the high frequency of 297 elements dispersed throughout the 
genome: any attempt at amplification using a primer pair complementary to a 297 
sequence resulted in numerous bands (data not shown).
In order to confirm that the 297 element was indeed inserted in CG6835, BACR29H04 was 
digested with Spel and Kpnl. The SpeI site is distal to CG6835, and is unique to the distal 
copy of DmGS. The positions of the restriction enzymes cleavage sites, and the expected 
sizes of the digestion products are illustrated in Figure 3.6. The positions of the probe and 
restriction sites, along with expected fragment sizes are listed in Table 3.4. The probe was 
amplified using the primer pair GS_upstream_forward and GS upstream reverse.
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Figure 3.6: Panel A is a cartoon illustrating the positions of restriction enzyme sites relative to DmGS 
and the probe. The sizes of the digestion fragments will depend on whether the 297 element is present 
in the distal copy of DmGS or not. If the 297 element is present in the distal copy (CG6835), the 
fragment expected will be 7779bp (blue bar). The 14093pb fragment (green bar) is present when there 
is incomplete digestion of the fragment with Spel. If the 297 element is absent from the distal copy of 
DmGS, the expected size of the fragment would be 20880bp. The positions of the restriction enzyme 
sites, as well as the copies of DmGS and the 297 element on BACR29H04 (Appendix A) are given on 
the lower half of the diagram. The position of the probe on BACR29H04 is 22931-23431 (500bp).
Panel B shows an X-ray film of the Southern blot performed on BACR29H04, with the DNA fragment 
expected if the 297 element is in the distal copy of DmGS, and there is the large 14093bp fragment 
produced from an incomplete digestion with Spel.
Table 3.4: Positions of restriction sites, DmGS and the probe on BACR29H04.
Molecular element Position on BACR29H04
Spel 22936
Kpnl 16623 + 30715 + 43829
Distal copy of DmGS (CG6835) 24784-33692
Proximal copy of DmGS (CG32495) 34939-41115
Probe 22931-23431
297 element 28890-31633
EP element EP1322 25010
3.2.4 Resolution o f the position o f P-element EP1322 in the DmGS 
gene duplication
It was important to unambiguously determine which copy of DmGS contained the P-
element in strain EP1322. In order to resolve this question, two primer sets were used to 
amplify the region upstream of the P-element. One set used a forward primer designed
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from the unique sequence upstream of the distal copy of DmGS (GS-upstream-F), and the 
second set used a forward primer designed from the sequence at the end of the distal copy 
of DmGS (Exl2F). Both sets used PlacR, which is complementary to the proximal end of 
the P-element in strain EP1322, as a reverse primer.
The primers GS-upstream-F, which is not in the duplicated region, and Plac-R, were 
expected to amplify the region upstream of the duplication to the 5' region of the P-element 
if the P-element was present in the distal copy (Figure 3.7A). The second primer pair 
Exl2F and Plac-R would amplify the region from the 3' end of the first copy of DmGS to 
the 5' end of the P-element if  the P-element was present in the proximal copy. The PCR 
was performed on DNA extracted from male EP1322 flies, using the CantonS strain as a 
control. The result from this experiment was an amplification of the 231 Obp region 
between GS-upstream-F and Plac-R (Figure 3.7B), whereas no product was amplified with 
primers Exl2F and Plac-R (data not shown). These results confirmed that the location of 
the P-element in EP1322 was in the distal copy of DmGS, as is indicated on the sequence 
data from FlyBase (Celniker et al., 2002).
Plac Ex12F
upstream F
P-element
Distal copy of GS -  CG6835 Proximal copy of GS -  CG32495
M EP1322 CantonS
m
«----------2 .3kb
Figure 3.7: Confirmation of the P-element position in the distal copy of DmGS. Panel A : Placement of 
primers on the DmGS locus used to determine the position of the p-element EP1322 within the DmGS 
duplication. Panel B: Agarose gel containing the PCR product from primer pair G S u p s t r e a m F  and 
Plac. PCR cycling conditions were standard, with an annealing temperature of 53°C, and an extension 
time of 3 minutes.
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3.3 Discussion
The data in this chapter have clarified the position of the 297 element and the P-element in 
strain EP1322 . The P-element in strain EP1322, as well as the 297 element, is in the distal 
copy of DmGS, confirming their positions in the published sequence. The transcriptional 
consequences of the 297 element in an intron of the distal copy of DmGS (CG6836) are 
unclear.
The data presented in this chapter have also demonstrated the presence of a DmGS 
duplication in certain strains of D. melanogaster. The majority of D. melanogaster 
laboratory and wild type strains tested for the duplication carried two copies of DmGS. The 
duplication was not, however, present in any of the Drosophila sibling species tested. The 
only D. melanogaster strains tested that did not have a duplicated DmGS locus specific to 
D. melanogaster were inbred laboratory strains including X-chromosome balancer strains, 
and the mutant 1(1)8.3/FM6. The X-linked lethal mutant 1(1)8.S/FM6 was created from the 
EP1322 parental stock using P-element excision mutagenesis, as discussed further in 
Chapter 4. The loss of a copy of DmGS in 1(1)8.3 could have resulted from the repair of the 
double strand break induced during P-element excision, by the same mechanism used in 
targeted mutagenesis to reduce two copies of the target sequence to one (Engels, 1996).
The only other instance of a GS duplication in other lineages studied is in the legume 
family of plants (Frendo et al., 2001). The GS locus in legumes contains a tandem 
duplication of GS which occurred through unequal crossing over after the divergence 
between Fabates (legumes), Solanales and Brassicales families. The legume duplicate GS 
gene encodes two different proteins; one copy encodes a GS homologue, and the second 
copy encodes ‘homoglutathione synthetase’ which catalyses the formation of homo­
glutathione as a result of 2 amino acid mutations (Frendo et al., 2001). Homo-glutathione 
differs from glutathione in that homo-glutathione contains a p-alanine molecule instead of 
the glycine residue found in GSH (Matamoros et al., 1999). The two forms of GS have
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differing distribution patterns between members of different genera, as well as between 
different plant organs within one species (Frendo et al., 2001).
Identical tandem gene duplications are thought to arise from unequal cross-over during 
homologous recombination, where there is a misalignment between genes during meiosis, 
leading to the formation of gametes with different copy numbers of genes (Lynch and 
Conery, 2000; Lynch, 2002; Zhang, 2003), illustrated in Figure 3.8.
Unequal crossing over 
■  ■ ■
Tandem duplication
Figure 3.8: Cartoon of the 'unequal crossing over' mechanism of gene duplication. Unequal 
recombination between paralogous (share a common ancestor due to a duplication event) sequences 
(light and dark blue boxes) results in a tandem duplication (green box) in the genome of the gamete. 
Diagram modified from Hurles (2004).
Gene duplications are estimated to arise at a rate one in a hundred genes every million 
years (Lynch and Conery, 2000), and are thought to play a vital role in the evolution of 
new gene functions. A large proportion of genes are duplicated in most organisms, with 
Drosophila carrying an average number of duplicated genes, as shown in Table 3.5.
Table 3.5: Gene duplication prevalence in selected organisms. (Zhang, 2003)
Organism Total number of 
genes
Percentage of genes 
arising from duplications
Mycoplasma 677 44
penumoniae
Helicobacter pylori 1590 17
Haemophilus influenzae 1709 17
Saccharomyces 6241 30
cerevisiae
Caenorhabditis elegans 18 424 49
Drosophila 13 601 41
melanogaster
Arabidopsis thaliana 25 498 65
Homo sapiens 30 000 -50
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There are four possible fates for a duplicated gene: dose repetition, pseudogenisation, 
neofunctionalisation or subfunctionalisation. In dose repetition, both copies of the gene 
remain active. This is beneficial in the case of highly expressed proteins, e.g. histones and 
ribosomal RNA genes (Hurles, 2004). In pseudogenisation, one of the genes develops a 
null mutation and becomes a pseudogene (Walsh, 1995; Zhang, 2003), in a process which 
takes several million years in animals (Lynch, 2002). Neofunctionalisation is the process 
whereby the duplicated gene either evolves into a new gene with a new function, or, more 
commonly, a gene with a function related to the parental gene’s function (Zhang, 2003). In 
the GS duplication reported in legumes (Frendo et al., 2001), one copy of GS retained the 
original function, and the duplicated copy of GS acquired the ability to synthesise homo- 
GSH.
It has been proposed that it is evolutionarily more favourable for gene duplicates to be 
conserved by subfunctionalisation (Lynch and Force, 2000), where both copies of the gene 
accumulate mutations which partition the functions of the single copy gene between the 
duplicates, necessitating the preservation of both copies (Lynch and Conery, 2000). In this 
case there is an extended period where both gene copies are exposed to natural selection, 
enhancing the chance of a beneficial mutation with a new function. One example of 
subfunctionalisation is the expression of each copy in different tissues and different 
developmental stages, as is observed in the Drosophila p-tubulin gene family (Lynch and 
Force, 2000; Conant and Wagner, 2003). Another interesting case in Drosophila is the 
Pax-6 homologue eyeless, which is involved in eye development. A duplication of eyeless 
was discovered, and named twin o f eye (toy). Toy acts upstream of eyeless by directly 
regulating expression of eyeless (Czerny et al., 1999). In this case of 
subfunctionalisation/neofunctionalisation, the duplicated gene has a different function to
the parental gene, but is involved in the parental gene network.
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It is not known at this stage what effect the presence of two copies of DmGS has on strains 
which carry the duplication, or whether both copies are even functional. It is interesting to 
note that the sequences of the two copies, according to FlyBase, are identical, including the 
large stretches of intronic sequence. This would suggest a very recent appearance of the 
duplication, as the sequence has not diverged at all. Thornton and Long (2002) suggest 
there was a recent burst of duplication events on the Drosophila melanogaster X- 
chromosomes.
The lack of any difference between the two copies seems to suggest the recent appearance 
of the second copy of DmGS, supported by the lack of the duplication in any sibling 
Drosophila species. It must, however, be noted that the similarity of the sequences in 
published data could be an artefact of the sequence assembly methods. The presence of a 
DmGS duplication in all tested wild type strains of D. melanogaster suggests that the 
reduction from two copies to one copy of DmGS in a few laboratory strains of D. 
melanogaster may have happened recently, perhaps in the last 100 years, in a parental 
stock kept in captivity. This parental strain could then have been used to create marked 
stocks that inadvertently carried the single copy DmGS mutation.
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4 Chapter 4: Characterising a putative GS knockout fly 
4.1 Introduction
The molecular structure of the glutathione synthetase (GS) locus was confirmed in the 
previous chapter, leading to the next stage in the project: determining the function of GS in 
Drosophila melanogaster. A starting technique for determining gene function is a 
bioinformatic analysis of the region. The locus under investigation in this study has a 
sequence similarity to GS enzymes from a series of both prokaryotes and eukaryotes, 
including yeast, worms and mice (Drysdale and Crosby, 2005). After a bioinformatic 
suggestion of the function of a gene, experimental work involving gene knockouts and 
overexpression follows.
A powerful method of studying the phenotype of a specific gene is to obtain a mutation in 
the gene of interest. The effects observed as a result of knocking out the gene of interest 
can give useful information on the function of the gene. In Drosophila, mutants can be 
created by chemical mutagens or irradiation, but random mutations created using those 
techniques are not useful when a mutation is required in a specific gene. P-element 
mutagenesis is a far more valuable technique in the creation of mutations in a particular 
locus (Adams and Sekelsky, 2002).
P-elements, described in Chapter 1 (section 1.3.2.1), can be used to disrupt gene function 
by insertion into a gene of interest (Ryder and Russell, 2003). Alternatively, P-elements are 
used to create mutants by imprecise excision: in approximately 1% of excision events, the 
break at the excision site will not be repaired correctly, resulting in a deletion of the region 
surrounding the P-element and a subsequent loss-of-function mutation in a neighbouring 
gene (Engels, 1996; Ryder and Russell, 2003).
A candidate lethal allele of DmGS (1 (1)8.3) had previously been obtained. This chapter 
describes work aimed at determining whether 1(1)8.3 was in fact mutant for DmGS.
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4.2 Results
4.2.1 P-element mutagenesis of DmGS
The attempt to induce a mutation of DmGS was started when the existence of a tandem 
duplication of DmGS was not known (Pushpa Kansagra, pers. comm.). This section 
reviews the derivation of a candidate lethal allele of DmGS. Strain EP1322 contains an EP- 
element situated in the 5' end of the distal copy of DmGS. An EP element is a modified P- 
element which carries a UAS near one end (Adams and Sekelsky, 2002). Despite the 
additional UAS sequence, the EP element functions in the same manner as a non- 
autonomous P-element would when exposed to transposase, therefore the EP element used 
in this study will be referred to as a P-element throughout this chapter. The EP1322 P- 
element was mobilised by a dysgenic cross, using a A2-3 transposase element bearing 
strain (Section 2.30). Occasional mobilisation events would be expected to be imprecise, 
disrupting a portion of the DmGS gene, and some of these events would be expected to be 
lethal. In four P- element mobilisation experiments, one X-linked ‘rip-out’ lethal was 
recovered (Pushpa Kansagra, pers. comm.).
The crossing scheme used to mobilise the EP1322 P-element is illustrated in Figure 4.1. In 
the first cross, strain EP1322, marked with white (w) and singed (sn3) (Pushpa Kansagra, 
pers. comm.) was crossed to a stock containing A2-3 transposase on a chromosome marked 
with Stubble (Sb), which enabled mobilization of the P-element. In the second cross, the 
transposase was eliminated by segregation, and progeny with white eyes were collected as 
this indicated a loss of the P-element, which was marked with w+. In the third cross, white­
eyed progeny were balanced over FM6. The progeny of these single pair matings would be 
scored for sn, which marked the parental EP1322 chromosome, and if males carrying sn 
were absent, it would indicate the presence of a sex-linked lethal mutation. In the case of a 
sex-linked lethal, female siblings were crossed to FM6 males to obtain a balanced stock.
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The same crossing scheme was performed using strain EP0970 which contains an EP- 
element approximately 4.5 KB from the 3' end of the proximal copy of DmGS.
Cross (i)
99 w1118 sn3 EP1322 X GG w1118 / Y\Sb A2-3/TM6B,7b
I
Cross (ii)
a a  iV1118 sn3 EP1322 / Y; Sb A2-3 /+ X 99 winscy
I
Cross (iii)
9 w1118 sn3 EP1322* /winscy; X a  FM6
isingle pair matings
If males in the class marked with sn indicated below were absent, it indicated a sex- 
linked lethal
a  w1118 s/73 EP1322*/Y
If a male lethal class was discovered, the female flies were collected and crossed to FM6 
males to obtain a balanced stock 
9 sn3 EP1322*/FM6
Figure 4.1: The mating scheme followed for imprecise mutagenesis of DmGS in stock EP1322. In the 
first cross strain EP1322 females were crossed to flies carrying a transposase on a chromosome 
marked with Sb. In the second cross male flies carrying a copy of EP1322 as well as the transposase 
were crossed to winscy X-chromosome balancer to segregate the transposase from EP1322. In the third 
cross, female flies were crossed to an FM6 balancer to detect X-linked lethal flies. *EP1322 indicated 
EP1322 exposed to transposase. The winscy balancer was used in cross (ii) because FM6/FM6 females 
are sterile.
Four rounds of imprecise excision mutagenesis using EP1322 were completed, resulting in 
the recovery of the recessive lethal 1(1)8.3/FM6. This lethal stock has been the subject of 
subsequent studies into the gene encoding glutathione synthetase. No lethal mutants were 
recovered from EP0970 mutagenesis, probably as a result of the larger distance between 
DmGS and the P-element.
4.2.2 Determination of the source of iethaiity in l(1)8.3/FM6
After the recovery of the lethal mutant 1(1) 8.3, it was important to ascertain whether the 
lethality was due to disruption of DmGS or a result of the disruption of another gene 
surrounding the P-element after mobilisation of EP 1322. The P-element may also have 
transiently inserted into another region of the genome, where it could interrupt the 
sequence of an essential gene or its promoter. Three methods are available to determine
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whether the lethality in 1(1)8.3 was due to DmGS disruption; firstly, the lethal mutation 
could be mapped by crossing 1(1)8.3/FM6 to a marker stock with a series of easily scorable 
mutations along the X chromosome. A study of the recombinant classes should then be 
able to place the source of the lethal mutation close to 1(1)8.3/FM6 or elsewhere along the 
chromosome. A second approach used was a complementation test using a duplication of a 
region known to contain DmGS. The third and most convincing method to confirm whether 
the lethality of 1(1)8.3/FM6 is a result of the disruption of DmGS would be to rescue the 
males via a P-element mediated transformation with a transgenic form of GS; if  the 
functional transgenic GS inserted into the genome allowed males to live, it would prove 
that DmGS was disrupted in 1(1)8.3/FM6.
4.2.3 Recombination mapping l(1)8.3
In order to carry out this recombination experiment, a stock with markers along the X- 
chromosome (y2 m74F wy741 sd1 oss) was crossed to 1(1)8.3/FM6. The crossing scheme 
illustrated below (Figure 4.2) was followed, and the resultant recombinant flies were 
scored for the presence of markers. The proportion of recombinant progeny recovered 
would then indicate where on the X-chromosome the lethal mutation is situated.
g g  y2 m74F w / 4i s d  03s x 99 wsn /(1J8.3/FM6
I mass mating
99 /(1 )8.3/ y2 m74F wy™ scf1 os® x 
I
9  Recombinant/FM7 x
GG FM7/Y
G y2 m74F wy74' sd  os® /Y
[ single crosses, score progeny
Examine progeny;
Score recombinant/y2 m74F wy74' sd  oss 9for all markers, and check for viability of recombinant G
Figure 4.2: Recombination mapping of l(l)8.3. In the first cross, a multiple balanced stock is crossed to 
l(l)8.3/FM6 in mass matings. The l(l)8.3/marker females were then crossed to FM7 males. The 
recombinant marker/l(l)8.3 was then crossed to the parental marker stock in single pair matings.
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This experiment was hindered by the low penetrance of the os* phenotype, a round, small 
eye placed more on the top of the head than on the side (Lindsley and Zimm, 1992). The 
map of the markers in relation to DmGS (Figure 4.3) indicates the importance of this 
marker in determining which parental copy of DmGS the recombinant flies carried, as it is 
the only marker proximal to DmGS. Fortunately it was possible to distinguish between the 
two parental copies of DmGS using PCR because the marker stock carried a duplicated 
form of DmGS, while 1(1)8.3 has a single copy of DmGS. The number of recombinants 
recovered in each class is shown in Table 4.1.
y w +  sr>+ m wy sd G Sos
ihi  i   n n  i m
Figure 4.3: Linkage map of the markers present in the marker stock in relation to the markers on 
l(l)8.3 and GS. The positions of the alleles on the X-chromosome which has a recombination map 
length of 66 are: y=0.0, w=1.5, sn=21.0, m=36.1, wy=40.7, sd=51.5, DmGS=59, os=59.2
It was unexpected that one of the parental classes (sn m wy+ set) would be so poorly
represented, and the reason for this is not known. The majority of the recombinants with
the wild type se t phenotype originating from 1(1)8.3 exhibited X-linked lethality, while
most sel recombinants were not male lethal. The exception is the class 2 recombinant (sn
m+ wy sel) which was present only as a male lethal stock, where it is possible that a second
recombination even occurred between sd  from the marker stock chromosome, and DmGS
from the 1(1)8.3 chromosome, sel is the closest marker distal to DmGS, thus making it less
likely for a recombination event to occur between sel and DmGS. All male flies with the
wild type set allele originating from 1(1)8.3 were then assayed for the DmGS duplication,
which was present only in the marker stock, using PCR. Every set recombinant tested had
a duplicated DmGS, indicating the presence of the wild type DmGS originating from the
marker stock. The lack of viable males with the mutated form of DmGS originating from
1(1)8.3 is good evidence that lethality in 1(1)8.3 is closely linked to the DmGS gene.
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Table 4.1: Recombinant classes for 1(1)8.3/FM6 crossed to the marker stocky2 m74F wy1*1 sd1 oss. The 
total number of vials containing each of the recombinant classes is shown. Of that total, the number of 
vials containing male lethal flies is listed. All male recombinants with the sd+ phenotype were tested 
for the DmGS duplication by PC R , and each one of the recombinant males carried the wild type 
DmGS from the marker stock.
Markers present on 
recombinant lines
Total number of 
vials containing 
the recombinant 
class
Number of 
vials
containing 
male lethal 
recombinants
Number of vials 
with male flies 
containing GS 
duplication
parental sn *Fm wy se t 1 - 1
3 4~sn 4~m wy sd - - -
2 sn +m wy sd 1 1 -
1 4“sn +m wy set 1 1 -
1 4~sn 4~m wy se t 8 1 7
2 4-sn m wy set 1 1 -
3 4~sn m wy se t 2 - 2
parental +sn m wy sd 30 2 All tested 
individuals had the 
duplication
4.2.4 Rescue of 1(1)8.3/FM6 by crossing to a strain with DmGS dupiication
The mapping of 1(1)8.3 lethality to the DmGS locus region in the previous experiment 
suggested that 1(1)8.3 lethality should be rescued by a duplication including DmGS.
1(1)8.3/FM6 was crossed to a strain with a duplication of the region containing DmGS on 
the Y chromosome. The Y chromosome of strain Dp(1; Y) W73, y 31d B1BS /  C(1)DXy!f  / y 1 
bazEH1?1 contains a duplication of region 15B1 to 16F of the X-chromosome (Grumbling 
and Strelets, 2006), which covers region 16F on the X-chromosome containing DmGS. 
1(1)8.3/Dp(l :Y)W73 males with white eye and singed hair phenotypes would indicate a 
rescue of DmGS however once the experiment was performed, it was found that 1(1)8.3 
was not rescued by the duplication Dp(l:Y)W73 (Table 4.2).
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Table 4.2: Crossing scheme to attempt rescue of l(l)8.3IFM6 by a stock containing a duplication of 
DmGS on the Y chromosome (Dp(l;Y) W73, y31d B1#* /  C(l)Dxy1f / y l baz?H1?1). The genotypes of male 
and female gametes are shown to illustrate the four possible progeny outcomes. The genotype in red is 
that of the male fly that would be present in the case of a successful rescue by the duplicated 
chromosome region. Over 200 individual progeny were scored in this experiment.
Female gametes
VIV
V
E
CSW>
y  baz
.§ Dp(l;Y)W73
FM6
y  baz / FM6
FM61 Dp(l;Y)W73
l(l)8.3
1(1)8.3 /  y  baz
l(l)8.31Dp(l;Y)W73
The lack of rescue could be a result of inaccurate mapping of the duplicated portion of the 
X-chromosome in strain Dp(l;Y) W73, y31dB113s /  C(1)Dxy1f / y 1 bazEH17\  or it could mean 
that the lethality of 1(1)8.3 is not in fact a result of DmGS disruption.
4.2.5 Attempted rescue of l(1)8.3 by complementation with a cloned copy of 
human GS
The failure to complement I(1)8.3 with a duplication expected to contain a copy of the 
DmGS locus led to a third strategy to resolve the issue of whether the lethal was mutant for 
GS. In order to convincingly prove the linkage of lethality in 1(1)8.3 to DmGS, a cloned 
functional copy of a GS gene would have to be introduced into a 1(1)8.3 fly, and be shown 
to reverse the X-linked lethality. In this experiment, human GS was used to create a 
transgenic fly because previous attempts to clone genomic DmGS had been unsuccessful 
due to the large size of the gene and the complexity of the genomic arrangement. At the 
time of creating the transgenic fly, there was no information available on which of the 
DmGS cDNA clones were functional, or which of the duplicated copies of DmGS was 
functional.
Human GS (hGS) cDNA in the bluescript pSK vector was provided by Lesley McLellan 
(Dundee University). The 1.8kb hGS cDNA (Appendix C) was excised from the
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Bluescript vector using the restriction enzymes Xbal and Xhol, and was cloned in the 
multiple cloning site of the pUAST vector, behind the UAS element (Figure 4.4)
Xhol X bal
UAS TATA hGS cDNA Term white 4-
Figure 4.4: A schematic diagram of hGS cloned into the pUAST vector. hGS-pUAST was marked with 
a white gene, allowing easy scoring of transformants. Transcription of hGS would be driven by the 
UAS promoter on activation by a GAL4 molecule. The length of the hGS cDNA was 1.8kb, making the 
hGS-pUAST plasmid a total of 10900bp.
Positive clones containing the hGS-pUAST construct were verified by PCR amplification 
of an insert of the correct size using a primer pair corresponding to the 5' and 3' end of the 
pUAST multiple cloning site (pUAST F seq and p U A S T R s e q ) .  The orientation of the 
hGS insert in pUAST was established by sequencing using the pUAST_F_seq and 
pUAST R seq primer pair.
The transgenic fly line was created by embryo microinjection, as described in Section 2.27. 
One viable transgenic line was established, and further unique insertions of the hGS 
transgene were obtained by remobilisation in order to recover a greater number of insertion 
points, as a means to eliminate the ‘position effect’ (Tower, 2002). The crossing scheme 
below describes the P-element remobilisation (Figure 4.5). Three separate lines were 
created from this remobilisation event (lines A, B and C).
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C ross (i)
99  w+ hGS-pUAST X GG w1118/ Y ; SbA2-3/TM6B, Tb
I
C ross (ii)
GO w+ hGS-pUAST / Y; Sb A2-3 / + X $ w 1118
I
Collect orange eyed, Sb+ 9  and c? 
w* hGS-pUAST / w1118; + / + 
iv" hGS-pUAST/Y; +/+
The siblings were mated to create a homozygous stock.
Figure 4.5: Mapping the transgene hGS-pUAST. In the first cross, homozygous hGS-pUAST females 
were crossed to male flies carrying a transposase on a chromosome marked with Sb. In the second 
cross, males carrying hGS-pUAST as well as the transposase were crossed to w1118 virgins, enabling the 
segregation of the transgene and the transposase in the following generation. Flies which lacked 
transposase (Sb*) which carried hGS-pUAST (w4) were collected, and crossed to create a remobilised 
homozygous stock. A darker orange eye colour indicated a double copy of the transgene, and therefore 
homozygotes.
Following remobilisation, the three hGS-pUAST insertions were mapped to chromosomes 
by segregation analysis (Figure 4.6). Briefly, the transgenic flies were crossed to a stock 
marked on the second and third chromosomes, allowing the linking of the transgene 
(marked with w+) and a marker specific to a particular chromosome. The insertion of a 
transgene onto the fourth chromosome is very rare because of the small size of this 
chromosome, so it was not tested in this study. Of the three separate insertion events 
created with the remobilisation, two were on the X-chromosome (lines B and C), and one 
(Line A3) had the transgene inserted on the second chromosome. The hGS insertion in a 
second line (A4) originating from the original insertion point ‘A’ also mapped to the 
second chromosome.
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Cross (i)
V  hGS-PUAST X a a  i/v1118/ Y ; CyO/BI; TM677?/TM2Ui?x
I
Collect c  with red eyes (hGS-pUAST)
C ross (ii)
r /Y ;  Cyo/?; TM677?/?
w*/Y; Bl/?; TM2U£?x/? X $ w1118
If hGS-pUAST was on the:
X chromosome: there would be no red eyed o  progeny
2nd chromosome: there would be no red eyed flies marked with Cyo or Bl
3rd chromosome: there would be no red eyed flies marked with 77? or Ubx
Figure 4.6: Crossing scheme to determine which chromosome the transgene hGS-pUAST was inserted 
into. In the first cross, homozygous hGS-pUAST females were crossed to male flies carrying a 
dominant marker on each chromosome. Male progeny which carried the transgene (red eyes) in an 
unknown chromosomal position, shown by ‘?’, were crossed to >v1118 females. The resulting progeny 
would give information on the chromosomal positioning of the transgene.
In order to drive expression of hGS-pUAST, it was necessary to introduce an appropriate 
GAL4 driver element. GAL4 would bind to the yeast UAS promoter upstream of hGS, 
thereby driving hGS expression in the tissues where GAL4 was expressed (Duffy, 2002).
A stock with GAL4 fused to a heat shock promoter was used as the source of GAL4 to 
cross into the hGS-pUAST transgenic line. This stock, w*;P{w+mC=GAL4- 
Hsp70.PB}2/CyO, was previously shown to have a ‘leaky’ heat-shock promoter, and 
GAL4 expression was shown even in the absence of a heat shock being administered to the 
flies (Ruth Akhtar, pers. comm.). Even though the heat shock promoter was known to be 
active in the absence of a heat shock, the crosses using this fly stock were exposed to a 
heat shock to ensure high activity. The crossing scheme to obtain a 1(1)8.3/FM6; GAL4- 
HS/GAL4-HS fly is illustrated in Figure 4.7 overleaf.
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To make /(1)8.3/FM6;Gal4/Gal4, the progeny of cross(ii) was mated with the progeny of 
cross(iii) in cross(iv).
Cross (i)
a  w/Y;CyO/B/
I
Cross (ii)
c? FM6/Y;B//+ [from (i)] 
i
9FM6//(1)8.3;fl//+
x $ /(1)8.3/FM6 
x $ /(1J8.3/FM6
x C iv*/Y; P{w+mc=Gal4-Hsp70PB}/Cyo
x $/(1)8.3/FM6
x a  FM6/Y; B //P K mc=Gal4-Hsp70PB} [from (ii)]
Cross (iii)
c? FM6/Y; CyO/+ [from (i)]
I
Cross (iv)
0/(1)8.3/FM6; CyO/+ [from (iii)] 
i
Collect male and female progeny, marked with Cyo, and BI+ and cross to make a balanced 
stock.
Q /(1)8.3/FM6; CyO/Gal4 
a  FM6/Y; CyO/Gal4
In the next generation, flies homozygous for Gal4 were collected, resulting in the stock: 
/(1)8.3/FM6; Gal4/Gal4
Figure 4.7: Crossing scheme to introduce a GAL4-HS driver into l(l)8.3IFM6. First, the second 
chromosome of l(l)8.3IFM6 was marked with Bl or CyO by crossing to a Bl/CyO stock. The progeny of 
cross (i) was used in cross (ii) as well as in cross (iv). In cross (ii) the GAL4-HS strain was crossed to 
1(1)8.3/FM6FM6 marked with Bl. The progeny from that cross was mated to the progeny from cross 
(iii) in cross (iv). The male and female progeny from cross (iv) which were marked with CyO were 
collected and crossed to create a stock homozygous for the heat shock GAL4 driver on the second 
chromosome.
Expression of GAL4 in l(l)8.3IFM6; GAL4-HS/+ flies
To test whether the GAL4-HS driver in the 1(1)8.3/FM6; GAL4-HS stock was capable of 
driving a UAS-transgene, flies were crossed to two different stocks containing GFP-UAS 
transgenes. The first stock (w*; P{w+mc=UAS-GFP.S65T}T2) ubiquitously expressed GFP 
when driven by GAL4, and the second stock (w1118; P {w+mcUAS-GFP.NLS} 14) expresses 
a GFP with a nuclear localisation signal. By following the pattern of GFP expression once 
crossed to 1(1)8.3/FM6; GAL4-HS, the pattern of where the transgenic hGS expression 
could be inferred.
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Fi larvae were observed under a fluorescent microscope at first, second and third larval 
instar stage. It was not possible to view adult flies under the fluorescent microscope 
because the adult cuticle did not allow penetration of the GFP fluorescent signal, and there 
was auto-fluorescence from the cuticle itself. The results show that the GAL4-HS driver 
was expressing ubiquitously (Figure 4.8). The parental UAS-GFP stocks did not fluoresce 
(Figure 4.8A and B), but when strain w*;J>{w+mc=UAS-GFP.565T}T2 was crossed to 
1(1)8.3/FM6;GAL4-HS, there was a high level of expression throughout the larval body 
(Figure 4.8C and D). The UAS-GFP-NLS stock crossed to 1(1)8.3/FM6;GAL4-HS had an 
unusual pattern of expression, seemingly localised to the salivary glands, and trachea 
(Figure 4.8E). This could be an effect of the NLS tag on the GFP. This experiment 
confirms the efficacy of the GAL4 driver chosen to drive expression of the hGS-pUAST 
transgene.
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Figure 4.8: Fluorescent microscopy of second instar larvae from l(l)8.3IFM6; GAL4-HS crossed to two 
different GFP-UAS sources. Panel A is the parental strain w*;P{w+mc=UAS-GFP.S65T}T2, and Panel B 
is the parental strain w1118; P{w>+mTJAS-GFP.NLS}14. In Panel A and B, the exposure was for 2 
seconds. Panels C and D are second instar larvae from l(l)8.3/FM6;GAL,4-HS crossed to 
w*;P{w+mc=UAS-GFP.S65T}T2. Panel C is a second instar larva with a 2 second exposure, and Panel D 
is the same larva, but with a lOOmillisecond exposure. Panel E is a third instar larva from 
l(l)8.3/FM6;GAL4-HS crossed to >v1118; P{H’+mcUAS-GFP.NLS14}, with a 500 millisecond exposure. 
Embryos and larvae were heat shocked at 30°C for 30 minutes each day.
In order to ascertain whether expression of a human GS transgene could rescue 1(1)8.3,
w/Y;hGS-pUAST flies were crossed with l(l)8.3/FM6;YiS-GAL4/CyO. Second
chromosome hGS-pUAST insertion lines A3 and A4 were used for the rescue experiment
illustrated in Figure 4.9 below. The presence of B + males of the genotype 1(1)8.3/Y;HS-
GAL4/hGS-pUAST would indicate rescue of 1(1)8.3 by hGS. There were, however, no
male flies recovered with this genotype in over 200 individual progeny scored. This result
cast further doubts on whether 1(1)8.3/FM6 is indeed a DmGS mutant, but because the
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failed rescue may have been due to incorrect expression of hGS, further analysis of the 
hGS transgenic fly was required.
0 w/Y; hGS-pUAST x $ /(1)8.3/FM6; Gal4
1
The possible progeny are: 
wf /(1)8.3; Gal4/hGS-pUAST 
W/FM6; Gal4/hGS-pUAST 
FM6/Y; Gal4/hGS-pUAST 
/(1)8.3/Y; Gal4/hGS-pUAST
Figure 4.9: Cross to test whether a transgenic copy of humanGS could rescue the putative DmGS lethal 
l(l)8.3. Males from a homozygous stock of /iGiS'-pUAST were crossed to female l(l)8.3IFM6 flies. The 
presence of a male progeny without Bar eyes (marker on FM6) would indicate a successful rescue of 
the lethal. The parental stocks and embryos were heat shocked at 30°C for 30 minutes each day.
The apparent failure of 1(1)8.3 to be rescued by expression of an hGS transgene could be
explained in three ways. Firstly, the transgene might not express hGS, secondly the
expression pattern of the hGS transgene might be inappropriate for rescue of a DmGS
mutant, and finally, the lethality of 1(1)8.3 may be unconnected with defects in DmGS. To
clarify the situation, western blotting analysis of transgenic flies was undertaken. Protein
was extracted from l(l)8.3/w; HS-GAL4/hGS-pUAST flies. The hGS-pUAST stock was
also crossed to a variety of GAL4 drivers, and protein extracted for western blot analysis
(Table 3). No bands were present on the blot, indicating that no hGS protein was being
expressed in the driven hGS-pUAST flies, using the HS-GAL4 driver or any of the other
drivers.
Table 4.3: List of GAL4 drivers crossed to hGS-pUAST to test protein expression of hGS from the
transgene.________________________________________________________________________
Driver element________________________ Expression pattern of GAL4
w ; P{w+m =GAL4-Hsp70.PB}2/CyO Heat shock GAL4 - Ubiquitous
y 1 w*; P{w+mC=tubP-GAL4}LL7/TM3, Sb1 Tubulin
yV; P{w+mC=Act5C-GAL4}25F01/CyO Actin
w~;; P(w+, GAL4}-D42_________________ Motomeuron__________________
The lack of protein expression from the hGS-pUAST transgene was an unexpected result, 
and it is still not clear why no protein was expressed. The most likely reason is that the 
cDNA sequence was cut directly from the bluescript plasmid and cloned into pUAST, 
without the addition of a translation initiation sequence. The translation initiation sequence
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specific to Drosophila is known as a Cavener sequence (Cavener, 1987). The sequence 
which should precede the ATG start codon in Drosophila to initiate translation is 
(A/C)AA(C/A)ATG. The sequence preceding the start codon in the human GS cDNA used 
to create the hGS-pUAST transgene was TGGGATG. The human cDNA therefore did not 
contain the Cavener sequence, and it may be the cause of the lack of translation of the 
transgenic protein. For future cloning attempts, the human cDNA should be amplified 
using primers which would incorporate the Cavener sequence into the hGS sequence 
(Ullmann et al., 1996).
4.2.6 Attempted rescue of l(1)8.3/FM6 by glutamate-cysteine-ligase (GCL)
After the unsuccessful rescue of 1(1)8.3 by hGS, rescue of the putative DmGS mutation 
was attempted with glutamate cysteine ligase (GCL). GCL holoenzyme is the precursor to 
GS in the glutathione synthesis pathway, and is the rate-limiting step in the reaction. GCL 
is a heterodimer which consists of a catalytic subunit (GCLC) and a modifier subunit 
(GCLM). GCLC is functional in isolation, however its activity is enhanced in the presence 
of GCLM. In S. cerevisiae, incubation with the intermediate product produced by GCL, y- 
glutamylcysteine, can rescue a glutathione deficiency caused by a mutation in either GCL 
or GS, thereby negating the need for GS (Grant et al., 1997). If this is true in Drosophila, 
overexpresing GCL might be expected to rescue a DmGS mutant.
1(1)8.3/FM6;GAL4-HS was crossed to two transgenic flies; the first overexpressed GCLC 
only, and the second over-expressed both GCLC and GCLM. The GCLC-pUAST and 
GCLC/GCLM-pUAST transgenic flies were both created by Pushpa Kansagra (pers. 
comm.). The crossing scheme for the attempted rescue of 1(1)8.3 by overexpressing GCL is 
illustrated in Figure 4.10 below:
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a wiY; GCLC-pUAST
Or w/Y; GCLC-pUAST; GCLM-pUAST x § /(1)8.3/FM6; Gal4 
I
The possible progeny are:
Q/(1)8.3/w; Gal4/GCL 
QFM6/w; Gal4/GCL 
CJ FM6/Y; Gal4/GCL 
a /(1)8.3/Y; Gal4/GCL
Figure 4.10: Crossing scheme for attempted rescue of l(l)8.3 by overexpressing GCL. Males 
homozygous for GCLC-pUAST or homozygous for GCLM-pUAST;GCLC-pUAST were crossed to 
female l(l)8.3IFM6;GAL4-HS flies. The presence of a male progeny without Bar eyes (marker on 
FM6) would indicate a successful rescue of the lethal. The parental stocks and embryos were heat 
shocked at 30°C for 30 minutes each day.
The presence of B+ eyed males with the genotype 1(1)8.3/FM6; GAL4/UAS-GCL would 
indicate rescue of 1(1)8.3 by GCL. There were, however, no male flies recovered with this 
genotype. This outcome is ambiguous, however, because the lack of rescue could be a 
result of y-glutamylcysteine not being sufficient to cover for decreased GSH levels in a 
Drosophila GS mutant, or it could be because 1(1)8.3 is not a DmGS mutant.
4.3 Discussion
This chapter reports work aimed at establishing whether or not a recessive lethal derived 
from the mobilisation of a P-element inserted in the distal copy of DmGS indeed resulted 
from loss of GS expression. It is known that when a P-element is mobilised, the 
transposition creates a double strand break (Engels, 1996). The majority of the repair 
events following the mobilisation involve homologous recombination with a sister 
chromatid, resulting in a replacement of the excised P-element, while approximately 15% 
of the repair events use a homologous chromosome (Engels, 1996). Imprecise excision of a 
P-element is a consequence of aberrant repair, and often results in a deletion of the P- 
element and a portion of the sequence surrounding the element (Figure 4.11). Because P- 
elements often insert between the promoter and the protein coding region of a gene, 
imprecise excision can lead to a complete loss-of-function mutation in the gene containing 
the P-element (Adams and Sekelsky, 2002). The frequency of imprecise excisions is 
approximately 1% of the excision events (Ryder and Russell, 2003).
152
Gene
T ransposase
▼
Figure 4.11: Three possible outcomes from P-element mutagenesis. The parental P-element construct is 
shown at the top of the diagram. Pink bars indicate the promoter/intergenic region, yellow bars 
indicate the 8-bp target site duplication, green bars indicate the coding region of the gene, and the blue 
arrow is the P-element with inverted repeats at the ends. ‘A’ illustrates a homologous recombination 
event from a sister chromatid which results in a reproduced P-element, occasionally with an internal 
deletion. ‘B’ illustrates a homologous recombination event from a homologous chromosome where the 
P-element undergoes ‘precise excision’. ‘C’ is an example of ‘imprecise excision’ which arises from a 
non-homologous end joining event after the ends of the break have been degraded, resulting in a 
deleted portion of the gene of interest. Adapted from Adams and Sekelsky (2002).
The hypothesis of the mobilisation experiment was that since EP1322 is situated in the 
5'end of DmGS, its transposition resulted in an imprecise excision in 1(1)8.3, leading to a 
null mutation in DmGS. The deletion of a portion of the DmGS locus surrounding EP1322 
in 1(1)8.3 is supported by the reduction in DmGS copy number from two to one in 1(1)8.3, 
as described in Table 3.1. The strain in which 1(1)8.3 was induced (EP1322) has two copies 
of DmGS, suggesting that the P-element transposition caused a deletion of the distal copy 
o f DmGS in 1(1)8.3.
One of the possible mechanisms whereby the two copies of DmGS could be reduced to one 
copy in 1(1)8.3 is homologous recombination. A possible scenario is illustrated in Figure 
4.12, where a double strand break induced by the transposed P-element is repaired by 
homologous recombination using the duplicated copy of Dm GS on the same chromatid as 
the break. The effect of this is the reduction of the tandem duplication to one copy. This 
mechanism of reducing a tandem duplication to one copy by homologous recombination 
following a double strand break has been documented previously in a gene targeting 
system (Rong and Golic, 2000).
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Figure 4.12: A possible mechanism for the reduction of GS copy number from two to one in 1(1)83 
following P-element mutagenesis. The parental EP1322 strain sister chromatids each had a duplicated 
copy of GS (blue) and a P-element situated in the 5'end of GS (yellow). After exposure to transposase, 
the P-element was excised, leaving a double strand break. The break was then repaired by homologous 
recombination using the duplicated copy of GS on the same chromatid as the excised P-element, rather 
than the sister chromatid. The net effect of this recombination event was the loss of the first copy of 
GS, creating a single copy of the gene where there was a duplication.
The most robust way to test the hypothesis that 1(1)8.3 was a DmGS mutant would be by 
complementation with a GS transgene. Previous studies have expressed human SOD 
(Parkes et al., 1998) and catalase (Ha et al., 2005) enzymes in Drosophila with success, 
achieving lifespan extension as well as elevated oxidative stress resistance in the transgenic 
flies. Human GS and Drosophila GS proteins share 35% identity over the whole sequence, 
with three out of the four active site residues conserved (Marchler-Bauer and Bryant,
2004). Because of the high homology in conserved regions between Drosophila and 
human GS proteins, it was thought that the human GS protein should have functional 
activity when expressed in Drosophila (Figure 4.13).
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Figure 4.13: ClustalW alignment of human GS and Drosophila GS (CG 32495B) protein. The active 
site residues are marked with a box. The alignment was performed using BioEdit (Hall, 1999).
The GAL4-UAS system used to drive expression of a hGS transgene is described in detail 
in Chapter 1. The hGS cDNA cloned into a pUAST vector should have led to 
overexpression of hGS when crossed to a fly expressing GAL4. Unfortunately no 
expression of hGS was detectable, using a UAS-hGS element in combination with four 
different GAL4 driver stocks, each expressing GAL4 in different tissues. The lack of hGS 
expression confounded interpretation of the complementation experiment. One of the 
possible causes of no protein expression could have been that the hGS cDNA was cloned 
into pUAST directly from a vector, without the addition of a translation initiation sequence 
upstream of the start codon by PCR amplification before cloning. Although this has not 
been a problem in our laboratory before (Pushpa Kansagra, pers. comm.) it could be the 
case that for this particular cDNA, an initiation sequence was essential for the protein to be 
produced.
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The question of whether 1(1)8.3 is a DmGS mutant is still unresolved. Evidence linking 
DmGS to the lethality in 1(1)8.3 came from the mapping experiment, which suggested that 
the lethality in 1(1)8.3 was linked to DmGS. Also supporting the linkage of DmGS and 
1(1)8.3 lethality was the observation of GS copy number reduction in 1(1)8.3. The 
hypothesis that 1(1)8.3 lethality is linked to DmGS was countered by the lack of rescue by a 
stock carrying a duplicated region of DmGS (16F1 on the X-chromosome) on the Y- 
chromosome. The stock with the duplicated DmGS region listed on FlyBase as having a 
duplication covering the region of 15BD to 16F. There is, however, a note attached to this 
stock on the Bloomington Stock Centre record raising the possibility of non-continuous 
coverage around the region of 15BD to 16F on the X-chromosome in the duplicated stock 
(Eberl et al., 1992). The DmGS duplication is situated in the 16F1 region of the X- 
chromosome, from position 17723484-17732392 (distal copy) to 17733676-17739814 
(proximal copy) on the annotated sequence. It is possible therefore that the region intended 
to cover DmGS in the duplicated stock is missing the portion deleted from DmGS in 
1(1)8.3. This would explain the unsuccessful rescue seen in this experiment.
The failed rescue of 1(1)8.3 by GCL overexpression was also inconclusive, and may have 
been because the product of GCL overexpression, y-glutamylcysteine, was not functionally 
capable of rescuing a glutathione deficiency in Drosophila, as is the case in S. cerevisiae 
(Grant et al., 1997). The ability of y-glutamylcysteine to act as an antioxidant in the place 
of glutathione has only been observed in S. cerevisiae, making it conceivable that 
Drosophila, as with other multicellular organisms, requires glutathione in addition to y- 
glutamy Icy steine.
On balance, although a lethal mutation in DmGS in strain 1(1)8.3 can not be ruled out, it is 
likely that the lethal mutation is not in DmGS, but is rather a mutant of a gene in the region 
surrounding DmGS. The region neighbouring DmGS in 16F on the X-chromosome is a 
well-documented haplolethal region where a high percentage of the genes have vital 
functions compared to the surrounding loci outside the gene cluster (Prado et al., 1999).
The region, known as the Shaker region is approximately 350kb long, and consists of a 
dense cluster of genes with a close functional relationship, where a deletion in one gene 
would inactivate the whole set of related genes. It is possible that the imprecise 
mutagenesis of EP1322 was associated with mutation of a locus in the haplolethal region.
It has been established by PCR that a portion of the distal copy of DmGS was removed in 
1(1)8.3, however it may not be the cause of the lethality in 1(1)8.3. Further evidence for this 
will be discussed in Chapter 6 , where glutathione levels in this strain balanced over FM6 
were found to be equivalent to other fly strains tested, instead of the expected lower 
glutathione levels in the case of an inactive copy of DmGS.
157
5 Chapter 5: Analysis of predicted DmGS transcripts
5.1 Introduction
Release 4 of the Drosophila genome sequence assigns six transcripts to DmGS: three each are 
assigned to CG6835 and CG32495. In addition to these six transcripts, another transcript 
present in an earlier release of the sequence has subsequently been removed. Our collaborators 
at Dundee University (Shanks, 2004) have isolated a further cDNA transcript, and one further 
transcript discussed in this chapter was isolated in this study.
The presence of these nine possible transcripts raised two questions. Firstly whether all these 
transcripts are present in vivo, and secondly, what the biological functions of all the transcripts 
are. The existence of multiple GS transcripts has previously only been observed in the mouse 
(Shi et al., 1996). Murine GS is encoded by a single gene, and has six different transcripts, 
three of which encode identical proteins and differ only in their transcription start sites (Al, 
A2, A3). Two of the transcripts encode a second protein, but differ in their transcription start 
sites (Bl, B2), and the final mouse GS transcript (C) is unique (Shi et al., 1996). It is 
interesting to note that of the three transcript classes, only class A produced a protein which 
could complement a GS deficient S. pombe strain, leaving unanswered the question of the 
function of the remaining two classes of transcripts which did not produce an active GS 
enzyme, although they were present in specific tissues. This is one of the questions that will 
require further study in mice as well as in Drosophila.
In this chapter, the nine proposed transcripts for Drosophila GS are studied to try to determine 
which transcripts produce an active protein. Several strategies are used: a bioinformatic 
approach, a molecular approach by cloning and sequencing of DmGS cDNAs, as well as a 
genetic complementation study in a GS deficient strain of S. pombe (Mutoh and Hayashi,
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1988). Finally, the temporal and spatial pattern of DmGS transcription in Drosophila was 
studied.
5.2 Results
5.2.1 Predicted Drosophila GS transcripts
During the course of this project, the sequence of the DmGS locus was released for the first 
time, with transcripts attached to each of the DmGS gene copies. The nine transcripts so far 
predicted are illustrated in Figure 5.1. T l, T2 and T3 are the transcripts which were assigned 
to the distal copy of DmGS, CG6835, and T6 , T8 , and T9 are assigned to the proximal copy of 
DmGS called CG32495 in Release 4.3 of the Drosophila Genome Sequence (Grumbling and 
Strelets, 2006). Transcript T7 was originally assigned to CG32495 in the Release 3.0 of the 
Drosophila sequence, however this particular transcript has been removed from subsequent 
annotated versions. Transcript T4 was isolated by Shanks (2004), and transcript T10 was 
isolated in this study as a new transcript.
The size of the predicted proteins from each of the frill length transcripts is in the range of 
491-650 amino acids, as listed in Table 5.1. The two truncated proteins from T3 and T9 are 
predicted to be 127aa, and 308aa respectively. The proteins encoded by each transcript will be 
discussed in more detail in section 5.2.4.
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Figure 5.1: A diagrammatic representation of the transcripts predicted for DmGS as well as the 
neighbouring CG32495. Specific exons are indicated by numbers 1-12. The genomic region length is shown 
by the scale at the top of the diagram (Obp to 9000bp). Transcript 4 was isolated as a cDNA clone by our 
collaborators in Dundee (Shanks, 2004). A second cDNA transcript (T5) recovered by this group was 
identical to T2, and has therefore been removed from this schematic. Transcripts T1 and T2 correspond to 
transcripts CG6835 RC and RD respectively, and T3 corresponds to CG6835 RA. T6, T8 and T9 
correspond to CG32495 RA, RB and RC. Transcript 7 was removed from FlyBase in release 3 of the 
annotated sequence. There is EST coverage of all of the exons, however no complete cDNA sequences had 
been submitted for any of the transcripts before this study.
Table 5.1: Sizes of the predicted proteins from all nine transcripts.
Transcript/ Class Transcript name on Flybase Predicted protein size (aa)
T1 / Class 1 CG6838-RC 551
T2 / Class2 CG6838-RD 551
T3 / Class2 CG6838-RA 127
T 4 / Class 1 (Shanks, 2004) 491
T 6/C lass 1 CG32495-RA 362
T 7/C lass 1 CG32495-RD 650
T8 / Class2 CG32495-RB 491
T9 / Class3 CG32495-RC 308
T10/ Class2 Isolated in this study 362
The exons have been assigned numbers (Figure 5.1) for easy reference, and the transcripts 
have been placed in three classes according to their transcriptional start site. These transcript 
classes differ in the arrangement of their 5'exons (Figure 5.2). Class 1 transcripts contain the
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exon designated as exon 1, which is spliced to exon 3. Exon 2 corresponds to the 3' end of 
exon 1, intron 1 and exon 3: class 2 transcripts begin with exon 2. All the Class 1 transcripts 
are predicted to have the start codon in exon 3 Figure 5.2. Class 2 transcripts, containing exon 
2, result either from transcriptional initiation within the first intron, or from initiation further to 
the 5', without removal of intron 1. Therefore transcripts which start with exon 2 contain an 
untranslated sequence absent from Class 1 transcripts. However, the translation start codon 
ATG of the class 2 transcripts is identical to that of the class 1 transcripts (Figure 5.2). All the 
transcripts except T9, which appears to be a 5' truncation, share exon 4. All transcripts are 
identical from exon 9 through to 12, except for T3 which appears to be truncated at the 3'end.
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Figure 5.2: Schematic respresentation of the 5' end of DmGS. The positions of the exons, according to the 
DmGS sequence in Appendix B, are shown at the edge of each exon. The ATG start codon is situated at 
position 535, in the region shared between exons 2 and 3. The P-element EP1322 is situated in the first 
exon. This schematic diagram is a modification of the FlyBase Genome Browser map (release 4.2.1).
Between exons 4 and 9 are three unique exons named exon 5, exon 7 and exon 8, which can 
be used to distinguish between the different transcripts. None of these exons correlate to 
specific transcript classes. The relative positions of each of the exons is listed in
Table 5.2. Transcripts T l, T2, T7 and T9 are all predicted to contain exon 5 (Figure 5.1).
Because transcript T9 starts in the middle of exon 5, the first exon of T9 was originally named
exon 6. It is, however, most likely that T9 is a truncated cDNA clone probably corresponding
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to Class 1 or 2, and the exon originally designated exon 6  probably corresponds to a truncated 
exon5. Exon 7 is thought to exist in T3 and T7, while exon 8  appears in T4, T7 and T8  (Figure 
5.1).
Table 5.2: Position of exons, the start codon, 297 element and EP1322 within the DmGS genomic region. 
Positions shown are taken from the transcript alignment against the genomic region in Appendix B.
Genomic element Position on genomic sequence (Appendix B)
Exon 1 91 -3 3 9
Exon 2 370-693
Exon 3 470-693
Exon 4 1005-1217
Exon 5 2132-2478
Exon 7 2996-3153
Exon 8 7072-7205
Exon 9 7734 -  7776
Exon 10 7922-8160
Exon 11 8237-8621
Exon 12 8699-9001
‘297’ element 3182-6932
ATG start codon 535
EP1322 319
The presence of the nine different predicted transcripts led to the question of which transcripts 
were present in vivo, and whether there was a difference in temporal expression of the 
transcripts. The first step taken was to test for the existence of each of the unique exons in 
cDNA isolated from different life stages of Drosophila.
5.2.2 Presence o f specific exons in Drosophila lifestages
To test whether the exons predicted by FlyBase were present in vivo, cDNA was made by RT-
PCR from RNA extracted from embryos, first instar larvae, second instar larvae, third instar 
larvae, pupae, and adult male and female flies. Primers complementary to specific exons were 
designed in order to test for their presence by PCR amplification. The primers used in this 
analysis are illustrated in Figure 5.3.
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Figure 5.3: Cartoon of the 12 exons present in Drosophila GS, with the positions of primers specific to each 
of the exons which are labelled with the exon number. The three distinguishing exons are shown in pink, 
green and yellow boxes. F indicates a forward primer, and R indicates a reverse primer.
The results of this PCR analysis are shown in Figure 5.4 overleaf. Amplification of actin5C 
was also performed on all the cDNA samples as a positive control. Exon 7 was of particular 
interest because the only full length transcript containing this exon (T7) was present in Release 
3.0 of the Drosophila sequence, but was removed from the later Release 4.1 of the sequence.
Primer Pair Ex4F-Ex7R: The first row of Figure 5.4 shows the PCR products using the primer 
pairs Ex4F and Ex7R, predicted to amplify fragments of 3 12bp, (exon 4 + exon 7, missing 
exon 5) or 669bp (exon 4 + exon 5 + exon 7). The size of the smaller band on the gel is 
consistent with the smaller product, while the larger band is consistent with the larger 
predicted product. To clarify this issue both the larger and the smaller bands were cloned into 
TOPO-TA vector and sequenced. The smaller band aligned with the sequence predicted for 
the exon 4 - exon 7 splice variants. However, the larger band was a non-specific PCR product 
(corresponding to a region on the 3L chromosome). This result confirms that there are no 
detectable transcripts in any of the life stages of Drosophila which contain exon 5 as well as 
exon 7, supporting the removal of T7 from the published sequence. It is interesting to note that 
exon 7 does exist in all life stages, suggesting that T3 may in fact also exist, although whether 
it is in this truncated form is unclear. The band of intermediate size between the large and 
small bands observed in the embryo life stage is suspected to be a non-specific PCR artifact 
since the presence of the band varied with repeated PCR amplification reactions.
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Figure 5.4: PCR fragments from cDNA corresponding to different life stages of Drosophila. 1st = 1st instar, 
2nd = 2nd instar, 3rd =3rd instar, P = pupa, C = adult male, Q= adult female, E = embryo. The panels show 
samples of RT-PCR amplified with primers Ex4F-Ex7R (Exon7 specific), Ex5F-Exl2R (Exon 5 specific), 
Ex8F-Exl2R (Exon 8 specific), In lF-E xl2R  (full-length), E xlF-E xl2R  (full length), and actin5C. The 
presence of genomic contamination was ruled out because the fragment sizes expected from genomic DNA 
amplification would have been a larger size than the fragments amplified from cDNA due to the presence 
of additional intronic sequence in the genomic DNA. There were no additional bands amplified in any of 
the PCR reactions, indicating the absence of genomic contamination.
Primer pairs Ex5F-12R and Ex8F-12R: The second and the third rows of Figure 5.4 confirm 
the presence of exon 5 as well as exon 8 in all life stages. The single band when amplifying 
the cDNA with primer pair ex5F and exl2R  confirms the prediction that no transcripts include 
both exon 5 and exon 8. If there were any further exons between exons 5 and 9 there would 
have been one or more bands in addition to the band amplified from transcripts lacking any 
exons between exons 5 and 9 (T1 and T2).
Primer pairs InlF-12R and ExlF-12R: These primer pairs were designed to amplify the full 
length transcripts corresponding to Class 1 (ExlF-12R) and Class 2 (InlF-12R) transcripts. 
The fourth and fifth rows of Figure 5.4 show amplifications performed with these two primer 
pairs, with both transcript classes present in all lifestages. Class 1 transcripts, however, appear 
to be poorly represented in the embryonic stage.
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These results show that all the predicted exons are present in all life stages of Drosophila. The 
shortcoming of this approach is that it did not give a complete picture of full length transcripts 
and the combination of the exons present in vivo.
5.2.3 Molecular analysis o f DmGS cDNAs
RNA was extracted from male and female flies of the y s n v  strain shown previously to carry 
the DmGS duplication (Chapter 3), and from Drosophila S2 cells which are embryonically 
derived, and which also contain the DmGS duplication. The primer sets used to amplify the 
whole transcripts (Figure 5.3) were InlF - Exl2R (to amplify transcripts Tl, T4, T6 , T7), and 
ExlF-Exl2R (to amplify transcripts T2, T3, T8 , T10). The amplified cDNAs were cloned in 
the TOPO-TA vector and were then sequenced, as described in Section 2.9 and 2.18.
The results of the sequencing are shown in Figure 5.5, where all the predicted transcripts 
corresponding to clones sequenced in this study are shown in colour. Transcripts T7 and T9 
were not represented in the clones isolated. The absence of T7 was expected, since T7 was 
removed from the published sequence annotation, and it was verified in the previous section 
that exon 5 and exon 7could not be detected together in any transcripts. T9 is probably a 5' 
truncated cDNA clone, so this experiment would not be expected to identify it as it lacks 
priming sites for both Ex IF and InlF primers. Similarly transcript T3 would be expected to be 
absent because it lacks a priming site for primer 12R due to 3' truncation. Transcript T3 is 
included in Figure 5.5 despite resting solely on evidence for a transcript containing exon 7 in 
the previous section - it could not be corroborated in this experiment.
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Figure 5.5: Schematic diagram of all the predicted transcripts with information on transcripts present in 
vivo. T3, T7 and T9 are blanked out because there were no clones sequenced which corresponded to these 
transcripts. The numbers of clones derived from adult fly and S2 cell mRNA that match with each 
transcript is shown in the column on the right of the diagram.
A new transcript was isolated in this analysis. Transcript T10 has not been previously 
described, and was found only in female flies. The protein predicted to be encoded by this 
transcript is identical to that of T6: the only sequence difference between these transcripts 
being in the 5' UTR (Figure 5.5). Little can be read into the significance of some transcripts 
being found only in female flies, or S2 cells because the numbers of clones sequenced is not 
sufficient for statistical analysis. The high number of transcripts present in female flies is more 
likely a function of preferential cloning of the cDNAs from that sample.
5.2.4 Bioinformatic analysis o f the predicted proteins
Sequencing cDNAs from adult flies and S2 cells confirmed the presence of different DmGS
transcripts in vivo. This result led to further investigation into the function of the different
transcripts. A bioinformatic approach of comparing the predicted protein sequences of the
Drosophila GS transcripts with other eukaryotic GS protein sequences was chosen to gain a
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greater understanding of the functions of the Drosophila GS proteins. The alignment used the 
BLAST conserved domain search programme (Marchler-Bauer and Bryant, 2004), and the 
features of the GS enzyme were annotated using the human protein as the template (Figure 
5.6). The protein encoded by each transcript has been named “DrosGS” and the number 
corresponding to the transcript number, e.g., the protein encoded by T1 is called DrosGS 1, and 
the protein encoded by T2 is called DrosGS2.
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Figure 5.6: ClustalW alignment of the eight Drosophila GS protein sequences with representatives of other 
eukaryotic GS protein sequences created using BioEdit. Active site residues which form specific binding 
sites in human GS are labelled in green (glutathione binding site), red (ATP binding site) and blue 
(magnesium binding site). Amino acids that are strictly conserved in virtually all eukaryotic ATP-grasp 
enzymes are highlighted in boxes (Polekhina et al., 1999). In accordance with Polekhina et al. (1999) and 
Njalsson et al. (2004) the domains of the ATP-grasp superfamily are illustrated with coloured bars (a- 
helixes) and arrows (P-sheets): red, N-terminal domain; orange, linker domain to the lid region; green, lid 
domain; blue, C-terminal domain. The secondary structures specific to GS are shown with grey coloured 
bars.
The human GS amino acids conserved in the eukaryotic consensus sequence (Polekhina et al., 
1999) are highly conserved in DrosGS4 and DrosGS8 . After position Phe-152 (for the sake of 
consistency, numbering of amino acids in this chapter refers to the human protein), DrosGS6  
and DrosGS9 also share a high homology with the consensus eukaryotic sequence for GS 
(Figure 5.6). Proteins DrosGS 1, DrosGS 2, and DrosGS 7 all lose their homology after Met- 
129, which is caused by a frameshift due to the presence of exon 5 in these proteins. DrosGS3 
is terminated prematurely at position 118 on the alignment, followed shortly by the stop codon 
termination of DrosGS 10 at position 126, presumably also caused by a frameshift.
Eliminating the proteins that are terminated prematurely, or those that do not share any 
homology with other eukaryotic GS sequences, DrosGS4, DrosGS6 , DrosGS8  and DrosGS9 
remain. DrosGS4 and DrosGS8  are the only proteins which share a full homology with 
eukaryotic GS, while DrosGS6  and DrosGS9 are truncated on the 5' end, and share homology 
from residue 152. DrosGS6  is truncated from the 5'end because this protein has a different 
start codon from the other full length proteins (DrosGS4 and DrosGS8 ). An alignment of 
DrosGS6  using the predicted start codon from Flybase, along with the potential DrosGS6  
protein initiating from the same ATG as DrosGS8  illustrates how neither start codon produces 
a full length GS protein from T6  cDNA (Figure 5.7).
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Figure 5.7: Protein alignment of DrosGS6 with two alternative start codons and DrosGS8. DrosGS6-FB is 
the predicted protein sequence on Flybase which corresponds to T6. DrosGS6-st is the predicted protein 
from the T6 cDNA sequence using the same start codon as DrosGS8. The residues shared between 
DrosGS6-FB and DrosGS8 are shown in blue, while the residues shared between DrosGS6-st and DrosGS8 
are shown in pink.
The critical amino acids in the human GS catalytic site are highly conserved in these four 
remaining GS proteins (note that DrosGS6 and DrosGS9 only start at residue 152). The 
residues that bind glutathione are conserved (Arg-124, Ser-151, Asn-216, Gln-220, Arg-267, 
Tyr-270, Arg-450, Val-461, Ala-462), except for residues Ser-149, Glu-214 (Table 5.3). 
Human Ser-149 is an alanine residue in DrosGS4 and DrosGS8. Although Ser-149 is the 
consensus sequence at this position, Xenopus and C. elegans proteins share an alanine at that 
position with Drosophila. Glu-214 is a serine residue in the Drosophila sequence, and it 
appears that this is a variable residue in two of the other eukaryotic sequences as well.
The residues that form the magnesium ion binding sites (Glu-144, Asn-146, Glu-368) are 
conserved in DrosGS4 and DrosGS8, however in DrosGS6 and DrosGS9, the first two 
residues listed are not present due to the truncated proteins. The residues contributing to the
171
ATP binding site are also conserved (Met-129 Lys-305, Val-362, Lys-364, Gly-370, Asn-373, 
Tyr-375, Met-398, Ile-401) except for lie-143, which is a valine residue in the Drosophila 
proteins (Table 5.3). The Ile-143 residue is however variable amongst eukaryotes, and the 
Drosophila valine is shared by S. cerevisiae as well as S. pombe at this position. The three 
residues that differ from the human sequence (Ser-149, Glu-214 and Ile-143) are all 
conservative substitutions, and therefore should not alter the protein function dramatically 
(Betts and Russell, 2003).
The three residues that are strictly conserved (Polekhina et al., 1999; Dinescu et al., 2004) 
throughout all ATP grasp family members (Lys-305, Lys-364, and Glu-144) are also 
conserved in DrosGS4 and DrosGS8 , as well as in DrosGS6  and DrosGS9, although in the 
latter two the Glu-144 residue is in the truncated portion of the protein.
These results strongly suggest that the only active GS protein is likely to be translated from 
transcripts T4 and T8 . The function of the other transcripts which, on the basis of this 
sequence comparison, do not appear likely to encode an active GS protein but which are 
present in vivo, is unknown at this time. In order to confirm the biological activity of 
DrosGS4/DrosGS8, the T8  cDNA was used in a yeast complementation experiment.
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Table 5.3: Position of conserved GS residues involved in critical GS functions. The residue positions are 
relative to the human GS protein sequence. The four Drosophila GS proteins listed are the full length 
DrosGS4 and DrosGS8, as well as the truncated proteins DrosGS6 and DrosGS9. Conserved residues 
shared with the human protein are shaded.
Residue Human DrosGS4 DrosGS6 DrosGS8 DrosGS9
position
124 | Arg Arg Arg Arg Arg
149 Ser Ala — Ala —
151 i Ser Ser Ser Ser Ser
<D4-> 214 Glu Ser Ser Ser Ser
O 216 Asn Asn Asn Asn Asn
2 2 0 1 Gin Gin Gin Gin Gin
o 267 ! Arg Arg Arg Arg Arg
co
o 270 Tyr Tyr Tyr Tyr Tyr
450 Arg Arg Arg Arg Arg
461 Val Val Val Val Val
462 1 Ala Ala Ala Ala Ala
129 i Met Met Met Met Met
143 lie Val Val Val Val
305 !' Lys Lys Lys Lys Lys
bfla 362 | Val Val Val Val Val
• ^
g 364 Lys Lys Lys Lys Lys
3
Oh 370 Gly Gly Gly Gly GlyH
< 373 ; Asn Asn Asn Asn Asn
375 1 Tyr Tyr Tyr Tyr Tyr
398 Met Met Met Met Met
401 lie He He He He
bO#g 144 Glu — Glu — Glu
a
•
146 Asn — Asn — Asn
bO
S.
368 : GlU Glu Glu Glu Glu
5.2.5 Complementation o f S. pombe deficient in GS by a Drosophila 
cDNA
5.2.5.1 GS deficient S. pombe strain MN101
Schizosaccharomyces pombe was chosen for functional complementation experiments because 
it is a eukaryotic system which has proved useful for expression of heterologous proteins.
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MN101 is a GS null S. pombe strain derived from the parental strain HM123 (h‘, leu'1),
(Mutoh and Hayashi, 1988). Loss of GS in MN101 results in a cadmium hypersensitivity 
because glutathione synthesising enzymes are involved in the formation of phytochelatin, a 
molecule that forms complexes with cadmium (Mutoh and Hayashi, 1988). Cadmium is highly 
toxic to cells, and is detoxified in plants and yeast by phytochelatin. Biosynthesis of 
phytochelatin [(y-Glu-Cys]n-Gly] is controlled by GCL and GS (Al-Lahham et al., 1999), the 
same enzymes involved in glutathione production, as described in Chapter 1. Cadmium is also 
known to cause glutathione depletion, thereby resulting in increased oxidative stress (Radyuk 
et al., 2003). Wild type S. pombe strain HM123 has slightly inhibited growth in the presence 
of 0.5mM CdCC, while the growth of MN101 mutants is severely inhibited at this 
concentration, as shown in Figure 5.8. Strain MN101 has no GS activity (Mutoh et al., 1991), 
and the minimal amounts of glutathione measured in the cells (less than 17% of wild type) is 
most likely derived from trace GSH in the media (Mutoh and Hayashi, 1988).
The cadmium hypersensitivity of strain MN101 can be used in an assay for testing the activity 
of different transgenic GS proteins. Functional complementation of MN101 GS has been 
achieved with GS cDNAs from the mouse (Shi et al., 1996) as well as from Arabidopsis 
thaliana (Wang and Oliver, 1996).
Figure 5.8: Wild type parent strain HM123 (Panel A) and the GS deficient MN101 strain which is sensitive 
to CdCl2 (Panel B). Each of the strains was grown on YE plates containing 0.5mM CdCl2.
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5.2.5.2 Complementation of S. pombe deficient in GS
The bioinformatic analysis performed on the DmGS transcripts in the previous section 
suggested that the GS protein predicted to be encoded by transcripts T4 and T8 would be the 
active protein. To test the biological function of the protein encoded by these two cDNAs, a 
complementation experiment was performed using a S. pombe strain lacking GS. The protein 
encoded by T4 and T8 is predicted to be identical, therefore a cDNA corresponding to T8 was 
cloned in the plasmid pNMTl-TOPO for further expression studies. The resulting clone was 
named M N 10110. Because T6 had strong homology with the eukaryotic GS consensus (apart 
from the 5' truncation), a similar construct, M N 10112, containing this cDNA was also used 
in this experiment. T8 and T6 correspond to the sequences listed on FlyBase as CG32495-B 
and CG32495-A respectively. S. pombe mutant strain MN101 was transformed with each of 
these constructs (Figure 5.9).
T6 cDNA
pN M T-TO PO
6.1 kb
Figure 5.9: Constructs using the pNMTl-TOPO vector. Panel A : Schematic diagram of the features of the 
pNMTl-TOPO vector. Figure was obtained from www.invotrogen.com. Panel B: Construct M N 10110  
containing cDNA from transcript T8 (CG32495-B). Panel C: Contruct M N 10112 containing cDNA from 
transcript T6 (CG32495-A).
The cDNAs were amplified using PCR, and cloned in the TOPO vector pNMTl-TOPO. The 
pNMTl-TOPO vector illustrated in Figure 5.9 contains the S. pombe arsl origin of replication 
which maintains a high copy number of the plasmid in S. pombe cells, and does not require 
chromosomal integration. The selection marker for E. coli cells is ampicillin resistance, and in
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yeast cells it is a S. cerevisiae LEU2 auxotrophic marker that allows growth of transformed 
cells on medium that does not contain leucine. The transgene expression is driven by an nmtl 
promoter which allows for thiamine-regulated expression in S. pombe cells by switching off 
gene expression in the presence of 15pM thiamine. This promoter has, however, been found to 
still allow gene expression in the presence of thiamine, and the ability to ‘shut o ff completely 
seems to be gene-dependent (Forsburg, 1993). For this reason the thiamine control was not 
used in this experiment. The NMT1 version of the promoter used in these complementation 
experiments offers high expression levels of protein expression (Basi et al., 1993). The 
plasmid also has a C-terminal V5 epitope and a polyhistidine tag, however neither was used in 
this experiment as the cDNA sequences cloned into the plasmid contained the native stop 
codon at the 3' end of exon 12.
T6  and T8  clones were confirmed, and the orientation of the insert verified, by sequencing 
using the primers NMT (forward) and URA4 (reverse). MN101 cells were transformed with 
verified clones as described in Section 2.11. As shown in Figure 5.10, the GS protein encoded 
by T8  (clone MN101_10) was able to complement the loss of GS function in MN101. The 
heterologous GS allowed the yeast to produce phytochelatins, thereby restoring the ability of 
the mutant MN101 to grow in the presence of 0.5mM CdC^, although colony growth was 
slower than the wild type strain HM123. The product of transcript T6  (clone M N 10112) did 
not, however, rescue the cadmium hypersensitivity of MN101.
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cFigure 5.10: S. pombe GS deficient MN101 strain transformed with two different GS cDNAs. Panel A 
shows all the S. pombe clones transformed with different Drosophila GS cDNAs. The two MN101 clones 
carrying pN M T-TO PO lO  (transcript T8) are highlighted in red, and two clones carrying pNMT- 
TOPO_12 (transcript T6) are highlighted in yellow. The clones were grown on the plasmid selection 
medium (EMM without Leu). In Panels B and C, MN101 cells containing a pNMT-TOPO plasmid with a 
GS transcript were grown on YE plates containing 0.5mM CdCl2. Two different clones containing the 
same transcript were tested (Colony 4 and 8 for M N 10110, and Colony 1 and 4 for M N 10112), and each 
different clone was streaked out twice (quarters of the plates labelled i and ii), to allow for even colony 
spread. Panel B shows MN101 cells transformed with a pNMT-TOPO containing transcript T6. This 
cDNA did not result in expression of a protein which could rescue the GS deficiency. Panel C shows 
MN101 cells transformed with a pNMT-TOPO containing transcript T8. The protein expressed in these 
cells did rescue the GS deficiency in the MN101 S. pombe strain, although the colonies were slow growing 
(colonies are indicated with arrows).
To test whether the S. pombe cells containing the M N 10110 or M N 10112 constructs were 
expressing a transgenic protein, SDS-PAGE was carried out on soluble protein extracted from 
the yeast cells. Coomassie staining of the separated proteins (Figure 5.11 A) revealed no 
distinct band in the yeast cells transformed with M N 10110 or M N10112  compared to 
MN101 with no plasmid, and the parental strain HM123. It was expected that there would be a 
unique 62 kDa band in M N 10110 cells which carried T8 cDNA, and another distinct band of 
approximately 52 kDa in M N 10112 cells carrying T6 cDNA, as this is the predicted size of 
the truncated protein coded for by T6. It was not possible to distinguish any unique bands,
T6 (MN101 _12)-clone4 
OR
T8 (MN101 _10)-clone4 
. Streak2
T6 (MN101 12)-done4  
OR
T8 (MN101 _10)-clone4 
Streakl
T6 (MN101 _12)-done1 
OR
T8 (MN101 _10)-done8 
\ Streakl
T6 (MN101_12)-done1 
OR
T8 (MN101 _10)-done8 
Streak2
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which could be because this method of staining is not sensitive enough to detect one additional 
band. A Western blot of the separated yeast proteins probed with an antibody to Drosophila 
GS (a gift from Lesley McLellan) is illustrated in Figure 5.1 IB. The anti-DmGS antiserum 
was raised against the T2 protein (Shanks, 2004).
20.1 kDa
14.3 kDa H
Figure 5.11: SDS-PAGE separation of proteins extracted from S. pombe GS mutant strain MN101 and 
HM123 parental strain, as well as MN101 carrying pNM T-TO PO lO  (transcript T8) and pNMT- 
TOPO_12 (transcript T6). M N 1 0 1 1 0 4  and M N 1 0 1 1 0 8  refer to two clones carrying transcript T8, and 
M N 1 0 1 1 2 1  and M N 1 0 1 1 2 4  refer to two clones carrying transcript T6. Panel A : A Coomassie Blue 
stained SDS-PAGE gel. A total of 20pg protein was loaded in each lane. Coomassie staining detects bands 
as low as 50-1 OOng. Panel B: Western blot of the same gel as in Panel A. Only the S. pombe cells carrying 
pNMT-TOPO lO expressed a 62kDa protein recognised by a Drosophila GS antibody.
Drosophila GS was only detected in yeast cells carrying the M N 10110 construct. The
parental HM 123 and M N101 strains were not expected to have a positive signal for
Drosophila GS, however it is surprising that MN10112  containing cells did not have any
reaction with the Drosophila antiserum. MN101 cells transformed with the construct
containing T6 cDNA either do not synthesise the predicted DrosGS protein, or the truncated
protein they create does not bear the epitopes detected by the Drosophila GS antisera, which
was raised to transcript T2 protein (Shanks, 2004). It is unknown at this stage what epitopes
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are recognised by this Drosophila GS antibody, but it is possible that they lie in the N terminal 
region of the protein truncated in the protein encoded by T6 . It is unfortunate that the 
predicted truncated protein could not be distinguished by the Coomassie stain.
5.2.6 DmGS expression patterns in Drosophila
To determine the temporal and spatial expression patterns of DmGS in Drosophila, rtPCR was 
used to compare the level of total DmGS transcripts in different life stages of Drosophila, as 
well as in different tissues of the adult fly. The primer pair used to amplify total DmGS 
transcripts was ‘first ex o n F ’ and ‘Exl2_R’. This primer pair spans all DmGS transcripts, with 
the forward primer situated in the region shared by exon 1 and intron 1 , and the reverse primer 
situated on the shared terminal exon (Figure 5.3). To assess the relative levels of DmGS 
transcripts, a semi-quantitative PCR approach was taken. Amplification of actin5C was used 
as an internal reference against which levels of DmGS were estimated, using the Typhoon 
9410 variable mode imager and Imagequant software, as described in Section 2.17. Each 
experiment was performed at least three times to allow for statistical analysis of the results.
5.2.6.1 Relative expression of DmGS in different life stages
Larval full length DmGS transcript levels were highest in the first instar, and reduced steadily 
as the larvae grew, reaching the lowest levels in the pupal phase (Figure 5.12). DmGS 
expression levels in adult male and female flies was comparable to first and second instar 
larvae. DmGS transcript levels are minimal during embryonic development. During first larval 
instar, the feeding rate is known to increase, reaching a peak at the transition between the first 
and second instar, after which the rate declines to the lowest point in the third instar (Ruiz- 
Dubreuil et al., 1996; Godoy-Herrera et al., 2004). It is possible that this reduction in feeding 
rate in second, and especially third, instar larvae creates less of an antioxidant requirement 
compared to the first instar stage when the larvae are exposed to a wide range of
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environmental oxidants through the diet. It is unclear why male flies have a higher DmGS 
expression level than the female flies, although this sex specific difference will be analyzed in 
detail in the following chapter.
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Figure 5.12: GS expression in different life stages of the single copy GS duplication reference strain (w sn3). 
The lifestages shown are 1st instar (1st), 2nd instar (2nd), 3rd instar (3rd), pupa (P), male adult (CJ), female 
adult (9 ) and embryo (E). Panel A shows samples of GS and actin RT-PCR separated on an agarose gel. 
Panel B is a graphical representation of the relative intensities of the GSrActin RT-PCR product from the 
gel in Panel A. Means±SEM are shown. Statistical differences between GS transcript levels in each of the 
consecutive lifestages was determined by Student’s T-test, where *=p<0.05 and **=p<0.01.
In all life stages, the smaller DmGS band, corresponding to transcript T4/T8 based on size, is 
denser than the larger band, which corresponds to T1/T2 (Figure 5.12). This suggests that the 
T4/T8 transcripts, which are highly likely to encode the active GS protein, are significantly 
more abundant than the T1/T2 transcripts in all Drosophila developmental stages.
5.2.6.2 Relative expression of DmGS in different adult fly body parts
To determine whether DmGS was more highly expressed in one particular tissue type in 
Drosophila, RNA was extracted from different regions of the adult fly. Because of the small
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size of Drosophila, preparation of purified tissue would be very demanding, therefore body 
parts enriched for specialised tissues were used (Zheng et al., 2005; Girardot et al., 2006). The 
head was used to represent neural tissue, the thorax represented muscle tissue, and the 
abdomen represented reproductive tissue. The level of full length DmGS transcripts in 
different tissues was determined in male as well as female flies.
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Figure 5.13: DmGS expression in different body parts of adult males and females. The analysis was 
performed on the DmGS duplication reference strain (y sn v). Panel A shows samples of DmGS and actin 
RT-PCR PCR separated on an agarose gel. Panel B is a graphical representation of the GS:Actin relative 
intensities from the gel in Panel A. There was no significant difference in GS expression between different 
body parts in males or females. Statistical significance was calculated using Students ‘t’test. Means±SEM  
are shown.
5.3 Discussion
The results presented in this chapter show that the numerous transcripts predicted for DmGS 
do in fact exist. The only other instance of multiple GS transcripts in the literature is in the 
mouse, where six transcripts encode three different proteins (Shi et a l ,  1996). The Drosophila 
GS gene is predicted to produce nine transcripts, six of which have been found in vivo in this 
study. It is possible that the remaining three transcripts also exist in vivo, however in the case
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of transcript T7, no evidence was found for exons five and seven existing together in the same 
transcript. The remaining two transcripts, T3 and T9, are both truncated transcripts, and 
although they may have a biological function, it is more likely that they exist merely as 
cloning or sequencing artefacts of incomplete EST clones. It is unclear as to how the different 
transcripts were assigned to each of the two copies of DmGS because the sequence of the two 
copies is identical except for the 291 element present in the distal copy.
The predicted protein sizes from each of the Drosophila transcripts are more varied than any 
of the eukaryotic GS sequences published to date, which are in the size range of 474 to 492 
amino acids, as listed in Table 5.4. The two Drosophila transcripts which encode a protein in 
this size range (491aa) are T4 and T8, and T8 cDNA was able to rescue the GS deficient S. 
pombe strain MN101.
Table 5.4: Comparison of the sizes of eukaryotic GS proteins
Organism GS protein size 
(amino acids)
Reference
Homo sapiens 474 (Njalsson et al., 2004)
Arabidopsis thaliana 478 (Wang and Oliver, 
1997)
Schizosaccharomyces pombe 498 (Phlippen et al., 2003)
Saccharomyces cerevisiae 492 (Grant et a l, 1997)
Mus musculus 474 (active protein) & 
432
(Shi e ta l,  1996)
Rattus norvegicus 474 (Huang et a l, 1995)
Drosophila melanogaster 491 (predicted active) Predicted protein size
A comparison of the Drosophila amino acid sequence with other eukaryotic GS sequences
revealed a high homology of Drosophila GS (DrosGS4 and DrosGS8) to the other eukaryotic
sequences. Only three (Ser-149, Glu-214, Ile-143) of the 24 active site residues identified in
human GS were different in Drosophila GS, and none of these three residues are one of the
16 mutations known to alter GS activity (Polekhina et al., 1999; Njalsson et al., 2004). Neither
Ser-149 nor Glu-214 appear to play a role in the secondary structure of GS, while Ile-143 is
situated in a N-terminal (3-sheet named (35 in Figure 5.6. Because the only residues that vary
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between DrosGS4/DrosGS8, and the human protein at the active site are three residues which 
are not strictly conserved across eukaryotic GS sequences, it is likely that the protein from 
these two transcripts is the active GS protein in Drosophila.
DrosGS6 and DrosGS9 share a close homology with other eukaryotic GS protein sequences, 
however they have a large portion of the N-terminal end of the sequence missing, thereby 
losing the first six of the twenty four active site residues. Included in those six residues are 
three of the four residues that create the magnesium binding site. It is therefore unlikely that 
the proteins encoded by transcripts T6 and T9 are active GS enzymes. Deletions of the 5' 
region of the Arabidopsis GS gene resulted in complete loss of enzyme activity, even when 
only 5 amino acids were deleted (Wang and Oliver, 1997). This suggests an essential function 
for the N-terminal end of GS in determining enzyme activity, and casts more doubt on the 
likelihood of transcripts T6 and T9 encoding active proteins.
The structure of the transcript which encodes the active form of GS in Drosophila appears to 
be that of transcripts T4 and T8: after the start codon, the presence of exons 4, 8, 9, 10, 11, and 
12 result in a RNA transcript which codes for a GS protein with a high sequence homology to 
other eukaryotic GS sequences, and shares 21 of the 24 active site residues with human GS. 
Transcripts T4 and T8 are predicted to encode identical proteins, but have different 
transcription start sites. Transcripts T l, T2 and T7 lose homology with the eukaryotic GS 
sequence at the start of exon 5, while T3 and T10 are truncated by a stop codon in exon 7.
The presence of transcripts which do not produce an active protein has also been noted in 
mice, and the distribution of the different murine transcripts was tissue specific (Shi et al., 
1996). In both Drosophila and mice it appears that only one active protein is produced from 
the multiple DmGS transcripts present in the cell.
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The biological activity of transcripts T4 and T8 was confirmed by complementation of the GS 
deficient S. pombe strain MN101. Gene complementation in S. pombe was chosen because it is 
a eukaryotic system which has proved useful for expression of heterologous proteins 
(Forsburg, 1993). The MN101 GS deficient strain has been used for functional 
complementation of GS in the mouse (Shi et al., 1996) as well as in Arabidopsis (Wang and 
Oliver, 1996).
The S. pombe GS protein contains 498 amino acids and has an estimated molecular mass of
56.2 kDa (Wang and Oliver, 1997), while the Drosophila protein is 491aa long, and has a 
MW of 62 kDa. The GS proteins from each species share only a 36% homology, as illustrated 
in Figure 5.14. Despite the differences between the S. pombe and Drosophila protein 
sequences, the T8 Drosophila cDNA complements MN101 GS deficiency by encoding a GS 
protein that restored glutathione synthesis in the mutant MN101. This in turn is assumed to 
have increased the phytochelatin levels in MN101, and restored cadmium resistance. 
Glutathione was probably not restored to wild type levels as growth on cadmium was slower 
than the wild type HM123 strain. This lack of complete activity has been noted previously 
with heterologous expression of GS synthesis proteins (Ullmann et al., 1996; Saunders and 
McLellan, 2000), and may be because the Drosophila protein requires factors not present in S. 
pombe for full activity. S. pombe contains a 15aa sequence between helix a8 and beta sheet p6 
which does not occur in any other eukaryotic sequences, as shown in Figure 5.14 (Phlippen et 
a l, 2003) . It is feasible that the presence of that unique sequence is necessary for optimal 
functioning within S. pombe cells.
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S . p o m b e  9 E QIEELGKGARDFAFAHGTOF-TEL SVSKE GRNIAT Q IPITLFPSVIPHGAFVEAVSVQK 67
+++ E+ A+D+A HG + +  + S +  H A  P L P S P  F  +AV++Q 
P .  m e l a n  2 1  DELLEVTAKAKDYAIMHGAAMRSKTAFSPDSLHFA PFVLVPSSFPRKEFEKAVALQP 7 7
S . p o m be 6 8  AYHKLYAKIAHDYEFLRLHLQSITKYDEFMHKLHHL YQKHREAVAHLKENQFQPLSLGVF 1 2 7
H+L +A+D EF+ L K DEF L+1T+Y+K +AH Q S+G+
D . m e lo n  7 8  IINRLMHHVAKDEEFITTTLAETIKVDEFTAHLF1TIYRK VLAH GFTQAYSIGLL 1 3 1
S . p o m b e  1 2 8  RSDYMVHQDDSFIGC— KQVEFNTISVSFGGVS-KAVSHLHAYCSQSGLYRKPLTTHYLT 1 8 4  
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P .  m e l a n  1 3 2  RSDYMAHVSE GCAIKQVEIHTVASSFAGIATQLVPQQKFVLSELGHADK LHHMP 1 8 5
S . p o m b e  1 8 5  VHTSVSGICTGISHAVDAYRDYVKHITSKMN1ASDHTKPIVLFVVKGGERHITDQRTLEY 2 4 4
H +++G+C G+ A  D Y + ++LF+++ H I  DQR E+
P .  m e l a n  1 8 6  DHHALAGLCDGMVKAWDIYA------------------------------ KPQAVILFIIEDVSYHICPQRFHEF 2 3 0
S . p o m b e  2 4 5  ELLHRF-HVISKRIDIAELHSLIHPKSSHKLYMKT SFTTYEVAOTYYHVGYALDDYPSQE 3 0 3  
+ +  H+ R +  E++ S +L +  +  EVAV+Y+R GY Y SQ
P .  m e l a n  2 3 1  YIRETYPHIKVLRRTLTEVHREGKLGQSKELLLGSQ EVAVIYFRAGYEPGHYHSQA 2 8 6
S . p o m b e  3 0 4  AWPMRLTIENTLAIKCPSISTHLAGSKKIQQVLAESHALERFL-EGDELQAVRSTFAPMY 3 6 2
HP R +E + L A IK C PSI HLAG+KK+QQ LA+ LERF+ +  +E++AV F  +Y 
P .  m e l a n  2 8 7  PHPARYLMETSLAIKCPSIHYHLAGTKKVQQALAQPAVLERFIHPPEEIKAVGKIFTGLY 3 4 6
S . p om be 3 6 3  PLODTPRGKEGIKLAFEKPEPFVLKPQREGGGHHIYGKPIPGLLSKHPQEEHPSYILMRY 4 2 2
LDP G ++A PE FVLKPQREGGGHN YG P I P  L +M +  E ++ILM  
P .  m e l a n  3 4 7  SLDDHEAGHASYEMALRTPERFVLKPQREGGGHHVYGVDIPDALKBMSRVERSAHILMDL 4 0 6
S . po m b e  4 2 3  IHAVP S QHYILK— GERPEKF - P W P E I  G IL  GTIVHHIKTDEWQHGQ S GFICRTKPKKT 4 7 9  
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Figure 5.14: Alignment of S. pombe and D. melanogaster GS protein sequences using BLAST 2 (Tatusova 
and Madden, 1999).
T4/T8 transcripts are significantly more abundant than the T1/T2 transcripts in all Drosophila
developmental stages. This observation fits the hypothesis that the protein encoded by
transcripts T4/T8 is the active GS protein in Drosophila. Different levels of GS expression
occur in mice and rats, with the majority of enzyme activity being located in the kidneys,
followed by the liver (Meister, 1985; Shi et al., 1996). In Drosophila neural tissue specific
overexpression of antioxidant genes has extended lifespan (Parkes et al., 1998; Ruan et al.,
2002; Morrow et al., 2004; Bauer et al., 2005), raising the question as to whether there would
be a particular spatial expression pattern of GS. The lack of tissue-specific DmGS expression
observed may suggest that GS is an essential enzyme required throughout the organism by all
tissue types. In this study, the temporal expression pattern of DmGS transcripts showed that
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GS is ubiquitous throughout all developmental stages, but with stronger expression in early 
larval instars and adults.
The question arising from these data is: What is the function of these multiple transcripts? It 
can be speculated that the RNA transcripts or even the proteins produced by the different 
transcripts are involved in GS regulation. The different RNA transcripts may also be regulated 
in different ways, thereby contributing to the regulation of GSH in different organs. It remains 
to be investigated whether the transcripts besides T4/T8, or their putative proteins, are 
involved in GS regulation.
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6 Chapter 6: Role of GS in oxidative stress resistance of 
adult Drosophila
6.1 Introduction
Glutathione (GSH) has many cellular functions, including protecting cells against 
oxidative damage, amino acid transport, detoxification of xenobiotic compounds, 
provision of reducing equivalents, and being a co-factor for many enzymes (Kehrer and 
Lund, 1994; Meister, 1994; Polekhina et al., 1999). In its role as antioxidant, GSH can 
react directly with hydroxyl radicals (OH#) reducing them to H2O, and it also serves as an 
electron donor to glutathione peroxidase which detoxifies peroxides (H2O2) (Inoue et al., 
1998; Parkinson, 2001). The antioxidant activity of GSH is of interest in ageing studies as 
there is evidence that raising the antioxidant defences of an organism can result in 
increased oxidative stress resistance, and an increase in longevity (Finkel and Holbrook, 
2000; Sohal et al., 2002).
The correlation between oxidative stress resistance and longevity in many organisms 
including worms, flies and mice has been well documented (Wallace, 1999; Finkel and 
Holbrook, 2000; Hekimi and Guarente, 2003). Because oxidative stress resistance and 
longevity are closely linked, screening for factors that influence oxidative stress resistance 
is an effective alternative to the more time consuming direct screening for lifespan in 
studies (Lin et al., 1998).
The capacity of cells to regenerate glutathione during an oxidative challenge is important 
in preventing loss of cellular function due to oxidative damage to cellular components, and 
de novo GSH synthesis plays an important role in maintaining cellular GSH levels (Shi et 
al., 1994). GSH is synthesised in a two-step reaction with the first rate limiting step 
catalysed by glutamate-cysteine ligase (GCL) and the second step is catalysed by 
glutathione synthetase (GS). GCL is a heterodimer composed of a catalytic subunit 
(GCLC) and a regulatory subunit called GCLM. GCLC has catalytic function independent
of GCLM, however the binding of GCLC to GCLM greatly increases the activity of GCL 
by increasing the affinity of the enzyme for the substrates glutamate and cysteine (Huang 
et al., 1993a; Huang et al., 1993b). Drosophila GCLC, which shares the same catalytic 
properties as human and rat GCLC (Fraser et al., 2002), has been overexpressed in the 
motomeurons of flies, with the result of increasing the glutathione content, longevity and 
resistance to oxidative stress in transgenic flies (Orr et al., 2005; Kotecki et al., manuscript 
in preparation). Ubiquitous overexpression of Gclm was shown to have less of an effect on 
lifespan than Gclc, although the increase in longevity was significant (Orr et al., 2005).
In the experiments described in this chapter, the effect of DmGS overexpression in 
Drosophila was studied to establish its role in determining the GSH content in flies, as well 
as its possible effect on oxidative stress resistance. DmGS was overexpressed along with 
the catalytic subunit of GCL to determine the relative effects of the two major enzymes 
involved in GSH production, with the hypothesis that increased GSH levels would increase 
oxidative stress resistance.
6.2 Results
6.2.1 Effects o f DmGS copy number on glutathione production and  
resistance to oxidative stress
DmGS exists as a tandem duplication in the majority of Drosophila melanogaster strains, 
though as discussed in Chapter 3 some strains contain a single copy of the gene. In the case 
of strains with the GS duplication it was unclear if both copies are active and if they 
produce more glutathione than the single copy strains, and consequently, whether the 
DmGS duplication would confer increased oxidative stress resistance to those strains. 
Several strains were tested for glutathione titre and resistance to oxidative stress (Table 
6.1) including the reference single and double copy strains, w sn3, and y s n 3 v respectively. 
The w sn EP1322 parental strain, (referred to EP1322 in this chapter), the balancer FM6,
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and the putative DmGS mutant 1(1)8.3/FM6 (Chapter 3) were also tested because the 
1(1)8.3 and FM6 chromosomes carry a single copy and a double copy of DmGS 
respectively, putting that stock in the unique position of containing a total of 3 copies of 
DmGS in each female diploid cell. Because only female 1(1)8.3/FM6 flies were viable, 
only females were used in this study for comparative purposes.
Table 6.1: Genotypes, DmGS duplication status, and GSH levels of D. melanogaster strains tested in 
this study. Assays were performed on two independent samples in triplicate.
Genotype DmGS Duplication 
Status
Number of 
DmGS copies 
(diploid)
GSH concentration 
(pmol GSH/mg tissue)
w sn Single copy 2 36.9
y  sn v Double copy 4 37.2
w sn EP1322 Double copy 4 19.5
FM6 Double copy 4 28.9
wsn 1(1)8.3/FM6 Single/Double copy 3 37.3
Total glutathione content was measured in these experiments (Chapter 2, section 2.19), and 
although it would have been useful to measure oxidised glutathione levels, it is well 
established in the literature that enzymatic, fluorimetric and colorimetric assays are not 
suitable to measure GSSG, not least because GSH is easily oxidised to GSSG during 
processing (Meister and Anderson, 1983; Jones, 2002; Rebrin et al., 2003). Ion-paring 
HPLC in combination with coulometric electrochemical detection has been found to be the 
most reliable and specific method to detect GSSH (Rebrin et al., 2003), however we did 
not have access to appropriate equipment.
The glutathione concentration in the strains tested appears to be unrelated to the DmGS 
copy number (Figure 6.1). 1(1)8.3IFM6 (3 DmGS copies) has the same concentration of 
GSH as both y  sn v (4 DmGS copies) and w sn (2 DmGS copies). The strain with the lowest 
levels of DmGS is the parental EP1322 genotype, which contained just over half the 
amount of GSH as 1(1)8.3/FM6 and the two reference strains, despite carrying the DmGS 
gene duplication. FM6 females contained 78% of the GSH value from the two reference
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strains and 1(1)8.3/FM6.
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Figure 6.1: Glutathione levels in fly strains with different DmGS copy numbers, expressed as pinoles 
glutathione per mg tissue. GSH was tested in 3 day old non-virgin female flies. Results are the mean of 
two experiments performed in triplicate. Error bars indicate the standard error of the mean. 
Significant difference between EP1322 and each of l(l)8.3/FM6, y sn v, and w sn; as well as between 
FM6 and each of l(l)8.3/FM6, y  sn v, and w sn was calculated using a paired Students t-test where *** 
= p<0.001 and ** = p<0.01.
To investigate the effect of copy number on DmGS expression under conditions of 
oxidative stress, fly strains with different copy numbers were exposed to paraquat, which 
generates the superoxide radical, and also to the glutathione depleting agent diethyl 
maleate (DEM). In these experiments, groups of three day old non-virgin flies were fed a 
chemical stressor, either 5mM paraquat or 6mM DEM. The number of surviving flies was 
counted each day, as described in Chapter 2, section 2.28. For flies of all the genotypes 
tested, control flies which had not been exposed to any chemical stressor had lower DmGS 
expression levels than those exposed to either paraquat or DEM (Figure 6.2), although a 
statistically significant induction of DmGS was seen only with paraquat in 1(1)8.3/FM6.
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Figure 6.2: Expression of DmGS in flies after treatment with either DEM or paraquat. 3 day old 
female flies were treated with 6mM DEM or 5mM paraquat for 5 days. RNA was then extracted from 
the flies and RT-PCR was performed on each of the genotypes tested. The flies tested included 
l(l)8.3IFM6 (has one copy of DmGS on one X chromosome, and two copies of DmGS on the second X 
chromosome), w sn3 (has one copy of DmGS), EP1322 (has two copies of DmGS), y  sn3 v (has two copies 
of DmGS). Panel A shows a sample of RT-PCR for DmGS and for actin5C from each of the treated fly 
groups. Panel B shows the intensity of pooled GS transcript bands relative to actin5C intensity. 
Experiments were performed in triplicate. Significant difference between treated flies and the controls 
was calculated using a Students t-test, where *=p<0.05. Error bars indicate the standard error of the 
mean.
The survival of three day old flies from strains with different DmGS copy numbers 
exposed to DEM or paraquat was calculated to determine whether DmGS copy number had 
an effect on oxidative stress resistance. DmGS copy number was found to have no effect on 
oxidative stress resistance induced by paraquat (Figure 6.3A). The least resistant and most 
resistant strains (y sn v and EP1322) both carry a duplicated DmGS gene, while the single 
copy strains (w sn and 1(1)8.3/FM6) were intermediate in survival. There is also no effect 
of DmGS copy number on oxidative stress resistance in flies fed on DEM (Figure 6.3B). In
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fact, strains carrying the duplicated gene appear to have decreased resistance to oxidative
stress induced by DEM.
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- - - • - - • N o  P a r a q u a t  control
3  4 5 6 7 8 9 10 11 12 13 14
Tim e (Days)
10 12 14 16 18 20 22
Tim e (Days)
80
w sn  (1 copy) 
y sn  v (2 cop ie s )  
l(1)8.3/FM6 (1/2 cop ie s )  
—  E P 1 3 2 2  (2 cop ies )
No DEM control
Figure 6.3: Survival curves of fly strains with different DmGS gene copy numbers exposed to oxidative 
stress. Mated 3 day old female flies were placed in a population tub, and fed on a 10% sucrose solution 
containing the appropriate chemical stressor (Day 0). Untreated controls were fed on 10% sucrose 
only, and represent the mean survival results of untreated EP1322 and 1(1)8.3/FM6 flies. Panel A 
shows flies fed on 5mM paraquat. Panel B shows flies fed on 6mM DEM. (n=~170 for each genotype).
Lower endogenous GSH concentrations also do not correlate with decreased oxidative 
stress resistance in the strains tested. The double copy strain y  sn v  has the lowest 
resistance to both DEM and paraquat, however it has the highest amount of cellular GSH 
along with 1(1)8.3/FM6 (Table 6.1). In contrast, 1(1)8.3/FM6 exhibited high resistance to 
both chemical stressors tested.
This set of experiments is likely to be confounded by separate and unrelated genetic factors 
specific to each strain, and the number of strains tested is not great enough to show a 
pattern despite these genetic differences. To evaluate the impact of elevated DmGS
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expression of oxidative stress resistance, the EP1322 element was used to drive DmGS
expression.
6.2.2 Effect o f DmGS up-regulation on glutathione production and  
oxidative stress survivai
Strain EP1322 contains an EP element insertion in the 5’ UTR of the distal copy of DmGS, 
upstream of the translation initiation ATG codon, as illustrated in Figure 6.4. An EP 
element is a 7987bp transposable P-element containing a basal promoter and 14 copies of 
the yeast GAL4 Upstream Activating Sequence (UAS) sequence (Kraut et al., 2001). The 
UAS sequences are oriented such that GAL4-dependent transcription of genomic 
sequences flanking the element’s insertion site occurs. The GAL4 protein regulates 
expression of genes under the control of a UAS by binding directly to the UAS sequence 
(Duffy, 2002), as described in detail with reference to Drosophila in Section 1.3.2.3. 
Crossing strain EP1322 to a strain expressing GAL4 would be expected to drive DmGS 
transcription from the UAS sequence in cells expressing GAL4.
  Genom ic sequence
 ■ T1 sequence
 ■ T2 sequence
C Z > T3 sequence
Figure 6.4: Schematic diagram of the insertion site of the EP element within the distal copy of DmGS in 
strain EP1322. The cartoon with the EP element insertion point marked on it is from FlyBase. The 
positions marked on the diagram are the nucleotide positions on the genomic sequence in Appendix B. 
The three transcripts shown in the diagram are those associated with the distal copy of DmGS 
(CG6835). The position of the EP element in strain EP1322 has been published (Liao et al., 2000).
P{EP}EP1322 (Position 319)
G (Position 535)
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RT-PCR on flies driven with a series of GAL4 drivers
Six different strains carrying P elements which expressed GAL4 in tissue-specific patterns 
were used to drive expression from the EP1322 element, in an attempt to measure 
increased DmGS transcription initiated from the EP1322 UAS sequence. The six GAL4 
driver strains chosen had distinct spatial expression patterns, or alternate induction 
systems, as listed in Table 6.2
Table 6.2: GAL4 drivers crossed to strain EP1322 to measure possible changes in DmGS expression 
levels.
Stock name Genotype Expression pattern
Elav_GS-GAL4 P [EL AV-Gene Switch] 
(3rd chromosome)
Nervous system 
(RU486-dependent)
Actin(2)-GAL4 y  w'; P[w+mC=Act5C- 
GAL4]25FO 1/CyO, y* 
(2 chromosome)
Ubiquitous
Actin(3)-GAL4 y 1 w*; P[w+mC=Act5C- 
GAL4] 17bFO 1/TM6B, Tb' 
(3 chromosome)
Ubiquitous
D42-GAL4 w; P[w+, GAL4]-D42 
(3 chromosome)
Adult motomeuron 
and salivary gland
Tubulin-GAL4 y 1 w ;  P[w+mC=tubP- 
GAL4JLL7/TM3, Sb' 
(3 chromosome)
Ubiquitous
Males from each driver line were crossed to virgin females from the EP1322 stock. The 
progeny were then tested for DmGS expression levels using RT-PCR. In the case of the 
Elav-GS GAL4 driver, which utilises the GeneSwitch system, binding of GAL4 to UAS is 
dependent on the presence of the activator molecule RU486 (mifepristone). Progeny from 
the Elav-GS driver crossed to EP1322 were either fed on RU486 from larval or adult stage, 
or not at all. The protocol for administering RU486 to flies and the mechanism of the 
GeneSwitch system is described in section 2.29.
Of the five GAL4 drivers tested, the ubiquitously expressing Tubulin-GAL4 driver in
combination with EP1322 resulted in the highest DmGS expression level in both female
and male progeny relative to the parental EP1322 strain (Figure 6.5). The increase in
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DmGS expression levels in the Tubulin-GAL4>7iP7522 progeny is particularly evident in 
female flies (~4 fold increase), although DmGS expression in male progeny is 
approximately double that of the parental EP1322 strain. DmGS expression in the progeny 
ofElav-GS>£/>7522 and D42-GAL4>EP1322 did not show any elevation compared to the 
parental strain. This could be a result of the drivers’ genetic background, or it may be 
because any increase in DmGS expression in the neural tissues alone would not be 
sufficient to be measured by RT-PCR of whole body samples.
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Figure 6.5: RT-PCR data showing DmGS expression relative to actinSC. EP1322 flies were crossed to 
a series of GAL4 drivers, and the GS expression in the driven progeny was compared to the undriven 
control. Panels A and B show the relative expression of GS in male and female flies respectively. The 
Elav flies fed on RU486 were either given the RU486 from the larval stage through to adult (L-F) or in 
the adult stage only (A-F). The driver which resulted in the highest GS expression levels in male as well 
as female flies (Tubulin-GAL4) is indicated by a red bar, while the undriven EP1322 stock is marked 
with a green bar. Panels C and D show the original agarose gel images of GS and actin5C RT-PCR  
samples of male and female flies from which the data in panels A and B were obtained. This data is 
from a single experiment.
Tubulin-GAL4 driven EP1322 flies were examined more closely, as there appeared to be 
upregulation of DmGS in both female and male driven flies.
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Tubulin-GAL4 induced overexpression of DmGS and/or Gclc
A UAS-Gclc transgene created previously (Pushpa Kansagra, Open University, pers. 
comm.) was included in experiments aimed at evaluating the impact of GAL4 driven 
expression of GS in EP1322, using the Tubulin-GAL4 driver. The UAS-Gclc transgene is 
fused to a UAS sequence which permits GAL4 initiation of transcription. Gclc was over­
expressed without the modifier component, as ubiquitous high level simultaneous over­
expression of Gclc and Gclm using the Tubulin-GAL4 driver has been found to be lethal 
(Orr et al., 2005; Kotecki et al., manuscript in preparation). The Gclc transgenic stock is 
transformed with a pUAST construct bearing a complete Drosophila Gclc cDNA: the 
resulting transformant stocks express Gclc in response to GAL4 driver elements (Fraser et 
al., 2002). A stock carrying both the EP1322 P-element and the pUAST-Gc/c transgene 
was constructed (Figure 6.6). The markers used to create the stock included CyO and Sp. 
Both EP1322 and UAS-Gc/c elements are marked with a mini-white marker, allowing 
identification of flies bearing both elements on the basis of darker eye pigmentation 
compared to single element flies. To create a stock homozygous for pUAST-Gc/c, the 
males in step 6 were crossed to female siblings carrying pUAST-Gclc and FM6. The stock 
was eventually maintained as EP1322; pUAST-Gc/c, although experiments were 
performed on flies with the EP1322I¥M6; pUAST -Gclc genotype.
1. F M 6/Y  X 7  w; P{w+mC=Act5C-GAL4}/C.yO
6. w sn EP1322IFM6; pUAST-GCLC
Figure 6.6: Crossing scheme to introduce a construct containing a UAS-Gclc transgene into the EP1322 
stock. In step 5 heterozygous and homozygous pUAST-Gc/c carrying flies were distinguished by a 
darker eye colour in the heterzygotes as a result of the mimwhite gene carried by pUAST.
/
2. F M 6IY ; CyOf+ X w ; pUAST-GCLC and w s n  EP1322 X  y lY \  CyOISp
3. FM Sf w; pUAST-GCLC/CyO X w  sn EP1322/Y; CyO/+
/
4. FM 6i ws»EP1322 ; pUAST-GCLC/QO X FM 6/Y- pUAST-GCLCJCyO
5 .w s n  EP1322/Y; pUAST-GCLC/CyO X F M 6/Y; pUAST-GCLCfCyO
The crossing scheme to create Tubulin-GAL4 driven EP1322 flies with or without the 
presence of a transgenic copy of UAS-Gc/c is illustrated below in Figure 6.7. Darker eyed 
flies from the EP1322 cross were collected as there is a w+ marker in both the EP1322 and 
GAL4 driver elements, as well as in the pUAST-Gc/c construct, resulting in a darker eyed 
phenotype in flies carrying all three elements.
C? Tubulin-GAL4/7M?, Sb X Qwsh3EPZ322
or 9  w sn'5 EPl 322/FM6;
or 9  pUAST-GCLC
1
w sn3 EPl322/+', Tubulin-GAL4/+ 
or w sn3 EPl 322/+; Tubulin-GAL4/pUAST-GCLC 
or pTJAST-GCLC/Tubulin- GAL4
Figure 6.7: Crossing scheme to introduce a Tubulin GAL-4 driver to three stocks containing 
combinations of EP1322 and UAS-Gclc.
Levels of DmGS transcription were measured in the three driven stocks described in Figure 
6.7, as well as in the tubulin-GAL4 driver stock and the parental pUAST-Gc/c and E P l322 
stocks. The genotypes of the flies used in all following experiments are given in Table 6.3.
Table 6.3: Genotypes of flies used in the oxidative stress experiments that follow
Fly name Genotype
Tubulin-Gal4 Driver (TubGAL4) y  w; P[w =tubP-GAL4]LL7/TM3, Sb'
EP1322 w sn EPl 322
UAS-Gclc wu,s; pUAST-Gclc
E P l322; Gclc w sn EP1322/FM6; pUAST-Gclc
Driven EPl 322 w sn EP l322/+; TubGAL4/+
Driven Gclc pUAST-Gc/c/TubGAL4
Driven E P l322; Gclc w sn E P l322/+; pUAST-Gcfc/TubGAL4
RNA was extracted from 3day old male and female flies, and cDNA was created and 
amplified in PCR reactions as described in Chapter 2, sections 2. 4.2 and 2.16. DmGS 
expression was increased in male and female E P l322 ; tubulin-GAL4/+ flies compared 
with the undriven parental strain E P l322 (Figure 6.8). The increase in DmGS expression
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was greater in £’P/522;tubulin-GAL4/+ compared with £P7522;tubulin-GAL4/UAS- 
Gclc. In all cases DmGS was more highly expressed in males than in females, although the 
reason for this is not known at this stage. In order to rule out the possibility that the 
presence of the tubulin-GAL4 driver alone could raise DmGS expression, expression of 
DmGS was tested in tubulin-GAL4/UAS-Gc/c flies which did not carry the E P l322 
element. There was no increase in DmGS expression in these stocks, confirming that the 
increase in DmGS expression seen in driven E P l322 stocks is due to the GAL4-induced 
activation of DmGS expression mediated by the EP element E P l322.
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Figure 6.8: RT-PCR data showing GS expression relative to actin5C. EP1322 flies with and without a 
Gclc transgene were crossed to Tubulin-GAL4 driver, and the GS expression in the driven progeny 
was compared to the undriven control. Panels A shows the GS and actin5C RT-PCR samples from 
male and female driven and control EP1322 and Gclc flies. Panel B shows the expression of GS 
relative to actin5C in male and female driven and control E P l322 and Gclc fly strains. Statistically 
significant difference between the GS levels in both male and female driven EPl 322 flies (Driven 
EP1322; GCLC and Driven GCLC) and their non-driven EP1322 counterparts (EP1322) is indicated 
with an asterisk (Students t-test; *p<0.05).
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The level of Gclc expression was also measured in the genotypes discussed above. The 
E P l322; UAS-Gclc genotypes crossed to the tubulin driver had at least a 3-fold increase in 
Gclc expression compared to the undriven parental genotypes (Figure 6.9). As is the case 
with DmGS expression, driven EP1322\ UAS-Gc/c males exhibited an unexplained higher 
level of Gclc transcription compared to their female siblings.
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Figure 6.9: RT-PCR data showing Gclc expression relative to actin5C. EP1322 flies with and without a 
Gclc transgene were crossed to Tubulin-GAL4 driver, and the Gclc expression in the driven progeny 
was compared to the undriven control. Panel A shows Gclc and actin5C RT-PCR samples from driven 
and control male and female flies. Panel B shows the expression of GCLC relative to actin5C in male 
and female driven and control EP1322 and Gclc flies. Statistically significant difference between the 
Gclc levels in both male and female driven Gclc flies (Driven EP1322; GCLC and Driven GCLC) and 
their non-driven Gclc counterparts (GCLC) is indicated with an asterisk (Students t-test; *p<0.05).
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Glutathione levels in flies overexpressing DmGS and Gclc.
After confirming that DmGS expression was increased in EP1322 ; tubulin-GAL4/+, and 
that Gclc expression was increased in UAS-Gc/c/Tubulin-GAL4 flies, the glutathione 
content of these flies was measured as described (Chapter 2, section 2.19) in order to 
ascertain whether increased expression of the genes encoding components of the 
glutathione synthetic pathway was reflected by increased GSH synthesis.
All the female flies exhibiting increased transcription of DmGS and/or Gclc had greater 
concentrations of GSH than their non-driven counterparts (Figure 6.10A). The difference 
in glutathione levels among the driven flies and their parental stocks is shown to be 
statistically highly significant (Figure 6.10B-D). The highest GSH level was seen in 
EP1322; UAS-Gc/c/Tubulin-GAL4 flies, suggesting a cumulative effect of DmGS and 
Gclc on GSH levels (Table 6.4). The GSH content in these flies was significantly different 
to that in both the EP1322; Tubulin-GAL4/+ and UAS-Gc/c/Tubulin-GAL4 flies (Figure 
6.10E). EP1322; Tubulin-GAL4/+ flies had the lowest GSH levels of all three driven flies, 
suggesting GS has less impact on physiological GSH concentrations than does GCLC.
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Figure 6.10: Glutathione concentrations in female flies with increased levels of GS or Gclc or GS+Gclc. 
Glutathione was measured in 3 day old mated flies. Glutathione levels are expressed as pmoles 
glutathione per mg of fly tissue, thus removing the bias of body size differences between genotypes and 
sexes. Panel A=all transgenic fly strains, alongside the control flies and the tubulin-GAL4 driver. Panel 
B=Levels of glutathione in driven and control female flies carrying the Gclc transgene. Panel C=Levels 
of glutathione in control and driven EP1322; Gclc flies which exhibited increased GS and Gclc 
expression levels. Panel D= Levels of glutathione control and driven EP1322 flies which exhibited 
increased GS expression levels. Panel E=Compares the amount of glutathione present in flies 
overexpressing GS, Gclc, and GS+Gc/c. The asterisks indicate a statistically significant difference 
between the samples using a Students t-test, where *=p<0.05, **=p<0.01, ***=p<0.001
Table 6.4: Glutathione levels in Gclc and DmGS overexpressing flies
Fly strain Glutathione
(pmoles/mg
tissue)
Sex Increase in GSH in 
driven flies vs non­
driven
pUAST-Gc/c 21.08 Female
pUAST-Gc/c 20.75 Male
EP1322 19.48 Female
EP1322 19.76 Male
EP1322; pUAST-Gclc 27.24 Female
EP1322; pUAST-Gclc 30.14 Male
Tubulin-GAL4 driver 27.09 Female
Tubulin-GAL4 driver 24.72 Male
Driven EP1322 28.47 Female 49.5%
Driven EP1322 31.01 Male 63.2%
Driven pUAST-Gc/c 51.03 Female 142.9%
Driven pU AST-Gclc 70.22 Male 243.2%
Driven EP1322; pUAST-Gc/c 58.88 Female 118.5%
Driven EP1322; pUAST-Gc/c 68.78 Male 128.2%
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In a similar pattern to the female flies, males with increased DmGS and/or Gclc expression 
had greater concentrations of GSH than their non-driven counterparts (Figure 6.11A and 
Table 6.4). The difference in glutathione levels among the driven flies and their parental 
stocks was statistically highly significant (Figure 6.11B-D). In contrast to the female 
siblings, the highest GSH levels were seen in flies carrying a transgenic copy of Gclc, 
where the presence of the EP element EP1322 did not appear to have an effect on the 
amount of GSH present. The GSH content in the EP1322/+; UAS-Gc/c/Tubulin-GAL4 
flies was not significantly different to the UAS-Gc/c/Tubulin-GAL4 flies, however both 
these flies had a statistically significant higher level of GSH when compared to undriven 
parental genotypes (Figure 6.1 IE). When comparing the GSH levels of male and female 
siblings of the genotypes in which expression of DmGS and Gclc is driven by Tubulin- 
GAL4, male flies always had higher levels of GSH (Table 6.4). This is consistent with the 
higher DmGS and Gclc expression levels in male flies.
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Figure 6.11: Glutathione concentrations in male flies with increased levels of DmGS or Gclc or 
DmGS+Gclc expression. Panel A=all transgenic fly strains, alongside the control flies and the tubulin 
driver. Panel B=Levels of glutathione in driven and control female flies carrying the Gclc transgene. 
Panel C=Levels of glutathione control and driven EP1322; Gclc flies which exhibited increased DmGS 
and Gclc expression levels. Panel D= Levels of glutathione control and driven EP1322 flies which 
exhibited increased DmGS expression levels. Panel E=Compares the amount of glutathione present in 
flies overexpressing DmGS, Gclc, and DmGS+Gclc. The asterisks indicate a statistically significant 
difference between the samples using a Student’s t-test, where **=p<0.01, ***=p<0.001
Survival of flies exposed to oxidative stress
After confirming that driving DmGS expression from the EP1322 UAS sequence using a 
tubulin-GAL4 driver resulted in raised DmGS mRNA levels, and that this increase in 
DmGS expression led to an increase in GSH levels in female flies, the driven flies were 
tested for oxidative stress resistance. Flies overexpressing Gclc, as well as flies 
overexpressing both DmGS and Gclc (GS+Gclc) were also tested in this survival assay to 
determine whether DmGS could have any effect alone, or whether both enzymes involved 
in glutathione biosynthesis would need to be present for an effect to be observed. The 
chemicals used to induce oxidative stress were DEM and paraquat, fed to the flies in a
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sucrose solution as described in (Chapter 2, section 2.28). The tests were performed on 
female and male siblings, and survival experiments were repeated at least twice in tubs 
containing a minimum of 75 individuals. The data from all repeated experiments was 
pooled to allow for greater power of statistical analysis.
Survival o f  flies fe d  on DEM
Flies were fed a 6mM DEM solution made up in 10% sucrose. DEM is a glutathione 
depleting compound that binds directly to GSH, and also indirectly affects glutathione 
content by interfering with glutathione S-transferase (Parkinson, 2001; Yang et al., 2004). 
DEM therefore induces oxidative stress due to glutathione depletion. It is also an 
interesting stressor to use in this project as it allows the specific study of a low level of 
glutathione, and the effect of increasing the glutathione biosynthetic enzymes in this 
context.
The positive consequence of raising DmGS expression levels under conditions of DEM- 
induced oxidative stress is noticeable in female flies (Figure 6.12B&C), whereas in males 
the induction of DmGS expression appears to have no effect on survival (Figure 
6.13B&C). Female flies overexpressing DmGS, with or without Gclc overexpressed have 
an increased resistance to oxidative stress. Both male and female flies overexpressing Gclc 
do not fare any better than the non-driven control flies (Figure 6.12A and Figure 6.13A). 
When comparing the survival curves of all driven flies, with either DmGS and/or Gclc 
over-expressed, there is no difference in the survival curves for female flies (Figure 
6.12D). Conversely, the male siblings over-expressing Gclc only survive almost twice as 
long as those overexpressing a combination of DmGS and Gclc (driven EP1322/+; UAS- 
Gclc/+), or DmGS only (driven EP1322/+) (Figure 6.13D), but this extension in survival is 
problematic because the non-driven Gclc control flies also have an extended survival curve 
(Figure 6.13 A). This suggests that there is an unidentified genetic factor in the UAS-Gc/c 
stock conferring resistance to DEM-induced stress.
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Figure 6.12: Comparison of survival curves of female flies fed on 6mM DEM. Panel A compares the 
survival of flies overexpressing Gclc compared to control flies. Panel B compares the survival of flies 
overexpressing DmGS, achieved by driving the P-element EP1322, compared to control flies. Panel C 
compares the survival of flies over-expressing both DmGS and Gclc compared to the controls. Panel D 
compares the survival curves of flies with different combinations of DmGS and Gclc over-expression.
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Figure 6.13: Comparison of survival curves of male flies fed on 6mM DEM. Panel A compares the 
survival of flies overexpressing Gclc compared to control flies. Panel B compares the survival o f flies 
overexpressing DmGS, achieved by driving the P-element EP1322, compared to control flies. Panel C 
compares the survival of flies overexpressing both DmGS and Gclc compared to the controls. Panel D 
compares the survival curves of flies with different combinations of DmGS and Gclc overexpression. 
The full genotypes of the flies used are: Driven EP1322 = w sn EP1322/+; TubGAL4/+. Driven 
EP1322/+; GCLC/+ = EP1322/+; GCLC/TubGAL4. Driven GCLC = w; GCLC/TubGAL4. Driver = y  
w; TubGAL4/7M3, Sb.
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Table 6.5: Median and maximum lifespan values of driven and non-driven flies overexpressing DmGS 
and/or Gclc when exposed to DEM. Values shown are±SEM._______________________
Fly strain Sex Median lifespan Maximal lifespan
EP1322 a 2.92 ±0.11 5.26 ±0.10
Driven EP1322 a 2.59 ± 0.06 4.66 ±0.08
EP1322;UAS-Gclc a 2.6 ± 0.08 4.68 ±0.01
Driven £P/322;UAS-Gc/c a 2.62 ± 0.08 4.72 ± 0.07
UAS-Gclc a 5.78 ± 0.20 10.40 ±0.16
Driven UAS -Gclc a 4.81 ±0.27 8.66 ±0.01
Tubulin Driver a 4.16 ±0.13 7.49 ± 0.06
EP1322 9 4.64 ±0.12 8.35 ± 0.07
Driven EP1322 9 8.11 ±0.16 14.60 ± 0.26
EP 1322;UAS-Gclc 9 4.62 ±0.14 8.32 ±0.13
Driven is/7322;UAS-Gc/c 9 7.01 ± 0.27 12.62 ±0.26
UAS-Gc/c 9 7.52 ± 0.28 13.54 ±0.01
Driven UAS-Gc/c 9 7.22 ±0.15 13.00 ±0.09
Tubulin Driver 9 3.82 ±0.12 6.88 ± 0.05
A comparison of the time point at which 50% of the population survive (the median 
survival time) of driven and non-driven flies is shown in Figure 6.14 and Table 6.5). The 
statistical test used to compare the survival curve data was the non-parametric Mann- 
Whitney U test, which compares the medians of two data sets (Pallant, 2005). In female 
flies, the driven EP1322 and driven EP1322; UAS-Gclc flies live significantly longer than 
their non-driven counterparts. This effect is unlikely to be due to the genetic background in 
the tubulin-GAL4 driver stock because there is no significant difference between the driver 
stock and the non-driven EP1322 and EP1322; UAS-Gclc control flies. In male flies, the 
driven flies over-expressing DmGS or Gclc never have an increased median survival 
(Figure 6.14B). In the case of EP1322 and UAS-Gc/c flies, the driven male flies have a 
significantly lower survival rate, which is contrary to the expectation.
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Figure 6.14: Median survival (time point at which 50% of the flies survive) in driven EP1322 flies (red 
bars) over-expressing DmGS, DmGS+Gclc or Gclc alone, as well as control flies (green bars). All 
genotypes were fed on 6mM DEM. Panel A shows data for female flies, and Panel B shows data for 
male flies. Statistically significant differences between survival times of driven and undriven flies were 
calculated using the Mann-Whitney U test, where *=p<0.05, **=p<0.01 and ***=p<0.001
Survival o f  flies fe d  on Paraquat
In addition to DEM, paraquat was also used as an oxidative stressor. Paraquat is a 
superoxide (O2 ) generator, and glutathione has been found to be an important cellular 
protector against a paraquat assault (Palmeira, 1999), making paraquat a useful source of 
chemically induced oxidative stress in this study. Paraquat was administered to flies in tubs 
in the same manner as DEM.
The survival results from paraquat-induced oxidative stress were similar to those from
DEM-induced stress with respect to the sex differences. Female flies over-expressing
DmGS and/or Gclc exposed to paraquat all survived for longer periods of time than the
non-driven controls (Figure 6.15). Male sibling flies which over-expressed DmGS and/or
Gclc did not, however, show an increase in oxidative stress resistance (Figure 6.16). The
most extensive increase in survival was in females of the tubulin-GAL4 driven EPJ322
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strain, which exhibited the longest survival time of all genotypes exposed to paraquat, as 
well as the greatest increase in maximum survival time compared to the non-driven 
counterparts (Figure 6.15D).
In a comparison of all the tubulin-GAL4 driven females, the stock overexpressing Gclc had 
the lowest resistance to oxidative stress. The male flies overexpressing DmGS alone or 
with Gclc had similar survival curves, while the greatest resistance to oxidative stress was 
observed in the tubulin-GAL4 driver. Male UAS-Gc/c flies crossed to the tubulin-GAL4 
driver were not tested for paraquat resistance because there was a high level of mortality 
amongst the embryos of this genotype, and the numbers of flies collected were not 
sufficient to give statistically robust data. It has recently been suggested that global 
overexpression of Gclc may interfere with signal transduction and protein folding in a 
redox dependent manner (Orr et al., 2005).
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Figure 6.15: Comparison of survival curves of female flies fed on 5mM paraquat. Panel A compares 
the survival of flies overexpressing Gclc compared to control flies. Panel B compares the survival of 
flies overexpressing DmGS, achieved by driving the P-element EP1322, compared to control flies. Panel 
C compares the survival of flies over-expressing both DmGS and Gclc compared to the controls. Panel 
D compares the survival curves of female flies with different combinations of DmGS and Gclc over­
expression.
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Figure 6.16: Comparison of survival curves of male flies fed on 5mM paraquat. Panel A compares the 
survival of flies overexpressing DmGS, achieved by driving the P-element EP1322, compared to control 
flies. Panel B compares the survival of flies overexpressing both DmGS and Gclc compared to the 
controls. Panel C compares the survival curves of male flies with either DmGS or a combination of 
DmGS and Gclc overexpression
Table 6.6: Median and maximum lifespan values of driven and non-driven flies overexpressing DmGS 
and/or Gclc when exposed to paraquat. Values shown are±SEM_____________________
Fly strain Sex M edian lifespan Maximal lifespan
EP1322 Male 6.7 ± 0.25 12.06 ±0.19
Driven EP1322 Male 7.62 ±0.33 13.71 ± 0.50
EP1322,Gclc Male 6.01 ±0.34 10.82 ±0.27
Driven EP1322;Gclc Male 7.76 ±0.31 13.97 ±0.14
Tubulin Driver Male 10.46 ±0.19 18.82 ±0.23
EP1322 Female 5.19 ±0.23 9.34 ±0.42
Driven EP1322 Female 9.07 ±0.57 16.33 ±0.33
EP1322,Gclc Female 7.67 ± 0.25 13.81 ±0.76
Driven EP1322; Gclc Female 10.17 ±0.29 18.31 ±0.20
Gclc Female 4.05 ±0.11 7.29 ±0.31
Driven Gclc Female 6.03 ±0.6 10.86 ± 1.00
Tubulin Driver Female 3.9 ± 0.51 7.02 ±0.27
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A comparison of the median survival time of driven and non-driven flies exposed to 
paraquat is shown in Figure 6.17 and Table 6.6. In female flies, the trend seen in the 
survival curves in Figure 6.15 where all driven fly strains were more resistant to paraquat 
than the non-driven controls is confirmed statistically using the Mann-Whitey U test. The 
time point where 50% of the driven population survived is significantly different to the 
non-driven controls (Figure 6.17A). In male flies, the driven stocks over-expressing DmGS 
with or without Gclc have a significantly raised survival compared to the non-driven 
control flies, with the flies over-expressing DmGS as well as Gclc showing a more 
significant difference compared to their non-driven counterparts (Figure 6.17B).
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Figure 6.17: Median survival (time point at which 50% of the flies survive) in driven EP1322 flies (red 
bars) over-expressing DmGS, DmGS+Gclc or Gclc alone, as well as control flies (green bars). All 
genotypes were fed on 5mM paraquat. Panel A shows data for female flies, and Panel B shows data for 
male flies. Statistically significant differences between survival times of driven and undriven flies were 
calculated using the Mann-Whitney U test, where *=p<0.05, **=p<0.01 and ***=p<0.001.
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6.3 Discussion
Levels of antioxidant defences have been postulated to affect the resistance of animals to 
stressful environments, and in particular to environmental oxidative stress (Arking et al., 
2000; Sohal et al., 2002; Dugan and Quick, 2005; Orr et al., 2005). An age-related increase 
in ROS production with a simultaneous decrease in glutathione is observed in a wide 
variety of organisms including Drosophila (Sohal et al., 1995; Rebrin et al., 2004; Orr et 
al., 2005). The mechanisms of age-related GSH decline are not understood, but may be due 
to increased demand from increased ROS, or from a decrease in de novo synthesis (Zhu et 
al., 2006). A recent study where the capacity for glutathione biosynthesis was enhanced by 
overexpressing GCL was shown to increase lifespan by up to 50%, and also increase 
resistance of flies to oxidative stress resistance (Orr et al., 2005). The hypothesis that 
increasing the levels of the antioxidant GSH can increase oxidative stress resistance was 
tested in this study by genetically manipulating levels of glutathione in flies and exposing 
them to oxidative stress. Flies over-expressing DmGS and/or Gclc were exposed to two 
oxidative stressors to assess the effects of increased expression of both glutathione 
biosynthesis genes on artificially induced oxidative stress resistance.
The chemicals used to induce oxidative stress were DEM and also paraquat. DEM is a 
glutathione depletor, lowering GSH by over 85% at ImM concentrations (Ito et al., 1998; 
Parkinson, 2001). DEM is used to chemically induce oxidative stress because GSH 
depletion causes an increase in free radical generation, although the mechanism for the 
increase in ROS is still unclear (Back et al., 1998). Superoxide radicals are generated 
when paraquat is reduced by NADPH-diaphorase to a paraquat radical, which in turn 
reacts with dioxygen to produce superoxide radicals (Bus and Gibson, 1984; Orr and 
Sohal, 1993). Paraquat exposure is used as a non-chronological bioassay of ageing in 
Drosophila where lifespan and Paraquat resistance have been shown to track together in
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laboratory strains (Arking et al., 1991; Ruan et al., 2002; Morrow et al., 2004; Bauer et al., 
2005; Droge, 2005) as well as in wild caught flies (Baidal et al., 2006).
A preliminary study was performed looking at DmGS copy number and DmGS expression 
in relation to oxidative stress in a variety of non-driven Drosophila strains, however there 
was no correlation between DmGS copy number, DmGS expression and GSH content. 
DmGS copy number also had no effect on oxidative stress resistance when the flies were 
exposed to DEM or paraquat. The results of this experiment are probably confounded by 
separate and unrelated genetic factors specific to each fly strain, and prompted the use of 
GAL4 driven flies where the genetic background would be more comparable. This 
experiment did, however, confirm that DmGS expression was increased in all genotypes 
when exposed to DEM as well as paraquat, although the trend was only statistically 
significant in 1(1)8.3/FM6 flies. A previous study also found an increase in DmGS 
expression in 3 day old male flies exposed to paraquat compared to the control flies 
(McCarroll et al., 2004), while DEM has been shown to upregulate GS in rat hepatocytes 
(Huang et al., 2000). DEM and paraquat-induced oxidative stress are thought to increase 
GSH by a mechanism that involves the redox sensitive transcription factors AP-1 and 
NKkB, as well as transcription factors Nrfl and Nrf2 (Coe et al., 2002), as discussed in 
detail in Chapter 1, section 1.1.4.
In order to minimize the genetic background problems encountered using unrelated stocks 
with different DmGS copy numbers, transgenic flies that had raised DmGS and Gclc 
expression levels when crossed to a GAL4 driver were used. The EP1322 insertion was 
used to drive DmGS expression when driven by a tubulin-GAL4 driver, and a pUAST-Gc/c 
insertion overexpressed Gclc when similarly combined with a tubulin-GAL4 driver. A 
recombinant strain carrying both the EP1322 element and the pUAST-Gclc transgene, 
showed increased transcription of both DmGS and Gclc when crossed to the tubulin-GAL4 
driver.
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The choice of GAL4 driver was informed by the level of increase in DmGS transcription in 
driven EP1322 flies. The tubulin-GAL4 driver caused the highest levels of DmGS 
expression in both male and female EP1322 flies. The variability of target gene expression 
levels using different GAL4 drivers was also noted in a study overexpressing ApoE 
(Walker et al., 2006). Most recent studies in Drosophila that have shown increased stress 
resistance or lifespan after overexpressing a transgenic antioxidant have used a 
motomeuron GAL4 driver (Parkes et al., 1998; Phillips et al., 2000; Spencer et al., 2003; 
Hwangbo et al., 2004; Morrow et al., 2004; Fridell et al., 2005; Orr et al., 2005; 
Thiruchelvam et al., 2005). Here, a neuronal GAL4 driver was not used because firstly, the 
neuronal Elav-GAL4 driver (GeneSwitch) did not elevate DmGS transcription in 
combination with EP1322, and secondly, the examples cited above involved 
overexpression of genes that perform an antioxidant function as the single gene. GS has a 
secondary role in GSH synthesis, as it is not the rate limiting step. In this regard GS and 
GCLM are similar, and in a previous study, an increase in longevity was only achieved by 
overexpressing Gclm ubiquitously with a tubulin driver, while a neuronal expression of the 
active Gclc unit caused an increase in longevity (Orr et al., 2005).
When using the tubulin-GAL4 driver, DmGS expression levels were raised in driven 
EP1322 flies, as well as driven EP1322; UAS-Gc/c flies. Both male and female flies had 
increased DmGS expression, but higher levels of induction were seen in male flies. This 
sex bias was also noted in the driven UAS-Gc/c flies where males had higher Gclc 
expression levels than their female siblings. The higher DmGS and Gclc expression levels 
also corresponded to higher GSH levels in driven male flies compared to their female 
counterparts.
Both male and female driven EP1322 flies had the lowest GSH levels of all three
genotypes of driven flies, suggesting GS has less impact on biological GSH concentrations
than does GCLC. This was an expected result since kinetic studies performed largely on rat
liver GS indicates that GS is not the rate limiting step in GSH biosynthesis (Huang et al.,
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2000). GS is, however, an essential component of the GSH cycle, as shown when the 
simultaneous overexpression of DmGS and GCL in E. coli improved GSH production, 
while neither enzyme had an effect when expressed alone (Liao et al., 2006) Global over­
expression of Gclm in adult flies resulted in a moderate increase in lifespan (Orr et al., 
2005), even though this subunit of GCL is not essential for the production of GSH. The 
highest increase in GSH levels was seen in tubulin driven EP1322; UAS-Gc/c and UAS- 
Gc/c flies. Flies over-expressing Gclc both with and without DmGS overexpression 
exhibited a GSH increase of 118-243%, which is comparable to values obtained by Gclc 
upregulation in a previous study (Orr et al., 2005). In female flies, overexpressing Gclc in 
addition to DmGS had a cumulative effect on the increase in GSH, however this 
cumulative effect was not observed in male flies. Overexpressing DmGS and Gclc in rats 
has been found to increase GSH synthesis to levels comparable with Gclc overexpression 
alone, although this study was done using male rats only (Huang et al., 2000).
Cellular ROS are critical in diseases which can shorten lifespans, although their effect is 
typically not seen in standard unstressed laboratory conditions (Dugan and Quick, 2005). 
ROS would, however, be crucial to wild animals exposed to environmental toxins and 
stresses on a regular basis, for example through ingestion. It is therefore thought that in an 
experimental model of oxidative stress, an increase in glutathione could protect an 
organism against ROS damage. The hypothesis that raised GSH levels could protect 
against an environment of increased oxidative stress was tested by exposing flies 
overexpressing DmGS and/or Gclc to DEM or paraquat. Using oxidative stress resistance 
as a predictor of longevity in Drosophila has been well documented (Seto et al., 1990; 
Arking et al., 1991; Lin et al., 1998; Giannakou et al., 2004). Female flies overexpressing 
DmGS were shown to have increased DEM and paraquat resistance, with the effect most 
prominent in flies exposed to paraquat. All female flies with DmGS and/or Gclc expressed 
exhibited statistically significant increases in stress resistance on exposure to paraquat,
with flies over-expressing DmGS as well as Gclc showing the highest median and
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maximum survival times. The increase in both median (average lifespan of a population) 
and maximal (the maximum age to which an individual of a specific population can be 
expected to live) survivorship of female flies over-expressing DmGS and/or Gclc is an 
important result, as the implication is that both ‘quality of life’, as well as length of life 
could be extended through the induction of both DmGS and Gclc in flies. The idea that an 
increase in mean mortality could indicate an increased ‘quality of life’ in Drosophila was 
recently proposed by Ruan et al. (2002). It is interesting to note that none of the male flies 
over-expressing DmGS or Gclc exhibited any resistance to either DEM or paraquat, 
especially since male flies had higher DmGS and Gclc expression, as well as higher GSH 
levels than the females. In a study where Gclc was over-expressed in male flies only, Orr et 
al (2005) only saw an increase in the oxidative stress resistance of 40 day old flies, and not 
in the younger 10 day old flies. It may be the case that the positive effect of DmGS or Gclc 
overexpression on stress resistance is only seen in older male flies, so the effect would not 
be seen in the 3 day old flies used in this current study.
This sex bias has been noted in several studies on oxidative stress and longevity in fruit 
flies (Lints et al., 1983; Carey et al., 1995; Spencer et al., 2003; Forbes et al., 2004; 
Magwere et al., 2004; Valenzuela et al., 2004; Magwere et al., 2006). In some of the 
studies, though, it could be argued that the increase in female survival is due to infertility 
caused as an additional effect of a single gene mutation conferring increased oxidative 
stress resistance, as is the case with the chico mutant (Clancy et al., 2001). This sex- 
specific effect on longevity has also been noticed in other species including humans 
(Hazzard, 1986; Lio et al., 2002; Christiansen et al., 2006), mice (Jackson et al., 2002), 
spiders (Burger and Promislow, 2004) and medflies (Carey et al., 1995). It has been 
proposed that longevity factors may be sex-specific, with males and females employing 
different biological strategies (Christiansen et al., 2006).
In a review of 218 studies where the lifespan of female and male Drosophila were
compared, the mean lifespan of female flies was found to be greater than that of the males
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in approximately half of the cases; however, the maximal lifespan was consistently higher 
for females than it was for males (Lints et al., 1983). Interventions that extend the lifespan 
and oxidative stress resistance of females significantly more than male flies include caloric 
restriction (Mair et al., 2003; Magwere et al., 2004), Chico mutants (Clancy et al., 2001) 
and SOD overexpression in motomeurons (Spencer et al., 2003). Until recently, only 
males have been used in the majority of life extension experiments in Drosophila, 
including reports of methuselah (mth) mutants (Lin et al., 1998), heat shock protein 
overexpression (Morrow et al., 2004), and MnSOD mutants (Sun et al., 2002), usually to 
avoid the confounding factor of female reproduction (Burger and Promislow, 2004). In a 
study comparing female and male responses to 16 different life-extending interventions, it 
was found that females fared better than males overall, although in certain situations 
including hyper-gravity and desiccation resistance, male flies exhibited an increase in 
lifespan where female flies did not (Burger and Promislow, 2004).
The reasons for these sex biases are unknown, however it is likely to include a combination 
of diverse factors including reproductive cost (e.g. some interventions may reduce egg 
laying in females, thereby increasing longevity), sexual selection (male traits making them 
more attractive to females may reduce their lifespan), sex linkage (a change in gene 
expression on the Y or X chromosome may be detrimental to males or advantageous to 
females) or behavioural aspects (Carey et al., 1995; Burger and Promislow, 2004).
Reduced reproductive cost can probably be ruled out as a cause of sex bias in this study 
because the females were fertile: virgin female transgenic stocks crossed to male tubulin- 
GAL4 flies did produce offspring. It is possible, however, that the female flies had a 
reduced fecundity. Another possible reason for sex-specific effects on lifespan put forward 
is a difference in metabolic rates between males and females; female’s mitochondria 
produce less ROS, and have lower levels of oxidative damage than their male counterparts 
(Vina et al., 2003). The sex-biased phenomenon observed in this study and many others is
one that deserves further attention in future studies (Burger and Promislow, 2004).
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The positive result of increased oxidative stress resistance in all females overexpressing 
DmGS and/or Gclc is tempered by the lack of stress resistance in male flies overexpressing 
DmGS and/or Gclc, even though the male flies had higher GSH levels than their female 
counterparts. Drawing a direct correlation between upregulation of GSH and increased 
oxidative stress resistance is made difficult by the sex specificity of the effect, despite 
many other studies reporting a similar sex bias in resistance to oxidative stress.
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7 Chapter 7: Oxidative stress resistance and viability in 
Drosophila S2 cells
7.1 Introduction
Glutathione is an important cellular antioxidant that may have an effect on longevity, 
according to the free radical theory of ageing (Kehrer and Lund, 1994; Meister, 1994; 
Polekhina et al., 1999; Finkel and Holbrook, 2000; Sohal et al., 2002). Glutathione is 
maintained by reduction of GSSG by NADH via glutathione reductase, and also by de novo 
synthesis (Shi et al., 1994). The role of glutathione synthetase (GS) was examined in adult 
Drosophila melanogaster in the previous chapter by overexpressing DmGS as well as the 
catalytic subunit of glutamate-cysteine ligase {Gclc) and exposing the flies to oxidative stress. 
These data required an elucidation of the functional role of GS in a simpler system, leading to 
the use of Drosophila cells which under-expressed DmGS and which were exposed to 
treatments causing oxidative stress.
Drosophila Schneider 2 (S2) cells (Schneider, 1972) were used as the cell culture system in 
this study. S2 cells are derived from late-stage embryos and are thought to have endothelial or 
haematopoietic origins (Hammond, 2003). The cells are not well differentiated and attach 
lightly to plastic surfaces, allowing non-enzymatic removal of the cells from flasks (Caplen et 
al., 2000; Hammond, 2003). The use of the well established S2 cell system has many 
advantages, including their ease of culture, a doubling time of 20-24 hours (Hammond, 2003), 
and the data obtained from cell culture studies can potentially be confirmed in whole organism 
experiments since RNAi has been effective not only in S2 cells but in flies (Giordano et al., 
2002; Carthew, 2003; Lee and Carthew, 2003; Morozova et al., 2003; Sledz and Williams, 
2005). Gene knockdown by RNAi has been shown to be efficient and reproducible in S2 cells 
and can be sustained through many cell divisions, provided the protein is not required for 
viability (Worby et al., 2001).
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RNA interference (RNAi) is a naturally occurring gene regulation process responsible for gene 
silencing using microRNAs (miRNAs) to repress translation of certain transcripts, specifically 
those involved in development and cell death (Hammond, 2005; Kavi et al., 2005; Sledz and 
Williams, 2005). The phenomenon of RNAi was first described in C. elegans where the 
presence of exogenous dsRNA resulted in degradation of the complementary mRNA target 
(Fire et al., 1998). dsRNA has since been shown to induce post-translational gene silencing in 
a number of species including zebrafish, flies, and mammals (Caplen et al., 2000; Clemens et 
al., 2000; Birchler et al., 2003). The cellular RNAi mechanism is described in detail in Chapter 
1, section 1.3.2.6.
In Drosophila cells, the RNAi machinery can be triggered by experimentally introduced 
dsRNAs. RNAi is used as a reverse genetic technique by degrading endogenous mRNA 
complementary to the dsRNAs, making it an efficient approach to loss-of-function phenotype 
analyses (Boutros et al., 2004; Sledz and Williams, 2005). The experimental dsRNAs used in 
Drosophila systems are longer (~500bp) than the ~22bp siRNAs required to achieve silencing 
in mammalian systems, because in mammals large dsRNA fragments activate an interferon 
driven inhibition of translation; a process which is absent in Drosophila and C. elegans 
(McManus and Sharp, 2002).
In this chapter, the RNAi technique was used to knock down DmGS and/or Gclc in S2 cells, 
and in cells exposed to oxidative stress. GCL expression is significantly reduced with age in 
rats (Liu and Choi, 2000; Zhu et al., 2006), and the concentration of GSH has been shown to 
decrease with age in many species, including Drosophila (Sohal and Weindruch, 1996; Schulz 
et al., 2000). The capacity of cells to maintain GSH titres during an oxidative challenge has 
previously been shown to be important in preventing cell death (Shi et al., 1994), and in this 
study GSH levels and cellular viability in response to DmGS and/or Gclc knockdown and 
oxidative challenges were investigated. Furthermore, the effect of the DmGS and/or Gclc
knockdown on DNA damage following oxidative challenge was determined because GSH 
depletion has been associated with elevated levels of DNA damage (Reliene and Schiestl, 
2005).
7.2 Results
7.2.1 RNA interference in S2 ceils
The RNAi technique was used to knock down the transcription levels of DmGS and Gclc in S2 
cells. RNAi in Drosophila cells is relatively simple because it is possible to introduce larger 
(~500bp) portions of RNA molecules directly into cells, which are cleaved into ~22bp siRNA 
fragments by the cellular machinery. dsRNA templates of 500-700bp are desirable (Kavi et al., 
2005), with longer molecules performing more effectively than molecules smaller than 300bp 
(Caplen et al., 2000; Hammond et al., 2000). Once introduced into the cell, down-regulation of 
gene expression by siRNA is transient, with the effect noticeable from 18hours post 
transfection (Caplen et al., 2000), and lasting as long as 6-7 days post transfection (Clemens et 
al., 2000; Hannon, 2002; Radyuk et al., 2003).
dsRNA was synthesised according to Chapter 2, section 2.23. The protocol for introducing 
dsRNA into cells used in this study was to soak cells in dsRNA because this has been 
described as the method of choice for S2 cells (Hammond, 2003). The alternative technique 
for introducing dsRNA into cells is a calcium phosphate transfection, however this technique 
is more time consuming, and damaging to the cells. A modified methodology for introducing 
dsRNA into S2 cells by soaking was devised in this study because soaking the cells in dsRNA 
alone (Clemens et al., 2000) did not have any effect on DmGS and Gclc expression levels 
when tested in this study. The technique used in this study made use of a transfection reagent, 
and two separate additions of dsRNA, as described in detail in Chapter 2,section 2.24. The use 
of the cationic lipid transfection agent allowed for the use of lower concentrations of dsRNA
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to achieve gene knockdown, and is a non-invasive technique, causing little or no damage to 
cells (Hammond, 2003). The inhibition of gene expression by dsRNA has been shown to be 
dose dependent: dsRNA concentrations above lpg per 5xl06 cells plated are reported not to 
have any additional effect (Caplen et al., 2000). In this thesis, 2pg dsRNA was added to the 
cells at two time points on the first day, using a total of 4pg (10-17nM) dsRNA for gene 
knockdown, while in the original paper by Clemens et al (2000), 16fig dsRNA (=40nM for 
700bp dsRNA) was added to cells to achieve knockdown (Hammond, 2003).
GFP control
To test whether the process of introducing any dsRNA molecule into S2 cells had an effect on 
DmGS expression, a 500bp dsRNA complementary to a GFP gene segment present on plasmid 
pQBI25-fC3 (Q-Biogene) was synthesised as described (Chapter 2, section 2.23; AppendixD). 
The use of GFP as a control for the effect of dsRNA in S2 cells has been established 
previously (Caplen et al., 2000; Boutros et al., 2004). 4pg (final concentration lOnM) GFP 
dsRNA was added to S2 cells, and its effect on DmGS expression was measured by RT-PCR. 
Control cells with no dsRNA added had an equivalent volume of transfection agent added with 
water substituted for the GFP dsRNA.
Figure 7.1 shows that the addition of GFP dsRNA had no significant effect on DmGS 
expression levels over a 2 day time period, which was the proposed duration for the 
experiments to follow. The time point ‘Day 1 ’ was measured 24 hours after the first addition 
of dsRNA.
223
0
G F P  No
dsR N A  dsR NA
fl5 <T5 CT5Q Q Q Q
GS
Actin
n G F P dsR N A  
■ n o  dsRNA
H  0 . 3 5
s .  u . 3
G 0.2
[ / )  0 . 1 5
Day 1 Day 2
Figure 7.1: RT-PCR data showing DmGS expression relative to actin5C. Panel A shows the original 
agarose gel image of RT-PCR samples of cells with and without the addition of GFP dsRNA. Panel B is a 
graphical representation of GS:actin expression. There is no statistically significant difference in GS 
expression between cells treated with GFP dsRNA and no dsRNA, as determined by Students t-test. Means 
±SEM are shown.
DmGS and Gclc RNAi
dsRNA corresponding to DmGS was synthesised using a primer (Chapter 2, Table 4) from the
MRC’s Geneservice RNAi construct library (Miah et al., 2004). The primers contain a dual T7
promoter sequence allowing for RNA transcription by T7 transcriptase. The dsRNA sequence
corresponded to the final exon of DmGS, which all transcripts have in common, ensuring that
all known transcripts of DmGS would be silenced. Gclc dsRNA was synthesised using a
primer pair which incorporated a T7 promoter sequence. The dsRNA fragments were 350bp in
length for DmGS, and 650bp in the case of Gclc. The first reaction cDNA products created
were sequenced to confirm the identity of the cDNA. 4pg of DmGS dsRNA (17nM) or Gclc
dsRNA (lOnM) was then added to S2 cells as described previously, and the expression of each
gene was measured for a three day period, starting 24 hours after the first addition of dsRNA.
Figure 7.2 shows the knockdown of DmGS expression achieved in S2 cells after incubation
with DmGS dsRNA. The greatest reduction in expression is seen on Day 1 and Day 2, and on
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Day 3 a slight increase in the level of DmGS transcripts is seen, although the expression is still 
significantly less than in the control cells which did not have any dsRNA added to them. For 
the following studies on RNAi, a 2 day assay period was chosen because the transcript 
knockdown remained low for the first two days following dsRNA incubation.
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Figure 7.2: DmGS mRNA knockdown using dsRNA to DmGS. Panel A shows a sample of RT-PCR from 
cells over a three day period after the addition of DmGS dsRNA as well as control cells with no dsRNA  
added. The results are represented graphically in Panel B where relative expression of DmGS is shown. 
Statistical significance of the difference between DmGS expression in control and treatment samples at 
each time point was calculated using Students ‘t’test (*P<0.05, **p<0.005). Means ±SEM are shown.
In this study, it was not possible to test GS protein knockdown by western blot because there 
is no GS antibody available commercially, and the available anti-DmGS polyclonal antibody 
(Lesley McLellan, pers. comm.) was unreliable when tested on S2 cell extracts.
Gclc expression was also significantly reduced after the corresponding dsRNA was added to 
the cells (Figure 7.3). Knockdown of the Gclc transcript was highly significant over the three 
day measurement period. The degree of knockdown achieved with the Gclc RNAi is more 
prominent than with DmGS RNAi, a gene specific effect which has been noted in several
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studies (Caplen et al., 2000). The slight difference in the efficacy of the dsRNA against the 
two different genes is most likely due to differences in sequence and structure of the siRNAs, 
and because the DmGS dsRNA was almost half the size of the Gclc dsRNA (Caplen et al., 
2000; Radyuk et al., 2003).
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Figure 7.3: Gclc mRNA knockdown using dsRNA to Gclc. Panel A shows a sample of RT-PCR from cells 
over a three day period after the addition of Gclc dsRNA as well as control cells with no dsRNA added. 
The results are represented graphically in Panel B where relative expression of Gclc is shown. Statistical 
significance of the difference between Gclc expression in control (no dsRNA) and Gclc RNAi treated 
samples at each time point was calculated using Students ‘t ’test (***P<0.001). Means ±SEM are shown.
7.2.2 Effects o f DmGS and Gclc knockdown on cell viability
To determine whether dsRNA transfection per se had an effect on cell viability, cells were 
transfected with GFP dsRNA and viability evaluated by trypan blue exclusion (Chapter 2, 
section 2.22). The survival of these cells was compared to untransfected cells. Figure 7.4 
illustrates that there was no statistically significant difference in viability between cells 
exposed to GFP dsRNA and control cells over a 2 day period. This experiment suggests that
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the presence of dsRNA in S2 cells at the levels used to silence genes (4pg / 3x l06 cells) does 
not have an effect on cell viability.
Figure 7.4: Cell viability measured over two days with and without addition of GFP dsRNA. dsRNA was 
added to the cells at Day 0. Means ± SEM are shown, and means were compared using a Students t-test.
No significant difference was found between cells with and without the addition of dsRNA.
Glutathione is an important cellular antioxidant, and it was expected that silencing one or both 
of the GSH biosynthesis genes would impact on cellular viability. To test whether viability 
was adversely affected over the two day period following DmGS or Gclc knockdown, viability 
was assayed following transfection with dsRNA. There was, however, no difference between 
the viability of cells exposed to any of the RNAi treatments and the control cells (Figure 7.5).
■  G S  RIMAi □  G S + G C L C  RNAi □  G CL C RNAi E n o R N A
Figure 7.5: Effect of DmGS and Gclc knockdown alone and the combination of DmGS and Gclc 
knockdown on S2 viability. Means ±SEM are shown. Means were compared using the Students t-test, with 
no significant difference seen between the viability of control cells without dsRNA present, and cells with 
DmGS and/or Gclc knockdown.
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7.2.3 Comparison o f the effects o f DmGS and/or Gclc knockdown on 
glutathione levels in S2 cells
Despite effective RNAi mediated knockdown of DmGS and Gclc (Figure 7.2 and Figure 7.3),
no effect on cell viability was seen in the 48h following transfection. In order to evaluate the 
impact of DmGS and/or Gclc knockdown on glutathione levels, transfections with appropriate 
dsRNAs were carried out and glutathione titres determined 48hours following transfection.
Figure 7.6: Glutathione concentration (jimoles per 106 cells) in S2 cells transfected with DmGS, Gclc or 
DmGS+Gclc RNAi. Samples were taken 48hrs after dsRNA addition. Experiments were performed in 
triplicate, and repeated twice. Means ±SEM are shown. Statistical significant difference was determined 
using students ‘t’test. * indicates a significant difference in GSH levels between RNAi treated cells and 
those with no RNAi added (**p<0.005, ***p<0.001), and •  indicates a significant difference between cells 
treated with the combined DmGS+Gclc dsRNA and the remaining RNAi treatments (••p<0.005
•••p<0.001).
Control cells with no dsRNA added had an average GSH content of 36.3 pmoles per million 
cells (Table 7.1). Although the addition o f DmGS dsRNA decreased the GSH content by 
13.5% compared to the control, this difference was not statistically significant, as indicated on 
Figure 7.6. The presence of Gclc dsRNA did decrease the GSH content of the cells 
significantly (by 28.4%) compared to the control cells, while the combination of DmGS and 
Gclc dsRNA had the greatest effect on GSH levels. The presence of Gclc dsRNA decreased 
the GSH content of the cells significantly (71.8% of the control), while the combination of 
DmGS and Gclc dsRNA had the greatest effect on GSH levels: a reduction to 43% of control 
levels. These results suggest a cumulative effect of each of the glutathione biosynthesis genes.
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Table 7.1; GSH content of S2 cells grown in the presence of DmGS and/or Gclc dsRNA.
RNAi Treatment GSH (uinoles / 106 cells) % GSH of the control
No RNAi 36.3 -
GS RNAi 31.4 86.5%
GCLC RNAi 26 71.6%
GS+GCLC RNAi 15.6 43%
This experiment confirms that RNAi reduces gene expression, rather than completely 
silencing gene expression (Clemens et al., 2000; Hannon, 2002; Radyuk et al., 2003). There 
will be a residual level of expression that escapes the RNAi mechanism, especially in genes 
with a high level of transcription. The residual levels of GSH could also be a result of a slow 
depletion of the existing cellular GSH pool, implying a long half-life for GS and GCLC 
proteins, or because DmGS and Gclc RNAi does not obliterate cellular GSH, but merely 
reduces the levels considerably.
7.2.4 The effect o f chemically induced oxidative stress on S2 cells
Because GSH has an antioxidant role, the effect of oxidative stress in cells with reduced
expression of GSH biosynthesis genes would be expected to be greater than in control cells. 
This hypothesis was tested by inducing conditions of oxidative stress in S2 cells with diethyl 
maleate (DEM) and hydrogen peroxide (H2O2).
DEM is a P-unsaturated carbonyl compound. DEM is conjugated to GSH by an addition 
reaction, where GSH is added to an activated double bond (Parkinson, 2001). In addition to 
this chemical reaction, DEM reacts with glutathione enzymatically via glutathione 
transferases, both of which cause a lowering of endogenous GSH pools (Cardozo-Pelaez et al., 
2002). The depletion of cellular glutathione by DEM increases oxidative stress (Back et al., 
1998), making DEM a useful chemical test for the ability of S2 cells to withstand oxidative 
stresses.
H2O2 is a normal cellular metabolite which is decomposed by catalase (peroxide produced
within peroxisomes) and glutathione peroxidase (peroxide formed in cytosol) (Eklow et al.,
1984; Dringen et al., 1999). It is a strong oxidant that is capable of rapidly diffusing through
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cell membranes from its endogenous site of origin and is a potent agent of cell death and 
mutagenic events (Mackay and Bewley, 1989). The glutathione system exerts a key function 
in the detoxification of H2O2 (Figure 7.7), and on exposure to hydrogen peroxide, glutathione 
oxidation occurs in a matter of minutes (Srivastava et al., 1974; Eklow et al., 1984; Dringen et 
al., 1999).
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Figure 7.7: Schematic diagram of the role of glutathione in the detoxification of peroxide. Glutathione 
peroxidase (Gpx) catalyses the reduction of hydrogen peroxide via GSH. In Drosophila, glutathione 
reductase (GR) does not exist, and instead the thioredoxin system performs the role of glutathione 
reduction.
The effect of oxidative stress on S2 cell viability
Because both DEM and H2O2 expose cells to increased levels of oxidative stress, the 
hypothesis was that the presence of either of the two chemicals would have a negative effect 
on viability.
Effect o f DEM on cell viability
Two concentrations of DEM were tested; a low dose of 0.25mM and a high dose of 0.5mM. 
At the low dose of DEM, viability of S2 cells was not affected over the two day period 
assayed, with no statistical difference between the treated and untreated cells(Figure 7.8). At 
the higher dose of 0.5mM DEM, however, S2 cells did not have a good survival rate, with 
51.4% of the cells alive one day after DEM addition and only 14.1% viability on the second
OxidisedReduced
Thioredoxin Thioredoxin
Oxidised
Glutathione Glutathione
Peroxiredoxin / 
catalase
[GPx]
230
day following the addition of DEM. There was a significant difference in viability of cells 
treated with 0.5mM DEM, and those treated with 0.25mM DEM. The lower dose of DEM was 
chosen for further studies because the dose was not high enough to kill the cells, allowing 
further analysis to be performed on the cells.
0  No DEM control l 0 . 2 5 m M D E M  lO.SmMDEM
Figure 7.8: S2 ceil viability after the addition of 0.25mM DEM (green bars), 0.5mM DEM (blue bars) and 
a no treatment control (black striped bars). DEM was added to cells on Day 0, and viability was assayed 
on the two following days. Experiments were repeated at least twice, and performed in triplicate. Mean 
±SEM is shown. Means were compared using the students t-test (** p<0.005, *** p<0.001 in comparison 
with untreated control).
The effect o f  H2O2 on S2 cell viability
Two concentrations of hydrogen peroxide, lOmM and 30mM, were tested for effects on S2 
cell viability. Both concentrations of H2O2 had a significant negative effect on viability, with 
the loss of cell viability more pronounced in cells exposed to the higher concentration of 
peroxide (Figure 7.9). After 8 hours, the percentage of viable cells was 96.2% in control cells, 
compared to 89.2% in cells treated with lOmM H2O2, and 57.4% in cells treated with 30mM 
H2O2. The viability results obtained are comparable to published data where 70% S2 cell 
viability was observed after a 4 hour treatment with 20mM H2O2 (Radyuk et al., 2001; Radyuk 
et al., 2006). After 4 hours of treatment, the difference in viability between cells treated with 
lOmM H2O2 and those treated with 30mMH2O2 became statistically significant, while the 
difference in viability between cells treated with lOmM H2O2 or 30mM H2O2 was statistically 
significant after 2 hours of treatment, suggesting a rapid effect of peroxide on cell survival.
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Figure 7.9: S2 cell viability after the addition of lOmM H20 2 (green bars), 30mM H20 2 (blue bars) and no 
treatment control (black striped bars). H20 2 was added to cells at 0 hours, and viability was assayed at 2 
hourly intervals for the period of 1 day. Mean ±SEM is shown. Means were compared using the students 
t-test, where * indicates a significant difference between the peroxide treated cells and the control cells (** 
p<0.005, *** p<0.001), and •  indicates a significant difference between cells treated with lOmM H20 2 and 
those treated with 30mM H20 2.
The effect of oxidative stress on DmGS and Gclc expression in S2 cells
The aim of this set of experiments was to test the hypothesis that an increase in environmental
oxidative stress would result in an upregulation of glutathione biosynthesis enzymes because 
GSH is an important cellular antioxidant. DmGS and Gclc expression levels were measured in 
S2 cells which had been exposed to 30mM H2O2, as well as a low dose (0.25mM) and a high 
dose (0.5mM) of DEM. DmGS and Gclc expression was measured 6 hours after H2O2 
addition, which was the period of the H2O2 viability assay in S2 cells described by Radyuk et 
al (2003). DmGS and Gclc expression was measured 24 hours after DEM addition, a time 
point at which cells were viable and not damaged. Figure 7.10 shows the relative expression of 
DmGS (Panels A and C) and Gc/c(Panels B and D) in S2 cells exposed to one of two different 
concentrations of DEM, or 30mM H2O2.
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Figure 7.10: DmGS expression levels in S2 cells exposed to chemically induced oxidative stress. Panels A 
and B are examples of agarose gels with DmGS (Panel A) or Gclc (Panel B) and actin RT-PCR samples. 
The treatments compared include 0.25mM DEM, 0.5mM DEM, 30mM H20 2, and a control of cells grown 
in SFM media only. Panel C, a graphical representation of the relative intensities of the DmGS and Actin 
bands in Panel A, compares DmGS expression in samples treated with 0.25mM, 0.5mM DEM, or 30mM  
H20 2. Panel D is a graphical representation of the gel in Panel B, and compares the relative Gclc intensities 
between cells treated with 0.25mM, 0.5mM DEM, or 30mM H20 2. Statistically significant differences 
between DmGS or Gclc expression in control cells and treated cells are shown by asterisks (*p<0.05, 
**p<0.005). Statistical significance was calculated using Students ‘t’test. Means ±SEM are shown.
The expression of DmGS in cells treated with 0.25mM DEM is slightly higher than untreated 
control cells, although this increase is not statistically significant (Panel C). When cells are 
treated with 0.5mM DEM, however, the increase in DmGS expression is statistically 
significant. The converse is true for cells treated with H2O2, where DmGS expression is 
significantly lower than in untreated cells. The same trends are present when analysing Gclc 
expression in S2 cells treated with DEM and H2O2 (Panel D).
This set of experiments shows that enzymes of glutathione biosynthesis are up regulated in the 
presence of DEM, particularly at the high concentration of 0.5mM. Unexpectedly both DmGS 
and Gclc are down regulated by exposure to H2O2.
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7.2.5 Effect o f DmGS and Gclc RNAi on oxidative stress resistance of 
S2 cells
In a previous experiment (Section 7.2.2), it was determined that knockdown of DmGS and 
Gclc mRNA, either separately, or in combination, had no effect on S2 cell viability over the 
time course followed. This led to the current question: whether knockdown of GSH 
biosynthesis genes would alter viability in S2 cells exposed to oxidative stress.
7.2.5.1 GFP controls
To confirm that the addition of dsRNA per se did not have an effect on S2 cell viability in the 
presence of an oxidative stressor, S2 cells were incubated with GFP dsRNA for 24 hours. The 
cells were exposed to 0.25mM DEM 24 h after addition of dsRNA, and viability assayed over 
a two day period.
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Figure 7.11: Cell viability measured over three days with and without addition of GFP dsRNA, in the 
presence of 0.25mM DEM. The viability assay was started at the point of DEM addition (one day after the 
addition of dsRNA). Mean ±SEM is shown, and means were compared using a students t-test. No 
significant difference was found between cells with and without the addition of GFP dsRNA.
In the presence of 0.25mM DEM, there was no significant difference in the viability of cells 
treated with GFP dsRNA and those with where there was no dsRNA addition (Figure 7.11). 
This is corroborated by the experiment on cell viability with GFP dsRNA in the absence of an 
oxidative stress (section 7.2.1), and a study by Boutrous et al (2004), where the presence of 
GFP dsRNA also had no effect on cell viability.
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7.2.5.2 DmGS and/or Gclc knockdown effect on S2 viability in the presence of DEM
S2 cells were incubated with the relevant dsRNA for 24 hours, followed by an exposure to
0.25mM or 0.5mM DEM for a further 48 hours. Viability was assayed prior to DEM addition 
and at 24h and 48h following DEM addition. Cells which were not treated with dsRNA were 
unaffected by 0.25mM DEM treatment over the two day assay time, whereas those cells with 
DmGS knockdown had a statistically significant decline in viability 24 hours and 48 hours 
after the addition of DEM (Figure 7.12 A). The silencing of DmGS therefore significantly 
reduces the DEM-induced oxidative stress resistance of S2 cells. Administration of 0.5mM 
DEM had significant effects on viability of S2 cells regardless of whether they had been 
subjected to RNAi mediated knockdown o f DmGS (Figure 7.12B). There was a slight 
decrease in viability between cells with and without DmGS knockdown after 24 hours, 
although this difference was not statistically significant. After 48 hours of DEM exposure, 
however, there was a statistically significant decrease in viability of cells with DmGS RNAi 
compared to those with no RNAi. The concentration of 0.5mM DEM is likely to be causing a 
degree of cellular damage too large to be a useful assay in combination with the RNAi 
treatment. For this reason, the lower dose of 0.25mM DEM was used for further experiments.
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Figure 7.12: Comparison of cell viability after the addition of DmGS dsRNA (red bars) and no RNA (green 
bars). Double stranded RNA was added a day before the addition of DEM on Day 0. Panel A shows 
viability of cells exposed to 0.25mM DEM, and Panel B shows cell viability after the addition of 0.5mM  
DEM. Mean ±SEM is shown. Means of cells treated with GS-RNAi were compared to those which were 
untreated using the students t-test (* p<0.05, ** p<0.005, *** p<0.001).
Figure 7.13 compares the viability of cells treated with a combination of DmGS and Gclc 
dsRNA, and cells treated with either DmGS dsRNA or Gclc dsRNA. The control cells were 
not exposed to any RNAi treatment, and were unaffected by the addition of 0.25mM DEM 
over the two day assay period. Cells treated with DmGS and/or Gclc dsRNA as well as DEM 
all showed a significant decline in viability over two days. These results suggest that 
expression of DmGS and Gclc are equally important in protecting Drosophila S2 cells from 
DEM induced oxidative stress.
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Figure 7.13: Viability of S2 cells with DmGS (blue bar) and Gclc (green bar) knockdown alone, as well as 
the combination of DmGS and Gclc (red bar) knockdown in the presence of 0.25mM DEM. Proportion of 
cells alive with no dsRNA added are shown with a black striped bar. Mean ±SEM is shown. Means of cells 
treated with RNAi were compared to those which were untreated using the students t-test (*** p<0.001 in 
comparison with the treated samples).
7.2.5.3 DmGS and Gclc expression levels in cells treated with DmGS or Gclc RNAi in 
the presence of DEM
DmGS and Gclc expression were unaffected by 0.25mM DEM, and at 0.5mM DEM, 
expression of both genes was significantly increased. In order to evaluate whether DEM 
treatment partially reduced the impact of RNAi-mediated knockdown of DmGS or Gclc, S2 
cells were treated with DmGS and/or Gclc dsRNA for 24 hours, followed by the addition of 
0.25mM or 0.5mM DEM. RNA was extracted from the cells 24 hours and 48 hours after the 
DEM addition, and RT-PCR was performed on the samples to determine the relative 
expression of DmGS (Figure 7.14) and Gclc (Figure 7.15).
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Figure 7.14: DmGS expression levels with different RNAi and DEM treatments. dsRNA was added to cells 
one day before DEM to ensure effective mRNA knockdown. Panel A is an agarose gel with DmGS and 
actin RT-PCR samples. The treatments compared include with and without DmGS, Gclc or DmGS+Gclc 
RNAi under different concentrations of DEM, or no DEM. In the sample labels, D1 indicates samples 
taken 1 day after DEM addition, and D2 indicates samples taken two days after DEM addition. Panel B 
compares DmGS expression in cells with DmGS RNAi (green bars) and those with no RNAi treatment 
(black bars) at 0.25mM and 0.5mM DEM. Significant differences between the expression of cells with 
DmGS RNAi and no RNAi treatments (*p<0.05, **p<0.005) are shown, as well as the difference in DmGS 
expression between no DEM and different DEM concentrations without RNAi, shown with dots(»P<0.05). 
Panel C shows DmGS expression levels with different DmGS and Gclc knockdown combinations over two 
days in the presence of 0.25mM DEM. There was no statistically significant difference of DmGS expression 
levels between Day 1 and Day 2 after DEM addition for any of the RNAi treatments. Panel D shows means 
of DmGS expression levels from Day 1 and Day 2 samples shown in Panel C. Significant differences 
between the DmGS expression levels in the control sample and different RNAi treatments are shown with 
dots (•••p < 0 .001), and significant differences between cells treated with DmGS RNAi and the other 
treatments are shown with asterisks (***p<0.001).
As expected, DmGS mRNA was decreased significantly in cells exposed to DmGS dsRNA 
compared to cells without RNAi (Figure 7.14B), thus confirmed the efficacy of the dsRNA in 
knocking down gene expression. Cells which were exposed to 0.5mM DEM without any 
RNAi had significantly increased DmGS expression compared to the control cells which were 
not exposed to any DEM or RNAi. In the presence of DmGS RNAi, however, this effect was 
obliterated, showing that the mechanism of the gene silencing could be maintained even as
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DmGS was significantly up-regulated. There was no significant difference in DmGS 
expression between cells treated with DEM and DmGS/Gclc RNAi for 24hours or 48 hours 
(Figure 7.14C), allowing for the pooling of results from the two days (Figure 7.14D). In the 
presence of 0.25mM DEM, treatment with Gclc RNAi alone had no effect on DmGS 
expression levels, however, cells treated with Gclc dsRNA in addition to DmGS dsRNA 
exhibited significantly lower DmGS expression than cells treated with DmGS dsRNA alone. 
The reason for Gclc dsRNA further decreasing DmGS expression levels only when combined 
with DmGS dsRNA is unclear, although it may be possible that DmGS expression is 
upregulated when substrate levels are raised.
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Figure 7.15: Gclc expression levels with different RNAi and DEM treatments. dsRNA was added to cells 
one day before DEM to ensure effective mRNA knockdown. Panel A is an agarose gel with Gclc and actin 
RT-PCR samples. The treatments compared include with and without DmGS, Gclc or DmGS+Gclc RNAi 
under different concentrations of DEM, or no DEM. Panel B compares Gclc expression in cells with 
DmGS knockdown (green bars) and those with no RNAi treatment (black bars) at 0.25mM and 0.5mM  
DEM. Significant differences between the expression of cells with Gclc RNAi and no RNAi treatments 
(*p<0.05) are shown, as well as the difference in Gclc expression between no DEM and different DEM  
concentrations in cells with no RNAi treatment, shown with a dot(*P<0.05). Panel C shows means of 
DmGS expression levels over a two day period. Significant differences between the DmGS expression levels 
in the control sample and different RNAi treatments are shown with asterisks (*p<0.05).
239
Gclc expression was examined in cells treated with a combination of DmGS and/or Gclc 
RNAi, in the presence of DEM. DmGS RNAi in cells treated with 0.25mM DEM had the 
effect of significantly upregulating Gclc expression compared to cells with no RNAi treatment 
(Figure 7.15B). This effect was not a result of the DEM, since untreated cells had Gclc 
expression levels similar to those exposed to 0.25mM DEM. These results suggest that a 
decrease in DmGS expression causes a significant increase in Gclc expression at a low dose of 
DEM. At the higher dose of 0.5mM DEM, however Gclc expression was significantly lower 
in cells treated with DmGS RNAi than the control cells with no gene knockdown. This is an 
interesting result since in the absence of DmGS RNAi, Gclc expression was found to increase 
significantly in the presence of 0.5mM DEM, and Gclc is also upregulated by DmGS RNAi at 
low DEM concentrations. DmGS knockdown combined with a severe oxidative stress has the 
effect of negating the upregulation of Gclc normally seen both in conditions of severe 
oxidative stress and also with DmGS RNAi. The reason for this effect at the high DEM 
concentration is unknown at this stage, possibly because of general toxicity, or because the 
high dose of DEM in combination with a removal of DmGS transcripts is likely to cause 
disruptions of GSH signalling pathways.
Cells treated with DmGS RNAi only in the presence of 0.25mM DEM showed significantly 
increased levels of Gclc expression compared to control cells with no RNAi treatment (Figure 
7.15C). The presence of DmGS dsRNA did not have any additional effect on Gclc knockdown 
in cells treated with Gclc RNAi. This is noteworthy because the presence of Gclc dsRNA did 
have an additional effect on DmGS knockdown in the presence of DmGS RNAi (Figure 
7.14D).
7.2.5.4 DmGS and/or Gclc knockdown effect on S2 viability in the presence of H2O2
Hydrogen peroxide was used as an alternative source of oxidative stress to compare with the
results from the effect of DmGS knockdown on oxidative stress resistance using DEM as an
oxidative stressor. S2 cells were treated with DmGS dsRNA for 24 hours, followed by an 
exposure to either lOmM H2O2 or 30mM H2O2. At both the low dose (Figure 7.16A) and high 
dose (Figure 7.16B) of H2O2 there was no difference in the survival of cells treated with 
DmGS knockdown compared to those without any RNAi treatment. DmGS knockdown 
therefore has no additional effect on cell viability under conditions of peroxide-mediated 
oxidative stress. It was possible that the lack of an additional effect from DmGS RNAi on 
viability might be specific to DmGS, therefore Gclc RNAi and a combination of DmGS and 
Gclc RNAi was tested in the presence of H2O2.
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Figure 7.16: Comparison of cell viability after the addition of DmGS dsRNA (red bars) and no RNA (blue 
bars). Double stranded RNA was added a day before the addition of H20 2 on Day 0. Panel A shows 
viability of cells exposed to lOmM H20 2 and Panel B shows cell viability after the addition of 30mM H20 2. 
Mean ±SEM is shown. Means were compared using the Student’s t-test, and no significant difference was 
found between survival of cells treated with GS dsRNA and those not treated with any dsRNA .
The following experiment aimed to determine whether the DmGS and Gclc double knockdown 
would have an effect on the viability of cells exposed to lOmM H2O2. As illustrated in Figure 
7.17, there was no statistically significant difference between the viability of cells treated with
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DmGS dsRNA, Gclc dsRNA or a combination of the two. None of the treatments had any 
effect on viability in the presence of peroxide, as there was no decrease in viability compared 
to control cells which did not have any RNAi treatment.
■ GS dsR NA a  GCLC dsRNA ■ GS+GCLC dsRNA 0 no dsRNA
2 hours 6 hours4 h<
Figure 7.17: Viability of S2 cells with DmGS (blue bar) and Gclc (green bar) knockdown alone, as well as 
the combination of DmGS and Gclc (red bar) knockdown in the presence of lOmM H20 2. Proportion of 
cells alive with no dsRNA added are shown with a black striped bar. Mean ±SEM is shown. Means were 
compared using the Students t-test (no significant differences were found between the different treatment 
groups over 6 hours).
These results are interesting in light of the negative effect of DmGS and/or Gclc knockdown 
on cells exposed to a low concentration of DEM (Section 7.2.5.2). The difference between the 
H2O2 and DEM treatments on cells treated with DmGS and/or Gclc dsRNA is most likely due 
to the glutathione depleting effects of DEM, which is examined further in the discussion 
section of this chapter. H2O2 is primarily detoxified by catalase, which may also explain the 
apparent lack of effect of GSH depletion on peroxide resistance.
7.2.6 Glutathione levels in cells treated with DmGS and/or Gclc dsRNA, 
and DEM
Glutathione levels in cells treated with DmGS and/or Gclc dsRNA in the presence of 0.25mM 
DEM were calculated to determine the cumulative effect of DEM and DmGS/Gclc RNAi on 
reducing cellular glutathione. The appropriate dsRNA was added to samples and incubated for 
24 hours, after which time 0.25mM DEM was added to the cells. After a further 24 hours, 
samples were taken for the glutathione assay.
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■  no  DEM
■  0 .25m M  DEM
G C L C  RNAi G S + G C L C  RNAi
Figure 7.18: Glutathione concentration (pM per 106 cells) in S2 cells with DmGS, Gclc or DmGS+Gclc 
RNAi. dsRNA was added to cells at Ohrs, 0.25mM DEM was added at 24hrs, and samples for GAH 
determination were taken at 48hrs. Experiments were done in triplicate, and repeated twice. The graph 
shows a comparison of GSH in cells with (green bars) and without (black bars) the addition of DEM. 
Means ±SEM are shown. Statistically significant differences were determined using student’s t’test.
* indicates a statistically significant difference between GSH levels in cells grown in the presence of DEM 
and cells grown without DEM in presence of various dsRNAs (**p<0.005, ***p<0.001). •  indicates a 
significant difference in GSH levels between cells treated with GS+Gclc RNAi, and all the other RNAi 
treatments, in the presence of DEM (*p<0.05). n indicates a significant difference between cells not treated 
with any dsRNA, and those treated with GS and/or Gclc dsRNA in the presence of DEM.
The presence of DEM was shown to significantly lower the level of GSH in the presence of 
DmGS or Gclc RNAi, as well as in control cells with no RNAi (Figure 7.18). DEM lowered 
cellular GSH concentrations to a greater extent than DmGS RNAi or Gclc RNAi did, except in 
the case of a combination of DmGS and Gclc RNAi, which reduced GSH to the same GSH 
concentration (~15 pmoles/106 cells) as the DEM treatment did (Table 7.2). The lowest GSH 
content (6.5 pmoles/106 cells) was in cells treated with DEM and Gclc RNAi (Table 7.2), 
which caused a decrease in GSH to 18% of untreated control cells. The presence of DmGS 
RNAi in cells exposed to DEM had no additional effect on GSH levels. This is consistent with 
GSH results obtained for cells treated with DmGS RNAi in the absence DEM, described in 
section 7.2.3
In the presence of DEM, there was no statistical significant difference in GSH levels between 
cells treated with Gclc RNAi and cells treated with a combination of DmGS and Gclc RNAi 
(green bars in Figure 7.18). This is in contrast to cells that had not been treated with DEM,
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where DmGS and Gclc knockdown had an additive effect, decreasing the cellular GSH levels 
(Figure 7.6). The reason for this difference could be that the combination of DEM and Gclc 
RNAi reduces the GSH content (6.5 pmoles/106 cells) to a level beyond which cell survival is 
not supported, ie, GSH levels could not be further reduced in viable cells. The combination of 
DEM treatment and DmGS and/or Gclc RNAi resulted in -50% reduction in cell viability 
compared to untreated cells (Figure 7.13). This observation is consistent with evidence in S. 
cerevisiae that approximately 15% of the wild type glutathione content is critical for survival 
(Kistler et al., 1986; Ullmann et al., 1996).
Table 7.2: GSH content of S2 cells grown in the presence of DmGS and/or Gclc dsRNA and 0.25mM DEM. 
Data in this table originates from the experiment represented in Figure 7.18.
NO DEM 0.25mM DEM
RNAi treatment GSH
(pmoles/106
cells)
%GSH of 
untreated 
control
GSH
(pmoles/106
cells)
%GSH of 
untreated 
control
No RNAi 36.3 - 15 41.3%
GS RNAi 31.4 13.5% 14.3 39.4%
Gclc RNAi 26 28.4% 7.6 20.9%
GS+Gclc RNAi 15.6 57% 6.5 17.9%
7.2.7 Effect o f DmGS and Gclc knockdown on DNA damage
Assays of DNA fragmentation have been used to evaluate DNA damage in cells exposed to
oxidative stress conditions (Radyuk et al., 2003; Nygren et al., 2005; Reliene and Schiestl,
2005). In the following experiments, S2 cells exposed to DEM-mediated oxidative stress and 
DmGSlGclc knockdown were assayed for DNA damage using the Comet assay. In the Comet 
assay, also known as the single-cell gel (SCG) cells are immobilised and subjected to 
electrophoresis, with the effect that the DNA of cells with an increased frequency of DNA 
double strand breaks migrates further towards the anode (Tice et al., 2000). The current Comet 
assay method of choice in genotoxicology studies employs alkaline (pH >13) electrophoresis 
(Singh et al., 1988), which causes DNA denaturation and unwinding due to hydrogen bond
disruption, and the weakened bonds are transformed to single strand breaks (Olive and Banath, 
1993; Tice et al., 2000).
Because the Comet assay requires a minimum of 75% cells alive to prevent false positives, the 
cells analysed were exposed to 0.25mM DEM only, and not the higher concentration of 
0.5mM. Cells were analysed after a 24 hour incubation with the relevant dsRNA, followed by 
a further 24 hour exposure to 0.25mM DEM. The Comet protocol used in this study was a 
combination of various methodologies, and is described in detail in Chapter 2, section 2.26. 
Briefly, cells were embedded in agarose on a glass slide, then lysed and treated with an 
alkaline solution to denature the DNA and hydrolyse sites of damage. The embedded cells 
were then placed in an electrophoresis tank at 20 volts and stained with SYBR Green to reveal 
the DNA. The samples were then visualised by epifluorescence microscopy, and analysed 
using the CometScore software application described below.
7.2.8 Comet analysis using CometScore v1.05 software application
The CometScore freeware application, available from http://autocomet.com, uses image
processing algorithms to analyse specific features of the tail and head of the DNA ‘comet’.
The image of the cell obtained with fluorescent microscopy is analysed by first drawing a box 
around the whole head and tail, thus separating the comet from the background, followed by 
designating the central portion of the head (Figure 7.19). The intensity of each pixel in the 
image is directly proportional to the amount of DNA at that location in the cell, allowing for a 
calculation of the amount of DNA in the designated area.
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Figure 7.19: Images from the CometScore program. First a box is drawn around the total comet area, 
followed by clicking on the centre of the nucleus. The program then gives a graphical representation of the 
DNA amount in the nucleus (green line), and DNA in the tail (purple line). Panel A shows two cells with 
little DNA damage, and small tail lengths. Panel B shows two cells with a greater extent of DNA damage 
exhibiting the longer tail length.
The parameter used in this study to evaluate the extent of DNA damage in comet analysis is 
the percentage DNA in the tail, because this is linearly related to DNA break frequency up to 
about 80 % DNA in the tail. The intensity of the comet tail relative to the head reflects the 
number of DNA breaks, because the DNA loops containing a break lose their supercoiling and 
become free to extend toward the anode, or small broken fragments can leave the nucleus and 
travel towards the anode (Collins, 2004).
At least 150 cells from each treatment in this study were analysed in duplicate, giving data on 
numerous cells which tended to have a large range of values for % DNA in the tail. Each 
experiment was performed at least twice. Tice et al. (2000) suggest classifying the comet data 
into five categories based on the % DNA in the tails, allowing the visualisation of the average 
extent of DNA migration in a culture of cells. In this study, data were broken into five classes, 
based on the %DNA in the tail of each cell: 0-19%, 20-39%, 40-59%, 60-79%, and 80-100%, 
as illustrated in Figure 7.20 and Figure 7.21.
7.2.9 GFP RNAi control
Cells were exposed to GFP dsRNA to determine whether the presence of dsRNA molecules 
would interfere with the DNA repair process, making cells more susceptible to DNA damage. 
The GFP dsRNA was added in the absence (Figure 7.20A) and presence (Figure 7.20B) of
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DEM. In both cases, the addition of the GFP dsRNA did not cause any significant change in 
the amount of DNA damage. The presence of DEM did, however, cause an increase in the 
proportion of cells with a higher percentage DNA in the tails, indicating a higher level of 
DNA damage. The significant effect of DEM on DNA fragmentation was observed both in the 
presence and absence of GFP dsRNA, and is seen clearly when the mean percentage DNA in 
the tails are compared in Figure 7.20C, where DEM increases the DNA in the tail from 18% to 
28%.
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Figure 7.20: The effect of GFP dsRNA and DEM on DNA fragmentation (Percentage DNA in the tail). The 
analysis was performed on data obtained from the Comet assay. Cells were treated with no DEM (Panel 
A), or with 0.25mM DEM (Panel B). Panel C shows a comparison of the means from each group. Means ± 
SEM are shown. Means were compared using Student’s t-test. There was no significant difference between 
the noRNA and the GFP control groups, however there was a highly statistically significant difference 
between the means of cells treated with DEM, and those not treated with DEM (***p<0.001).
247
7.2.10 The effect o f DmGS and/or Gclc RNAi on S2 cell DNA damage in 
cells exposed to an oxidative stress
This set of experiments aimed to determine the effect of DmGS and/or Gclc RNAi on DNA
damage, and whether DmGS and/or Gclc knockdown had an additional effect to DEM. Cells 
were treated with dsRNA and DEM as described in the previous section.
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Figure 7.21: The effect of DmGS and/or dsRNA and DEM on DNA fragmentation. The analysis was 
performed on data obtained from the Comet assay. Cells were treated with no DEM (blue bars in panels A 
and C) or with 0.25mM DEM (green bars in Panels B and D). Cells were treated with either no RNAi 
(Panel A), DmGS RNAi (Panel B), Gclc RNAi (Panel C) or a combination of DmGS and Gclc RNAi (Panel 
D). Panel E compares the DNA damage in cells treated with combinations of RNAi in the absence of DEM, 
and Panel F compares DNA damage of cells treated with 0.25mM DEM, as well as DmGS and Gclc RNAi.
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The percentage DNA in the tails of cells treated with no RNAi (Figure 7.21 A), DmGS RNAi 
(Figure 7.2 IB), Gclc RNAi (Figure 7.21C) and a combination of DmGS and Gclc RNAi 
(Figure 7.2 ID) increased in the presence of 0.25mM DEM. When comparing the effect of the 
RNAi combinations in the presence of DEM (Figure 7.2 IF) and in the absence of DEM 
(Figure 7.2 IE), it appears that the combination of DmGS and Gclc RNAi caused the most 
DNA damage, with the effect more apparent in cells subjected to the DEM treatment.
Figure 7.22 clearly illustrates the effect of DEM on DNA damage by comparing the means of 
the percentage DNA in the tail of the various treatments. Cells exposed to DEM always 
displayed a significantly greater degree of DNA damage compared to their untreated controls, 
regardless of the accompanying RNAi treatment. In the absence of DEM, there was no 
significant difference in percentage DNA in the tail between cells treated with no RNAi, and 
those treated with DmGS and/or Gclc RNAi (black bars in Figure 7.22). This suggests that the 
knockdown of DmGS or Gclc or the combination of the two does not increase the incidence of 
DNA damage in S2 cells. In the presence of 0.25mM DEM, however, there was a statistically 
significant increase in the amount of DNA in the tail of cells treated with Gclc RNAi, with or 
without DmGS RNAi, compared to cells not treated with any RNAi (Figure 7.22). In the 
presence of DEM, the addition of DmGS and Gclc dsRNA did not have a cumulative effect on 
DNA damage compared to Gclc dsRNA alone. Cells exposed to DmGS RNAi in the presence 
of DEM had a 6% increase in DNA in the tail compared to DEM-treated cells with no RNAi, 
although this increase is not statistically significant. DmGS RNAi, therefore, does not have 
any effect on DNA damage in the presence or absence of DEM, while Gclc RNAi does have 
an effect on DNA damage in the presence of the oxidative stressor DEM.
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Figure 7.22: Percentage DNA in tail in the presence of DEM or not, and with different combinations of 
DmGS and Gclc knockdowns. The means compared originate from the data presented in Figure 7.21. 
Asterisks indicate a statistically significant difference (**p<0.01, ***p<0.001) between DEM and no DEM 
treatment. • • •  indicates a statistical difference (p<0.001) between DmGS+Gclc treated cells and other 
treatment groups with DEM. Statistical significance was calculated using Student’s t-test. Means ±SEM  
are shown.
7.3 Discussion
The use of RNAi in Drosophila cell culture has previously been shown to be a quick and 
effective method to characterize the role of specific genes by causing significant down- 
regulation of target genes (Radyuk et al., 2003). In work reported in this chapter, RNAi was 
used to decrease the expression of DmGS and Gclc in S2 cells in an attempt to elucidate the 
role of DmGS in Drosophila cell viability, resistance to oxidative stress and protection from 
oxidative stress induced DNA damage. The use of RNAi knockdown of DmGS and Gclc 
allows the study of GSH depletion without the possibility of unrecognized effects o f GSH 
depleting chemicals.
In order to fully characterize DmGS in S2 cells, it was also necessary to study the effects of 
Gclc knockdown, and a combination of DmGS and Gclc RNAi since DmGS catalyses only one 
of the two steps of GSH biosynthesis. RNAi has been used in the S2 cell culture system in 
previous studies, eliciting a robust gene silencing effect which lasted up to 7 days (Clemens et 
ah, 2000; Hannon, 2002; Radyuk et ah, 2003). The results presented in this chapter show that
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RNAi resulted in a significant reduction of DmGS and Gclc expression, both individually and 
in combination. 1.3pg dsRNA was added per million cells (~10-17nM, depending on the 
length of the dsRNA fragment), resulting in a significant reduction of the relevant transcript 
after 24 hours, with the effect lasting for at least 3 days. The two day time period was thought 
to be sufficient to measure GSH biosynthesis gene knockdown since the half life of GSH is 5 
hours in rat cell culture (Komlosh et al., 2002), and lasts only 2 minutes in human serum 
(Lomaestro and Malone, 1995).
DmGS knockdown was slightly less efficient than Gclc knockdown, most likely due to the 
smaller size of the DmGS dsRNA (350bp) compared to the Gclc dsRNA (650bp). It has been 
previously reported that the optimal length of dsRNA for efficient RNAi in S2 cells is in the 
region of 500-700bp (Hammond et ah, 2000; Kavi et ah, 2005), with 300bp being the lower 
limit for efficient knockdown (Caplen et ah, 2000). The difference in the secondary structure 
of dsRNA for different genes has also been shown to be responsible for the disparity in 
knockdown efficacy of certain genes (Caplen et ah, 2000; Radyuk et ah, 2003).
The effect of oxidative stress on control S2 cells was evaluated. The hypothesis tested was that 
cells exposed to oxidative stress would have decreased GSH levels, decreased viability, 
increased DNA damage and increased DmGS and/or Gclc gene expression. To test the 
response of cells to oxidative stress, different concentrations of DEM and H2O2 were used to 
induce conditions of oxidative stress. DEM-induced oxidative stress has previously been 
shown to cause a decrease in human cell viability (Back et ah, 1998), most likely through 
induction of apoptosis (Valverde et ah, 2006). It was found that both DEM and H2 O2 caused a 
decrease in S2 cell viability. Although a low dose of DEM did not have a statistically 
significant effect on cell viability, cells experienced a 58% decrease in GSH levels, and a 10% 
increase in DNA damage. This phenomenon of a significant reduction in cellular GSH having 
no immediate effect on viability has been noted in mouse cells, where cells survive with as
little as 2% of the wild type GSH levels, although at those levels cells do not grow as well as 
wild type cells (Valverde et al., 2006).
It is interesting to note that the response of DmGS and Gclc expression to the two oxidants 
was not the same, as summarized in Table 7.3. Exposure to DEM caused an upregulation of 
DmGS as well as Gclc, while cells exposed to H2 O2 had reduced expression of the two genes. 
The increase in DmGS and Gclc expression was only statistically significant at 0.5mM DEM, 
although the trend was present at the lower dose of 0.25mM DEM. In previous studies using 
rat and human tissue culture systems, exposure to H2O2 was shown to upregulate Gclc and 
increase cellular GSH content (Soltaninassab et al., 2000; Seo et al., 2004). In S. cerevisiae, 
Gclc was upregulated in response to H2 O2 (Monje-Casas et al., 2004), although there are 
conflicting reports of the GS expression upon exposure to H2O2 ; one study saw a slight 
reduction in GS expression (Monje-Casas et al., 2004), while another showed an increase in 
GS expression (Carmel-Harel and Storz, 2000). The conflicting GS and Gclc expression 
levels in response to DEM compared to H2 O2 is likely a result of the GSH depleting effects of 
DEM which would cause an increase in GSH biosynthesis gene expression, while exposure to 
H2 O2 would have an indirect effect on GSH by increasing the oxidative stress in the cell, 
however catalase is the major H2O2 detoxifier.
DEM was chosen as the source of oxidative stress for further experiments because the results 
could be compared to DEM-induced oxidative stress in adult flies, and DEM also has the 
added advantage of being a glutathione depletor, allowing the examination of conditions of 
severe glutathione depletion in S2 cells when combined with DmGS/Gclc RNAi. DEM- 
induced GSH depletion is well established as a source of oxidative stress, which has been 
shown to cause an increase in free radical generation after 12 hours (Back et al., 1998). A 
withdrawal of GSH leads to a fall in mitochondrial dehydrogenase, an increase in ROS
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production, a rise in pro-apoptotic RNA, and a fall in anti-apoptotic RNA, and finally after 
approximately 48 hours, DNA fragmentation occurs (Shen et al., 2005; Valverde et al., 2006).
Table 7.3: Summary of principal results obtained with various RNAi and oxidative stressors. Up arrows 
indicate and increase, down arrows indicate a decrease, and horizontal arrows indicate no change.
RNAi Oxidative Effect
treatment stressor
30mM H2 O2 I  viability by 50%
I GS expression 
i  GCLC expression
None
0.25mM DEM viability 
|  DNA damage by 10%
I  GSH by 58% 
f GS expression (N-S) 
t  GCLC expression (N-S)
0.5mM DEM I  viability by 50% (after 1 day) 
f GS expression 
t  GCLC expression
None viability 
<-> DNA damage 
1 GSH by 13.5% (N-S)
GS 30mM H2O2 viability
0.25mM DEM I  viability by 50% (compared to no RNAi) 
t  DNA damage (N-S)
GSH (compared to no RNAi) 
t  GCLC expression
None <-» viability 
«-> DNA damage 
i  GSH by 28.4%
GCLC 30mM H2O2 viability
0.25mM DEM I  viability by 50% (compared to no RNAi) 
t  DNA damage (compared to no RNAi) 
j  GSH by 79.1%
GS expression (compared to no RNAi)
None viability 
<-+ DNA damage 
i  GSH by 57%
GS 4- GCLC 30mM H2 O2 «-> viability (compared to no RNAi)
0.25mM DEM I  viability by 50% (compared to no RNAi) 
t  DNA damage (not more than GCLC RNAi) 
i  GSH by 82.1% (N-S more than GCLC RNAi) 
IGS expression compared to GS RNAi 
GCLC expression compared to GCLC RNAi
The next hypothesis tested was that a decrease in either or both of the glutathione biosynthesis
genes would decrease glutathione levels, increase DNA damage, and have an adverse effect on
253
cell viability. It was found that RNAi mediated knockdown of DmGS had little measurable 
effect on viability, DNA damage or GSH levels. Similarly, Drosophila SOD (Seto et al., 1990) 
and catalase (Mackay and Bewley, 1989) mutants expressing 50% of wild type enzyme levels 
have viability comparable to wild type strains. In addition, GS null human fibroblasts 
subjected to a Comet Assay were not found to be more sensitive to DNA damage than control 
cells, despite lower GSH levels, leaving the authors to conclude that GSH is not essential to 
protect DNA against DNA damage. It is, however, unlikely that the DmGS mRNA remaining 
after the RNAi treatment were active throughout the period of the assay, as the half-life of GS 
mRNA, measured in S. cerevisiae, is 16 minutes (Monje-Casas et al., 2004), and the protein 
half life, measured in E. coli, is 50 minutes (Inoue et al., 1996). Another possibility for the 
lack of effect is that GS is dispensable in Drosophila, since GS has been found to be 
dispensable for viability in S. cerevisiae, and E. coli (Grant et al., 1997; Cardozo-Pelaez et al., 
2002). In humans, however, homozygous GS null mutations tend to be lethal, although 
heterozygous GS mutation carriers with GS expression of only 50% of control levels display 
no symptoms (Janaky et al., 1999). It is likely that the reduction of DmGS by RNAi left 
enough DmGS to be translated to carry out baseline GSH synthesis.
While DmGS RNAi did decrease the cellular GSH concentration, it was a statistically non­
significant change, however DmGS RNAi in combination with Gclc RNAi reduced the GSH 
content of cells significantly more than Gclc alone, indicating that DmGS does indeed play an 
important role in GSH synthesis. Overexpressing DmGS and Gclc in rats increased GSH 
synthesis to a greater degree than Gclc alone, while upregulating GS in a human liver cell line 
also resulted in a significant increase in GSH, despite no change in GCL expression (Huang et 
al., 2000). Reduction of GS activity has also been shown to have lowered GSH content when 
there is no change in GCL activity, as observed post surgery in humans (Luo et al., 1998), and 
in Tat mice (Choi et al., 2000). It may be the case that GS is able to increase Gclc activity,
since it appears that GS has an effect on GSH content only in the presence of Gclc. In 
addition, when GSH levels are decreased, the feedback inhibition of GCL is released, thus 
requiring an increase in GS to produce more GSH. This release of inhibition may also explain 
why a drop in DmGS expression has a greater effect on GSH concentration in the absence of 
Gclc.
Gclc knockdown decreased cellular GSH concentration by a significant 28.4%, although there 
was no change in viability of the cells, or in the extent of DNA damage, compared to untreated 
control cells. A combination of DmGS and Gclc knockdown also had no effect on viability or 
DNA damage within the cells, although cellular GSH was reduced dramatically by 57%. 
Knockdown of DmGS and/or Gclc transcription, which may cause a severe decline in GSH 
concentration, therefore does not have an effect on cell viability in standard culture conditions. 
The final set of experiments aimed to investigate whether the combined effect of DmGS/Gclc 
RNAi and oxidative stress would be more pronounced than either of the treatments separately. 
It was found that DmGS and/or Gclc RNAi combined with a low dose of DEM did have a 
pronounced effect on cellular viability (Table 7.3). DmGS RNAi treatment in cells exposed to 
DEM did not cause a decrease in GSH levels greater than the DEM treatment (60.5% vs 57%), 
but the cell viability was significantly reduced compared to DEM treatment alone, and there 
was a slight, but statistically non-significant, increase in DNA damage. This result is puzzling 
because it would suggest that GS plays a role in maintaining cellular function that is not 
directly related to the synthesis of GSH. A similar situation was found by Yang et al. (2002) 
who studied GCLM null mice, which were viable with no phenotype, however, cultured tissue 
from these mice exposed to hydrogen peroxide was 10 fold more sensitive than control tissue. 
GSH depletion was simulated chemically to the same level as in the GCLM null cells, and the 
knockout cells were still dramatically more sensitive to peroxide killing (Yang et al., 2002). 
The conclusion the authors reached is also applicable to the findings in this chapter; that cell
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death is less dependent on existing cellular GSH than on the capacity for de novo GSH 
synthesis.
Another point to consider is the GSH assay used in this study. The protocol is based on a 
glutathione reductase recycling assay (Tietze, 1969) which measures the total amount of GSH 
by reducing the oxidized form of GSH (GSSG) to GSH. In normal cellular conditions, GSH 
exists mainly in its reduced form, with only about 1-5% existing as GSSG (Njalsson, 2005), 
however in the experimental conditions of increased oxidative stress resulting from DmGS 
RNAi and exposure to DEM, it is likely that the amount of GSSG would be significantly 
increased. Measuring the total GSH therefore did not reflect the probable increase in the 
GSSG:GSH ratio in cells exposed to DmGS RNAi and DEM, which is the ostensible cause of 
the drop in viability with both treatments.
Similar results were found for cells exposed to DEM and Gclc RNAi or a combination of 
DmGS and Gclc RNAi (Table 7.3). In both cases cells experienced a significant decrease in 
GSH and an increase in DNA damage. The increase in DNA damage may have due to the 
large amounts of ROS released when mitochondria are destroyed in conditions of GSH 
depletion, as seen in a previous study in mouse embryos (Reliene and Schiestl, 2005). It is 
interesting to note that in the presence of DEM the viability of cells was not further decreased 
by the addition of Gclc RNAi compared to cells with DmGS RNAi alone, even though the 
effects of Gclc RNAi alone or in combination with DmGS RNAi are more pronounced with 
respect to DNA damage and GSH depletion. The lack of a cumulative effect of DmGS and 
Gclc double knockdown on cell viability suggests that expression of DmGS and Gclc are 
equally important in protecting Drosophila S2 cells from DEM-induced oxidative stress, even 
though their effect on cellular GSH levels is not the same. These results also reiterate the 
findings of previous studies in whole organisms, as well as cell culture, showing that a 
reduction in antioxidant gene expression is only detrimental to viability under conditions of
oxidative stress (Mackay and Bewley, 1989; Seto et al., 1990; Radyuk et al., 2003; Van 
Remmen et al., 2004).
The effect of DmGS and/or Gclc RNAi treatment in combination with the DEM-induced 
oxidative stress was not corroborated by exposure of cells to H2 O2 (Table 7.3). The addition of 
H2 O2 to cells which under-expressed DmGS, Gclc or a combination of the two genes had no 
further effect on cell viability, which is interesting because GSH is required to protect cells 
against the O2 *' radical formed by peroxide, as illustrated in Figure 7.7 (Eklow et al., 1984; 
Dringen et al., 1999). This unforeseen result may reflect the sufficiency of catalase, which is 
the primary cellular defense against peroxide (Mackay and Bewley, 1989), or it may be due to 
the different mechanisms of action of each of the oxidative stressors. The manner in which 
DEM causes oxidative stress is by irreversibly binding GSH, thereby causing the depletion of 
a key cellular antioxidant (Back et al., 1998). H2 O2 , on the other hand, is a powerful oxidant 
which causes a rapid oxidation of GSH via glutathione peroxidase, but it does not remove 
GSH permanently from the system (Eklow et al., 1984; Dringen et al., 1999). The use of DEM 
as a source of oxidative stress may have been more effective in reducing the viability of cells 
under-expressing the GSH biosynthesis enzymes DmGS and Gclc because of the already 
reduced cellular GSH levels.
The second aspect considered in this chapter was how the level of DmGS and Gclc 
transcription affected each other’s expression. As discussed earlier, a low dose of DEM had 
the effect of slightly up-regulating DmGS and Gclc expression (not statistically significant), 
while H2O2 had the effect of down-regulating DmGS and Gclc expression. Gclc RNAi slightly 
reduced DmGS expression, however, DmGS RNAi had the effect of up-regulating Gclc 
expression (Table 7.3). The more pronounced effect of DmGS RNAi on Gclc expression in the 
presence of DEM may be a result of the DEM-induced GSH depletion which caused a further 
increase in Gclc transcription by increasing the oxidative stress. These results suggest that
DmGS and Gclc are regulated in a similar manner, although the downregulation of DmGS has 
a greater effect on Gclc expression than in the reciprocal situation. This could be because Gclc 
is the rate-limiting step, and is more tightly regulated with respect to changes in the cellular 
environment that affect GSH levels, including DmGS transcript levels.
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8 Chapter 8: General Discussion
Glutathione depletion has been linked to a variety of human diseases including Parkinson’s 
disease, Alzheimer’s, liver damage, amyotrophic lateral sclerosis and cystic fibrosis, in 
addition to ageing (Anderson, 1998; Schulz et al., 2000; Townsend et al., 2003). The 
experimental depletion of glutathione by both chemical and genetic means results in altered 
redox potential, and triggers an increase of ROS, mitochondrial permeability, apoptotic 
signalling events, and eventually cell death (Meister, 1995; Armstrong and Jones, 2002; 
Njalsson, 2005; Shen et al., 2005; Hong et al., 2006; Valverde et al., 2006). GSH 
concentrations have been shown to decline dramatically with age in Drosophila, and it has 
been suggested that the GSH-dependent cellular redox state is a determinant of the 
physiological age of flies, and may be involved in determining the rate of ageing (Rebrin et 
al., 2004). Ageing rats also exhibit lower levels of GSH (Zhu et al., 2006), and in mice there is 
a pro-oxidising shift in the glutathione redox state with age (Rebrin et al., 2003).
The free radical theory of ageing (Harman, 1956) proposes that ageing is caused largely by 
ROS damage to macromolecules. It has also been suggested that ROS have an effect on the 
ageing process by interfering with redox gene expression and intracellular signalling 
pathways. For example Sir2, implicated in CR-mediated lifespan extension,in Drosophila is 
regulated by the cellular redox status (Dugan and Quick, 2005; Guarente and Picard, 2005). 
The proposed link between oxidative stress and longevity has been strengthened firstly by the 
identification, in several species, of mutants that have increased longevity and increased 
resistance to oxidative stress, and secondly by transgenic organisms with enhanced oxidative 
stress resistance that were also found to have extended lifespans (Parkes et al., 1998; Orr et al., 
2003; Morrow et al., 2004; Fridell et al., 2005). Thirdly, the increase in oxidative damage to
macromolecules has been observed with increasing age (Yu et al., 1982; Sohal et al., 1995;
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Finkel and Holbrook, 2000; Stadtman, 2002; Landis and Tower, 2005). One of the tenets of 
the free radical theory of ageing is that an increase in antioxidants will result in increased 
oxidative stress resistance, and ultimately increased longevity. In this thesis, it was proposed 
that altering the level of GSH would have an impact on oxidative stress resistance.
GSH is synthesised in a two step reaction involving two distinct enzymes. Glutathione 
synthetase (GS) has received less attention in the literature because it is widely accepted that 
glutamate cysteine ligase (GCL) catalyses the rate-limiting step in GSH synthesis, although 
this is based on kinetic data obtained from enzyme studies in the rat kidney (Yang et al., 
2002a). A recent collection of studies in mice, humans and E. coli has, however, suggested a 
greater role for GS in determining the rate of GSH synthesis than previously thought (Choi et 
al., 2000; Huang et al., 2000; Yang et al., 2002a; Njalsson and Norgren, 2005; Liao et al.,
2006). This thesis aimed to characterise the gene encoding GS in Drosophila melanogaster 
(DmGS% and to determine whether altering DmGS expression would alter oxidative stress 
resistance in this organism.
The first objective of the thesis was to determine the structure of the DmGS gene. It was found 
that DmGS exists as a tandem duplication in the majority of D. melanogaster laboratory 
strains tested, as well as in all the D. melanogaster wild type strains tested. The lack of the GS 
duplication in any sibling species of Drosophila tested, and the lack of sequence divergence 
between the two copies suggests a very recent duplication event. DmGS is an 8kb gene present 
on the X-chromosome, and consists of nine exons which are alternatively spliced, resulting in 
nine predicted DmGS transcripts.
The second objective of this study was to analyse the multiple DmGS transcripts predicted
from the published D. melanogaster sequence. Six of the predicted transcripts were found in
vivo by cDNA cloning and sequencing, although it appears that only two of the six transcripts
are likely to encode an active GS protein. The two transcripts (T4 and T8) encode the same
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protein sequence, and differ only in their transcription start sites. Multiple GS transcripts have 
been observed in mice, which express six separate transcripts that encode three different 
proteins, although only one of those proteins is active (Shi et al., 1996). The active Drosophila 
GS protein is predicted to consist of 491 amino acid residues, which is comparable to the GS 
protein sizes in eukaryotic species studied to date (Huang et al., 1995; Shi et al., 1996; Grant 
et al., 1997; Wang and Oliver, 1997; Phlippen et al., 2003; Njalsson et al., 2004). The 
predicted active Drosophila GS protein also shares strong homology with other eukaryotic GS 
protein sequences, and 21 of the 24 active residues mapped on human GS are identical to the 
Drosophila protein (Njalsson et al., 2004). The transcripts encoding the active GS protein also 
appear to be significantly more abundant than the larger sized T1 and T2 transcripts in all 
developmental stages of Drosophila. It is possible that the transcripts which do not encode 
active proteins are involved in GS regulation, although the mechanisms of this predicted 
regulation are unknown at this stage. Another question which remains unanswered is: which 
transcripts originate from each of the duplicated gene copies? The two gene sequences are 
identical, and no indication is given on the annotated sequence as to how the predicted 
transcripts are assigned to each gene.
It is unclear from this study what effect the presence of the second copy of DmGS has on the
strains which carry the duplication, since the GSH levels were unaffected by GS copy number,
and there was no difference in oxidative stress resistance between single and double copy
number strains. The third objective of this study was to determine the role of GS in
maintaining GSH levels, and in oxidative stress resistance in Drosophila. DEM-mediated
GSH depletion, which has been shown to cause an increase in ROS generation after 12 hours
of treatment (Back et al., 1998), was used as a source of oxidative stress in adult flies as well
as in S2 cells. Expression of DmGS as well as Gclc was found to increase in response to DEM
and Paraquat-mediated oxidative stress, both in adult flies, and in the S2 cell culture system, as
261
supported by previous reports (Ruth Akhtar, pers comm.; Orr et al, 2005). A 58% increase in 
GSH in response to a low dose of DEM was also observed in cultured Drosophila cells.
An EP element inserted in the 5’ end of the distal DmGS copy was used to drive expression of 
DmGS in combination with a ubiquitously expressed GAL4 driver. Gclc was also 
overexpressed using the GAL4-UAS system, in combination with DmGS or separately, to 
determine the effect of each gene on the GSH biosynthesis rate. DmGS overexpression 
resulted in a lower GSH increase (49.5-63.2%) than Gclc overexpression (142-243%) in both 
male and female flies compared to their non-driven controls, which is consistent with Gclc 
being the rate limiting step in GSH biosynthesis. The combined overexpression of DmGS and 
Gclc caused a further increase GSH levels compared to Gclc expression alone, highlighting 
the importance of GS in GSH synthesis, although this effect was observed only in female 
flies.
The rationale for testing the oxidative stress resistance of flies overexpressing GSH 
biosynthesis genes originates from the idea that laboratory conditions are generally stress-free 
and do not simulate the variable and often stressful environmental conditions to which wild 
type animals are exposed. Overexpression of antioxidants would be expected to have a greater 
effect on lifespan when assayed in conditions of severe oxidative stress (Lin et al., 1998), 
compared to unstressed conditions. This was corroborated by the evidence in this thesis which 
showed that female flies overexpressing DmGS and/or Gclc had statistically significant 
increases in stress resistance. A recent study overexpressing GCL in Drosophila showed a 
50% increase in lifespan, and higher resistance of flies to oxidative stress (Orr et al., 2005). 
The increase in both median and mean survival implied that there would be a delayed onset of 
mortality rate increase, as well as the overall length of lifespan, through DmGS/Gclc 
overexpression.
262
An interesting sex difference was noted in flies overexpressing DmGS: males had higher 
DmGS transcript levels, as well as higher GSH concentration than their female counterparts, 
although an increase in oxidative stress resistance in DmGS overexpressing flies was only 
observed in the female flies. This result was counterintuitive, and may be an artefact of the 
gender differences which have confounded many previous studies on oxidative stress and 
ageing in Drosophila (Lints et al., 1983; Carey et al., 1995; Spencer et al., 2003; Forbes et al., 
2004; Magwere et al., 2004; Valenzuela et al., 2004; Magwere et al., 2006). As yet, the reason 
for the sex biases often observed in lifespan studies is unknown, although there are theories 
suggesting reproductive cost, sex linkage of genes, and difference in male and female 
metabolic rates (Vina et al., 2003; Burger and Promislow, 2004).
The effect DmGS has on GSH levels, as well as oxidative stress resistance was corroborated in 
the Drosophila S2 cell culture system using RNAi, thus fulfilling the final objective of this 
thesis. Although RNAi-mediatedDwGS knockdown alone did not affect GSH levels, DmGS 
RNAi did have a significant cumulative effect on GSH reduction in the presence of Gclc 
RNAi. Because RNAi results in a knockdown of the gene, and does not completely obliterate 
mRNA molecules, a low baseline of activity of GS or GCLC remains despite treatment of 
cells with dsRNA complementary to a portion of the DmGS or Gclc genes. This may explain 
the lack of effect of GS/Gclc RNAi on cell viability and DNA damage. The ability of cells to 
survive with very low levels of GSH (as low as 2% of wild type) has previously been observed 
in a murine GCL knockout system, although the cells did ‘teeter on the edge of survival’ 
(Valverde et al., 2006). A complete withdrawal of GSH led to initiation of apoptosis after 24 
hours, although the cells continued to synthesise DNA and divide for approximately 48 hours 
in the absence of GSH (Valverde et al., 2006). These findings may explain why no effect on 
viability was seen with DmGS and Gclc knockdown, since the maximum reduction of GSH
was -50%, and the time period of the viability assay was 48 hours.
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As was the case in adult flies, a change in the expression of GSH biosynthesis genes had the 
greatest effect on viability when S2 cells were exposed to an oxidative stressor. DmGS or Gclc 
RNAi halved S2 cell viability in the presence of a low dose of DEM. This effect on viability is 
not solely due to extreme GSH depletion in the presence of DEM, as shown by the similar 
GSH levels in cells treated with DEM, with or without DmGS RNAi, although the significant 
reduction in viability was observed only with the combination of DEM and DmGS RNAi 
exposure. This result is supported by evidence from a study on Gclm null mice which 
exhibited no phenotype, although cultured cells were 10 fold more sensitive to the presence of 
peroxide stress (Yang et al., 2002b) compared to control cells. These results together suggest 
that cell survival is dependent on the capacity for de novo GSH synthesis in the presence of an 
oxidative challenge, rather than on the amount on GSH present in the cells. The ability of 
Drosophila to survive in conditions of oxidative stress with reduced antioxidant levels was 
observed in SOD hypomorphs (Seto et al., 1990), as well as in catalase hypomorphs (Mackay 
and Bewley, 1989).
The combination of DEM and Gclc RNAi caused a reduction in viability, as well as a
significant increase in DNA damage. Although Gclc knockdown causes a greater incidence of
DNA damage than DmGS knockdown, there was no cumulative effect on cell death when
both DmGS and Gclc expression were reduced. It is possible therefore that GS and Gclc are
equally important in protecting S2 cells from DEM-induced oxidative stress, despite different
effects on GSH concentrations. Once again, this draws attention to the idea that altering the
levels of antioxidant genes has an effect only under oxidative stress conditions, as seen in
previous studies using Drosophila adult organisms or cell culture (Mackay and Bewley, 1989;
Seto et al., 1990; Radyuk et al., 2003; Van Remmen et al., 2004).
Overexpression o f ‘major’ cellular antioxidants, such as MnSOD, catalase and Gclc in
ubiquitous tissue distribution has been shown have no effect, or to be detrimental to
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Drosophila viability (Bayne et al., 2005; Orr et al., 2005), probably due to the damaging 
effects of extreme ROS depletion on cell signalling. Conversely, overexpression of major 
antioxidants specifically in neural tissues, has a positive effect on oxidative stress resistance 
and longevity (Parkes et al., 1998; Sohal et al., 2002; Landis and Tower, 2005). In relation to 
these findings, this thesis suggests that the ubiquitous overexpression of genes with a more 
minor role in antioxidant protection, such as Gclm (Orr et al, 2005) or GS (this thesis) can 
have a beneficial effect on Drosophila viability under conditions of raised oxidative stress. 
The difference in ubiquitous expression between major and minor antioxidants is probably a 
result of the minor antioxidants not decreasing ROS below the baseline value where the 
reduction of ROS has detrimental effects by disrupting signal transduction pathways and gene 
regulation (Phillips et al., 2000; Mockett et al., 2003; Bayne et al., 2005). Under normal 
conditions there are probably optimal levels of DmGS present, however under conditions of 
oxidative stress, an increased level of DmGS is beneficial.
This thesis could also be seen to support the free radical theory of ageing. Since the 
overexpression of DmGS resulted in increased survival under conditions of oxidative stress in 
female adults, and the knockdown of DmGS in S2 cells resulted in a decrease in oxidative 
stress resistance, the expectation is that flies overexpressing DmGS would also have increased 
lifespan, although these experiments could not be performed due to time limitations. These 
two findings highlight the negative effect of DmGS knockdown on cell viability only in 
conditions of increased oxidative stress emphasises the idea that there is a degree of 
redundancy in the cellular antioxidant defence, and when ROS production is increased under 
stressful conditions, the upregulation of the antioxidant system would be beneficial for the 
rapid removal of the toxic species. Under normal physiological conditions when ROS 
production rates are relatively slow, however, the increase in antioxidants may not have any 
additional beneficial effect.
The overexpression of GS would therefore be expected have a positive effect on oxidative 
stress resistance and possibly protect against early death in non-laboratory organisms which 
are exposed to stress, pathogens and toxins on a daily basis (Dugan and Quick, 2005). This 
finding, as well as the positive effect of ubiquitous Gclm overexpression encourages further 
work on minor antioxidants which may reduce ROS to a level where oxidative damage is 
decreased while maintaining functional cell signalling pathways and gene regulation.
8.1 Future work
Further work that could arise from this thesis includes lifespan studies of flies overexpressing 
DmGS alone, and in combination with Gclc. In the S2 cell culture system, DmGS could be 
overexpressed using the cDNA of the transcript predicted to produce the active GS protein 
(T4/T8). This could confirm the results of the DmGS overexpression experiment performed in 
adult flies, and could also determine whether there is a GSH level above which there is no 
beneficial effect on oxidative stress resistance. Further RNAi experiments could also be 
performed in the S2 cell culture system. It would be interesting to investigate the effect of 
knocking down the expression of specific DmGS exons compared to the total DmGS 
knockdown performed in this thesis using dsRNA specific to unique exons. This would help 
determine the function of the different transcripts, and identify whether all transcripts play a 
role in cell survival. A similar approach has been used to study the 95 alternative exons of 
Dscam, where dsRNA fragments were created to specific exons to facilitate RNAi in S2 cells 
(Schmucker et al., 2000). A further technique to determine the location of specific transcripts 
within larvae or adult flies would be the use of in-situ hybridisation. Probes with sequences 
identical to unique portions of each of the transcripts would bind to the tissues or cells in 
which the corresponding transcripts are present.
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RNAi-mediated knockdown of total DmGS, as well as the specific transcripts, could also be 
performed in adult flies using the pWIZ plasmid in which a transgene is inserted in two 
orientations separated by an intronic sequence, resulting in the production of dsRNA with a 
hairpin structure (Lee and Carthew, 2003). This endogenous RNAi system has the potential to 
be stably inherited and can be controlled by the GAL4/UAS system. Adult flies with DmGS 
knockdown could be exposed to oxidative stressors to confirm the results obtained using the 
S2 cell culture system in this thesis, and the effects of DmGS knockdown on Drosophila 
development could be observed.
A technical addition to this thesis could be including GSSG measurements with the GSH 
measurements. The Tietze method used in this study measures total glutathione levels, 
including the reduced and oxidised forms. With access to an HPLC facility, accurate 
measurements of the oxidized form of GSH could be taken, and may shed light specifically on 
the experiment where S2 cells were treated with DmGS RNAi and DEM, in which it is likely 
that the amount of GSSG would be significantly increased. It has previously been noted that 
upon exposure to an oxidative stress, the oxidation of GSH to GSSH, coupled with rapid GSH 
synthesis can account for the lack of a decrease in total GSH levels (Coe et al., 2002). The 
ratio of GSHrGSSG provides more information in oxidative stress studies than total GSH 
alone.
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9 Appendixes
9.1 Appendix A: Region of BACR29H04 containing both copies 
of GS (position 22880 to 42300).
The P-element insertion point in strain EP1322 is highlighted at position 25010 
The 297 element is highlighted (position 28890-31619), and is present only in the distal 
copy of DmGS.
The mRNA of the distal DmGS copy starts at position 24784-33692, and the proximal 
DmGS copy mRNA is at position 34939-41115.
The duplicated region spans positions 23700-41280, with the duplication starting at 
position 33860.
2 2 8 9 0  2 2 9 0 0  2 2 9 1 0  2 2 9 2 0  2 2 9 3 0  2 2 9 4 0  2 2 9 5 0  2 2 9 6 0
C T T T A C T T T A  A A T T A A T T T C  C G C T C T A T G C  A T A A C C A A T G  C A T C G C A T T G  G G A C C A C TA G  T T C A C G A C A G  C T T G A G T T G T
2 2 9 7 0  2 2 9 8 0  2 2 9 9 0  2 3 0 0 0  2 3 0 1 0  2 3 0 2 0  2 3 0 3 0  2 3 0 4 0
A T T T T T T A A T  G G A C T T T T T T  T T T T T T T T T A  A T T C A A A T C C  T T T G C A A T T A  A A A A T T T C A T  T T C C A T T T A A  A T G T A A C T T T
2 3 0 5 0  2 3 0 6 0  2 3 0 7 0  2 3 0 8 0  2 3 0 9 0  2 3 1 0 0  2 3 1 1 0  2 3 1 2 0
C A A C C G G T T T  T A A T T A G A A C  A C C C A A A T A C  A G T T A T T T T G  A A A A A C G A A G  A A G T T G T A A A  A T T G T G A C C C  G A T T T A A A A A
2 3 1 3 0  2 3 1 4 0  2 3 1 5 0  2 3 1 6 0  2 3 1 7 0  2 3 1 8 0  2 3 1 9 0  2 3 2 0 0
G T T A A G C A T C  A T A A A A G T G A  G G C AC TG C G A G A A T A T A A T G  A T T T G T A A A T  A C G A T T T T T G  C A T T C A C A T T  A T A T A T T A T A
2 3 2 1 0  2 3 2 2 0  2 3 2 3 0  2 3 2 4 0  2 3 2 5 0  2 3 2 6 0  2 3 2 7 0  2 3 2 8 0
A A A T C G A A T T  T A T T T A A A A A  G A A T G C C C A T  T T A T C G C T G T  G C A A A G T T C A  A A C C C A T T T C  A T C C T C T G T G  C G A A T T T A T G
2 3 2 9 0  2 3 3 0 0  2 3 3 1 0  2 3 3 2 0  2 3 3 3 0  2 3 3 4 0  2 3 3 5 0  2 3 3 6 0
T G G A C A C T T A  A A C T C G C G A C  T T A A A A T G C C  G A A G A C T C T A  A A G C A A C A C G  T T A T T A A A A A  T T T G A T G G G C  A C A T C A A G T G
2 3 3 7 0  2 3 3 8 0  2 3 3 9 0  2 3 4 0 0  2 3 4 1 0  2 3 4 2 0  2 3 4 3 0  2 3 4 4 0
C T T A T A A A T A  T T C A T T A G C G  C A T A A A A A A T  C A G T T T A T T T  CG G CG CAG CA A C T G G C A C A G  T T C G C A T G T T  C A G G A T A A T G
2 3 4 5 0  2 3 4 6 0  2 3 4 7 0  2 3 4 8 0  2 3 4 9 0  2 3 5 0 0  2 3 5 1 0  2 3 5 2 0
A A A A C C G C A T  A C C T C A T C C T  G A T T C T T T C G  C T C T C G A T A T  C C A C T T C C T T  G G C T A A C G A T  CC G C AG AG G T C C T T C G A T C A
2 3 5 3 0  2 3 5 4 0  2 3 5 5 0  2 3 5 6 0  2 3 5 7 0  2 3 5 8 0  2 3 5 9 0  2 3 6 0 0
G AATG C G G AC  A A T C C G T G C A  G TG C TC A C C G  C A T T T G G G T T  TG G A G A C C C A  T C C T C G A T C G  A T T C G C C A A G  G T G A A C T C C A
2 3 6 1 0  2 3 6 2 0  2 3 6 3 0  2 3 6 4 0  2 3 6 5 0  2 3 6 6 0  2 3 6 7 0  2 3 6 8 0
G C G A TG A G C T G AAG AA C C A G  G T C A A C G C C A  TG TC G G A A A C  C A TC A A G G A C  C TG C AG AC G C  G C A T T G G C C A  C A A G A A C G A G  
Start of duplicated region
2 3 6 9 0  2 3 7 0 0  2 3 7 1 0  2 3 7 2 0  2 3 7 3 0  2 3 7 4 0  2 3 7 5 0  2 3 7 6 0
C T G C T C C T G C  TG C A AG C C G G  T C A G A T C A A G  G A C C A A A G T G  C C A G G C TC A A  C G T T T T G A T C  A A A A A C A T G A  A A G T C C T T C G
2 3 7 7 0  2 3 7 8 0  2 3 7 9 0  2 3 8 0 0  2 3 8 1 0  2 3 8 2 0  2 3 8 3 0  2 3 8 4 0
A A G T G A G T G T  C T G A A TG C C C  AG G C G G AG AT C A A A A G C A A G  G A C A T A C A A A  T A C A A T T G A G  CG CG G CAAAG  A T C A A G C A A A
2 3 8 5 0  2 3 8 6 0  2 3 8 7 0  2 3 8 8 0  2 3 8 9 0  2 3 9 0 0  2 3 9 1 0  2 3 9 2 0
268
TGAGCAACGA ACTGGTGACG CAGTGCAGCC GCCAGGACAC GTGTCCCATC GACGGCAAAG GTGGCATCTA TAAGCTGAAG
2 3 9 3 0  2 3 9 4 0  2 3 9 5 0  2 3 9 6 0  2 3 9 7 0  2 3 9 8 0  2 3 9 9 0  2 4 0 0 0
A T C C G T G A A T  T G C C A G C A T T  CGAGGCGCCG T G C A G T T C C A  A C G G C T G G T T  G A C C A T A C A G  A A A C G A T A C G  AT G G C G C C G A
2 4 0 1 0  2 4 0 2 0  2 4 0 3 0  2 4 0 4 0  2 4 0 5 0  2 4 0 6 0  2 4 0 7 0  2 4 0 8 0
G A A C T T C G A T  C G C G G TTG G A A G G A C T A C A A  G G A T G G T T T C  G G AC G C G TG A G A G G TG A G TT T T T C A T C G G C  C T G G A G A A A G
2 4 0 9 0  2 4 1 0 0  2 4 1 1 0  2 4 1 2 0  2 4 1 3 0  2 4 1 4 0  2 4 1 5 0  2 4 1 6 0
T G C A C C T T A T  G AC G C G G C AA CG AC G C CACG  A A C T G T A C A T  TA A G C TG G G C  A A G A T T G A T G  G C A C C A C T A G  C C AC G C C C AC
2 4 1 7 0  2 4 1 8 0  2 4 1 9 0  2 4 2 0 0  2 4 2 1 0  2 4 2 2 0  2 4 2 3 0  2 4 2 4 0
T A C G A C A A C T  TC G A A C T C G G  C G G C G AG A TT G A A T C C T A T G  A G C T A A A G T C  AC TG G G C C G C  T A C A A T G G C A  C A G C CG G C G A
2 4 2 5 0  2 4 2 6 0  2 4 2 7 0  2 4 2 8 0  2 4 2 9 0  2 4 3 0 0  2 4 3 1 0  2 4 3 2 0
TT C T C T G C G G  C C A C A TG A G C  G C C A A A A G T T  C A C C A C C A A C  G A C A A G G A C A  A C G A T G C C T A  T C G G T T C A A C  TG TG C C G C C G
2 4 3 3 0  2 4 3 4 0  2 4 3 5 0  2 4 3 6 0  2 4 3 7 0  2 4 3 8 0  2 4 3 9 0  2 4 4 0 0
A C G A A T A T G G  TG G C TG G TG G  T A C T A C G A T T  G C G CCAAG AG  G T A A G T A C G C  C C A T T A T A T A  C A T A T G G T A T  A T A T A C A T A T
2 4 4 1 0  2 4 4 2 0  2 4 4 3 0  2 4 4 4 0  2 4 4 5 0  2 4 4 6 0  2 4 4 7 0  2 4 4 8 0
G T A C T T G C A T  G T A A T A T T A A  TC G G C G G A G T A A C T G C A G C A  T G C T C A A T G G  C A A G T T C T A C  AAG G AG G G CC G C TC G C G G A A
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T A C A T T C A A T  T T C A A T T A A A  T T A A A T A A C G  G G C A C T T A C T  A A A C T T T T C T  C G C C G T G TA T G C C C C T G G TA  T T T T T T G A T G
Start of distal DmGS copy
.. X | 1
2 4 7 3 0  2 4 7 4 0  2 4 7 5 0  2 4 7 6 0  2 4 7 7 0  2 4 7 8 0  2 4 7 9 0  2 4 8 0 0
C C A T A T T C T G  G C A T A T T G C G  G T A T A T C G C C  G G C T G G T A T T  T T T T G C C T A A  C C C G C TAC G C  A C A p A C T G C G  A A T A T T C G G C
2 4 8 1 0  2 4 8 2 0  2 4 8 3 0  2 4 8 4 0  2 4 8 5 0  2 4 8 6 0  2 4 8 7 0  2 4 8 8 0
C A A A A A C A T A  G T T A T A T T T T  T G TC T G TG G G  C T T T T A G A C A  A A T T G T A A A C  T G A T A G C T C C  CG AC C C C AG C  C G T T T A A C G G
2 4 8 9 0  2 4 9 0 0  2 4 9 1 0  2 4 9 2 0  2 4 9 3 0  2 4 9 4 0  2 4 9 5 0  2 4 9 6 0
T G T C C A A A T T  G A C A G T G C A A  CC G G TG G AAC A G G TG G AG C A CAAG CAG C G G  C A C C C AG AA G  G A A A C C A G C G  A T C C A G T C A C
P-element insertion site
2 4 9 7 0  2 4 9 8 0  2 4 9 9 0  2 5 0 0 0  § [5 0 1 0  2 5 0 2 0  2 5 0 3 0  2 5 0 4 0
A A C A A T C G C T  C G TTG AG AG C  G C A G C G A TA A  G A G T T C C A G A  G T T T C T A G A G  T T T C C A G C G A  TA C C C A G C A G  TG G T G A G T A G
2 5 0 5 0  2 5 0 6 0  2 5 0 7 0  2 5 0 8 0  2 5 0 9 0  2 5 1 0 0  2 5 1 1 0  2 5 1 2 0
C T A G T A G A C A  G TC G TC G C A C  TG C TC A G C A G  TG C T C A G T G C  C C A G TG A G C A  G TTC C G G C G A  G CAG AC CC CG  T G A G A T A C C G
2 5 1 3 0  2 5 1 4 0  2 5 1 5 0  2 5 1 6 0  2 5 1 7 0  2 5 1 8 0  2 5 1 9 0  2 5 2 0 0
C G G C G AAC AA C T A A C A A C T A  A G A T A C T C T G  C C C C T T T T C T  A G A C G C A G C T G AG C C C C A G A T C C C A G A T C C  C A G A T A C C A G
2 5 2 1 0  2 5 2 2 0  2 5 2 3 0  2 5 2 4 0  2 5 2 5 0  2 5 2 6 0  2 5 2 7 0  2 5 2 8 0
CAG C AG AC C G  A C C C A A G C A G  A A C G A T C A T G  TC C AG C G AC G  C C A A TA C G G C  CG TG CTG CG C A A C T G C A T C C  G C T T G C C G C T
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2 5 2 9 0  2 5 3 0 0  2 5 3 1 0  2 5 3 2 0  2 5 3 3 0  2 5 3 4 0  2 5 3 5 0  2 5 3 6 0
GGCGGAGGAT GAGCTACTGG AGGTGACGGC CAAGGCCAAG GATTATGCCA TTATGCACGG CGCCGCCATG CGATCGAAGA
2 5 3 7 0  2 5 3 8 0  2 5 3 9 0  2 5 4 0 0  2 5 4 1 0  2 5 4 2 0  2 5 4 3 0  2 5 4 4 0
CGGCCTTCAG TCCGGACTCG TTGAATGTGG GTGATACAAT GGGCACTCGC TAGTGAGGGC TCGTATTCAT GCTAAGGTGT
2 5 4 5 0  2 5 4 6 0  2 5 4 7 0  2 5 4 8 0  2 5 4 9 0  2 5 5 0 0  2 5 5 1 0  2 5 5 2 0
CTAGTTTCCG CTCAAGAAGC TCATTTCAAT GGAACAACAT TCATTACACA TCCCTTATCG AGTTCAGTTC CTTTTTAAGT
2 5 5 3 0  2 5 5 4 0  2 5 5 5 0  2 5 5 6 0  2 5 5 7 0  2 5 5 8 0  2 5 5 9 0  2 5 6 0 0
TATGTGTAAT GCCAAATGTG ATTGGATGCT TGAGTTTGTT TTTCATTTTA TTGACGGTAG AGAAAGATTA GCAATGTGAC
2 5 6 1 0  2 5 6 2 0  2 5 6 3 0  2 5 6 4 0  2 5 6 5 0  2 5 6 6 0  2 5 6 7 0  2 5 6 8 0
GGTATAAGCT ACACATTGGC ATTCAATCGA GCTTCAAGCT AGCGTGCTGC TGCTTGAGCA ACAGTTTGCC AGGATACTAA
2 5 6 9 0  2 5 7 0 0  2 5 7 1 0  2 5 7 2 0  2 5 7 3 0  2 5 7 4 0  2 5 7 5 0  2 5 7 6 0
ACATTTTCAT TTTCCAGTTC GCCCCCTTCG TGCTGGTGCC TTCCTCGTTT CCGCGCAAGG AGTTCGAAAA GGCGGTGGCC
2 5 7 7 0  2 5 7 8 0  2 5 7 9 0  2 5 8 0 0  2 5 8 1 0  2 5 8 2 0  2 5 8 3 0  2 5 8 4 0
CTACAGCCGA TCATCAACCG GCTGATGCAC AATGTGGCCC ACGACGAGGA GTTCATCACG ACGACGCTGG CGGAGACGAT
2 5 8 5 0  2 5 8 6 0  2 5 8 7 0  2 5 8 8 0  2 5 8 9 0  2 5 9 0 0  2 5 9 1 0  2 5 9 2 0
CAAAGTGGAC GAGTTCACGG CCAATCTGTT CAACATCTAT CGCAAGGTGC TGGCGCACGG ATTCACCCAG GTGAGATTCC
2 5 9 3 0  2 5 9 4 0  2 5 9 5 0  2 5 9 6 0  2 5 9 7 0  2 5 9 8 0  2 5 9 9 0  2 6 0 0 0
GTCAGCTGGC GTCCATCCAT CTCCGATCCT CCGCCCTCTG CACACCATCA TCGTATCACC CGCCAACGTA TCCACCTCAT
2 6 0 1 0  2 6 0 2 0  2 6 0 3 0  2 6 0 4 0  2 6 0 5 0  2 6 0 6 0  2 6 0 7 0  2 6 0 8 0
TCCCATCGGG AGGGAGCACA TCTACAGGCA GCCAGTGGGT TACTCGCTAG AATTTATTGG GCCCCTCCAC CCGCGGTCGC
2 6 0 9 0  2 6 1 0 0  2 6 1 1 0  2 6 1 2 0  2 6 1 3 0  2 6 1 4 0  2 6 1 5 0  2 6 1 6 0
AATCTAATCG CCATTCCATA AATCGCCCGG CCATAGCCAT AGCCGCAGTC AAAGCCCAGA AGTCGGCTGT AGTCGCTAAT
2 6 1 7 0  2 6 1 8 0  2 6 1 9 0  2 6 2 0 0  2 6 2 1 0  2 6 2 2 0  2 6 2 3 0  2 6 2 4 0
CTCGCGTGAT TTATGCGAGC ATCCTGGCCT CACAGCTCCT TATCGTTGGC TTGTAAATCG ACGTAGGACA GCCCATCCCT
2 6 2 5 0  2 6 2 6 0  2 6 2 7 0  2 6 2 8 0  2 6 2 9 0  2 6 3 0 0  2 6 3 1 0  2 6 3 2 0
GACCCCCATA ACGCTAGAAC TTTGCCATTG CTCCTCCTAC TTTGATTTAC ATGCATTTCC CCTAACGAAA CCAGCACAGA
2 6 3 3 0  2 6 3 4 0  2 6 3 5 0  2 6 3 6 0  2 6 3 7 0  2 6 3 8 0  2 6 3 9 0  2 6 4 0 0
GGCGAATCCA TTGAGCTCTT CCACGTCCAC AAGAAGCTTT AATCTTTGTA GATCCTATCA GAAAGGTGAC AGTTTTACAA
2 6 4 1 0  2 6 4 2 0  2 6 4 3 0  2 6 4 4 0  2 6 4 5 0  2 6 4 6 0  2 6 4 7 0  2 6 4 8 0
TTTGAATAGT TATTGGCCCG GTAACTGATA GGGTTTATTA AATATAACAA TGCCAGCGCT ATTTTTACTT TATTACTATT
2 6 4 9 0  2 6 5 0 0  2 6 5 1 0  2 6 5 2 0  2 6 5 3 0  2 6 5 4 0  2 6 5 5 0  2 6 5 6 0
CAAACTTTGT CTCGAATCTT ATCGAAGTCT CAATTGAAGC ATTTAAATGC TAGAATCAAT TAAACTATTG TTCATTTTAA
2 6 5 7 0  2 6 5 8 0  2 6 5 9 0  2 6 6 0 0  2 6 6 1 0  2 6 6 2 0  2 6 6 3 0  2 6 6 4 0
ACTCGTTGAT TTTTGCCAAT GATTTTCAAT GTTTTTACTT GCAACTTAAT CATTTTCATC ACCCAATATC AAGTTTAGTT
2 6 6 5 0  2 6 6 6 0  2 6 6 7 0  2 6 6 8 0  2 6 6 9 0  2 6 7 0 0  2 6 7 1 0  2 6 7 2 0
GCGAATTTTG CTCTCTGTGC AAAAATTTAG TTCACGATCT GTGCTTTTCT CGTCACCACT CCTTCAAAAA TTTTAAAACC
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2 6 7 3 0  2 6 7 4 0  2 6 7 5 0  2 6 7 6 0  2 6 7 7 0  2 6 7 8 0  2 6 7 9 0  2 6 8 0 0
TAACCACGCA ATTGTACAAA CTCTCGATCT CAAACGCAAT CTGTTGCTCC ATTATCCGTC TCTCATTGCA TCGCTGTGCT
2 6 8 1 0  2 6 8 2 0  2 6 8 3 0  2 6 8 4 0  2 6 8 5 0  2 6 8 6 0  2 6 8 7 0  2 6 8 8 0
ACGAAAAATG ATTTTGAATC AAAGAAAACA TCGCTGGGGA TGCTGCGCAG CGATCTGATG CTGGAGTCCG GCTGTCCCGA
2 6 8 9 0  2 6 9 0 0  2 6 9 1 0  2 6 9 2 0  2 6 9 3 0  2 6 9 4 0  2 6 9 5 0  2 6 9 6 0
GCTGTCGCCA CGGGCGCTGC GAACGGCGGC CGGTGAGGAT CGTGGTCAGG ATGCGGGCGC TGCTGTGGGG CAAATAGCTG
2 6 9 7 0  2 6 9 8 0  2 6 9 9 0  2 7 0 0 0  2 7 0 1 0  2 7 0 2 0  2 7 0 3 0  2 7 0 4 0
GAGCTAACGG AGCTGCAGGA GTCGGAACTG CCGCTGGCAC GGGCAGCAAG GAGGAGGAGC ACAGGGAGGT CCAGCTAAGC
2 7 0 5 0  2 7 0 6 0  2 7 0 7 0  2 7 0 8 0  2 7 0 9 0  2 7 1 0 0  2 7 1 1 0  2 7 1 2 0
CGGGTCACCA AAGAGCCGGA ACGGAGGGCG ACCGGCGCCC AGTCCGCTTA CTGCTGCTGG AAGCAAGTCG AGATCAATAC
2 7 1 3 0  2 7 1 4 0  2 7 1 5 0  2 7 1 6 0  2 7 1 7 0  2 7 1 8 0  2 7 1 9 0  2 7 2 0 0
GATAGCATCG GGCTTTGGCC ACTTGGGACC AGCAAGTAAA ACCATACAAA GGTGCTGTTC ACGCGCACAG TGCATCCATC
2 7 2 1 0  2 7 2 2 0  2 7 2 3 0  2 7 2 4 0  2 7 2 5 0  2 7 2 6 0  2 7 2 7 0  2 7 2 8 0
AGTGCAACTC CGCACCACGC CATCATCAGC AACACACCCC CTAAAAAAAA AAACCCAGTA TTCCTTCCAT GACACGTCAC
2 7 2 9 0  2 7 3 0 0  2 7 3 1 0  2 7 3 2 0  2 7 3 3 0  2 7 3 4 0  2 7 3 5 0  2 7 3 6 0
TCATCTCATC TCATCGCATT TTTGCATTCC TGCATCGCTT GCATCCTCCG CCTAACCGCA CAAAATCACA CACTAACTAT
2 7 3 7 0  2 7 3 8 0  2 7 3 9 0  2 7 4 0 0  2 7 4 1 0  2 7 4 2 0  2 7 4 3 0  2 7 4 4 0
TTTCGATACC CGAATCAAAT ATTAACTATA TTTGAATCCT TAACTTTGTC AATCGAAAGA ATCTTTTGCA TCTGAAAAGA
2 7 4 5 0  2 7 4 6 0  2 7 4 7 0  2 7 4 8 0  2 7 4 9 0  2 7 5 0 0  2 7 5 1 0  2 7 5 2 0
AAGAGCACTA AAGTCAAAGA TAGATCGGAA TTAAAACGAA GTTGCAACAA GAAGTGCATA ATCAGATATT TCGACTGAAA
2 7 5 3 0  2 7 5 4 0  2 7 5 5 0  2 7 5 6 0  2 7 5 7 0  2 7 5 8 0  2 7 5 9 0  2 7 6 0 0
TAAGCTATTT AAAATATTTA AAAAATATTT CAAACATATC TTGTAGTGTG TGCTTTTGTG TGTGTTGCTT TGTAAAATCC
2 7 6 1 0  2 7 6 2 0  2 7 6 3 0  2 7 6 4 0  2 7 6 5 0  2 7 6 6 0  2 7 6 7 0  2 7 6 8 0
TTTGTACTTT AGTTGAAGTT GATTTTGTTC CGCTGTTCCT TAGAAATGTA TTTATGATTA ACCATAGCTA CAAACGTTGC
2 7 6 9 0  2 7 7 0 0  2 7 7 1 0  2 7 7 2 0  2 7 7 3 0  2 7 7 4 0  2 7 7 5 0  2 7 7 6 0
TCCTCCAGAT TGTTGCCTAG AGTTTTCATT TGCTGACGCT GCTGTCGCCT GTCGCCCGTT GCCTCCTGCC TGCCTGCTCT
2 7 7 7 0  2 7 7 8 0  2 7 7 9 0  2 7 8 0 0  2 7 8 1 0  2 7 8 2 0  2 7 8 3 0  2 7 8 4 0
GCTCCTGCCT CCTGGCATCC CGCATCCTGC ATCCTGGCAC CTGCCAACCG ACACCTGCTC CTCCCGACCC AACCGTAGCA
2 7 8 5 0  2 7 8 6 0  2 7 8 7 0  2 7 8 8 0  2 7 8 9 0  2 7 9 0 0  2 7 9 1 0  2 7 9 2 0
TCTAACCCGC CCGCTAATAA TCTTCACTTC CGTCAGTGAT TGTCCGTTCT GCTGTCGCTT ACTCTACCAA CTCTATAGTA
2 7 9 3 0  2 7 9 4 0  2 7 9 5 0  2 7 9 6 0  2 7 9 7 0  2 7 9 8 0  2 7 9 9 0  2 8 0 0 0
GGTCAGGGGT TAGCCAATAT ATATGCATAT ATATCTTTCT AGAAGATTTG AAGATAGCGA TTTCACAAGA TCTGATAAAG
2 8 0 1 0  2 8 0 2 0  2 8 0 3 0  2 8 0 4 0  2 8 0 5 0  2 8 0 6 0  2 8 0 7 0  2 8 0 8 0
TGTTTGGATG ATACATCACA TCAATTTGTC ATTTGTAATC AGCAAAAGGC GCTAATCAAA AATTTCACCA CTTGTACGCT
2 8 0 9 0  2 8 1 0 0  2 8 1 1 0  2 8 1 2 0  2 8 1 3 0  2 8 1 4 0  2 8 1 5 0  2 8 1 6 0
TGGGCTATTA AAACCCTAGA AGTTTCTGGA GGTTGAATTA AACAATTTAA TTGTTTGAAA GAACAAATGT AGTTTTTACT
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28170 28180 28190 28200 28210 28220 28230 28240
TGCATAGATA TTAAACTCAC TCAACATTTT GGTCATACGT CGTTTTAGAC GAATCACACC TGTAGTTAGG AAGCCCCACA
28250 28260 28270 28280 28290 28300 28310 28320
TGGAGAGCCC ACAGCTGTAC TGCAGATAGG GTTACAGATA GGGATACGCT GATATAGATA CGCCTGGTAA TTGTTTATTT
28330 28340 28350 28360 28370 28380 28390 28400
AAAGTCGAGG CGTGTGCGAT AACAGACCCA ATAAGTGCAT TTGTGGGTGC AAAATGTTTG TCTTCAATTA CAAATTCAAG
28410 28420 28430 28440 28450 28460 28470 28480
ACTCGAATTT ATGAAATGCC AGCAGAACTC AAAACACTTT CATGCACGTT TCGAGTTTTT AGCTGTTTGT CTATTTGTTT
28490 28500 28510 28520 28530 28540 28550 28560
AATTGCCGGC AATGGTGACG TAAACATAAT TATAAACAGA TTATATCAGA GCATGTTTAT AAAATAGTCA AATTACCAGC
28570 28580 28590 28600 28610 28620 28630 28640
TGCAAATGGG CTAATAACTT GTTATTACTT CGTCATGCTT AGTTACATAT GGAAAATAGG TATTAGTAGT AGTATTATTA
28650 28660 28670 28680 28690 28700 28710 28720
TTATTATTTC ATTCAATAAC AGCTTGTAGT CATATCGGAA ATATTTAAAC AATTTGAAAC TGGCGGCGTT TGTGGCGAAA
28730 28740 28750 28760 28770 28780 28790 28800
TATTTGGAGT CTTTCATGGC CCTAAAAATT ATAGAGTTAA TAGCATTGGG AGATGCATCG TTTCTTGCAC CATTTCTCGC
28810 28820 28830 28840 28850 28860 28870 28880
CTCTCTCTCT CTCTCCGTCT CTTTTTGAAT ATATATAATT AAAAATTCGC ACCTGCCTCA TCCTACATAT ATATACATAT 
Start of 297 element
 I • • • J ^ J - . I . ;  :.:.- I I — • I  ^ ^  L ,- ■ I
28890 28900 28910 28920 28930 28940 28950 28960
ATATATATAG tTAAAATTGTT GTTTTATTTA TGAGTCGAAC TAATGTCCCGTCAGTTGACT AAGGACAACG CCAAGAAATA
-T .r r r r ;!— 1-T7~1T7T.1 :v: : i 7 .: y ::. : i . . i
28970 28980 28990 29000 29010 29020 29030 29040
.TAGTT TTTAGGAGAA ATAGTTTCAC GACTTTATTC TTTGGATCTC AGCTTAAGAC TAAAAATCAA ATGCAAATTG
r : r r | T 7 r : r T n q 7 r : r T r 7 7 r 7 r : r  7 7 7  | 7 7 7 7 | ^ 7 7 7 | 7 7 7 " i ~ 7 7 i ~ 7 r r i ~ ' . : :  i : : \ ~ : . :  / |  r r . v i
29050 29060 29070 29080 29090 29100 29110 29120
GATTGAGGAG AAGCCTCAGT ATTTGAACAA TATTTGTATT TCGGGAGAGC CTCGCTCTTG GGTTCTTAAG ATTAGGTAGC
I ' . : . .  I. r;; ; ; r . 7 . f7: : . 17  7 7 | 7771
29130 29140 29150 29160 29170 29180 29190 29200
G T T G A A A G A G  G G C A G T C A A A  T C T G C T T A G G T C A G G C T T T A  GGAT GT T T A C  A A G A A C G G C T  G C G C TG C C A A  A G A T A A A C G A
I • I 7 :[7771777177771 ”:77.17:7^-777717777r777rr.77 : f  7 .7 '. 17 7771 '77'77 ] 77771
t 29210 29220 29230 29240 29250 29260 29270 29280
kT G T T G C G C A  G C TG G G A TA C  G T T A T G G A A A  A T T A C T A G A G  T G C A T T A C T G  A T T T C T T T GA  A A T A A T G G A A  G T G G C T G G T T
[-777177771 7.7:r77:i“777:|77.Tr7r.77177'^7777^7717777177 '• '-'I’ • -1 • *7 • I • 77-1777 |
[ 29290 29300 29310 29320 29330 29340 29350 29360
JTGGACCACCC TG G G C TG G G A T T G A T G G A T A  T A G T G T G G G A
p 771 — 7|— ^ITTT'l’TTTTlTT I^ 7. 7  | 7.77 |7  7; 11777|"7777177771”777717::. | "7 .. | : |
f 29370 29380 29390 29400 29410 29420 29430 29440
k A T G G A G T T T  C T T C T A T T T C  .T G T T T G T T G T  G G T G T G T T T T  G A T T T T G A T T  J T T T T C T T A T T  T T A A G T T T T G  C A T A C A G C A T
-7 :r| .. 771 777 71 :::7|77  . 1 7 7 : 17 .:.  I 77 :. 17771 77771777T7777[. . .  . | .77 . | 77 7|
| 29450 29460 29470 29480 29490 29500 29510 29520
C A T A A A T G G T  T T A A A T G A T A  C A T A T C T T A A  A T A T G A G T A C  A A C A A A A T T A  G T G C G A T T A T  T A C A A T G A T C  A T T T G T A T G T
•77] . . . . 1 7 7 1  7 7 7 |:  7.71 7  7 7  1 77:7 f  7.7 7|: ;77|"777717777T-777'1'
29530 29540 29550 29560 29570 29580
r : 7 : T 1 7 _ ( , 
9590 29600
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^A G TG T R A T 'A T TGTTCTCT~~~Sg^TC&TCT CAACAATGTC GTTGTGTTTT ACAATTTTTA TTTTTGTTAT"ATTAAGTGGT
p^l77.Tr:^TlT:7Ti’-~:T| :::ti 777:1 t t v t i  77 j::::  |7 7 7 7 |7 7 7 tt7 :tt7 7 :t~ ::
29610 29620 29630 29640 29650 29660 29670 29680
PTGTATAGTG GTGTCAAATC TATTTCTGGT TCTAACAGAT TTTCACTTAA ATTATATTAT TGATTTCTAT TTTGCATTGC
r rr r \T 7 :7 r 7 7 :r .-7 :r r . :. i . :: : r . . ::  I.:: 'r 7 7 i 7 7 T |7 7 :. i 7 .7 1 7  • :"1‘• -7
| 29690 29700 29710 29720 29730 29740 29750 29760
GTTACTCTTA TCATTTTGTT TCCTTCTATT TTTATTTTAT TAATTGAATT TTGGCAATTT TGGTTAAGAA .TTGTTTGGGT
;;r .tj . :r ; i . i ; i . 7. . |
29770 29780 29790 29800 29810 29820 29830 29840
rAAGTTCCAG GTTACAATTG TGTTTGGTTC TATGTATTTT ATTATTTCGT TCGTGTGTAC TGGCTTAAAA TTACAAATTG
[771777]— .. |777 | 7 .. 7 |. .7 7| . . . .  17.77 | . . . :  |7 7 7| 7 7 7 | 7 7: f 7 7 : f 77 f 7 7 7 ]7 7 7 |
j 29850 29860 29870 29880 29890 29900 29910 29920
PATTTAAGTG TTTAATAATA T T G G T G A C A C  A T T C A T T T T T  T A C T T C T T T A  T T T T C G G T A T  T A T A A A C T T T  A T T T T C T T T T
77.7177:717777177 7| '777  f'..7." | 7 .7  f. 7  : r 7 7 : !7 7 7 f  7777|777| 7 .. : f . . 7T 7:7 |7  7 7 |
[ 29930 29940 29950 29960 29970 29980 29990 30000
JTC AAA ATA TG  A T T G T G T G T C  T G T G T A A T C T  A G C T G A T A G C  C G TTG G A G T C  TG G G TA A G G A  A T T A T T T T A A  T T G T G C T T A T
[77”| 7 : 7| .7 7  I 7 7 V 7  7 17 .71 7  7 17 7 1  7 771. . 71 ".7: | 777: rr77|777T77:7T777T_„
[ 30010 30020 30030 30040 30050 30060 30070 30080
jTAG TG AAA G G  T A A A T G G G T A  T G TGG G A T A T  G A T T A A T A C T  T G G T T A T C A T  T G T A G T T A A T  CCAAGTGGAT G T T T T A A T G T
p 7 I 7 7 7 T 7 7 7 T 7 7 7 |" 7 |7 7 7 |" :7 7 : | :7 7 T 7 7  7|77 1 7 7 7 1 7 7 7 7 7 7 7 7 1 7 V7 ] 7 7 7 |777T^
I 30090 30100 30110 30120 30130 30140 30150 30160
[PCAAAATGTT TTGGCTGTTC ACATTTTCAA GTTTGTCGTA GTTTAGTAAT TTGGGGTTAA ACAGTCCAAG TCTGGAAAGC
77 7|777717777177:i77777[7T7T177T7]777[77T7177Ty7777177771 7 :7 1 7 :7 1 7 7 7  [777T
j 30170 30180 30190 30200 30210 30220 30230 30240
FGCATAGCCA TTTCCAAATC TTCTATGTAT TCCGTAAACT GCATTAGTTC GAACAAAAGA CTGTCAATGA TGGTGTGGTT
. 771. • • • 1777.17: 7  | 7 : . .  | 7  7  | '. . 7 . 1 777 | .. 7 | . 7.. f 7 7 .  | 7 .  7|7 7 7 1 7  . 1  . .: 1777 . |
I 30250 30260 30270 30280 30290 30300 30310 30320
A T T T T C A T A A  T T C T G T A T T T  T T T G C A T T C C  G T C A T T T A T C  A A T C G T A T G G  C G T C G TT G A G  T T C A T G T A A T  T T T A C T G A G T  ^
[. 77T. 77 | 7 .. 1 .  .77| 7.7. | 7 . . 1  . . .  . | . . .  7]77717777 | 77771777177717771 77771 7  :Z\ _
30330 30340 30350 30360 30370 30380 30390 30400
y A T G G A C G T T  G A T T T C A A GT  T T T T T C T G T A  T T T C G A C T C G  A T C A T T T T C A  T C T A G TG T T C  C A A A T A G G T A  T T T A A A A C C T
p7T177777'^T77T777:7|--7r77T177-7T|~7771777T-r--T77Ti777 '^-7777TlT77Tr^T77T77.' 7| 77 71 7. 77|
30410 30420 30430 30440 30450 30460 30470 30480
G A A C C C A C A A T G T T A A T A A G  A C C C C G T T T G  T T T C T A T G T T  T C A G G G T T A T  T C C G G C T A G T  T C T C T T T T T A  T T T T A T T G T A
7177771— 177771 . 7. . | . . .  1 . . . .  |777T|— :T 77" |’7777f777TT. 71'. 77T 7' .7 | . V 7 T _
30490 30500 30510 30520 30530 30540 30550 30560
■VAAAAAATTG  A T C TG G G G T G  C A T G G T A A T C  G G T T C G T A G T  C T T T G C T C A A  A A T A G T C A A C  C A C G A T G T C T  A T T T C A G T T A  ”
I. . . .1 . 7 . | . .7.1 | . 1  . . . I . . . . ]  . . . 1 . . . . 1  . . . . ) .  ...1 . . . 1 7 . 1  7.71. . .71 _
30570 30580 30590 30600 30610 30620 30630 30640
TTGATTTT TAAGGAGTGA TGTTCAAAGG AGGATGGTAT CTGTACTGGC TTATCAGAAA AAAGGAGATA TCCGTGGTTG
7 7| 7:. 71 7 . . .  17 7. [ 7. .  1 . 7 .  | | .. . . | . . . . | 7  771777T 7 7 . . | 7. 7.1777.] . .  : 7 f_
30650 30660 30670 30680 30690 30700 30710 30720
GTGTCAATAT TATTAATTTG AATTTGTTGT CCATGAACAG CTGTGATCAG TATAAACAAT AGTGTTATCG GGTACCAGGT
7771771 . . . 17 . . 7T . . . 7 | . . . 7 |  7 . .  |7. . 7 f  7:71 7777T7771. 7  .1 777: | 7 : 1 7 7 :  7| .7 .7|
30730 30740 30750 30760 30770 30780 30790 30800
3CCTGTGAAA TTGAGAGTTT ATTATTTTTC TTTTGTTTTT TGAATTGTGT TTTGTAGTAG TGCGTAACTC TATTTCTATT
F: • •••l . ~ T ~ n ~ ~ i r 7 .  : y : : : .  i .. ~ r : : :  : \ " r n r n y r T T — r :: : : !  r : : : y30810 30820 30830 30840 30850 30860 30870 30880
AGTGATTTTG TAATGGTCAG GGTCTGTTTG TTCTACATTT TTGGTTGGTT TAAATGGGTT TTCTAATTTG CCTTTCTGTA
, 771.7.1 7 7 1 7 . 1  7 : 7 . 1 7 7 . 177 7 1:7:7|
30890 30900 30910 30920 30930 30940 30950 30960
5TGGACCTTT TCTGTAATTA GTGTCAATAT TAAATTCCTG TCTGTCTTCA TTTATTTTGT CTATTTTCTT CTCTTTAATT
:i7T77'7:T:77:7]77:7i::7::;i7 .71 .. 71. . . . .  1 . . 7 1 7 .  T 7 . 7  | . ..7] 77.17.71 777.177771'
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3 0 9 7 0  3 0 9 8 0  3 0 9 9 0  3 1 0 0 0  3 1 0 1 0  3 1 0 2 0  3 1 0 3 0  3 1 0 4 0
{TTTTGAGTGT CTAATATGGG ATGCCCAGCG■TATAAGAAAA T T T G A G C A G G  T G T C T G T C C A  G T A G T G T C A T  G T T T A A T T T T
i v . t . i  . . . . p . / : i  . : . : p 7: : i
3 1 0 5 0  3 1 0 6 0  3 1 0 7 0  3 1 0 8 0  3 1 0 9 0  3 1 1 0 0  3 1 1 1 0  3 1 1 2 0
.T G G T T G T A T  G TG T A G A G G A  T T G T T T C T A T  C T T G C T T A A T  T T T A C T T C T T  C A T C A T C A G A  T G A A T T G A T T  A T A C G A A T T T
7 r : : : : r : : .. ... i v r . T , " " - i \ i . . . ' i t t t t l
3 1 1 3 0  3 1 1 4 0  3 1 1 5 0  3 1 1 6 0  3 1 1 7 0  3 1 1 8 0  3 1 1 9 0  3 1 2 0 0
T T C A T T T A T  T G T T T T G T G T  A A T C T T T C G A  C G T C T G C T A C  C C C G T T T T T T  G C T G T A T T G A  G C T G T A A T C C  T A C C G A C T G C
[ ~ ~ T 7r:''ri —  . r . v r . i  . . . . p . : : i  : . . . | . : . . f  : - - - 1: :  - -1 . . . . | . 77: p
3 1 2 1 0  3 1 2 2 0  3 1 2 3 0  3 1 2 4 0  3 1 2 5 0  3 1 2 6 0  3 1 2 7 0  3 1 2 8 0
P C C A G T A A A A  T T G T T G T T T T  A T T T A T G A G T  C G A A C T A A T G  T C C C G T C A G T  T G A C T A A G G A  C A A C G C C A A G  A A A T A A A A A A
p :• r : : 7| 7 . 7 . p . .  .7 1 : 1  . . .7| . 1 . 7 . 7 p  7 . . :  1 . . ; . |  . . . .  1 . : . .  1
3 1 2 9 0  3 1 3 0 0  3 1 3 1 0  3 1 3 2 0  3 1 3 3 0  3 1 3 4 0  3 1 3 5 0  3 1 3 6 0
T A G T T T T T A G  G A G A A A T A G T  T T C A C G A C T T  T A T T C T T T G G  A T C T C A G C T T  A A G A C T A A A A  A T C A A A T G C A  A A T T G G A T T G
' . . :viv. .7r : : v . | : . v . |  vvr. | . : .vi  ; . i ; ; . : i  . : . . i . . . . i : ; j . ; . : |
3 1 3 7 0  3 1 3 8 0  3 1 3 9 0  3 1 4 0 0  3 1 4 1 0  3 1 4 2 0  3 1 4 3 0  3 1 4 4 0
W3GAGAAGCC T C A G T A T T T G  A A C A A T A T T T  G T A T T T C G G G  A G A G C C TC G C  T C T T G G G T T C  T T A A G A T T A G  G T A G C G T T G A
p : \ \— \ . :7:r. -.: i : i v::vi : : y . .: rp  : : r .  i : . y • I • . r : .  : : y . . . :  p .: . 7 | . /|
3 1 4 5 0  3 1 4 6 0  3 1 4 7 0  3 1 4 8 0  3 1 4 9 0  3 1 5 0 0  3 1 5 1 0  3 1 5 2 0
AAG AG G G C AG  T C A A A T C T G C  T T A G G T C A G G  C T T T A G G A T G  T T T A C A A G A A  C G G C TG C G C T G C C A A A G A T A  A A C G A A T G T T
[•• • • I • • T • • • : r .7.- |  . : . 7 | ; : i  : 7 . : i . .v.y : . . : r .7: . |  7 :7 :p : : .  | " : . 7. p . . 7.1 ~ 7:1
I 3 1 5 3 0  3 1 5 4 0  3 1 5 5 0  3 1 5 6 0  3 1 5 7 0  3 1 5 8 0  3 1 5 9 0  3 1 6 0 0
G CG CAG CTGG  G A T A C G T T A T  G G A A A A T T A C  T A G A G T G C A T  T A C T G A T T T C  T T T G A A A T A A  TG G A AG TG G C  T G G T T T G G A C  
E n d  o f  2 9 7  e l e m e n t
C77P777TT777IT:77| , . . . p . . . |  , . . . p . . . |  , . . . p . . . |  . . . , p . . . |
| 3 1 6 1 0  3 1 6 2 0  3 1 6 3 0  3 1 6 4 0  3 1 6 5 0  3 1 6 6 0  3 1 6 7 0  3 1 6 8 0
fZ A C C C A A A T A  C G T C A C T A T A  T A T A T A T A T A  T A T G C A C G T A  T A T A T C T A T G  G A C G A G G A TC  G T A A A C  C A T  A  C C T A G A C A T A
. . . , P . . . |  . . . . P - . - l  - . . . P . . . |  . . . . P . . . |  . . . . P . . . |  . . . . p . - . |  . . . . P . . . |
3 1 6 9 0  3 1 7 0 0  3 1 7 1 0  3 1 7 2 0  3 1 7 3 0  3 1 7 4 0  3 1 7 5 0  3 1 7 6 0
T T G A A T C G C T  T T A C C G G C T A  A G C A G C T A A T  C T T T A A G G G A  C G C A C C T A A T  G T A T A T A T A T  C T T G T A T A A C  G A T C A T A A T T
. . . . P - . - l  . . . . P . . - I  - . . . P . . . |  . . . . P . . . |  . . . , p . . . |  . . . . p . . . |  , . . . p . . . |  , . . . p . . . |
3 1 7 7 0  3 1 7 8 0  3 1 7 9 0  3 1 8 0 0  3 1 8 1 0  3 1 8 2 0  3 1 8 3 0  3 1 8 4 0
G C A G G C A TA T A G C A T C G G T C  T G T T G C G A T C  C G A C T A T A T G  G C A C A C G TG T CCGAGG GCTG  T G C G A T A A A G  C A G G TC G A G A
. . . . P - - - I  -I . . . . | . . .  -|
3 1 8 5 0  3 1 8 6 0  3 1 8 7 0  3 1 8 8 0  3 1 8 9 0  3 1 9 0 0  3 1 9 1 0  3 1 9 2 0
T C A A C A C G G T  G G C C TC C A G T TT C G C T G G C A  T A G C C A C C C A  A T T G G T G C C G  C A G C A G A A G T A T T A A G C G C T  C T T C T C T C T A
, . . . p . . . |  . . . . p . . . |  . . . , p . . . |  . . . . p . .  . |  . . . . p . . . |  , . . . p . . . |  , . . . p . . . |
3 1 9 3 0  3 1 9 4 0  3 1 9 5 0  3 1 9 6 0  3 1 9 7 0  3 1 9 8 0  3 1 9 9 0  3 2 0 0 0
T C T C T T T C T A  C A T A T A A T A T  A T A T A A A T A T  A T A T C T A T C A  A A C T A C A T A T  A T T C C T T T T A  C C A A A C G C A C  G A A T G C A C A A
. . . .  P - . - l
3 2 0 1 0  3 2 0 2 0  3 2 0 3 0  3 2 0 4 0  3 2 0 5 0  3 2 0 6 0  3 2 0 7 0  3 2 0 8 0
TG C A C A C A C C  T A A A A G C A A A  A G C A C A C T A C  A C A C C T G T C C  T A A T A T C C T T  C C A C C C A A C T  C C T T C T C C T T  C T C A C T G A T C
. . . . | . . . . |
3 2 0 9 0  3 2 1 0 0  3 2 1 1 0  3 2 1 2 0  3 2 1 3 0  3 2 1 4 0  3 2 1 5 0  3 2 1 6 0
A C T T A T C C A C  C T A C A G A G G T G C C A T C T C T A  T C G T T T G T T G  T C T C T T T C T G  C A T G T G T T T T  T T T T T T T T T T  A A T T G G T T A T
3 2 1 7 0  3 2 1 8 0  3 2 1 9 0  3 2 2 0 0  3 2 2 1 0  3 2 2 2 0  3 2 2 3 0  3 2 2 4 0
G G C T C T A T C C  G T C T C T T T C C  A C A C G C T G T A  G C T T C A T A A C  C C C A C T T C C A  C A A T T T C C C T  A A C C A T A A A C  A T A C A T A T G T
. . . . | . . . . |  . . . . | . . . . |
3 2 2 5 0  3 2 2 6 0  3 2 2 7 0  3 2 2 8 0  3 2 2 9 0  3 2 3 0 0  3 2 3 1 0  3 2 3 2 0
A T A T C C A T C C  G C C C A T T T G A  G A G G T T T T G G  T C T C A G T A A T  T A A C C C A A A T  T T C A A C C C C C  C C C C C C A T T A  C C A C C G A A C A
 |  |
3 2 3 3 0  3 2 3 4 0  3 2 3 5 0  3 2 3 6 0  3 2 3 7 0  3 2 3 8 0  3 2 3 9 0  3 2 4 0 0
T T T G T T G T T G  T T T G T T G C T G  T T G T T G G T C G  C T G A A A G A C T  G C G G A A T T A T  G C T A A T G T C T  G T C T C T T T C T  G T T C C G G C A C
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3 2 4 1 0  3 2 4 2 0  3 2 4 3 0  3 2 4 4 0  3 2 4 5 0  3 2 4 6 0  3 2 4 7 0  3 2 4 8 0
T A C C C G T C T C  T T T C G C C C G C  G C A G A T T C G T  A C TC A G C G A G  C TG G G A C ATG  C G G A T A A G C T  G C A C A A T G T G  A G T A T A T T A A
3 2 4 9 0  3 2 5 0 0  3 2 5 1 0  3 2 5 2 0  3 2 5 3 0  3 2 5 4 0  3 2 5 5 0  3 2 5 6 0
A C T A A G A T A T  A T A A T C T A T A  T A T A T A T A A A  C A T A T A T T C A  T A T A T A T A A T  A A T T A T A T G A  T C T G T G T T T C  C T G T A C A A T A
3 2 5 7 0  3 2 5 8 0  3 2 5 9 0  3 2 6 0 0  3 2 6 1 0  3 2 6 2 0  3 2 6 3 0  3 2 6 4 0
A A C C A T G A G T  A A C A A G A C A A  C T T A A A T G A T  A A T G T T C G T T  A T T C C G C T G C  A G A TG C C G G A  T A A C A A T G C A  CTG G CC G G AC
3 2 6 5 0  3 2 6 6 0  3 2 6 7 0  3 2 6 8 0  3 2 6 9 0  3 2 7 0 0  3 2 7 1 0  3 2 7 2 0
TC TG C G A TG G  C A TG G TG A A G  G CG TG G G A C A T C T A T G C A A A  GCCGCAGG CC G T C A T T C T G T  T C A T C A T C G A  G G A T G TG TC G
3 2 7 3 0  3 2 7 4 0  3 2 7 5 0  3 2 7 6 0  3 2 7 7 0  3 2 7 8 0  3 2 7 9 0  3 2 8 0 0
T A C A A C A T T T  G CG ACC AG CG  G TTC C A C G A G  T T C T A C A T T C  G C G A G A C A TA  T C C G C A C A T C  A A G G T G C T G C  G C C G C A C C C T
3 2 8 1 0  3 2 8 2 0  3 2 8 3 0  3 2 8 4 0  3 2 8 5 0  3 2 8 6 0  3 2 8 7 0  3 2 8 8 0
C A C C G A G G TC  CATCG G GAG G  G C AA AC TG G G  C C A G TC C A A G  G A G T T G C T C C  T G T A A G T G T A  C A T T A A T A C C  T C T A T T A T C A
3 2 8 9 0  3 2 9 0 0  3 2 9 1 0  3 2 9 2 0  3 2 9 3 0  3 2 9 4 0  3 2 9 5 0  3 2 9 6 0
T T C A T C A T T G  A A C T G T G T G C  T C A A C T C A C A  C G C TTG C C G C  A C C A C A G TG G  A T C C C A A G A G  G TG G C C G T C A  T C T A C T T C C G
3 2 9 7 0  3 2 9 8 0  3 2 9 9 0  3 3 0 0 0  3 3 0 1 0  3 3 0 2 0  3 3 0 3 0  3 3 0 4 0
A G C T G G C T A C  G AG C CC G G AC A C T A T C A C T C  G CAG G C G G AT TG G G ATG C C C  G C T A T C T G A T  G G AG AC C TC G  C T G G C C A T C A
3 3 0 5 0  3 3 0 6 0  3 3 0 7 0  3 3 0 8 0  3 3 0 9 0  3 3 1 0 0  3 3 1 1 0  3 3 1 2 0
A G TG C C C G TC  G A T T C A C T A C  C A TTTG G C G G  G C A C C A A G A A  G G TG CAG C AG  G C ATTG G C G C  AG CC G G CG G T G C TC G A G C G T
3 3 1 3 0  3 3 1 4 0  3 3 1 5 0  3 3 1 6 0  3 3 1 7 0  3 3 1 8 0  3 3 1 9 0  3 3 2 0 0
T T C A T C A A C G  A T C C G G A G G A  G ATC AAG G C G  G TG G G C AA G A TC T T C A C G G G  T C T C T A C T C G  C T G G A C G A C A  AC GAGG CG GG
3 3 2 1 0  3 3 2 2 0  3 3 2 3 0  3 3 2 4 0  3 3 2 5 0  3 3 2 6 0  3 3 2 7 0  3 3 2 8 0
C A A TG C C A G C  T A C G A G A TG G  C G CTG C G C AC TC C G G A G AG A T T C G T G C T G A  AG CC G C AG CG  CGAGGGAGGC G G C A A T A A T G
3 3 2 9 0  3 3 3 0 0  3 3 3 1 0  3 3 3 2 0  3 3 3 3 0  3 3 3 4 0  3 3 3 5 0  3 3 3 6 0
T C TA C G G C G T G G A T A T A C C A  G A T G C A C T A A  A G G T G A G T T A  T T C C A C T T T G  A T G A T T A T T T  G A A T T G T G A A  C A G T T T T G T A
3 3 3 7 0  3 3 3 8 0  3 3 3 9 0  3 3 4 0 0  3 3 4 1 0  3 3 4 2 0  3 3 4 3 0  3 3 4 4 0
A C A A A T C C T T  C T C C T T C T T T  A T C C A T C A G C  G C A T G TC A C G  CGTG GAGCGC T C C G C C TG G A  T T C T G A T G G A  T C T G A T T C A T
3 3 4 5 0  3 3 4 6 0  3 3 4 7 0  3 3 4 8 0  3 3 4 9 0  3 3 5 0 0  3 3 5 1 0  3 3 5 2 0
C C G C C G C TG A C C A A G G G C TA  TA TG G TG C G G  CCCGGTGGCG A T A T G C C G C C  C C A G A TC G T G  G A C A T G G T C T  CC GAGC TG GG
3 3 5 3 0  3 3 5 4 0  3 3 5 5 0  3 3 5 6 0  3 3 5 7 0  3 3 5 8 0  3 3 5 9 0  3 3 6 0 0
C A T C T T C G G T  G TG G TG A TC G  G AG A TG C G G A G C A C A T T G T G  C A C A A C T A C C  AG G C G G G AC A C A TG C TG C G C  A C A A A G C T C T
3 3 6 1 0  3 3 6 2 0  3 3 6 3 0  3 3 6 4 0  3 3 6 5 0  3 3 6 6 0  3 3 6 7 0  3 3 6 8 0
C A A C C G C C A A  CG AAGG AG GC G TGG CAGC CG  G TCTG G G C G C C C TG G A C A G T C C A T A T C T G A  T C G A T A G C G A  T G A C G A G G A T  
End of distal DmGS copy
p 6 9 0  3 3 7 0 0  3 3 7 1 0  3 3 7 2 0  3 3 7 3 0  3 3 7 4 0  3 3 7 5 0  3 3 7 6 0
G A G C A G A A G T A G G A T C C T T T  A A C G A G A T A A  A G G C T T C G A A  C G C C G G C A TT C C A C C T G T T G  C C T C A G T C T T  G T A T A A A T G A
3 3 7 7 0  3 3 7 8 0  3 3 7 9 0  3 3 8 0 0  3 3 8 1 0  3 3 8 2 0  3 3 8 3 0  3 3 8 4 0
T T A T T T T T G T  A A A G C G T A T T  G T A A A T T T T T  T G C A C T A T T T  T T T C C C C G T C  C C A A T G T C A A  T A A A T A A A A T  G T T A A A C T A G
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Point of duplication
3 3 8 5 0  [3 3 8 6 0  3 3 8 7 0  3 3 8 8 0  3 3 8 9 0  3 3 9 0 0  3 3 9 1 0  3 3 9 2 0
A A A T T C T G G T  C A A T A T G C A A  A C T A T G C A A A  A T A T G C C A G G  C T C A A C G T T T  T G A T C A A A A A  C A T G A A A G T C  C T T C G A A G T G
3 3 9 3 0  3 3 9 4 0  3 3 9 5 0  3 3 9 6 0  3 3 9 7 0  3 3 9 8 0  3 3 9 9 0  3 4 0 0 0
A G T G T C T G A A  TG CC CAG G CG  G A G A T C A A A A  G C A A G G A C A T A C A A A T A C A A  TTG AG C G C G G  C A A A G A T C A A  G C A A A T G A G C
3 4 0 1 0  3 4 0 2 0  3 4 0 3 0  3 4 0 4 0  3 4 0 5 0  3 4 0 6 0  3 4 0 7 0  3 4 0 8 0
A A C G A A C T G G  TG A C G C A G T G  CAGC CG CC AG  G A C A C G TG T C  C C ATC G A C G G  C A AA G G TG G C  A T C T A T A A G C  T G A A G A T C C G
3 4 0 9 0  3 4 1 0 0  3 4 1 1 0  3 4 1 2 0  3 4 1 3 0  3 4 1 4 0  3 4 1 5 0  3 4 1 6 0
T G A A T T G C C A  G C A T TC G A G G  C G CC G TG C AG  TT C C A A C G G C  T G G T T G A C C A  T A C A G A A A C G  A T A C G A T G G C  G C C G A G A A C T
3 4 1 7 0  3 4 1 8 0  3 4 1 9 0  3 4 2 0 0  3 4 2 1 0  3 4 2 2 0  3 4 2 3 0  3 4 2 4 0
TC G A TC G C G G  T TG G A A G G A C  T A C A A G G A T G  G TTTC G G A C G  C G TG AG AG G T G A G T T T T T C A  TC G G C C TG G A  G A A A G T G C A C
3 4 2 5 0  3 4 2 6 0  3 4 2 7 0  3 4 2 8 0  3 4 2 9 0  3 4 3 0 0  3 4 3 1 0  3 4 3 2 0
C T T A T G A C G C  G G C AAC G ACG  C C A C G A A C T G  T A C A T T A A G C  TG G G C A A G A T T G A TG G C A C C  A C T A G C C A C G  C C C A C T A C G A
3 4 3 3 0  3 4 3 4 0  3 4 3 5 0  3 4 3 6 0  3 4 3 7 0  3 4 3 8 0  3 4 3 9 0  3 4 4 0 0
C A A C T T C G A A  CTCG GCGGCG A G A T T G A A T C  C T A T G A G C T A  A A G T C A C T G G  G C C G C T A C A A  TG G C AC AG C C  G G C G A T T C T C
3 4 4 1 0  3 4 4 2 0  3 4 4 3 0  3 4 4 4 0  3 4 4 5 0  3 4 4 6 0  3 4 4 7 0  3 4 4 8 0
TG C G G C C A C A T G A G C G C C A A  A A G T T C A C C A  C C A A C G A C A A  G G A C A A C G A T G C C T A T C G G T  T C A A C T G T G C  C G C C G A C G A A
3 4 4 9 0  3 4 5 0 0  3 4 5 1 0  3 4 5 2 0  3 4 5 3 0  3 4 5 4 0  3 4 5 5 0  3 4 5 6 0
T A T G G T G G C T  G G T G G T A C T A  C G ATTG C G C C  A A G A G G T A A G  T A C G C C C A T T  A T A T A C A T A T  G G T A T A T A T A  C A T A T G T A C T
3 4 5 7 0  3 4 5 8 0  3 4 5 9 0  3 4 6 0 0  3 4 6 1 0  3 4 6 2 0  3 4 6 3 0  3 4 6 4 0
T G C A T G T A A T  A T T A A T C G G C  G G A G TA A C T G  C A G C A TG C T C  A A T G G C A A G T  T C T A C A A G G A  GGG CCGCTCG  C G G A A T G G A A
3 4 6 5 0  3 4 6 6 0  3 4 6 7 0  3 4 6 8 0  3 4 6 9 0  3 4 7 0 0  3 4 7 1 0  3 4 7 2 0
A A A C C A A T G G  C A T C C T G T G G  G G C TC C TG G C  A C A A C A A C G A  T T G G A C C T A C  T C G C T A A C C T  TC G T G G A G A T  G A T G A T A A G G
3 4 7 3 0  3 4 7 4 0  3 4 7 5 0  3 4 7 6 0  3 4 7 7 0  3 4 7 8 0  3 4 7 9 0  3 4 8 0 0
C C G C G A ATA G  A T T A G C T A T T  A C A G T A A G A A  T A A A A A A A T G  G C A C A A A T A A  A C G A A A A G G T  C T C A T T T G T A  A T C A T T A C A T
3 4 8 1 0  3 4 8 2 0  3 4 8 3 0  3 4 8 4 0  3 4 8 5 0  3 4 8 6 0  3 4 8 7 0  3 4 8 8 0
T C A A T T T C A A  T T A A A T T A A A  TA A C G G G C A C  T T A C T A A A C T  T T T C T C G C C G  T G T A T G C C C C  T G G T A T T T T T  T G A T G C C A T A
Start of proximal DmGS copy-
3 4 8 9 0  3 4 9 0 0  3 4 9 1 0  3 4 9 2 0  3 4 9 3 0  H ® ! Q  3 4 9 5 0  3 4 9 6 0
T T C T G G C A T A  T T G C G G T A T A  TC G C CG G C TG  G T A T T T T T T G  C C TA A C C C G C  T A C G C A C A C A  C T G C G A A T A T  T C G G C C A A A A
3 4 9 7 0  3 4 9 8 0  3 4 9 9 0  3 5 0 0 0  3 5 0 1 0  3 5 0 2 0  3 5 0 3 0  3 5 0 4 0
A C A T A G T T A T  A T T T T T G T C T  G T G G G C T T T T  A G A C A A A T T G  T A A A C T G A T A  G C TC C C G AC C  C C A G C C G T T T  A A C G G T G T C C
3 5 0 5 0  3 5 0 6 0  3 5 0 7 0  3 5 0 8 0  3 5 0 9 0  3 5 1 0 0  3 5 1 1 0  3 5 1 2 0
A A A T T G A C A G  TG C A A C C G G T G G AA C A G G TG  G AG C AC AAG C  AG C G G C AC C C  A G A A G G A A A C  C A G C G A TC C A  G T C A C A A C A A
3 5 1 3 0  3 5 1 4 0  3 5 1 5 0  3 5 1 6 0  3 5 1 7 0  3 5 1 8 0  3 5 1 9 0  3 5 2 0 0
T C G C T C G T T G  AG AG C G C A G C  G A T A A G A G T T  C C A G A G T T T C  T A G A G T T T C C  A G C G A T A C C C  AG C A G TG G TG  A G T A G C T A G T
3 5 2 1 0  3 5 2 2 0  3 5 2 3 0  3 5 2 4 0  3 5 2 5 0  3 5 2 6 0  3 5 2 7 0  3 5 2 8 0
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A G A C A G T C G T  C G C A C TG C T C  A G C A G T G C T C  A G T G C C C A G T  G A G C A G TTC C  G G C G AG C A G A C C C C G T G A G A  TA CCG CG G CG
3 5 2 9 0  3 5 3 0 0  3 5 3 1 0  3 5 3 2 0  3 5 3 3 0  3 5 3 4 0  3 5 3 5 0  3 5 3 6 0
A A C A A C T A A C  A A C T A A G A T A  C T C T G C C C C T  T T T C T A G A C G  CAG C TG AG C C  C C A G A T C C C A  G A T C C C A G A T  A C C A G C A G C A
3 5 3 7 0  3 5 3 8 0  3 5 3 9 0  3 5 4 0 0  3 5 4 1 0  3 5 4 2 0  3 5 4 3 0  3 5 4 4 0
G AC C G A C C C A A G C A G A A C G A  T C A T G T C C A G  C G A C G C C A A T AC G G CC G TG C TG C G C A A C T G  C A T C C G C T T G  CCGCTGGCGG
3 5 4 5 0  3 5 4 6 0  3 5 4 7 0  3 5 4 8 0  3 5 4 9 0  3 5 5 0 0  3 5 5 1 0  3 5 5 2 0
A G G A T G A G C T  AC TG G A G G TG  AC G G C C AA G G  C C A A G G A T T A  T G C C A T T A T G  CACG GCGCCG  C C A T G C G A T C  G AAG AC G G CC
3 5 5 3 0  3 5 5 4 0  3 5 5 5 0  3 5 5 6 0  3 5 5 7 0  3 5 5 8 0  3 5 5 9 0  3 5 6 0 0
TT C A G T C C G G  A C T C G T T G A A  T G T G G G T G A T  A C A A T G G G C A  C T C G C TA G TG  A G G G C T C G T A  T T C A T G C T A A  G G T G T C T A G T
3 5 6 1 0  3 5 6 2 0  3 5 6 3 0  3 5 6 4 0  3 5 6 5 0  3 5 6 6 0  3 5 6 7 0  3 5 6 8 0
T T C C G C T C A A  G A A G C T C A T T  T C A A T G G A A C  A A C A T T C A T T  A C A C A T C C C T  T A T C G A G T T C  A G T T C C T T T T  T A A G T T A T G T
3 5 6 9 0  3 5 7 0 0  3 5 7 1 0  3 5 7 2 0  3 5 7 3 0  3 5 7 4 0  3 5 7 5 0  3 5 7 6 0
G T A A T G C C A A  A T G T G A T T G G  A T G C T T G A G T  T T G T T T T T C A  T T T T A T T G A C  G G T A G A G A A A  G A T T A G C A A T  G T G A C G G T A T
3 5 7 7 0  3 5 7 8 0  3 5 7 9 0  3 5 8 0 0  3 5 8 1 0  3 5 8 2 0  3 5 8 3 0  3 5 8 4 0
A A G C T A C A C A  T T G G C A T T C A  A T C G A G C T T C  A A G C T A G C G T  G C T G C T G C T T  G A G C A A C A G T T T G C C A G G A T  A C T A A A C A T T
3 5 8 5 0  3 5 8 6 0  3 5 8 7 0  3 5 8 8 0  3 5 8 9 0  3 5 9 0 0  3 5 9 1 0  3 5 9 2 0
T T C A T T T T C C  A G T T C G C C C C  C T T C G T G C T G  G T G C C T T C C T  C G TTT C C G C G  C A A G G A G TT C  G AAAAG G C G G  T G G C C C T A C A
3 5 9 3 0  3 5 9 4 0  3 5 9 5 0  3 5 9 6 0  3 5 9 7 0  3 5 9 8 0  3 5 9 9 0  3 6 0 0 0
G C C G A T C A T C  A A C C G G C T G A  T G C A C A A T G T  G G C CCACG AC G A G G A G T T C A  T C A C G A C G A C  GCTG GCGG AG  A C G A T C A A A G
3 6 0 1 0  3 6 0 2 0  3 6 0 3 0  3 6 0 4 0  3 6 0 5 0  3 6 0 6 0  3 6 0 7 0  3 6 0 8 0
T G G A C G A G T T  C A C G G C C A A T C T G T T C A A C A  T C T A T C G C A A  G GTG CTGG CG  C A C G G A T T C A  CC CAG G TG AG  A T T C C G T C A G
3 6 0 9 0  3 6 1 0 0  3 6 1 1 0  3 6 1 2 0  3 6 1 3 0  3 6 1 4 0  3 6 1 5 0  3 6 1 6 0
C T G G C G TC C A  T C C A T C T C C G  A T C C T C C G C C  C T C T G C A C A C  C A T C A T C G T A  T C A C C C G C C A  A C G T A T C C A C  C T C A T T C C C A
3 6 1 7 0  3 6 1 8 0  3 6 1 9 0  3 6 2 0 0  3 6 2 1 0  3 6 2 2 0  3 6 2 3 0  3 6 2 4 0
TC G G G AG G G A G C A C A T C T A C  AG G C AG C C AG  T G G G T T A C T C  G C T A G A A T T T  A T TG G G C C C C  TC C AC C C G C G  G T C G C A A T C T
3 6 2 5 0  3 6 2 6 0  3 6 2 7 0  3 6 2 8 0  3 6 2 9 0  3 6 3 0 0  3 6 3 1 0  3 6 3 2 0
A A T C G C C A T T  C C A T A A A T C G  C C C G G C C A TA  G C C A TAG C C G  C A G T C A A A G C  C C A G A A G TC G  G C T G T A G T C G  C T A A T C T C G C
3 6 3 3 0  3 6 3 4 0  3 6 3 5 0  3 6 3 6 0  3 6 3 7 0  3 6 3 8 0  3 6 3 9 0  3 6 4 0 0
G T G A T T T A T G  C G A G C A TC C T G G C C TC AC A G  C T C C T T A T C G  T T G G C T T G T A  A A T C G A C G T A  G G AC AG C C C A T C C C T G A C C C
3 6 4 1 0  3 6 4 2 0  3 6 4 3 0  3 6 4 4 0  3 6 4 5 0  3 6 4 6 0  3 6 4 7 0  3 6 4 8 0
C C A T A A C G C T  A G A A C T T T G C  C A T T G C T C C T  C C T A C T T T G A  T T T A C A T G C A  T T T C C C C T A A  C G A A A C C A G C  A C A G A G G C G A
3 6 4 9 0  3 6 5 0 0  3 6 5 1 0  3 6 5 2 0  3 6 5 3 0  3 6 5 4 0  3 6 5 5 0  3 6 5 6 0
A T C C A T T G A G  C T C T T C C A C G  T C C A C A A G A A  G C T T T A A T C T  T T G T A G A T C C  T A T C A G A A A G  G T G A C A G T T T  T A C A A T T T G A
3 6 5 7 0  3 6 5 8 0  3 6 5 9 0  3 6 6 0 0  3 6 6 1 0  3 6 6 2 0  3 6 6 3 0  3 6 6 4 0
A T A G T T A T T G  G C C C G G TA AC  T G A T A G G G T T  T A T T A A A T A T  A A C A A T G C C A  G C G C T A T T T T  T A C T T T A T T A  C T A T T C A A A C
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3 6 6 5 0  3 6 6 6 0  3 6 6 7 0  3 6 6 8 0  3 6 6 9 0  3 6 7 0 0  3 6 7 1 0  3 6 7 2 0
T T T G T C T C G A  A T C T T A T C G A  A G T C T C A A T T  G A A G C A T T T A  A A T G C T A G A A  T C A A T T A A A C  T A T T G T T C A T  T T T A A A C T C G
3 6 7 3 0  3 6 7 4 0  3 6 7 5 0  3 6 7 6 0  3 6 7 7 0  3 6 7 8 0  3 6 7 9 0  3 6 8 0 0
T T G A T T T T T G  C C A A T G A T T T  T C A A T G T T T T  T A C T T G C A A C  T T A A T C A T T T  T C A T C A C C C A  A T A T C A A G T T  T A G T T G C G A A
3 6 8 1 0  3 6 8 2 0  3 6 8 3 0  3 6 8 4 0  3 6 8 5 0  3 6 8 6 0  3 6 8 7 0  3 6 8 8 0
T T T T G C T C T C  T G T G C A A A A A  T T T A G T T C A C  G A T C T G T G C T  T T T C T C G T C A  C C A C T C C T T C  A A A A A T T T T A  A A A C C T A A C C
3 6 8 9 0  3 6 9 0 0  3 6 9 1 0  3 6 9 2 0  3 6 9 3 0  3 6 9 4 0  3 6 9 5 0  3 6 9 6 0
A C G C A A T T G T  A C A A A C T C T C  G A T C T C A A A C  G C A A T C T G T T  G C T C C A T T A T  C C G T C T C T C A  T T G C A T C G C T  G T G C T A C G A A
3 6 9 7 0  3 6 9 8 0  3 6 9 9 0  3 7 0 0 0  3 7 0 1 0  3 7 0 2 0  3 7 0 3 0  3 7 0 4 0
A A A T G A T T T T  G A A T C A A A G A  A A A C A T C G C T  G G G G ATG C TG  C G C A G C G A TC  T G A T G C T G G A  G TC C G G C TG T C C C G A G C TG T
3 7 0 5 0  3 7 0 6 0  3 7 0 7 0  3 7 0 8 0  3 7 0 9 0  3 7 1 0 0  3 7 1 1 0  3 7 1 2 0
CGCCACGGGC G C TG C G AAC G  G CGGCCGGTG AG G A TC G TG G  TC A G G A T G C G  G G C G C TG C TG  T G G G G C A A A T A G C T G G A G C T
3 7 1 3 0  3 7 1 4 0  3 7 1 5 0  3 7 1 6 0  3 7 1 7 0  3 7 1 8 0  3 7 1 9 0  3 7 2 0 0
A A C G G A G C TG  CAG G AG TCG G  A A C T G C C G C T  G G CACG GG CA G C AA G G AG G A G G AG CACAGG  G AG G TC C AG C  TA A G C C G G G T
3 7 2 1 0  3 7 2 2 0  3 7 2 3 0  3 7 2 4 0  3 7 2 5 0  3 7 2 6 0  3 7 2 7 0  3 7 2 8 0
C A C C A A A G A G  C C G G AACG G A GGGCGACCGG C G C C C A G TC C  G C T T A C T G C T  G C TG G A A G C A  A G T C G A G A T C  A A T A C G A T A G
3 7 2 9 0  3 7 3 0 0  3 7 3 1 0  3 7 3 2 0  3 7 3 3 0  3 7 3 4 0  3 7 3 5 0  3 7 3 6 0
C A TC G G G C TT TG G C C A C T T G  G G A C C A G C A A  G T A A A A C C A T  A C A A A G G T G C  TG T T C A C G C G  C A C A G T G C A T  C C A T C A G T G C
3 7 3 7 0  3 7 3 8 0  3 7 3 9 0  3 7 4 0 0  3 7 4 1 0  3 7 4 2 0  3 7 4 3 0  3 7 4 4 0
A A C T C C G C A C  C A C G C C A T C A  T C A G C A A C A C  A C C C C C T A A A  A A A A A A A A C C  C A G T A T T C C T  T C C A T G A C A C  G T C A C T C A T C
3 7 4 5 0  3 7 4 6 0  3 7 4 7 0  3 7 4 8 0  3 7 4 9 0  3 7 5 0 0  3 7 5 1 0  3 7 5 2 0
T C A T C T C A T C  G C A T T T T T G C  A T T C C T G C A T  C G C T T G C A T C  C T C C G C C T A A  C C G C A C A A A A  T C A C A C A C T A  A C T A T T T T C G
3 7 5 3 0  3 7 5 4 0  3 7 5 5 0  3 7 5 6 0  3 7 5 7 0  3 7 5 8 0  3 7 5 9 0  3 7 6 0 0
A T A C C C G A A T  C A A A T A T T A A  C T A T A T T T G A  A T C C T T A A C T  T T G T C A A T C G  A A A G A A T C T T  T T G C A T C T G A  A A A G A A A G A G
3 7 6 1 0  3 7 6 2 0  3 7 6 3 0  3 7 6 4 0  3 7 6 5 0  3 7 6 6 0  3 7 6 7 0  3 7 6 8 0
C A C T A A A G T C  A A A G A T A G A T  C G G A A T T A A A  A C G A A G T T G C  A A C A A G A A G T  G C A T A A T C A G  A T A T T T C G A C  T G A A A T A A G C
3 7 6 9 0  3 7 7 0 0  3 7 7 1 0  3 7 7 2 0  3 7 7 3 0  3 7 7 4 0  3 7 7 5 0  3 7 7 6 0
T A T T T A A A A T  A T T T A A A A A A  T A T T T C A A A C  A T A T C T T G T A  G T G T G T G C T T  T T G T G T G T G T  T G C T T T G T A A  A A T C C T T T G T
3 7 7 7 0  3 7 7 8 0  3 7 7 9 0  3 7 8 0 0  3 7 8 1 0  3 7 8 2 0  3 7 8 3 0  3 7 8 4 0
A C T T T A G T T G  A A G T T G A T T T  T G T T C C G C T G  T T C C T T A G A A  A T G T A T T T A T  G A T T A A C C A T  A G C T A C A A A C  G T T G C T C C T C
3 7 8 5 0  3 7 8 6 0  3 7 8 7 0  3 7 8 8 0  3 7 8 9 0  3 7 9 0 0  3 7 9 1 0  3 7 9 2 0
C A G A T T G T T G  C C T A G A G T T T  T C A T T T G C T G  A C G C T G C T G T  CG C C TG TC G C  C C G T T G C C T C  C T G C C TG C C T G C T C T G C T C C
3 7 9 3 0  3 7 9 4 0  3 7 9 5 0  3 7 9 6 0  3 7 9 7 0  3 7 9 8 0  3 7 9 9 0  3 8 0 0 0
TG C C TC C TG G  C A T C C C G C A T  C C T G C A T C C T  G G C AC C TG C C  A A C C G A C A C C  T G C T C C T C C C  G AC C C A AC C G  T A G C A T C T A A
3 8 0 1 0  3 8 0 2 0  3 8 0 3 0  3 8 0 4 0  3 8 0 5 0  3 8 0 6 0  3 8 0 7 0  3 8 0 8 0
CC CG CC CG CT A A T A A T C T T C  A C T T C C G T C A  G T G A T T G T C C  G T T C T G C T G T  C G C T T A C T C T  A C C A A C T C T A  T A G T A G G T C A
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3 8 0 9 0  3 8 1 0 0  3 8 1 1 0  3 8 1 2 0  3 8 1 3 0  3 8 1 4 0  3 8 1 5 0  3 8 1 6 0
G G G G TTAG C C  A A T A T A T A T G  C A T A T A T A T C  T T T C T A G A A G  A T T T G A A G A T  A G C G A T T T C A  C A A G A T C T G A  T A A A G T G T T T
3 8 1 7 0  3 8 1 8 0  3 8 1 9 0  3 8 2 0 0  3 8 2 1 0  3 8 2 2 0  3 8 2 3 0  3 8 2 4 0
G G A T G A T A C A  T C A C A T C A A T  T T G T C A T T T G  T A A T C A G C A A  A A G G C G C T A A  T C A A A A A T T T  C A C C A C T T G T  AC G C TTG G G C
3 8 2 5 0  3 8 2 6 0  3 8 2 7 0  3 8 2 8 0  3 8 2 9 0  3 8 3 0 0  3 8 3 1 0  3 8 3 2 0
T A T T A A A A C C  C T A G A A G T T T  C TG G AG G TTG  A A T T A A A C A A  T T T A A T T G T T  T G A A A G A A C A  A A T G T A G T T T  T T A C T T G C A T
3 8 3 3 0  3 8 3 4 0  3 8 3 5 0  3 8 3 6 0  3 8 3 7 0  3 8 3 8 0  3 8 3 9 0  3 8 4 0 0
A G A T A T T A A A  C T C A C T C A A C  A T T T T G G T C A  T A C G T C G T T T  T A G A C G A A T C  A C A C C T G T A G  T T A G G A A G C C  C C A C A TG G A G
3 8 4 1 0  3 8 4 2 0  3 8 4 3 0  3 8 4 4 0  3 8 4 5 0  3 8 4 6 0  3 8 4 7 0  3 8 4 8 0
A G C C C A C A G C  T G T A C T G C A G  A T A G G G T T A C  A G A T A G G G A T  A C G C T G A T A T  A G A T A C G C C T  G G T A A T T G T T  T A T T T A A A G T
3 8 4 9 0  3 8 5 0 0  3 8 5 1 0  3 8 5 2 0  3 8 5 3 0  3 8 5 4 0  3 8 5 5 0  3 8 5 6 0
C G AG G C G TG T G C G A TA A C A G  A C C C A A T A A G  T G C A T T T G T G  G G T G C A A A A T  G T T T G T C T T C  A A T T A C A A A T  T C A A G A C T C G
3 8 5 7 0  3 8 5 8 0  3 8 5 9 0  3 8 6 0 0  3 8 6 1 0  3 8 6 2 0  3 8 6 3 0  3 8 6 4 0
A A T T T A T G A A  A T G C C A G C A G  A A C T C A A A A C  A C T T T C A T G C  A C G T T T C G A G  T T T T T A G C T G  T T T G T C T A T T  T G T T T A A T T G
3 8 6 5 0  3 8 6 6 0  3 8 6 7 0  3 8 6 8 0  3 8 6 9 0  3 8 7 0 0  3 8 7 1 0  3 8 7 2 0
C C G G CAATG G  T G A C G T A A A C  A T A A T T A T A A  A C A G A T T A T A  T C A G A G C A T G  T T T A T A A A A T  A G T C A A A T T A  C C A G C T G C A A
3 8 7 3 0  3 8 7 4 0  3 8 7 5 0  3 8 7 6 0  3 8 7 7 0  3 8 7 8 0  3 8 7 9 0  3 8 8 0 0
A T G G G C T A A T  A A C T T G T T A T  T A C T T C G T C A  T G C T T A G A T A  C A T A T G G A A A  A T A G G T A T T A  G T A G T A G T A T  T A T T A T T A T T
3 8 8 1 0  3 8 8 2 0  3 8 8 3 0  3 8 8 4 0  3 8 8 5 0  3 8 8 6 0  3 8 8 7 0  3 8 8 8 0
A T T T C A T T C A  A T A A C A G C T T  G T A G T C A T A T  C G G A A A T A T T  T A A A C A A T T T  G AAA C TG G C G  G C G T T T G T G G  C G A A A T A T T T
3 8 8 9 0  3 8 9 0 0  3 8 9 1 0  3 8 9 2 0  3 8 9 3 0  3 8 9 4 0  3 8 9 5 0  3 8 9 6 0
G G A G T C T T T C  A T G G C C C T A A  A A A T T A T A G A  G T T A A T A G C A  T T G G G A G A T G  C A T C G T T T C T  T G C A C C A T T T  C T C G C C T C T C
3 8 9 7 0  3 8 9 8 0  3 8 9 9 0  3 9 0 0 0  3 9 0 1 0  3 9 0 2 0  3 9 0 3 0  3 9 0 4 0
T C T C T C T C T C  C G T C T C T T T T  T G A A T A T A T A  T A A T T A A A A A  T T C G C A C C T G  C C T C A T C C T A  C A T A T A T A T A  C A T A T A T A T A
3 9 0 5 0  3 9 0 6 0  3 9 0 7 0  3 9 0 8 0  3 9 0 9 0  3 9 1 0 0  3 9 1 1 0  3 9 1 2 0
T A T A T A T A T A  T A T G C A C G T A  T A T A T C T A T G  G AC G AG G A TC  G T A A A C C A T A  C C T A G A C A T A  T T G A A T C G C T  T T A C C G G C T A
3 9 1 3 0  3 9 1 4 0  3 9 1 5 0  3 9 1 6 0  3 9 1 7 0  3 9 1 8 0  3 9 1 9 0  3 9 2 0 0
A G C A G C T A A T  C T T T A A G G G A  C G C A C C T A A T  G T A T A T A T A T  C T T G T A T A A C  G A T C A T A A T T  G C A G G C A T A T  A G C A T C G G T C
3 9 2 1 0  3 9 2 2 0  3 9 2 3 0  3 9 2 4 0  3 9 2 5 0  3 9 2 6 0  3 9 2 7 0  3 9 2 8 0
T G T T G C G A T C  C G A C T A T A T G  G C A C A C G TG T CC GAGG GCTG  T G C G A T A A A G  C A G G TC G AG A T C A A C A C G G T  G G C C TC C A G T
3 9 2 9 0  3 9 3 0 0  3 9 3 1 0  3 9 3 2 0  3 9 3 3 0  3 9 3 4 0  3 9 3 5 0  3 9 3 6 0
TT C G C T G G C A  T A G C C A C C C A  A T T G G T G C C G  C A G C A G A A G T A T T A A G C G C T  C T T C T C T C T A  T C T C T T T C T A  C A T A T A A T A T
3 9 3 7 0  3 9 3 8 0  3 9 3 9 0  3 9 4 0 0  3 9 4 1 0  3 9 4 2 0  3 9 4 3 0  3 9 4 4 0
A T A T A A A T A T  A T A T C T A T C A  A A C T A C A T A T  A T T C C T T T T A  C C A A A C G C A C  G A A T G C A C A A  T G C A C A C A C C  T A A A A G C A A A
3 9 4 5 0  3 9 4 6 0  3 9 4 7 0  3 9 4 8 0  3 9 4 9 0  3 9 5 0 0  3 9 5 1 0  3 9 5 2 0
A G C A C A C T A C  A C A C C T G T C C  T A A T A T C C T T  C C A C C C A A C T  C C T T C T C C T T  C T C A C T G A T C  A C T T A T C C A C  C T A C A G A G G T
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3 9 5 3 0  3 9 5 4 0  3 9 5 5 0  3 9 5 6 0  3 9 5 7 0  3 9 5 8 0  3 9 5 9 0  3 9 6 0 0
G C C A T C T C T A  T C G T T T G T T G  T C T C T T T C T G  C A T G T G T T T T  t T T T T T T T T T  A A T T G G T T A T  G G C T C T A T C C  G T C T C T T T C C
3 9 6 1 0  3 9 6 2 0  3 9 6 3 0  3 9 6 4 0  3 9 6 5 0  3 9 6 6 0  3 9 6 7 0  3 9 6 8 0
A C A C G C T G T A  G C T T C A T A A C  C C C A C T T C C A  C A A T T T C C C T  A A C C A T A A A C  A T A C A T A T G T  A T A T C C A T C C  G C C C A T T T G A
3 9 6 9 0  3 9 7 0 0  3 9 7 1 0  3 9 7 2 0  3 9 7 3 0  3 9 7 4 0  3 9 7 5 0  3 9 7 6 0
G A G G T T T T G G  T C T C A G T A A T  T A A C C C A A A T  T T C A A C C C C C  C C C C C C C C A T T A C C A C C G A A  C A T T T G T T G T  T G T T T G T T G C
3 9 7 7 0  3 9 7 8 0  3 9 7 9 0  3 9 8 0 0  3 9 8 1 0  3 9 8 2 0  3 9 8 3 0  3 9 8 4 0
T G T T G T T G G T  C G C T G A A A G A  C T G C G G A A T T  A T G C T A A T G T  C T G T C T C T T T  C T G TT C C G G C  A C T A C C C G T C  T C T T T C G C C C
3 9 8 5 0  3 9 8 6 0  3 9 8 7 0  3 9 8 8 0  3 9 8 9 0  3 9 9 0 0  3 9 9 1 0  3 9 9 2 0
G C G C A G A TT C  G TA C T C A G C G  A G C T G G G A C A  T G C G G A TA A G  C T G C A C A A T G  T G A G T A T A T T  A A A C T A A G A T  A T A T A A T C T A
3 9 9 3 0  3 9 9 4 0  3 9 9 5 0  3 9 9 6 0  3 9 9 7 0  3 9 9 8 0  3 9 9 9 0  4 0 0 0 0
T A T A T A T A T A  A A C A T A T A T T  C A T A T A T A T A  A T A A T T A T A T  G A T C T G T G T T  T C C T G T A C A A  T A A A C C A T G A  G T A A C A A G A C
4 0 0 1 0  4 0 0 2 0  4 0 0 3 0  4 0 0 4 0  4 0 0 5 0  4 0 0 6 0  4 0 0 7 0  4 0 0 8 0
A A C T T A A A T G  A T A A T G T T C G  T T A T T C C G C T  G C AG ATG C C G  G A T A A C A A T G  CACTG G CCG G  A C T C T G C G A T  G G C A TG G TG A
4 0 0 9 0  4 0 1 0 0  4 0 1 1 0  4 0 1 2 0  4 0 1 3 0  4 0 1 4 0  4 0 1 5 0  4 0 1 6 0
AG G C G TG G G A C A T C T A T G C A  AA G C C G C A G G  C C G T C A T T C T  G T T C A T C A T C  G A G G A T G TG T C G T A C A A C A T  T T G C G A C C A G
4 0 1 7 0  4 0 1 8 0  4 0 1 9 0  4 0 2 0 0  4 0 2 1 0  4 0 2 2 0  4 0 2 3 0  4 0 2 4 0
C G G TTC C AC G  A G T T C T A C A T  TC G C G A G A C A  T A T C C G C A C A  TC A A G G T G C T  G CG CCG CACC CTC AC C G AG G  T C C A T C G G G A
4 0 2 5 0  4 0 2 6 0  4 0 2 7 0  4 0 2 8 0  4 0 2 9 0  4 0 3 0 0  4 0 3 1 0  4 0 3 2 0
G G G C AA AC TG  G G C C A G TC C A  A G G A G T T G C T  C C T G T A A G T G  T A C A T T A A T A  C C T C T A T T A T  C A T T C A T C A T  T G A A C T G T G T
4 0 3 3 0  4 0 3 4 0  4 0 3 5 0  4 0 3 6 0  4 0 3 7 0  4 0 3 8 0  4 0 3 9 0  4 0 4 0 0
G C T C A A C T C A  C A C G C TT G C C  G C A C C A C A G T G G A T C C C A A G  AG G TG G C C G T C A T C T A C T T C  C G AG C TG G C T AC G A G C C C G G
4 0 4 1 0  4 0 4 2 0  4 0 4 3 0  4 0 4 4 0  4 0 4 5 0  4 0 4 6 0  4 0 4 7 0  4 0 4 8 0
A C A C T A T C A C  TC GC AG GC GG  A T T G G G A T G C  C C G C T A T C T G  A T G G A G A C C T  C G C TG G C C AT C A AG TG C C C G  T C G A T T C A C T
4 0 4 9 0  4 0 5 0 0  4 0 5 1 0  4 0 5 2 0  4 0 5 3 0  4 0 5 4 0  4 0 5 5 0  4 0 5 6 0
A C C A T T T G G C  G G G CAC CAAG  A A G G TG C A G C  AG G C A TT G G C  G CAGCCGGCG G TG C TC G AG C  G T T T C A T C A A  CG ATC C G G AG
4 0 5 7 0  4 0 5 8 0  4 0 5 9 0  4 0 6 0 0  4 0 6 1 0  4 0 6 2 0  4 0 6 3 0  4 0 6 4 0
G A G A TC A A G G  CG G TG G G C AA G A T C T T C A C G  G G T C T C T A C T  C G C TG G AC G A CAACGAGG CG  G G C A A TG C C A  G C T A C G A G A T
4 0 6 5 0  4 0 6 6 0  4 0 6 7 0  4 0 6 8 0  4 0 6 9 0  4 0 7 0 0  4 0 7 1 0  4 0 7 2 0
GGCGCTGCGC A C TC C G G A G A  G A T T C G T G C T  G AAG CC G C AG  CGCGAGGGAG G C G G C A A T A A  TG TC T A C G G C  G T G G A T A T A C
4 0 7 3 0  4 0 7 4 0  4 0 7 5 0  4 0 7 6 0  4 0 7 7 0  4 0 7 8 0  4 0 7 9 0  4 0 8 0 0
C A G A T G C A C T  A A A G G T G A G T  T A T T C C A C T T  T G A T G A T T A T  T T G A A T T G T G  A A C A G T T T T G  T A A C A A A T C C  T T C T C C T T C T
4 0 8 1 0  4 0 8 2 0  4 0 8 3 0  4 0 8 4 0  4 0 8 5 0  4 0 8 6 0  4 0 8 7 0  4 0 8 8 0
T T A T C C A T C A  G C G C A T G T C A  CG CG TG GAGC G C TC C G C C TG  G A T T C T G A T G  G A T C T G A T T C  A T C C G C C G C T  G AC C AA G G G C
4 0 8 9 0  4 0 9 0 0  4 0 9 1 0  4 0 9 2 0  4 0 9 3 0  4 0 9 4 0  4 0 9 5 0  4 0 9 6 0
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T A T A T G G T G C  G GCCCGGTGG C G A T A TG C C G  C C C C A G A TC G  T G G A C A T G G T  C T C C G A G C T G  G G C A T C T T C G  G TG T G G TG A T
4 0 9 7 0  4 0 9 8 0  4 0 9 9 0  4 1 0 0 0  4 1 0 1 0  4 1 0 2 0  4 1 0 3 0  4 1 0 4 0
CG G AGATG CG  G A G C A C A T T G  T G C A C A A C T A  CCAG GCGG GA C A C A TG C TG C  G C A C A A A G C T  C T C A A C C G C C  AA C G A A G G A G
End of proximal DmGS copy
. . . . [ [ . . . . I
4 1 0 5 0  4 1 0 6 0  4 1 0 7 0  4 1 0 8 0  4 1 0 9 0  4 1 1 0 0  4 1 1 1 0  4 1 1 2 0
G CG TG G CAG C CG G TCTG G G C G C C C TG G A C A  G T C C A T A T C T  G A T C G A T A G C  G ATG AC G AG G  A T G A G C A G A A  G T A G G A T C C T
4 1 1 3 0  4 1 1 4 0  4 1 1 5 0  4 1 1 6 0  4 1 1 7 0  4 1 1 8 0  4 1 1 9 0  4 1 2 0 0
T T A A C G A G A T  A A A G G C T T C G  AA C G C C G G C A  T T C C A C C T G T  T G C C T C A G T C  T T G T A T A A A T  G A T T A T T T T T  G T A A A G C G T A
End of duplicated region
| |  | |  | |  | |  | |  | | | |---|.. , J .
4 1 2 1 0  4 1 2 2 0  4 1 2 3 0  4 1 2 4 0  4 1 2 5 0  4 1 2 6 0  4 1 2 7 0  | j 2 8 0
T T G T A A A T T T  T T T G C A C T A T  T T T T T C C C C G  T C C C A A T G T C  A A T A A A T A A A  A T G T T A A A C T  A G A A A T T C T G  G T C A A T A T G C
4 1 2 9 0  4 1 3 0 0  4 1 3 1 0  4 1 3 2 0  4 1 3 3 0  4 1 3 4 0  4 1 3 5 0  4 1 3 6 0
A A A C T G G A T T  T G G G G C TA A A  G C T T T G C T A C  A G T T C A T G T A  A A C T C T T A G T  A T C T A A G A A C  T A T C A C C G T G  G A G T A G A A T G
4 1 3 7 0  4 1 3 8 0  4 1 3 9 0  4 1 4 0 0  4 1 4 1 0  4 1 4 2 0  4 1 4 3 0  4 1 4 4 0
G G A G TA G A C T TG G A G TTG G G  C C A A T G C T G T  G C A C A T C C C A  G C T A G C G T T C  A C T A C C G C A C  C G TC TTG C G G  TA G G TG G C G T
4 1 4 5 0  4 1 4 6 0  4 1 4 7 0  4 1 4 8 0  4 1 4 9 0  4 1 5 0 0  4 1 5 1 0  4 1 5 2 0
C C ATC AG G C G  G T C A A C C A T G  C T G T C A A T G G  G A T G G A T G A T  A A G C G G T A T G  C TG G C C AG AC  C C AC C AG G G T G G G CAC CG TC
4 1 5 3 0  4 1 5 4 0  4 1 5 5 0  4 1 5 6 0  4 1 5 7 0  4 1 5 8 0  4 1 5 9 0  4 1 6 0 0
T T T A G C A C G G  G C ATAG G C G C  T T T G C T C A G C  A G T G T T T T G G  TG G C C C AG G T G A T C C T A A A A  C G A T A T A A A T  G A G C A T T G C T
4 1 6 1 0  4 1 6 2 0  4 1 6 3 0  4 1 6 4 0  4 1 6 5 0  4 1 6 6 0  4 1 6 7 0  4 1 6 8 0
T A T T A T G T G A  A C A T A A A C T C  A T A A A A A T G G  G T A T G A T C T T  G G AG AG AACG  A T G A C T T C A T  C G T G T A T C T A  C A A A T A T A C A
4 1 6 9 0  4 1 7 0 0  4 1 7 1 0  4 1 7 2 0  4 1 7 3 0  4 1 7 4 0  4 1 7 5 0  4 1 7 6 0
A T A A A C C T G T  T T T T G C A A C A  T T G C A C A T G C  C A T T C T A C T A  C G T A T A T G C A  C T C T A T A G T A  T A A T T T T T A C  T A T G C T T A T A
4 1 7 7 0  4 1 7 8 0  4 1 7 9 0  4 1 8 0 0  4 1 8 1 0  4 1 8 2 0  4 1 8 3 0  4 1 8 4 0
T A A G A T A A G T  A T T A T G C A A C  T A A T G G A A A A  A G G G A A T C T T  T A A G A C G C C T  C A T T C C C T A C  T T C C A A C T A T  G T A A A T A C A A
4 1 8 5 0  4 1 8 6 0  4 1 8 7 0  4 1 8 8 0  4 1 8 9 0  4 1 9 0 0  4 1 9 1 0  4 1 9 2 0
C C A T T A A G T C  T A C G T T T T T G  G G C A A T T T T C  TG G C AAG G G T T G A A C G C A C C  G A T T G A T G A C  CAGG CCGG GA ATG G C G AC G G
4 1 9 3 0  4 1 9 4 0  4 1 9 5 0  4 1 9 6 0  4 1 9 7 0  4 1 9 8 0  4 1 9 9 0  4 2 0 0 0
AG G C C A G C A T CTG C C AG C A G  AA G A C G TC G C  C G C C C T TG A C  G G C C A C T T C T  C TG G AG G AAG  C G C C C T C C A T  TTG G AG G C G C
4 2 0 1 0  4 2 0 2 0  4 2 0 3 0  4 2 0 4 0  4 2 0 5 0  4 2 0 6 0  4 2 0 7 0  4 2 0 8 0
A G T G C C T T G T  C A A A A G T G T C  C G TG CAG AC G  T A T C C G A T G G  C C A T G C C G T A  G GATG C G G CC A C C A G A G A C T  TG G G C A C C AG
4 2 0 9 0  4 2 1 0 0  4 2 1 1 0  4 2 1 2 0  4 2 1 3 0  4 2 1 4 0  4 2 1 5 0  4 2 1 6 0
CGGGCGGAAG G A C T C G C C A A  T C T C G T T G C T  G TA G C C TG C A  A A G C C G T A A C  A A T T A A A C T C  A T A T A T T T C G  A T G G A T C T G G
4 2 1 7 0  4 2 1 8 0  4 2 1 9 0  4 2 2 0 0  4 2 2 1 0  4 2 2 2 0  4 2 2 3 0  4 2 2 4 0
G C A G A T T C T G  C TTG G G AG G A A C A C T C A C C C  A T A T A G C G A A  T G A A G G T G T C  C C G G TA G ATG  T C C A C C T C C T  T C A A A G A C G T
4 2 2 5 0  4 2 2 6 0  4 2 2 7 0  4 2 2 8 0  4 2 2 9 0  4 2 3 0 0  4 2 3 1 0  4 2 3 2 0
G G A A G T T T T C  T T G G T G C C C T  TA TC C C G G C G  G A T G A A C T G T  T T G T C C T C C G  A C A T T G T C T A  T T T T T T T T A T  T T T T A T T T T T
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9.2 Appendix B: Sequence alignment of all nine DmGS cDNAs 
against the genomic sequence
—  i —  i
1 0  2 0  3 0  4 0  5 0  SO 7 0  8 0
T1 ------------------  ------------------  ------------------  ------------------  ------------------  ------------------  ------------------ ---------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- --------------------------------------------------
T3 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------
T 4 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T 6  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  CGTGTATGCC CCTGGTATTT TTTGATGCCA TATTCTGGCA TATTGCGGTA TATCGCCGGC TGGTATTTTT TGCCTAACCC 
c o p y 2 CGTGTATGCC CCTGGTATTT TTTGATGCCA TATTCTGGCA TATTGCGGTA TATCGCCGGC TGGTATTTTT TGCCTAACCC
9 0  1 0 0  1 1 0  1 2 0  1 3 0  1 4 0  1 5 0  1 6 0
X I    CACTGCGAAT ATTCGGCCAA AAACATAGTT ATATTTTTGT CTGTGGGCTT TTAGACAAAT TGTAAACTGA
X2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T3 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 4 -----------------------  ----------------------  ----------------------  ---------------------- ------------------ AAT TCCGTTGCTG TCGGACAAAT TGTAAACTGA
T5 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6 -----------------------  ----------------------  ----------------------  ---------------------- ------------------ TGT CTGTGGGCTT TTAGACAAAT TGTAAACTGA
T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T8 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T9 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------
c o p y l  GCTACGCACA CACTGCGAAT ATTCGGCCAA AAACATAGTT ATATTTTTGT CTGTGGGCTT TTAGACAAAT TGTAAACTGA
c o p y 2 GCTACGCACA CACTGCGAAT ATTCGGCCAA AAACATAGTT ATATTTTTGT CTGTGGGCTT TTAGACAAAT TGTAAACTGA
1 7 0  1 8 0  1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
T 1 TAGCTCCCGA CCCCAGCCGT TTAACGGTGT CCAAATTGAC AGTGCAACCG GTGGAACAGG TGGAGCACAA GCAGCGGCAC
T2 -----------------------------------------------  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------
T4 TAGCTCCCGA CCCCAGCCGT TTAACGGTGT CCAAATTGAC AGTGCAACCG GTGGAACAGG TGGAGCACAA GCAGCGGCAC
T 5 ---------------------- -------------------------  ----------------------  ----------------------------------------------- ------------------------- ------------------------- -------------------------
T 6 TAGCTCCCGA CCCCAGCCGT TTAACGGTGT CCAAATTGAC AGTGCAACCG GTGGAACAGG TGGAGCACAA GCAGCGGCAC
T7    CCGT TTAACGGTGT CCAAATTGAC AGTGCAACCG GTGGAACAGG TGGAGCACAA GCAGCGGCAC
T8 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T 9 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  TAGCTCCCGA CCCCAGCCGT TTAACGGTGT CCAAATTGAC AGTGCAACCG GTGGAACAGG TGGAGCACAA GCAGCGGCAC
c o p y 2 TAGCTCCCGA CCCCAGCCGT TTAACGGTGT CCAAATTGAC AGTGCAACCG GTGGAACAGG TGGAGCACAA GCAGCGGCAC
2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  3 0 0  3 1 0  3 2 0
T 1  CCAGAAGGAA ACCAGCGATC CAGTCACAAC AATCGCTCGT TGAGAGCGCA GCGATAAGAG TTCCAGAGTT TCTAGAGTTT
T 2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- ------------------------- -------------------------  ----------------------
T 4 CCAGAAGGAA ACCAGCGATC CAGTCACAAC AATCGCTCGT TGAGAGCGCA GCGATAAGAG TTCCAGAGTT TCTAGAGTTT
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6 CCAGAAGGAA ACCAGCGATC CAGTCACAAC AATCGCTCGT TGAGAGCGCA GCGATAAGAG TTCCAGAGTT TCTAGAGTTT
T7 CCAGAAGGAA ACCAGCGATC CAGTCACAAC AATCGCTCGT TGAGAGCGCA GCGATAAGAG TTCCAGAGTT TCTAGAGTTT
T8 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T 9 ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- ------------------------- -------------------------  ----------------------
c o p y l  CCAGAAGGAA ACCAGCGATC CAGTCACAAC AATCGCTCGT TGAGAGCGCA GCGATAAGAG TTCCAGAGTT TCTAGAGTTT
c o p y 2 CCAGAAGGAA ACCAGCGATC CAGTCACAAC AATCGCTCGT TGAGAGCGCA GCGATAAGAG TTCCAGAGTT TCTAGAGTTT
3 3 0  3 4 0  3 5 0  3 6 0  3 7 0  3 8 0  3 9 0  4 0 0
T 1 CCAGCGATAC CCAGCAGTG- ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T2         C TCAGCAGTGC TCAGTGCCCA GTGAGCAGTT
T3         C TCAGCAGTGC TCAGTGCCCA GTGAGCAGTT
T4 CCAGCGATAC CCAGCAGTG- ----------------------  -----------------------------------------------  ----------------------  ---------------------- -------------------------
T5           GTT CCGTTGCTGT TNGAGCAGTT
T6 CCAGCGATAC CCAGCAGTG- ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 CCAGCGATAC CCAGCAGTG- ---------------------- ------------------------- ----------------------  ----------------------  ----------------------  ----------------------
xe -------------------------------- --------------- -------------------------------- ---------------  --------------------------------
1 9  ----------------------  ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  CCAGCGATAC CCAGCAGTGG TGAGTAGCTA GTAGACAGTC GTCGCACTGC TCAGCAGTGC TCAGTGCCCA GTGAGCAGTT
c o p y 2 CCAGCGATAC CCAGCAGTGG TGAGTAGCTA GTAGACAGTC GTCGCACTGC TCAGCAGTGC TCAGTGCCCA GTGAGCAGTT
4 1 0  4 2 0  4 3 0  4 4 0  4 5 0  4 6 0  4 7 0  4 8 0
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T 1
T2
T3
T4
T5
T6
T7
T8
T9
c o p y l  
c o p y  2
T 1
T2
T3
T 4
T5
T6
T7
T8
T9
c o p y l
c o p y 2
T 1
T2
T3
T4
T5
T6
T7
T8
T9
c o p y l  
c o p y  2
T 1
T2
T3
T 4
T5
T6
T7
T 8
T 9
c o p y l  
c o p y  2
T 1
T2
T3
T 4
T5
T6
T7
T8
T9
c o p y l
c o p y 2
T1
T2
T3
T4
T5
T6
            A  CGCAGCTGAG
CCGGCGAGCA GACCCCGTGA GATACCGCGG CGAACAACTA ACAACTAAGA TACTCTGCCC CTTTTCTAGA CGCAGCTGAG
CCGGCGAGCA GACCCCGTGA GATACCGCGG CGAACAACTA ACAACTAAGA TACTCTGCCC CTTTTCTAGA CGCAGCTGAG
            A  CGCAGCTGAG
CCGGCgagCA GACCCCGTGA GATACCGCGG CGAACAACTA ACAACTAAGA TACTCTGCCC CTTTTCTAGA CGCAGCTGAG
            A  CGCAGCTGAG
            A  CGCAGCTGAG
CCGGCGAGCA GACCCCGTGA GATACCGCGG CGAACAACTA ACAACTAAGA TACTCTGCCC CTTTTCTAGA CGCAGCTGAG
CCGGCGAGCA GACCCCGTGA GATACCGCGG CGAACAACTA ACAACTAAGA TACTCTGCCC CTTTTCTAGA CGCAGCTGAG 
CCGGCGAGCA GACCCCGTGA GATACCGCGG CGAACAACTA ACAACTAAGA TACTCTGCCC CTTTTCTAGA CGCAGCTGAG
4 9 0  5 0 0  5 1 0  521
CCCCAGATCC CAGATCCCAG ATACCAGCAG CAGACCGACC 
CCCCAGATCC CAGATCCCAG ATACCAGCAG CAGACCGACC 
CCCCAGATCC CAGATCCCAG ATACCAGCAG CAGACCGACC 
CCCCAGATCC CAGATCCCAG ATACCAGCAG TAGACCGACC 
CCCCAGATCC CAGATCCCAG ATACCAGCAG CAGACCGACC 
CCCCAGATCC CAGATCCCAG ATACCAGCAG CAGACCGACC 
CCCCAGATCC CAGATCCCAG ATACCAGCAG CAGACCGACC 
CCCCAGATCC CAGATCCCAG ATACCAGCAG CAGACCGACC
CCCCAGATCC CAGATCCCAG ATACCAGCAG CAGACCGACC 
CCCCAGATCC CAGATCCCAG ATACCAGCAG CAGACCGACC
I 5 3 0  5 4 0  5 5 0  5 6 0
CAAGCAGAAC GATCATGTCC AGCGACGCCA ATACGGCCGT 
CAAGCAGAAC GATCATGTCC AGCGACGCCA ATACGGCCGT 
CAAGCAGAAC GATCATGTCC AGCGACGCCA ATACGGCCGT 
CAAGCAGAAC GATCATGTCC AGCGACGCCA ATACGGCCGT 
CAAGCAGAAC GATCATGTCC AGCGACGCCA ATACGGCCGT 
CAAGCAGAAC GATCATGTCC AGCGACGCCA ATACGGCCGT 
CAAGCAGAAC GATCATGTCC AGCGACGCCA ATACGGCCGT 
CAAGCAGAAC GATCATGTCC AGCGACGCCA ATACGGCCGT
CAAGCAGAAC GATCATGTCC AGCGACGCCA ATACGGCCGT 
CAAGCAGAAC GATCATGTCC AGCGACGCCA ATACGGCCGT
5 7 0  5 8 0  5 9 0  6 0 0  6 1 0  6 2 0  6 3 0  6 4 0
GCTGCGCAAC TGCATCCGCT 
GCTGCGCAAC TGCATCCGCT 
GCTGCGCAAC TGCATCCGCT 
GCTGCGCAAC TGCATCCGCT 
GCTGCGCAAC TGCATCCGCT 
GCTGCGCAAC TGCATCCGCT 
GCTGCGCAAC TGCATCCGCT 
GCTGCGCAAC TGCATCCGCT
GCTGCGCAAC TGCATCCGCT 
GCTGCGCAAC TGCATCCGCT
TGCCGCTGGC GGAGGATGAG 
TGCCGCTGGC GGAGGATGAG 
TGCCGCTGGC GGAGGATGAG 
TGCCGCTGGC GGAGGATGAG 
TGCCGCTGGC GGAGGATGAG 
TGCCGCTGGC GGAGGATGAG 
TGCCGCTGGC GGAGGATGAG 
TGCCGCTGGC GGAGGATGAG
TGCCGCTGGC GGAGGATGAG 
TGCCGCTGGC GGAGGATGAG
CTACTGGAGG TGACGGCCAA 
CTACTGGAGG TGACGGCCAA 
CTACTGGAGG TGACGGCCAA 
CTACTGGAGG TGACGGCCAA 
CTACTGGAGG TGACGGCCAA 
CTACTGGAGG TGACGGCCAA 
CTACTGGAGG TGACGGCCAA 
CTACTGGAGG TGACGGCCAA
CTACTGGAGG TGACGGCCAA 
CTACTGGAGG TGACGGCCAA
GGCCAAGGAT TATGCCATTA 
GGCCAAGGAT TATGCCATTA 
GGCCAAGGAT TATGCCATTA 
GGCCAAGGAT TATGCCATTA 
GGCCAAGGAT TATGCCATTA 
GGCCAAGGAT TATGCCATTA 
GGCCAAGGAT TATGCCATTA 
GGCCAAGGAT TATGCCATTA
GGCCAAGGAT TATGCCATTA 
GGCCAAGGAT TATGCCATTA
6 5 0  6 6 0  6 7 0  6 8 0  6 9 0  7 0 0  7 1 0  7 2 0
TGCACGGCGC CGCCATGCGA TCGAAGACGG CCTTCAGTCC GGACTCGTTG AAT---------------  ----------------------  ----------------------
TGCACGGCGC CGCCATGCGA TCGAAGACGG CCTTCAGTCC GGACTCGTTG AAT---------------  ----------------------  ----------------------
TGCACGGCGC CGCCATGCGA TCGAAGACGG CCTTCAGTCC GGACTCGTTG AAT---------------  ----------------------  ----------------------
TGCACGGCGC CGCCATGCGA TCGAAGACGG CCTTCAGTCC GGACTCGTTG AAT---------------  ----------------------  ----------------------
TGCACGGCGC CGCCATGCGA TCGAAGACGG CCTTCAGTCC GGACTCGTTG AAT--------------- ---------------------- ----------------------- --
TGCACGGCGC CGCCATGCGA TCGAAGACGG CCTTCAGTCC GGACTCGTTG AAT---------------  ----------------------  ----------------------
TGCACGGCGC CGCCATGCGA TCGAAGACGG CCTTCAGTCC GGACTCGTTG AAT--------------- ----------------------  ----------------------
TGCACGGCGC CGCCATGCGA TCGAAGACGG CCTTCAGTCC GGACTCGTTG AAT---------------  ----------------------  ----------------------
TGCACGGCGC CGCCATGCGA TCGAAGACGG CCTTCAGTCC GGACTCGTTG AATGTGGGTG ATACAATGGG CACTCGCTAG 
TGCACGGCGC CGCCATGCGA TCGAAGACGG CCTTCAGTCC GGACTCGTTG AATGTGGGTG ATACAATGGG CACTCGCTAG
7 3 0  7 4 0  7 5 0  7 6 0  7 7 0  7 8 0  7 9 0  8 0 0
TGAGGGCTCG TATTCATGCT AAGGTGTCTA GTTTCCGCTC AAGAAGCTCA TTTCAATGGA ACAACATTCA TTACACATCC 
TGAGGGCTCG TATTCATGCT AAGGTGTCTA GTTTCCGCTC AAGAAGCTCA TTTCAATGGA ACAACATTCA TTACACATCC
8 1 0  8 2 0  8 3 0  8 4 0  8 5 0  8 6 0  8 7 0  8 8 0
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T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
c o p y l  CTTATCGAGT TCAGTTCCTT TTTAAGTTAT GTGTAATGCC AAATGTGATT GGATGCTTGA GTTTGTTTTT CATTTTATTG
c o p y 2 CTTATCGAGT TCAGTTCCTT TTTAAGTTAT GTGTAATGCC AAATGTGATT GGATGCTTGA GTTTGTTTTT CATTTTATTG
8 9 0  9 0 0  9 1 0  9 2 0  9 3 0  9 4 0  9 5 0  9 6 0
T 1 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 4  ----------------------  ---------------------- ------------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------
T 8  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T9 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  -----------------------------------------------
c o p y l  ACGGTAGAGA AAGATTAGCA ATGTGACGGT ATAAGCTACA CATTGGCATT CAATCGAGCT TCAAGCTAGC GTGCTGCTGC
c o p y 2 ACGGTAGAGA AAGATTAGCA ATGTGACGGT ATAAGCTACA CATTGGCATT CAATCGAGCT TCAAGCTAGC GTGCTGCTGC
9 7 0  9 8 0  9 9 0  1 0 0 0  1 0 1 0  1 0 2 0  1 0 3 0  1 0 4 0
T 1        TTCGCC CCCTTCGTGC TGGTGCCTTC CTCGTTTCCG
T2         TTCGCC CCCTTCGTGC TGGTGCCTTC CTCGTTTCCG
T3        TTCGCC CCCTTCGTGC TGGTGCCTTC CTCGTTTCCG
T 4         TTCGCC CCCTTCGTGC TGGTGCCTTC CTCGTTTCCG
T 5         TTCGCC CCCTTCGTGC TGGTGCCTTC CTCGTTTCCG
T 6         TTCGCC CCCTTCGTGC TGGTGCCTTC CTCGTTTCCG
T7         TTCGCC CCCTTCGTGC TGGTGCCTTC CTCGTTTCCG
T 8        TTCGCC CCCTTCGTGC TGGTGCCTTC CTCGTTTCCG
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  TTGAGCAACA GTTTGCCAGG ATACTAAACA TTTTCATTTT CCAGTTCGCC CCCTTCGTGC TGGTGCCTTC CTCGTTTCCG
c o p y 2 TTGAGCAACA GTTTGCCAGG ATACTAAACA TTTTCATTTT CCAGTTCGCC CCCTTCGTGC TGGTGCCTTC CTCGTTTCCG
1 0 5 0  1 0 6 0  1 0 7 0  1 0 8 0  1 0 9 0  1 1 0 0  1 1 1 0  1 1 2 0
T 1  CGCAAGGAGT TCGAAAAGGC GGTGGCCCTA CAGCCGATCA TCAACCGGCT GATGCACAAT GTGGCCCACG ACGAGGAGTT
T2 CGCAAGGAGT TCGAAAAGGC GGTGGCCCTA CAGCCGATCA TCAACCGGCT GATGCACAAT GTGGCCCACG ACGAGGAGTT
T3 CGCAAGGAGT TCGAAAAGGC GGTGGCCCTA CAGCCGATCA TCAACCGGCT GATGCACAAT GTGGCCCACG ACGAGGAGTT
T 4 CGCAAGGAGT TCGAAAAGGC GGTGGCCCTA CAGCCGATCA TCAACCGGCT GATGCACAAT GTGGCCCACG ACGAGGAGTT
T 5 CGCAAGGAGT TCGAAAAGGC GGTGGCCCTA CAGCCGATCA TCAACCGGCT GATGCACAAT GTGGCCCACG ACGAGGAGTT
T 6 CGCAAGGAGT TCGAAAAGGC GGTGGCCCTA CAGCCGATCA TCAACCGGCT GATGCACAAT GTGGCCCACG ACGAGGAGTT
T7 CGCAAGGAGT TCGAAAAGGC GGTGGCCCTA CAGCCGATCA TCAACCGGCT GATGCACAAT GTGGCCCACG ACGAGGAGTT
T 8 CGCAAGGAGT TCGAAAAGGC GGTGGCCCTA CAGCCGATCA TCAACCGGCT GATGCACAAT GTGGCCCACG ACGAGGAGTTTg ------------ ------------ -------------------------  ------------ ------------ --------------------------
c o p y l  CGCAAGGAGT TCGAAAAGGC GGTGGCCCTA CAGCCGATCA TCAACCGGCT GATGCACAAT GTGGCCCACG ACGAGGAGTT
c o p y 2  CGCAAGGAGT TCGAAAAGGC GGTGGCCCTA CAGCCGATCA TCAACCGGCT GATGCACAAT GTGGCCCACG ACGAGGAGTT
1 1 3 0  1 1 4 0  1 1 5 0  1 1 6 0  1 1 7 0  1 1 8 0  1 1 9 0  1 2 0 0
T 1 CATCACGACG ACGCTGGCGG AGACGATCAA AGTGGACGAG TTCACGGCCA ATCTGTTCAA CATCTATCGC AAGGTGCTGG
T 2 CATCACGACG ACGCTGGCGG AGACGATCAA AGTGGACGAG TTCACGGCCA ATCTGTTCAA CATCTATCGC AAGGTGCTGG
T3 CATCACGACG ACGCTGGCGG AGACGATCAA AGTGGACGAG TTCACGGCCA ATCTGTTCAA CATCTATCGC AAGGTGCTGG
T 4 CATCACGACG ACGCTGGCGG AGACGATCAA AGTGGACGAG TTCACGGCCA ATCTGTTCAA CATCTATCGC AAGGTGCTGG
T 5 CATCACGACG ACGCTGGCGG AGACGATCAA AGTGGACGAG TTCACGGCCA ATCTGTTCAA CATCTATCGC AAGATGCTGG
T 6 CATCACGACG ACGCTGGCGG AGACGATCAA AGTGGACGAG TTCACGGCCA ATCTGTTCAA CATCTATCGC AAGGTGCTGG
T7 CATCACGACG ACGCTGGCGG AGACGATCAA AGTGGACGAG TTCACGGCCA ATCTGTTCAA CATCTATCGC AAGGTGCTGG
T 8 CATCACGACG ACGCTGGCGG AGACGATCAA AGTGGACGAG TTCACGGCCA ATCTGTTCAA CATCTATCGC AAGGTGCTGG
T 9 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  CATCACGACG ACGCTGGCGG AGACGATCAA AGTGGACGAG TTCACGGCCA ATCTGTTCAA CATCTATCGC AAGGTGCTGG
c o p y 2 CATCACGACG ACGCTGGCGG AGACGATCAA AGTGGACGAG TTCACGGCCA ATCTGTTCAA CATCTATCGC AAGGTGCTGG
1 2 1 0  1 2 2 0  1 2 3 0  1 2 4 0  1 2 5 0  1 2 6 0  1 2 7 0  1 2 8 0
T 1  CGCACGGATT CACCCAGG-- ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T2 CGCACGGATT CACCCAGG- -  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 3 CGCACGGATT CA CC CA G g-- ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 4 CACACGGATT CACCCAGG-- ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T5 CGCACGGATT CACCCAG ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 6  CGCACGGATT CA CC CA G g-- ---------------------- ------------------------- ----------------------  ----------------------  ---------------------- -------------------------
T7 CGCACGGATT CA CC CA G g-- ---------------------- ------------------------- ----------------------  ----------------------  ---------------------- -------------------------
T 8 CGCACGGATT CA CC CA G g-- ---------------------- ----------------------  ---------------------- ------------------------- ------------------------- -------------------------
T9 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  CGCACGGATT CACCCAGGTG AGATTCCGTC AGCTGGCGTC CATCCATCTC CGATCCTCCG CCCTCTGCAC ACCATCATCG
c o p y 2 CGCACGGATT CACCCAGGTG AGATTCCGTC AGCTGGCGTC CATCCATCTC CGATCCTCCG CCCTCTGCAC ACCATCATCG
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1 2 9 0  1 3 0 0  1 3 1 0  1 3 2 0  1 3 3 0  1 3 4 0  1 3 5 0  1 3 6 0
T 1 ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- -------------------------  ---------------------- -------------------------
T2 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T3 ----------------------  ---------------------- ------------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
T4 ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
T5-------------- ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- -------------------------  --- ------------------ -------------------------
T6 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T8-------------- ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- -------------------------  ----------------------  ----------------------Tg ------------ -------------------------  ------------ ------------ ------------ ------------ ------------
c o p y l  TATCACCCGC CAACGTATCC ACCTCATTCC CATCGGGAGG GAGCACATCT ACAGGCAGCC AGTGGGTTAC TCGCTAGAAT
c o p y 2 TATCACCCGC CAACGTATCC ACCTCATTCC CATCGGGAGG GAGCACATCT ACAGGCAGCC AGTGGGTTAC TCGCTAGAAT
1 3 7 0  1 3 8 0  1 3 9 0  1 4 0 0  1 4 1 0  1 4 2 0  1 4 3 0  1 4 4 0
T 1------------------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ---------------------- -------------------------
T2 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------
T4 ----------------------------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T5------------------------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
T 6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T8 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 9  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  TTATTGGGCC CCTCCACCCG CGGTCGCAAT CTAATCGCCA TTCCATAAAT CGCCCGGCCA TAGCCATAGC CGCAGTCAAA
c o p y 2 TTATTGGGCC CCTCCACCCG CGGTCGCAAT CTAATCGCCA TTCCATAAAT CGCCCGGCCA TAGCCATAGC CGCAGTCAAA
1 4 5 0  1 4 6 0  1 4 7 0  1 4 8 0  1 4 9 0  1 5 0 0  1 5 1 0  1 5 2 0
T 1  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T4 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ------------------------------------
c o p y l  GCCCAGAAGT CGGCTGTAGT CGCTAATCTC GCGTGATTTA TGCGAGCATC CTGGCCTCAC AGCTCCTTAT CGTTGGCTTG
c o p y 2  GCCCAGAAGT CGGCTGTAGT CGCTAATCTC GCGTGATTTA TGCGAGCATC CTGGCCTCAC AGCTCCTTAT CGTTGGCTTG
1 5 3 0  1 5 4 0  1 5 5 0  1 5 6 0  1 5 7 0  1 5 8 0  1 5 9 0  1 6 0 0
T1 ------------------  ------------------ --------------------- ------------------  ------------------  ------------------  ------------------ ---------------------
T2 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------
T3 ------------ -------------------------  ------------ ------------ ------------ --------------------------
T 4 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 5 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 8 ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- -------------------------  ----------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  TAAATCGACG TAGGACAGCC CATCCCTGAC CCCCATAACG CTAGAACTTT GCCATTGCTC CTCCTACTTT GATTTACATG
c o p y 2  TAAATCGACG TAGGACAGCC CATCCCTGAC CCCCATAACG CTAGAACTTT GCCATTGCTC CTCCTACTTT GATTTACATG
1 6 1 0  1 6 2 0  1 6 3 0  1 6 4 0  1 6 5 0  1 6 6 0  1 6 7 0  1 6 8 0
T 1 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T2 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T3 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 4  ---------------------- ------------------------- -------------------------  ---------------------- -------------------------  ----------------------  -----------------------------------------------
T5 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T6 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T7 ----------------------  ---------------------- ----------------------  ---------------------- -------------------------  ----------------------  -----------------------------------------------
T8 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T9 ----------------------  ---------------------- -------------------------  ---------------------- -------------------------  ----------------------  -----------------------------------------------
c o p y l  CATTTCCCCT AACGAAACCA GCACAGAGGC GAATCCATTG AGCTCTTCCA CGTCCACAAG AAGCTTTAAT CTTTGTAGAT
c o p y 2  CATTTCCCCT AACGAAACCA GCACAGAGGC GAATCCATTG AGCTCTTCCA CGTCCACAAG AAGCTTTAAT CTTTGTAGAT
1 6 9 0  1 7 0 0  1 7 1 0  1 7 2 0  1 7 3 0  1 7 4 0  1 7 5 0  1 7 6 0
T 1 ----------------------  ---------------------- ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------------------  ---------------------- ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- ----------------------
T3 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
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T4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T5 ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T6 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------
T7 ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T8 ---------------------- ------------------------- ------------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  CCTATCAGAA AGGTGACAGT TTTACAATTT GAATAGTTAT TGGCCCGGTA ACTGATAGGG TTTATTAAAT ATAACAATGC
c o p y 2 CCTATCAGAA AGGTGACAGT TTTACAATTT GAATAGTTAT TGGCCCGGTA ACTGATAGGG TTTATTAAAT ATAACAATGC
 1 |
1 7 7 0  1 7 8 0  1 7 9 0  1 8 0 0  1 8 1 0  1 8 2 0  1 8 3 0  1 8 4 0
T 1 ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ---------------------- ------------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T4 ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T6 ---------------------- ------------------------- ------------------------- ----------- ------------- -------------------------  ----------------------  ----------------------  ----------------------
T7 ---------------------- ------------------------- ------------------------- ----------- ---------------------------------------  ----------------------  ---------------------- -------------------------
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T9 ---------------------- ------------------------- -------------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------
c o p y l  CAGCGCTATT TTTACTTTAT TACTATTCAA ACTTTGTCTC GAATCTTATC GAAGTCTCAA TTGAAGCATT TAAATGCTAG
c o p y 2 CAGCGCTATT TTTACTTTAT TACTATTCAA ACTTTGTCTC GAATCTTATC GAAGTCTCAA TTGAAGCATT TAAATGCTAG
1 8 5 0  1 8 6 0  1 8 7 0  1 8 8 0  1 8 9 0  1 9 0 0  1 9 1 0  1 9 2 0
T 1 ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 4 ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T8 ----------------------  ----------------------  ----------------------  ---------------------- --------------------------------------------------  ----------------------  ----------------------
T 9 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ------------------------------------
c o p y l  AATCAATTAA ACTATTGTTC ATTTTAAACT CGTTGATTTT TGCCAATGAT TTTCAATGTT TTTACTTGCA ACTTAATCAT
c o p y 2  AATCAATTAA ACTATTGTTC ATTTTAAACT CGTTGATTTT TGCCAATGAT TTTCAATGTT TTTACTTGCA ACTTAATCAT
1 9 3 0  1 9 4 0  1 9 5 0  1 9 6 0  1 9 7 0  1 9 8 0  1 9 9 0  2 0 0 0
T 1 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 2 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T 3 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 4 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- ------------------ --------------------------------
T 5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 6  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T7 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ------------------------------------
c o p y l  TTTCATCACC CAATATCAAG TTTAGTTGCG AATTTTGCTC TCTGTGCAAA AATTTAGTTC ACGATCTGTG CTTTTCTCGT
c o p y 2 TTTCATCACC CAATATCAAG TTTAGTTGCG AATTTTGCTC TCTGTGCAAA AATTTAGTTC ACGATCTGTG CTTTTCTCGT
2 0 1 0  2 0 2 0  2 0 3 0  2 0 4 0  2 0 5 0  2 0 6 0  2 0 7 0  2 0 8 0
T 1 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------------------  ----------------------  ----------------------  ---------------------- ---------------------- ------------------------- ------------------------- -------------------------
T3 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  -----------------------------------------------
T4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 5 ----------------------  ---------------------- -------------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------
T 6 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------
T7 ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T9 ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
c o p y l  CACCACTCCT TCAAAAATTT TAAAACCTAA CCACGCAATT GTACAAACTC TCGATCTCAA ACGCAATCTG TTGCTCCATT
c o p y 2 CACCACTCCT TCAAAAATTT TAAAACCTAA CCACGCAATT GTACAAACTC TCGATCTCAA ACGCAATCTG TTGCTCCATT
2 0 9 0  2 1 0 0  2 1 1 0  2 1 2 0  2 1 3 0  2 1 4 0  2 1 5 0  2 1 6 0
T 1 -----------------------  ----------------------  ----------------------  ---------------------- ----------------------  -AAAACATCG CTGGGGATGC TGCGCAGCGA
T 2 -----------------------  ----------------------  ----------------------  ---------------------- ----------------------  -AAAACATCG CTGGGGATGC TGCGCAGCGA
T3 ----------------------  ----------------------  ----------------------  ----------------------------------------------- ------------------------- ------------------------- -------------------------
T 4 ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------
T5 -----------------------  ----------------------  ----------------------  ---------------------- ----------------------  -AAAACATCG CTGGGGATGC TGCGCAGCGA
T 6 ---------------------- ----------------------  ----------------------  ----------------------------------------------- ------------------------- -------------------------  ----------------------
T7 -----------------------  ----------------------  ----------------------  ---------------------- ----------------------  -AAAACATCG CTGGGGATGC TGCGCAGCGA
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 9 ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- ------------------------- ---------------------------------------
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c o p y l  ATCCGTCTCT CATTGCATCG CTGTGCTACG AAAAATGATT TTGAATCAAA GAAAACATCG CTGGGGATGC TGCGCAGCGA
c o p y 2 ATCCGTCTCT CATTGCATCG CTGTGCTACG AAAAATGATT TTGAATCAAA GAAAACATCG CTGGGGATGC TGCGCAGCGA
2 1 7 0  2 1 8 0  2 1 9 0  2 2 0 0  2 2 1 0  2 2 2 0  2 2 3 0  2 2 4 0
T 1 TCTGATGCTG GAGTCCGGCT GTCCCGAGCT GTCGCCACGG GCGCTGCGAA CGGCGGCCGG TGAGGATCGT GGTCAGGATG
T2 TCTGATGCTG GAGTCCGGCT GTCCCGAGCT GTCGCCACGG GCGCTGCGAA CGGCGGCCGG TGAGGATCGT GGTCAGGATG
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T4 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T5 TCTGATGCTG GAGTCCGGCT GTCCCGAGCT GTCGCCACGG GCGCTGCGAA CGGCGGCCGG TGAGGATCGT GGTCAGGATG
T6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 TCTGATGCTG GAGTCCGGCT GTCCCGAGCT GTCGCCACGG GCGCTGCGAA CGGCGGCCGG TGAGGATCGT GGTCAGGATG
T8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  TCTGATGCTG GAGTCCGGCT GTCCCGAGCT GTCGCCACGG GCGCTGCGAA CGGCGGCCGG TGAGGATCGT GGTCAGGATG
c o p y 2 TCTGATGCTG GAGTCCGGCT GTCCCGAGCT GTCGCCACGG GCGCTGCGAA CGGCGGCCGG TGAGGATCGT GGTCAGGATG
2 2 5 0  2 2 S 0  2 2 7 0  2 2 8 0  2 2 9 0  2 3 0 0  2 3 1 0  2 3 2 0
T 1 CGGGCGCTGC TGTGGGGCAA ATAGCTGGAG CTAACGGAGC TGCAGGAGTC GGAACTGCCG CTGGCACGGG CAGCAAGGAG
T 2 CGGGCGCTGC TGTGGGGCAA ATAGCTGGAG CTAACGGAGC TGCAGGAGTC GGAACTGCCG CTGGCACGGG CAGCAAGGAG
T3 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------
T4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T5 CGGGCGCTGC TGTGGGGCAA ATAGCTGGAG CTAACGGAGC TGCAGGAGTC GGAACTGCCG CTGGCACGGG CAGCAAGGAG
T6 ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------
T7 CGGGCGCTGC TGTGGGGCAA ATAGCTGGAG CTAACGGAGC TGCAGGAGTC GGAACTGCCG CTGGCACGGG CAGCAAGGAG
T8 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  -----------------
T9 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  CGGGCGCTGC TGTGGGGCAA ATAGCTGGAG CTAACGGAGC TGCAGGAGTC GGAACTGCCG CTGGCACGGG CAGCAAGGAG
c o p y 2 CGGGCGCTGC TGTGGGGCAA ATAGCTGGAG CTAACGGAGC TGCAGGAGTC GGAACTGCCG CTGGCACGGG CAGCAAGGAG
2 3 3 0  2 3 4 0  2 3 5 0  2 3 6 0  2 3 7 0  2 3 8 0  2 3 9 0  2 4 0 0
T 1  GAGGAGCACA GGGAGGTCCA GCTAAGCCGG GTCACCAAAG AGCCGGAACG GAGGGCGACC GGCGCCCAGT CCGCTTACTG
T2 GAGGAGCACA GGGAGGTCCA GCTAAGCCGG GTCACCAAAG AGCCGGAACG GAGGGCGACC GGCGCCCAGT CCGCTTACTG
T 3 ______________  ______________ ________________  ______________  ______________  ______________  ______________ ________________
T4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T5 GAGGAGCACA GGGAGGTCCA GCTAAGCCGG GTCACCAAAG AGCCGGAACG GAGGGCGACC GGCGCCCAGT CCGCTTACTG
T6 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 7 GAGGAGCACA GGGAGGTCCA GCTAAGCCGG GTCACCAAAG AGCCGGAACG GAGGGCGACC GGCGCCCAGT CCGCTTACTG
T8 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------T9 ----------- ----------------------- ------------------------  ----------- -----------------------
c o p y l  GAGGAGCACA GGGAGGTCCA GCTAAGCCGG GTCACCAAAG AGCCGGAACG GAGGGCGACC GGCGCCCAGT CCGCTTACTG
c o p y 2  GAGGAGCACA GGGAGGTCCA GCTAAGCCGG GTCACCAAAG AGCCGGAACG GAGGGCGACC GGCGCCCAGT CCGCTTACTG
2 4 1 0  2 4 2 0  2 4 3 0  2 4 4 0  2 4 5 0  2 4 6 0  2 4 7 0  2 4 8 0
T 1  CTGCTGGAAG CAAGTCGAGA TCAATACGAT AGCATCGGGC TTTGGCCACT TGGGACCAGC AAGTAAAACC ATACAAAG --
T2 CTGCTGGAAG CAAGTCGAGA TCAATACGAT AGCATCGGGC TTTGGCCACT TGGGACCAGC AAGTAAAACC ATACAAAG --
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 4 ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 5 CTGCTGGAAG CAAGTCGAGA TCAATACGAT AGCATCGGGC TTTGGCCACT TGGGACCAGC AAGTAAAACC ATACAAAG --
T 6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T7 CTGCTGGAAG CAAGTCGAGA TCAATACGAT AGCATCGGGC TTTGGCCACT TGGGACCAGC A A-----------------  ----------------------
T8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 9      AT AGCATCGGGC TTTGGCCACT TGGGACCAGC AAGTAAAACC ATAC AA AG --
c o p y l  CTGCTGGAAG CAAGTCGAGA TCAATACGAT AGCATCGGGC TTTGGCCACT TGGGACCAGC AAGTAAAACC ATACAAAGGT
c o p y 2  CTGCTGGAAG CAAGTCGAGA TCAATACGAT AGCATCGGGC TTTGGCCACT TGGGACCAGC AAGTAAAACC ATACAAAGGT
 I I
2 4 9 0  2 5 0 0  2 5 1 0  2 5 2 0  2 5 3 0  2 5 4 0  2 5 5 0  2 5 6 0
T1 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ---------------------- ---------------------- ------------------------- -------------------------  ---------------------- ----------------------
T 4 ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T5 ---------------------- -------------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 6 ----------------------  ----------------------  ---------------------- ---------------------- ----------------------  ----------------------  -----------------------------------------------
T7 ----------------------  ---------------------- ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T8 ----------------------  ----------------------  ---------------------- ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
T 9 ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  GCTGTTCACG CGCACAGTGC ATCCATCAGT GCAACTCCGC ACCACGCCAT CATCAGCAAC ACACCCCCTA AAAAAAAAAA
c o p y 2  GCTGTTCACG CGCACAGTGC ATCCATCAGT GCAACTCCGC ACCACGCCAT CATCAGCAAC ACACCCCCTA AAAAAAAAAA
2 5 7 0  2 5 8 0  2 5 9 0  2 6 0 0  2 6 1 0  2 6 2 0  2 6 3 0
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T 1 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- -------------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T3 ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
T4 ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- -------------------------
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T7 ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- -------------------------
T8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------T9 ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------
c o p y l  CCCAGTATTC CTTCCATGAC ACGTCACTCA TCTCATCTCA TCGCATTTTT GCATTCCTGC ATCGCTTGCA TCCTCCGCCT
c o p y 2  CCCAGTATTC CTTCCATGAC ACGTCACTCA TCTCATCTCA TCGCATTTTT GCATTCCTGC ATCGCTTGCA TCCTCCGCCT
2 6 5 0  2 6 6 0  2 6 7 0  2 6 8 0  2 6 9 0  2 7 0 0  2 7 1 0  2 7 2 0
T 1  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 4  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6        — -------------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 8  ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------Tg ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------
c o p y l  AACCGCACAA AATCACACAC TAACTATTTT CGATACCCGA ATCAAATATT AACTATATTT GAATCCTTAA CTTTGTCAAT
c o p y 2 AACCGCACAA AATCACACAC TAACTATTTT CGATACCCGA ATCAAATATT AACTATATTT GAATCCTTAA CTTTGTCAAT
2 7 3 0  2 7 4 0  2 7 5 0  2 7 6 0  2 7 7 0  2 7 8 0  2 7 9 0  2 8 0 0
T 1  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 5  ---------------------- -------------------------  ----------------------  ----------------------------------------------- -------------------------  ---------------------- -------------------------
T 6               - - -
T 7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- -------------------------
c o p y l  CGAAAGAATC TTTTGCATCT GAAAAGAAAG AGCACTAAAG TCAAAGATAG ATCGGAATTA AAACGAAGTT GCAACAAGAA
c o p y 2  CGAAAGAATC TTTTGCATCT GAAAAGAAAG AGCACTAAAG TCAAAGATAG ATCGGAATTA AAACGAAGTT GCAACAAGAA
2 8 1 0  2 8 2 0  2 8 3 0  2 8 4 0  2 8 5 0  2 8 6 0  2 8 7 0  2 8 8 0
T 1  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 2  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------
T 3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 6  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 7 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8 ---------------------- ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------T9 ------------ ------------ ------------ ------------ ------------ ------------ --------------------------
c o p y l  GTGCATAATC AGATATTTCG ACTGAAATAA GCTATTTAAA ATATTTAAAA AATATTTCAA ACATATCTTG TAGTGTGTGC
c o p y 2 GTGCATAATC AGATATTTCG ACTGAAATAA GCTATTTAAA ATATTTAAAA AATATTTCAA ACATATCTTG TAGTGTGTGC
2 8 9 0  2 9 0 0  2 9 1 0  2 9 2 0  2 9 3 0  2 9 4 0  2 9 5 0  2 9 6 0
T 1  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 2 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
T 4  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 6 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 7 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  TTTTGTGTGT GTTGCTTTGT AAAATCCTTT GTACTTTAGT TGAAGTTGAT TTTGTTCCGC TGTTCCTTAG AAATGTATTT
c o p y 2  TTTTGTGTGT GTTGCTTTGT AAAATCCTTT GTACTTTAGT TGAAGTTGAT TTTGTTCCGC TGTTCCTTAG AAATGTATTT
2 9 7 0  2 9 8 0  2 9 9 0  3 0 0 0  3 0 1 0  3 0 2 0  3 0 3 0  3 0 4 0
T 1 ---------------------- -------------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3        ATTGT TGCCTAGAGT TTTCATTTGC TGACGCTGCT GTCGCCTGTC
T 4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------T5              ------------
T 6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
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T7
T8
T9
c o p y l  
c o p y  2
■ATTGT TGCCTAGAGT TTTCATTTGC TGACGCTGCT GTCGCCTGTC
ATGATTAACC ATAGCTACAA ACGTTGCTCC TCCAGATTGT TGCCTAGAGT TTTCATTTGC TGACGCTGCT GTCGCCTGTC 
ATGATTAACC ATAGCTACAA ACGTTGCTCC TCCAGATTGT TGCCTAGAGT TTTCATTTGC TGACGCTGCT GTCGCCTGTC
3 0 5 0  3 0 6 0  3 0 7 0  3 0 8 0  3 0 9 0  3 1 0 0  3 1 1 0  3 1 2 0
X I  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ------------------------------------
X2 ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
T3 GCCCGTTGCC TCCTGCCTGC CTGCTCTGCT CCTGCCTCCT GGCATCCCGC ATCCTGCATC CTGGCACCTG CCAACCGACA
1 4  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
X5 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
X6 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------
T7 GCCCGTTGCC TCCTGCCTGC CTGCTCTGCT CCTGCCTCCT GGCATCCCGC ATCCTGCATC CTGGCACCTG CCAACCGACA
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  GCCCGTTGCC TCCTGCCTGC CTGCTCTGCT CCTGCCTCCT GGCATCCCGC ATCCTGCATC CTGGCACCTG CCAACCGACA
c o p y 2 GCCCGTTGCC TCCTGCCTGC CTGCTCTGCT CCTGCCTCCT GGCATCCCGC ATCCTGCATC CTGGCACCTG CCAACCGACA
 |  |
3 1 3 0  3 1 4 0  3 1 5 0  3 1 6 0  3 1 7 0  3 1 8 0  3 1 9 0  3 2 0 0
X I  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
1 2              ----------------------
T3 CCTGCTCCTC CCGACCCAAC CGTAGCATCT AAC---------------- ----------------------  ----------------------  ----------------------  ----------------------
X4 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
15 ----------- ----------- ----------- -----------------------  ----------- -----------------------
16             ----------
T 7 CCTGCTCCTC CCGACCCAAC C---------------------------------------------  ----------------------  ----------------------  ---------------------- -------------------------
X8 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
X9 ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- -------------------------
c o p y l  CCTGCTCCTC CCGACCCAAC CGTAGCATCT AACCCGCCCG CTAATAATCT TCACTTCCGT CAGTGATTGT CCGTTCTGCT
c o p y 2 CCTGCTCCTC CCGACCCAAC CGTAGCATCT AACCCGCCCG CTAATAATCT TCACTTCCGT CAGTGATTGT CCGTTCTGCT
3 2 1 0  3 2 2 0  3 2 3 0  3 2 4 0  3 2 5 0  3 2 6 0  3 2 7 0  3 2 8 0
X I  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
X2 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------
13 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
14 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
15 ----------- ----------- ----------- ----------- -----------------------  -----------------------
16              ----------
17  ----------------------  ----------------------  ---------------------- ---------------------- ----------------------  ----------------------  ---------------------- ----------------------18              ----------
X9 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  GTCGCTTACT CTACCAACTC TATAGTAGGT CAGGGGTTAG CCAATATATA TGCATATATA TCTTTCTAGA AGATTTGAAG
c o p y 2 GTCGCTTACT CTACCAACTC TATAGTAGGT CAGGGGTTAG CCAATATATA TGCATATATA TCTTTCTAGA AGATTTGAAG
3 2 9 0  3 3 0 0  3 3 1 0  3 3 2 0  3 3 3 0  3 3 4 0  3 3 5 0  3 3 6 0
X I  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------
1 2                ----------------------
1 3  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- -------------------------
X4 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------  ----------------------
15 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
16            ----------
1 7  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- ------------------------- -------------------------
X8 ----------------------  ----------------------  ---------------------- ---------------------- ------------------------- -------------------------  ----------------------  ----------------------
1 9  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  ATAGCGATTT CACAAGATCT GATAAAGTGT TTGGATGATA CATCACATCA ATTTGTCATT TGTAATCAGC AAAAGGCGCT
c o p y 2  ATAGCGATTT CACAAGATCT GATAAAGTGT TTGGATGATA CATCACATCA ATTTGTCATT TGTAATCAGC AAAAGGCGCT
3 3 7 0  3 3 8 0  3 3 9 0  3 4 0 0  3 4 1 0  3 4 2 0  3 4 3 0  3 4 4 0
X I ------------ ------------------------- -------------  ------------ ------------ ------------ ------------
X2 ----------------------  ----------------------  -----------------------------------------------  ----------------------  ----------------------  ---------------------- -------------------------
13 ----------- ----------------------- ------------  ----------- ----------- -----------------------
X4 ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
15 ----------- ----------- ----------------------- ------------ ------------  ---------------- -------
16             -----------
17 ----------- ----------- -----------------------  ----------- ----------- -----------------------
X8 ---------------------- ---------------------- -------------------------  ----------------------------------------------- -------------------------  ---------------------- -------------------------
X9 ---------------------- ----------------------  ----------------------------------------------- ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  AATCAAAAAT TTCACCACTT GTACGCTTGG GCTATTAAAA CCCTAGAAGT TTCTGGAGGT TGAATTAAAC AATTTAATTG
c o p y 2 AATCAAAAAT TTCACCACTT GTACGCTTGG GCTATTAAAA CCCTAGAAGT TTCTGGAGGT TGAATTAAAC AATTTAATTG
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3 4 5 0  3 4 6 0  3 4 7 0  3 4 8 0  3 4 9 0  3 5 0 0  3 5 1 0  3 5 2 0
T 1 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2-------------- ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T3 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- ------------------------- -------------------------
T 4  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T6-------------- ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T7 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 8 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 9 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
c o p y l  TTTGAAAGAA CAAATGTAGT TTTTACTTGC ATAGATATTA AACTCACTCA ACATTTTGGT CATACGTCGT TTTAGACGAA
c o p y 2 TTTGAAAGAA CAAATGTAGT TTTTACTTGC ATAGATATTA AACTCACTCA ACATTTTGGT CATACGTCGT TTTAGACGAA
3 5 3 0  3 5 4 0  3 5 5 0  3 5 6 0  3 5 7 0  3 5 8 0  3 5 9 0  3 6 0 0
T 1 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6 ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------
T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T9 ----------------------  ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  TCACACCTGT AGTTAGGAAG CCCCACATGG AGAGCCCACA GCTGTACTGC AGATAGGGTT ACAGATAGGG ATACGCTGAT
c o p y 2 TCACACCTGT AGTTAGGAAG CCCCACATGG AGAGCCCACA GCTGTACTGC AGATAGGGTT ACAGATAGGG ATACGCTGAT
3 6 1 0  3 6 2 0  3 6 3 0  3 6 4 0  3 6 5 0  3 6 6 0  3 6 7 0  3 6 8 0
T 1 ---------------------- -------------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
T 2 ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 4 ---------------------- -------------------------  ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
T 5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 9 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
c o p y l  ATAGATACGC CTGGTAATTG TTTATTTAAA GTCGAGGCGT GTGCGATAAC AGACCCAATA AGTGCATTTG TGGGTGCAAA
c o p y 2 ATAGATACGC CTGGTAATTG TTTATTTAAA GTCGAGGCGT GTGCGATAAC AGACCCAATA AGTGCATTTG TGGGTGCAAA
3 6 9 0  3 7 0 0  3 7 1 0  3 7 2 0  3 7 3 0  3 7 4 0  3 7 5 0  3 7 6 0
T 1  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ---------------------- ---------------------- -------------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T3 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- ----------------------
T4 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6  ----------------------  ----------------------  ----------------------  -----------------------------------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T9 ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
c o p y l  ATGTTTGTCT TCAATTACAA ATTCAAGACT CGAATTTATG AAATGCCAGC AGAACTCAAA ACACTTTCAT GCACGTTTCG
c o p y 2 ATGTTTGTCT TCAATTACAA ATTCAAGACT CGAATTTATG AAATGCCAGC AGAACTCAAA ACACTTTCAT GCACGTTTCG
3 7 7 0  3 7 8 0  3 7 9 0  3 8 0 0  3 8 1 0  3 8 2 0  3 8 3 0  3 8 4 0
T 1 ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
T4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T5 ---------------------- -------------------------  ----------------------  -----------------------------------------------  ----------------------  ---------------------- -------------------------
T 6 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T7 ---------------------- -------------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T 8 ----------------------  ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ---------------------- -------------------------
T9 ----------------------  ---------------------- ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  AGTTTTTAGC TGTTTGTCTA TTTGTTTAAT TGCCGGCAAT GGTGACGTAA ACATAATTAT AAACAGATTA TATCAGAGCA
c o p y 2  AGTTTTTAGC TGTTTGTCTA TTTGTTTAAT TGCCGGCAAT GGTGACGTAA ACATAATTAT AAACAGATTA TATCAGAGCA
3 8 5 0  3 8 6 0  3 8 7 0  3 8 8 0  3 8 9 0  3 9 0 0  3 9 1 0  3 9 2 0
T 1 ---------------------- -------------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------------------  ----------------------  ----------------------  -----------------------------------------------  ----------------------  ----------------------  ----------------------
T3 ---------------------- -------------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------
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T4 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T5 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T6 ----------------------- ------------  ----------- ----------- ----------- -----------------------
T7 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T8 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T9 ----------- ----------- -----------------------  -----------------------  ----------- -----------
c o p y l  TGTTTATAAA ATAGTCAAAT TACCAGCTGC AAATGGGCTA ATAACTTGTT ATTACTTCGT CATGCTTAGT TACATATGGA
c o p y 2 TGTTTATAAA ATAGTCAAAT TACCAGCTGC AAATGGGCTA ATAACTTGTT ATTACTTCGT CATGCTTAGA TACATATGGA
3 9 3 0  3 9 4 0  3 9 5 0  3 9 6 0  3 9 7 0  3 9 8 0  3 9 9 0  4 0 0 0
T1  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------- ----------- ----------- ----------- ----------- ----------------------- ------------
T3 ----------- ----------- ----------- ----------- ----------- ----------- ---------------- ------
T4 ----------------------- ------------ ------------  ----------- ----------- -----------------------
T5 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T6 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T7 ----------------------- ------------  ----------- ----------- ----------- -----------------------
T8 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T9 ----------------------- ------------  ----------- ----------- ----------- -------------------------
c o p y l  AAATAGGTAT TAGTAGTAGT ATTATTATTA TTATTTCATT CAATAACAGC TTGTAGTCAT ATCGGAAATA TTTAAACAAT
c o p y 2 AAATAGGTAT TAGTAGTAGT ATTATTATTA TTATTTCATT CAATAACAGC TTGTAGTCAT ATCGGAAATA TTTAAACAAT
4 0 1 0  4 0 2 0  4 0 3 0  4 0 4 0  4 0 5 0  4 0 6 0  4 0 7 0  4 0 8 0
T 1  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ---------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
T3 ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 5 ---------------------- ------------------------- ------------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 6 ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------
T 8 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- ----------------------
T9 ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
c o p y l  TTGAAACTGG CGGCGTTTGT GGCGAAATAT TTGGAGTCTT TCATGGCCCT AAAAATTATA GAGTTAATAG CATTGGGAGA
c o p y 2  TTGAAACTGG CGGCGTTTGT GGCGAAATAT TTGGAGTCTT TCATGGCCCT AAAAATTATA GAGTTAATAG CATTGGGAGA
4 0 9 0  4 1 0 0  4 1 1 0  4 1 2 0  4 1 3 0  4 1 4 0  4 1 5 0  4 1 6 0
T1 ------------------  ------------------  ------------------  ------------------  ------------------  ------------------  ------------------  -------------------
T2 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T3 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T4 ----------- -----------------------  ----------- ----------- ----------- -----------------------
T5 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T6 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T7 --------------- ------- ------------  ----------- ----------- ----------- ----------- -----------
T8 ----------- ----------------------- ------------  ----------- ----------- -----------------------
T9 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
c o p y l  TGCATCGTTT CTTGCACCAT TTCTCGCCTC TCTCTCTCTC TCCGTCTCTT TTTGAATATA TATAATTAAA AATTCGCACC
c o p y 2 TGCATCGTTT CTTGCACCAT TTCTCGCCTC TCTCTCTCTC TCCGTCTCTT TTTGAATATA TATAATTAAA AATTCGCACC
4 1 7 0  4 1 8 0  4 1 9 0  4 2 0 0  4 2 1 0  4 2 2 0  4 2 3 0  4 2 4 0
T 1  ---------------------- ------------------------- -------------------------  ---------------------- ---------------------- ------------------------- ------------------------- -------------------------
T2 ----------- -----------------------  ----------- ----------- ----------- ----------- -----------
T3 ----------- -----------------------  ----------- ----------- ----------- ----------- -----------
T4 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------T5 ------------ ------------------------- -------------  ------------ ------------ --------------------------
T6 ----------- ----------- ----------- ----------- ----------- ----------------------- ------------
T7 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T8 ----------- ----------- -----------------------  ----------- ----------- ----------- -----------
T9 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
c o p y l  TGCCTCATCC TACATATATA TACATATATA TATATAGTAA AATTGTTGTT TTATTTATGA GTCGAACTAA TGTCCCGTCA
c o p y 2 TGCCTCATCC TACATATATA TACATATATA TATATA  -----------------------  ----------------------  ----------------------  ----------------------
4 2 5 0  4 2 6 0  4 2 7 0  4 2 8 0  4 2 9 0  4 3 0 0  4 3 1 0  4 3 2 0
T 1 ----------------------  ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T3 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T4 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T5 --------------------- ----------- ----------- ----------- ----------- -----------------------
T6 ----------- ----------- ----------- -----------------------  ----------- -----------------------
T7 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T8 ----------- ----------- ----------- -----------------------  ----------- -----------------------Tg ------------ ------------ ------------ ------------ ------------ ------------ --------------------------
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c o p y l  GTTGACTAAG GACAACGCCA AGAAATAAAA AATAGTTTTT AGGAGAAATA GTTTCACGAC TTTATTCTTT GGATCTCAGC 
c o p y 2  ---------------------- ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
4 3 3 0  4 3 4 0  4 3 5 0  4 3 6 0  4 3 7 0  4 3 8 0  4 3 9 0  4 4 0 0
T 1 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------12               ----------
T3 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T4 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T6-------------- ---------------------- -------------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
T7 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T8 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------  ----------------------
T 9 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ------------
c o p y l  TTAAGACTAA AAATCAAATG CAAATTGGAT TGAGGAGAAG CCTCAGTATT TGAACAATAT TTGTATTTCG GGAGAGCCTC 
c o p y 2  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
4 4 1 0  4 4 2 0  4 4 3 0  4 4 4 0  4 4 5 0  4 4 6 0  4 4 7 0  4 4 8 0
T 1  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
12                --------------------
T 3   — -------------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
T 4 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------
T 5 ---------------------- -------------------------  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------  ----------------------
T 6  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 8 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------
c o p y l  GCTCTTGGGT TCTTAAGATT AGGTAGCGTT GAAAGAGGGC AGTCAAATCT GCTTAGGTCA GGCTTTAGGA TGTTTACAAG 
c o p y 2  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
4 4 9 0  4 5 0 0  4 5 1 0  4 5 2 0  4 5 3 0  4 5 4 0  4 5 5 0  4 5 6 0
T 1  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------  ----------------------
T 2 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 4  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
T 5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6 ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 7 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 9  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------
c o p y l  AACGGCTGCG CTGCCAAAGA TAAACGAATG TTGCGCAGCT GGGATACGTT ATGGAAAATT ACTAGAGTGC ATTACTGATT 
c o p y 2  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
4 5 7 0  4 5 8 0  4 5 9 0  4 6 0 0  4 6 1 0  4 6 2 0  4 6 3 0  4 6 4 0
T 1  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 2 ---------------------- -------------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ---------------------------------- ----------------
T 4  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 5 ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 7 ----------------------  ---------------------- ---- -------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------
T 8  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 9 ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------
c o p y l  TCTTTGAAAT AATGGAAGTG GCTGGTTTGG ACCACCCAAA TACGTCACTC CCCTTCCCTT AAAGAGAAGC CTATACTTGG 
c o p y 2  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
4 6 5 0  4 6 6 0  4 6 7 0  4 6 8 0  4 6 9 0  4 7 0 0  4 7 1 0  4 7 2 0
T 1 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------
T 2 ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T3 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T4 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------
T5 ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- ------------------ ----------------------
T 6 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T7 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  GCTGGGATTG ATGGATATAG TGTGGGAAAT GGAGTTTCTT CTATTTCTGT TTGTTGTGGT GTGTTTTGAT TTTGATTTTT 
c o p y 2  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
4 7 3 0  4 7 4 0  4 7 5 0  4 7 6 0  4 7 7 0  4 7 8 0  4 7 9 0  4 8 0 0
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T1 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T2 ----------- ----------- ----------- ----------- ----------- ----------------------- ------------
T3 ----------- ----------- ----------- ----------------------- ------------  -----------------------
T4 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------T5 ------------ ------------  ------------ ------------  ------------ ------------------------- --------------
T6 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T7 -----------------------  ----------- ----------------------- ------------  ----------- -----------
T8 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------Tg ------------ ------------  ------------ ------------  ------------ ------------ --------------------------
c o p y l  TCTTATTTTA AGTTTTGCAT ACAGCATCAT AAATGGTTTA AATGATACAT ATCTTAAATA TGAGTACAAC AAAATTAGTG 
c o p y 2  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
4 8 1 0  4 8 2 0  4 8 3 0  4 8 4 0  4 8 5 0  4 8 6 0  4 8 7 0  4 8 8 0
T 1  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------- ----------- ----------- ----------------------- ------------  ----------- -----------
T3 ----------- -----------------------  ----------- ----------- ----------- -----------------------
T4 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T5 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T6 ----------- ----------- ----------------------- ------------ ------------  -----------------------
T7 ----------- -----------------------  -----------------------  ----------------------- ------------
T8 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T9 -----------------------  ----------- ----------- ----------- ----------- ----------- -----------
c o p y l  CGATTATTAC AATGATCATT TGTATGTAAA GTGTAATATT GTTCTCTGAA ATCATCTCAA CAATGTCGTT GTGTTTTACA 
c o p y 2  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
4 8 9 0  4 9 0 0  4 9 1 0  4 9 2 0  4 9 3 0  4 9 4 0  4 9 5 0  4 9 6 0
T 1 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T3 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T4 ----------- -----------------------  ----------- -----------------------  -----------------------
T5 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T6 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T7 ----------- -----------------------  ----------------------- ------------  ----------- -----------
T8 -----------------------  ----------- ----------- ----------- ----------- -----------------------
T9 ----------- ----------- ----------- ----------- -----------------------  ----------- -----------
c o p y l  ATTTTTATTT TTGTTATATT AAGTGGTGTG TATAGTGGTG TCAAATCTAT TTCTGGTTCT AACAGATTTT CACTTAAATT 
c o p y 2  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ------------ ----------------------------------
4 9 7 0  4 9 8 0  4 9 9 0  5 0 0 0  5 0 1 0  5 0 2 0  5 0 3 0  5 0 4 0
T 1 ----------------------  ---------------------- ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- ----------------------
T2 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T3 ----------- ----------- ----------- ----------- ----------- ----------- — -------  -----------
T4 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T5 ----------- ----------- -----------------------  ----------- ----------- ----------- -----------
T6 ----------- ----------- ----------------------- ------------  ----------------------- ------------
T7 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T8              --
T9 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
c o p y l  ATATTATTGA TTTCTATTTT GCATTGCGTT ACTCTTATCA TTTTGTTTCC TTCTATTTTT ATTTTATTAA TTGAATTTTG  
c o p y 2  ----------------------  ----------------------  ---------------------- ---------------------- -------------------------  ----------------------  -----------------------------------------------
5 0 5 0  5 0 6 0  5 0 7 0  5 0 8 0  5 0 9 0  5 1 0 0  5 1 1 0  5 1 2 0
T1 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T2 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T3 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T4 ----------- ----------- ----------- -----------------------  ----------- -----------------------
T5 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T6 ----------- ----------------------- ------------ ------------  ----------- ----------- -----------
T7 ----------- -----------------------  ----------- ----------- ----------- -----------------------
T8 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T9 ----------- -----------------------  ----------- -----------------------  ----------- -----------
c o p y l  GCAATTTTGG TTAAGAATTG TTTGGGTTAA GTTCCAGGTT ACAATTGTGT TTGGTTCTAT GTATTTTATT ATTTCGTTCG 
c o p y 2  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
5 1 3 0  5 1 4 0  5 1 5 0  5 1 6 0  5 1 7 0  5 1 8 0  5 1 9 0  5 2 0 0
T1 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T2 ----------- ----------- ----------- ----------- ----------- ---------------- ------ ------------
T3 ----------------------- ------------ ----------- - ----------- ----------- ----------- -----------
T4 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T5 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T6 ----------- ----------- ----------------------- ------------  ----------- ----------- -----------
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T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T8 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------Tg ------------ ---------------------------------------  ------------ ------------ --------------------------
c o p y l  TGTGTACTGG CTTAAAATTA CAAATTGGAT TTAAGTGTTT AATAATATTG GTGACACATT CATTTTTTAC TTCTTTATTT  
c o p y 2  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
5 2 1 0  5 2 2 0  5 2 3 0  5 2 4 0  5 2 5 0  5 2 6 0  5 2 7 0  5 2 8 0
T 1  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ---------------------- ------------------------- ------------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
T4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 5 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- ----------- -------------- ------------
T 6 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
T 7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------
c o p y l  TCGGTATTAT AAACTTTATT TTCTTTTTCA AAATATGATT GTGTGTCTGT GTAATCTAGC TGATAGCCGT TGGAGTCTGG 
c o p y 2  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
5 2 9 0  5 3 0 0  5 3 1 0  5 3 2 0  5 3 3 0  5 3 4 0  5 3 5 0  5 3 6 0
T l  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------
T2 ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- ----------------------  ---------------------- -------------------------
T3 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------
T4 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 6  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------
T9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  GTAAGGAATT ATTTTAATTG TGCTTATTAG TGAAAGGTAA ATGGGTATGT GGGATATGAT TAATACTTGG TTATCATTGT 
c o p y 2  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------
5 3 7 0  5 3 8 0  5 3 9 0  5 4 0 0  5 4 1 0  5 4 2 0  5 4 3 0  5 4 4 0
Tl ----------- ----------- ----------- ----------------------- ------------  -----------------------
T2 ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  AGTTAATCCA AGTGGATGTT TTAATGTTCA AAATGTTTTG GCTGTTCACA TTTTCAAGTT TGTCGTAGTT TAGTAATTTG 
c o p y 2  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
5 4 5 0  5 4 6 0  5 4 7 0  5 4 8 0  5 4 9 0  5 5 0 0  5 5 1 0  5 5 2 0
T l  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T2 ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ---------------------- -------------------------
T4 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 5 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 8 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  GGGTTAAACA GTCCAAGTCT GGAAAGCTGC ATAGCCATTT CCAAATCTTC TATGTATTCC GTAAACTGCA TTAGTTCGAA 
c o p y 2  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
5 5 3 0  5 5 4 0  5 5 5 0  5 5 6 0  5 5 7 0  5 5 8 0  5 5 9 0  5 6 0 0
T l  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- ------------------------- -------------------------
T 4 ----------------------  ---------------------- ---------------------- ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T5 ----------------------  ----------------------  -----------------------------------------------  ----------------------  ---------------------- ------------------------- -------------------------
T 6 ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8 ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T9 ----------------------  ----------------------  -----------------------------------------------  ----------------------  ---------------------- ------------------------- -------------------------
c o p y l  CAAAAGACTG TCAATGATGG TGTGGTTATT TTCATAATTC TGTATTTTTT GCATTCCGTC ATTTATCAAT CGTATGGCGT 
c o p y 2  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
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5 6 1 0  5 6 2 0  5 6 3 0  5 6 4 0  5 6 5 0  5 6 6 0  5 6 7 0  5 6 8 0
T l  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 3     —          -------------------------------
T 4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T5 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------
T 6 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------
T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------
T 9 ---------------------- -------------------------  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------
c o p y l  CGTTGAGTTC ATGTAATTTT ACTGAGTTAT GGACGTTGAT TTCAAGTTTT TTCTGTATTT CGACTCGATC ATTTTCATCT 
C o p y 2  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
5 6 9 0  5 7 0 0  5 7 1 0  5 7 2 0  5 7 3 0  5 7 4 0  5 7 5 0  5 7 6 0XI ------------ ------------ ------------ -------------------------  ------------ --------------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------
T 4  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------
T6 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  AGTGTTCCAA ATAGGTATTT AAAACCTGAA CCCACAATGT TAATAAGACC CCGTTTGTTT CTATGTTTCA GGGTTATTCC 
c o p y 2  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
5 7 7 0  5 7 8 0  5 7 9 0  5 8 0 0  5 8 1 0  5 8 2 0  5 8 3 0  5 8 4 0
X I  ------------ ------------ ------------ ------------ -------------------------  ------------ ------------
X2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
13 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
1 4  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
1 5  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- ----------------------
16              ----------
X7 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------
18               ----------
X9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  GGCTAGTTCT CTTTTTATTT TATTGTATAA AAAATTGATC TGGGGTGCAT GGTAATCGGT TCGTAGTCTT TGCTCAAAAT 
c o p y 2  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
5 8 5 0  5 8 6 0  5 8 7 0  5 8 8 0  5 8 9 0  5 9 0 0  5 9 1 0  5 9 2 0
X I  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
1 2               ----------------------
X3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
14  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
X 5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
X6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------
17  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
18             ----------
X9 ----------------------  ---------------------- -------------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  AGTCAACCAC GATGTCTATT TCAGTTAAAT TGATTTTTAA GGAGTGATGT TCAAAGGAGG ATGGTATCTG TACTGGCTTA 
c o p y 2  ---------------------- ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
5 9 3 0  5 9 4 0  5 9 5 0  5 9 6 0  5 9 7 0  5 9 8 0  5 9 9 0  6 0 0 0
X I  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
X2 ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
13 ----------- ----------- -----------------------  ----------- ----------- ----------- -----------
14 ----------- -----------------------  ----------- ----------- ----------- -----------------------
1 5  ----------------------  ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ---------------------- -------------------------
X6 ----------------------  ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ---------------------- -------------------------
X7 --------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
18               ----------
X9 ---------------------- -------------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- ----------------------
c o p y l  TCAGAAAAAA GGAGATATCC GTGGTTGGTG TCAATATTAT TAATTTGAAT TTGTTGTCCA TGAACAGCTG TGATCAGTAT 
c o p y 2  -----------------------------------------------  ----------------------  ---------------------- ---------------------- ------------------------- ------------------------- -------------------------
6 0 1 0  6 0 2 0  6 0 3 0  6 0 4 0  6 0 5 0  6 0 6 0  6 0 7 0  6 0 8 011 -------------------------  ------------ ------------ ------------ ------------ --------------------------
12               ----------
13 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
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T4 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T5 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T6 ----------- ---------------- ------ ------------  ----------- ----------- ----------- -----------
T7 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T8 ----------------------- ------------  ----------- ----------- ----------- -----------------------
T9 ----------- ----------- ----------- ----------- ----------- ----------- ----------- ------------
c o p y l  AAACAATAGT GTTATCGGGT ACCAGGTGCC TGTGAAATTG AGAGTTTATT ATTTTTCTTT TGTTTTTTGA ATTGTGTTTT 
c o p y 2  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ---------------------- -------------------------
6 0 9 0  6 1 0 0  6 1 1 0  6 1 2 0  6 1 3 0  6 1 4 0  6 1 5 0  6 1 6 0
T l  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------
T2 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T3 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T4 ----------- -----------------------  ----------- -----------------------  -----------------------
T5 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T6 ----------- -----------------------  ----------- ----------- ----------- -----------------------
T7 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T8 ----------- -----------------------  ----------- -----------------------  -----------------------
T9 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
c o p y l  GTAGTAGTGC GTAACTCTAT TTCTATTAGT GATTTTGTAA TGGTCAGGGT CTGTTTGTTC TACATTTTTG GTTGGTTTAA 
c o p y 2  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
6 1 7 0  6 1 8 0  6 1 9 0  6 2 0 0  6 2 1 0  6 2 2 0  6 2 3 0  6 2 4 0
T l  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------- ----------- ----------- -----------------------  ----------- -----------------------
T3 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T4 ----------- -----------------------  ----------- ----------- ----------- -----------------------
T5 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T6 ----------------------- ------------  ----------- ----------- ----------- -----------------------
T7 ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
T8 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T9 -----------------------  ----------- ----------- ----------- ----------- -----------------------
c o p y l  ATGGGTTTTC TAATTTGCCT TTCTGTAGTG GACCTTTTCT GTAATTAGTG TCAATATTAA ATTCCTGTCT GTCTTCATTT 
c o p y 2  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
6 2 5 0  6 2 6 0  6 2 7 0  6 2 8 0  6 2 9 0  6 3 0 0  6 3 1 0  6 3 2 0
T l  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T2 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T3 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T4 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T5 ----------- ----------------------- ------------  ----------- ----------- ----------- -----------
T6 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T7 ----------- -----------------------  ----------- ----------- ----------- -----------------------
T8 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T9 ----------- -----------------------  ----------- ----------- ----------- -----------------------
c o p y l  ATTTTGTCTA TTTTCTTCTC TTTAATTTTT TGAGTGTCTA ATATGGGATG CCCAGCGTAT AAGAAAATTT GAGCAGGTGT 
c o p y 2  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
6 3 3 0  6 3 4 0  6 3 5 0  6 3 6 0  6 3 7 0  6 3 8 0  6 3 9 0  6 4 0 0
T l  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T2 ----------- -----------------------  ----------- ----------- ----------- -----------------------
T3 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T4 ----------- ----------- -----------------------  ----------- ----------- ----------- -----------
T5 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T6 -----------------------  ----------- ----------- -----------------------  -----------------------
T7 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T8 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T9 -----------------------  ----------- ----------- ----------- ----------- ----------- -----------
c o p y l  CTGTCCAGTA GTGTCATGTT TAATTTTATG GTTGTATGTG TAGAGGATTG TTTCTATCTT GCTTAATTTT ACTTCTTCAT 
c o p y 2  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
6 4 1 0  6 4 2 0  6 4 3 0  6 4 4 0  6 4 5 0  6 4 6 0  6 4 7 0  6 4 8 0
T l  ---------------------- -------------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
T2 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T3 -----------------------  ----------- -----------------------  ----------- ----------- -----------
T4 ----------- ----------- ----------- -----------------------  ----------- ----------- -----------
T5 ----------- ----------- ----------- ----------- ----------- ----------- -----------------------
T6 ----------------------- ------------  ----------- ----------- ----------- ----------- -----------
T7 ----------- ----------- -----------------------  ----------- ----------- -----------------------
T8 ----------- -----------------------  ----------------------- ------------  -----------------------
T9 ----------------------- ------------ ------------  ----------- ----------- ----------- -----------
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c o p y l  CATCAGATGA ATTGATTATA CGAATTTTTT CATTTATTGT TTTGTGTAAT CTTTCGACGT CTGCTACCCC GTTTTTTGCT 
c o p y 2  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------
6 4 9 0  6 5 0 0  6 5 1 0  6 5 2 0  6 5 3 0  6 5 4 0  6 5 5 0  6 5 6 0
T l ------------------------------------ -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ------------------------------------
T2 -------------------------  ------------ ------------ ------------------- ------------------- --------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- --------------------------------------------------
T4-------------- ---------------------- -------------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T5-------------- ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 6 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- ------------------------- -------------------------
T7 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ------------------------------------
T8-------------- ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T9-------------- ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  GTATTGAGCT GTAATCCTAC CGACTGCGCC AGTAAAATTG TTGTTTTATT TATGAGTCGA ACTAATGTCC CGTCAGTTGA 
c o p y 2  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------  ----------------------  -----------------------------------------------
6 5 7 0  6 5 8 0  6 5 9 0  6 6 0 0  6 6 1 0  6 6 2 0  6 6 3 0  6 6 4 0
T l  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T2 ------------ ------------ ------------ -------------------------  ------------ --------------------------
T3 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T 4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 5 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  -----------------------------------------------
T 6  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T 7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8  ----------------------  ----------------------  ---------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  CTAAGGACAA CGCCAAGAAA TAAAAAATAG TTTTTAGGAG AAATAGTTTC ACGACTTTAT TCTTTGGATC TCAGCTTAAG 
c o p y 2  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------
6 6 5 0  6 6 6 0  6 6 7 0  6 6 8 0  6 6 9 0  6 7 0 0  6 7 1 0  6 7 2 0
T l  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------
T 2 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 3 ------------ ------------ ------------ ------------ ------------ ------------ --------------------------
T 4  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------
T 5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 6  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 7 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  -----------------------------------------------
T 8 ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 9 ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ---------------------- -------------------------
c o p y l  ACTAAAAATC AAATGCAAAT TGGATTGAGG AGAAGCCTCA GTATTTGAAC AATATTTGTA TTTCGGGAGA GCCTCGCTCT
c o p y 2  ---------------------- ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
6 7 3 0  6 7 4 0  6 7 5 0  6 7 6 0  6 7 7 0  6 7 8 0  6 7 9 0  6 8 0 0
T l  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- ----------------------
T2 ----------------------- ------------ ------------ ------------ ------------  --------------------------
T3 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 4 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T 5  ---------------------- -------------------------  ----------------------  ---------------------- ----------------------  ----------------------  -----------------------------------------------
T 6 ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
T 7 ----------------------  ---------------------- ------------------------- ------------------------- ----------------------  ----------------------  ----------------------  ----------------------
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T9 ----------------------  ----------------------  ----------------------  -----------------------------------------------  ----------------------  ----------------------  ----------------------
c o p y l  TGGGTTCTTA AGATTAGGTA GCGTTGAAAG AGGGCAGTCA AATCTGCTTA GGTCAGGCTT TAGGATGTTT ACAAGAACGG 
c o p y 2  -----------------------------------------------  ----------------------  ---------------------- ----------------------  ---------------------- ------------------------- -------------------------
6 8 1 0  6 8 2 0  6 8 3 0  6 8 4 0  6 8 5 0  6 8 6 0  6 8 7 0  6 8 8 0
T l  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  -----------------------------------------------
T2 ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ---------------------- -------------------------
T4 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ---------------------- ------------------------- -------------------------
T5 ---------------------- ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T 6  ---------------------- ------------------------- -------------------------  ---------------------- ----------------------  ----------------------  -----------------------------------------------
T7 ---------------------- ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T8 ---------------------- ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------------------------------- -------------------------  ---------------------- -------------------------
c o p y l  CTGCGCTGCC AAAGATAAAC GAATGTTGCG CAGCTGGGAT ACGTTATGGA AAATTACTAG AGTGCATTAC TGATTTCTTT 
c o p y 2  ---------------------- ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ---------------------- -------------------------
6 8 9 0  6 9 0 0  6 9 1 0  6 9 2 0  6 9 3 0  6 9 4 0  6 9 5 0  6 9 6 0
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Tl ------------ ------------ ------------ -------------------------  ------------ ------------ ------------
T2 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  --------------------- -------------------------  ----------------------
T3 ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 4 ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T6 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------
T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T8 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  GAAATAATGG AAGTGGCTGG TTTGGACCAC CCAAATACGT CACTATATAT ATATATATAT GCACGTATAT ATCTATGGAC
c o p y 2 ----------------------  ----------------------  ----------------------  ---------------------- ------------------ TAT ATATA T GCACGTATAT ATCTATGGAC
6 9 7 0  6 9 8 0  6 9 9 0  7 0 0 0  7 0 1 0  7 0 2 0  7 0 3 0  7 0 4 0
T l  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 2 ---------------------- ------------------------- -------------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------T3 ----------  ----------  ----------  ----------  ----------  ----------  ----------  ----------
T4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 5 ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------
T 6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------
T 8 ----------------------  ---------------------- -------------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  GAGGATCGTA AACCATACCT AGACATATTG AATCGCTTTA CCGGCTAAGC AGCTAATCTT TAAGGGACGC ACCTAATGTA
c o p y 2 GAGGATCGTA AACCATACCT AGACATATTG AATCGCTTTA CCGGCTAAGC AGCTAATCTT TAAGGGACGC AC CTAATGTA
7 0 5 0  7 0 6 0  7 0 7 0  7 0 8 0  7 0 9 0  7 1 0 0  7 1 1 0  7 1 2 0
T l  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 2 ------------ ------------ ------------  ------------ ------------ ------------ --------------------------
T3 ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------
T 4 -----------------------  ----------------------  ----------------------  --C ATATA GC ATCGGTCTGT TGCGATCCGA CTATATGGCA CACGTGTCCG
T 5 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 7 -----------------------  ----------------------  ----------------------  -GCATATAGC ATCGGTCTGT TGCGATCCGA CTATATGGCA CACGTGTCCG
T 8 -----------------------  ----------------------  ----------------------  -GCATATAGC ATCGGTCTGT TGCGATCCGA CTATATGGCA CACGTGTCCG
T 9 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  TATATATCTT GTATAACGAT CATAATTGCA GGCATATAGC ATCGGTCTGT TGCGATCCGA CTATATGGCA CACGTGTCCG
c o p y 2  TATATATCTT GTATAACGAT CATAATTGCA GGCATATAGC ATCGGTCTGT TGCGATCCGA CTATATGGCA CACGTGTCCG
7 1 3 0  7 1 4 0  7 1 5 0  7 1 6 0  7 1 7 0  7 1 8 0  7 1 9 0  7 2 0 0XI ------------ ------------ ------------ ------------ ------------  ------------ ------------ ------------
T 2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
T 4 AGGGCTGTGC GATAAAGCAG GTCGAGATCA ACACGGTGGC CTCCAGTTTC GCTGGCATAG CCACCCAATT GGTGCCGCAG
T 5 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T 6 ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------
T7 AGGGCTGTGC GATAAAGCAG GTCGAGATCA ACACGGTGGC CTCCAGTTTC GCTGGCATAG CCACCCAATT GGTGCCGCAG
T 8 AGGGCTGTGC GATAAAGCAG GTCGAGATCA ACACGGTGGC CTCCAGTTTC GCTGGCATAG CCACCCAATT GGTGCCGCAG
T 9 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  AGGGCTGTGC GATAAAGCAG GTCGAGATCA ACACGGTGGC CTCCAGTTTC GCTGGCATAG CCACCCAATT GGTGCCGCAG
c o p y 2  AGGGCTGTGC GATAAAGCAG GTCGAGATCA ACACGGTGGC CTCCAGTTTC GCTGGCATAG CCACCCAATT GGTGCCGCAG
7 2 1 0  7 2 2 0  7 2 3 0  7 2 4 0  7 2 5 0  7 2 6 0  7 2 7 0  7 2 8 0
X I  ----------------------  ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ------------------------------------
X2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
1 3  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 4 CAGAA ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
1 5  ----------------------  ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ---------------------- -------------------------
1 6              ----------------------
T 7 CAGAA ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8 CAGAA ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
1 9  ----------------------  ----------------------  ---------------------- ------------------------- ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  CAGAAGTATT AAGCGCTCTT CTCTCTATCT CTTTCTACAT ATAATATATA TAAATATATA TCTATCAAAC TACATATATT
c o p y 2 CAGAAGTATT AAGCGCTCTT CTCTCTATCT CTTTCTACAT ATAATATATA TAAATATATA TCTATCAAAC TACATATATT
7 2 9 0  7 3 0 0  7 3 1 0  7 3 2 0  7 3 3 0  7 3 4 0  7 3 5 0  7 3 6 011 ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------
12             ----------
X3 ----------------------  ----------------------  ----------------------  -----------------------------------------------  ----------------------  ---------------------- -------------------------
1 4  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------
1 5  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
X6 ---------------------- -------------------------  ----------------------  -----------------------------------------------  ----------------------  ---------------------- -------------------------
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T7 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T8 ----------------------  -----------------------------------------------  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------
T 9 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  CCTTTTACCA AACGCACGAA TGCACAATGC ACACACCTAA AAGCAAAAGC ACACTACACA CCTGTCCTAA TATCCTTCCA
c o p y 2 CCTTTTACCA AACGCACGAA TGCACAATGC ACACACCTAA AAGCAAAAGC ACACTACACA CCTGTCCTAA TATCCTTCCA
7 3 7 0  7 3 8 0  7 3 9 0  7 4 0 0  7 4 1 0  7 4 2 0  7 4 3 0  7 4 4 0
Tl ----------  ---------- -----------  ----------  ---------- ---------- ---------------------
T2 ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------
T3 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 4 ----------------------  ---------------------- ---------------------- ------------------------- -------------------------  ----------------------  ---------------------- -------------------------
T 5 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------
T 8 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T9 ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- -------------------------
c o p y l  CCCAACTCCT TCTCCTTCTC ACTGATCACT TATCCACCTA CAGAGGTGCC ATCTCTATCG TTTGTTGTCT CTTTCTGCAT
c o p y 2 CCCAACTCCT TCTCCTTCTC ACTGATCACT TATCCACCTA CAGAGGTGCC ATCTCTATCG TTTGTTGTCT CTTTCTGCAT
7 4 5 0  7 4 6 0  7 4 7 0  7 4 8 0  7 4 9 0  7 5 0 0  7 5 1 0  7 5 2 0
T l ------------------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ----------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------
T4 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T5 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T6 ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T8 ----------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------
T 9 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
c o p y l  GTGTTTTTTT TTTTTTTAAT TGGTTATGGC TCTATCCGTC TCTTTCCACA CGCTGTAGCT TCATAACCCC ACTTCCACAA
c o p y 2  GTGTTTTTTT TTTTTTTAAT TGGTTATGGC TCTATCCGTC TCTTTCCACA CGCTGTAGCT TCATAACCCC ACTTCCACAA
7 5 3 0  7 5 4 0  7 5 5 0  7 5 6 0  7 5 7 0  7 5 8 0  7 5 9 0  7 6 0 0
Tl ----------  ---------- ---------- ---------- -----------  ----------  ---------------------
T2 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T3 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 4 ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ---------------------- -------------------------
T 5 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 6 ----------------------  ----------------------  ---------------------- ---------------------- -------------------------  ----------------------  ---------------------- -------------------------
T7 ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 8  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------  ----------------------  ----------------------
T9 ---------------------- ------------------------- -------------------------  ---------------------- ------------------------- ----------------------  ---------------------- -------------------------
copyl TTTCCCTAAC CATAAACATA CATATGTATA TCCATCCGCC CATTTGAGAG GTTTTGGTCT CAGTAATTAA CCCAAATTTC
copy2 TTTCCCTAAC CATAAACATA CATATGTATA TCCATCCGCC CATTTGAGAG GTTTTGGTCT CAGTAATTAA CCCAAATTTC
7 6 1 0  7 6 2 0  7 6 3 0  7 6 4 0  7 6 5 0  7 6 6 0  7 6 7 0  7 6 8 0
T l  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- ----------------------
T2 ----------------------  ----------------------  ---------------------- ------------------------- -------------------------  ----------------------  -----------------------------------------------
T3 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 4 ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T 5  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  -----------------------------------------------
T 6 ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
T7 ----------------------  ---------------------- -------------------------  ---------------------- ----------------------  ----------------------  ---------------------- -------------------------
T8 ----------------------  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ---------------------- -------------------------
T 9  ----------------------  ---------------------- -------------------------  ----------------------  ----------------------  ----------------------  ----------------------  ----------------------
c o p y l  AACCCCCCCC C C C --A TT A C  CACCGAACAT TTGTTGTTGT TTGTTGCTGT TGTTGGTCGC TGAAAGACTG CGGAATTATG
c o p y 2 AACCCCCCCC CCCCCATTAC CACCGAACAT TTGTTGTTGT TTGTTGCTGT TGTTGGTCGC TGAAAGACTG CGGAATTATG
7 6 9 0  7 7 0 0  7 7 1 0  7 7 2 0  7 7 3 0  7 7 4 0  - 7 7 5 0  7 7 6 0
Tl           ATTCGTA CTCAGCGAGC TGGGACATGC
T 2          ATTCGTA CTCAGCGAGC TGGGACATGC
T3 ----------------------  ----------------------  ---------------------- ----------------------  ----------------------  ----------------------  ----------------------  - - - ...................
T 4         ATTCGTA CTCAGCGAGC TGGGACATGC
T 5           ATTCGTA CTCAGCGAGC TGGGACATGC
T 6        ATTCGTA CTCAGCGAGC TGGGACATGC
T 7          ATTCGTA CTCAGCGAGC TGGGACATGC
T 8           ATTCGTA CTCAGCGAGC TGGGACATGC
T9          ATTCGTA CTCAGCGAGC TGGGACATGC
c o p y l  CTAATGTCTG TCTCTTTCTG TTCCGGCACT ACCCGTCTCT TTCGCCCGCG CAGATTCGTA CTCAGCGAGC TGGGACATGC
c o p y 2 CTAATGTCTG TCTCTTTCTG TTCCGGCACT ACCCGTCTCT TTCGCCCGCG CAGATTCGTA CTCAGCGAGC TGGGACATGC
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7 7 7 0  7 7 8 0  7 7 9 0  7 8 0 0  7 8 1 0  7 8 2 0  7 8 3 0  7 8 4 0
T1 GGATAAGCTG CACAAT --------------------  --------------------  --------------------  -------------------- -----------------------  --------------------
T2 GGATAAGCTG CACAAT --------------------  --------------------  -------------------- -----------------------  --------------------  --------------------
T3 ................................................................................................................................................................................................................................................
T4 GGATAAGCTG CACAAT --------------------  --------------------  --------------------  --------------------  -------------------- -----------------------
T5 GGATAAGCTG CACAAT --------------------  --------------------  --------------------  --------------------  -------------------- -----------------------
T6 GGATAAGCTG CACAAT --------------------  --------------------  --------------------  --------------------  -------------------- -----------------------
T7 GGATAAGCTG CACAAT --------------------  --------------------  --------------------  --------------------  -------------------- -----------------------
T8 GGATAAGCTG CACAAT --------------------  -------------------- ----------------------- -----------------------  -------------------- -----------------------
T9 GGATAAGCTG CACAAT --------- :--------- -----------------------  -------------------- -----------------------  -------------------- -----------------------
c o p y l  GGATAAGCTG CACAATGTGA GTATATTAAA CTAAGATATA TAATCTATAT ATATATAAAC ATATATTCAT ATATATAATA
c o p y 2 GGATAAGCTG CACAATGTGA GTATATTAAA CTAAGATATA TAATCTATAT ATATATAAAC ATATATTCAT ATATATAATA
7 8 5 0  7 8 6 0  7 8 7 0  7 8 8 0  7 8 9 0  7 9 0 0  7 9 1 0  7 9 2 0
X I------------------------- ------------ ------------ ------------ ------------------------- -------------  ------------
T2 --------------------  --------------------  --------------------  --------------------  --------------------  --------------------  -------------------- -----------------------
T3 ................................................................................................................................................................................................................................................
T4--------------------------------- ----------------------- ----------------------- -----------------------  --------------------  -------------------- -----------------------  --------------------
T5---------------------------------  --------------------  --------------------  --------------------  --------------------  --------------------  --------------------  --------------------
X6---------------------------------  --------------------  --------------------  -------------------- -----------------------  --------------------  -------------------- -----------------------
T7---------------------------------  --------------------  --------------------  --------------------  --------------------  --------------------  -------------------- -----------------------
T8---------------------------------  --------------------  -------------------- -----------------------  --------------------  -------------------- ----------------------- -----------------------
T9 --------------------  -------------------- -----------------------  --------------------  -------------------- -----------------------  -------------------- -----------------------
c o p y l  ATTATATGAT CTGTGTTTCC TGTACAATAA ACCATGAGTA ACAAGACAAC TTAAATGATA ATGTTCGTTA TTCCGCTGCA
c o p y 2 ATTATATGAT CTGTGTTTCC TGTACAATAA ACCATGAGTA ACAAGACAAC TTAAATGATA ATGTTCGTTA TTCCGCTGCA
7 9 3 0  7 9 4 0  7 9 5 0  7 9 6 0  7 9 7 0  7 9 8 0  7 9 9 0  8 0 0 0
T1 -ATGCCGGAT AACAATGCAC TGGCCGGACT CTGCGATGGC ATGGTGAAGG CGTGGGACAT CTATGCAAAG CCGCAGGCCG
T2 -ATGCCGGAT AACAATGCAC TGGCCGGACT CTGCGATGGC ATGGTGAAGG CGTGGGACAT CTATGCAAAG CCGCAGGCCG
T3 ................................................................................................................................................................................................................................................
T4 -ATGCCGGAT AACAATGCAC TGGCCGGACT CCGCGATGGC ATGGTGAAGG CGTGGGACAT CTATGCAAAG CCGCAGGCCG
T5 -ATGCCGGAT AACAATGCAC TGGCCGGACT CTGCGATGGC ATGGTGAAGG CGTGGGACAT CTATGCAAAG CCGCAGGCCG
T6 -ATGCCGGAT AACAATGCAC TGGCCGGACT CTGCGATGGC ATGGTGAAGG CGTGGGACAT CTATGCAAAG CCGCAGGCCG
T7 -ATGCCGGAT AACAATGCAC TGGCCGGACT CTGCGATGGC ATGGTGAAGG CGTGGGACAT CTATGCAAAG CCGCAGGCCG
T8 -ATGCCGGAT AACAATGCAC TGGCCGGACT CTGCGATGGC ATGGTGAAGG CGTGGGACAT CTATGCAAAG CCGCAGGCCG
T9 -ATGCCGGAT AACAATGCAC TGGCCGGACT CTGCGATGGC ATGGTGAAGG CGTGGGACAT CTATGCAAAG CCGCAGGCCG
-ATGCCGGAT AACAATGCAC TG C G ACT ATGGTGA G
-ATGCCGGAT AACAATGCAC TG C G ACT ATGGTGA GG
X -ATGCCGGAT AACAATGCAC TG C G ACT ATGGTGA G
-ATGCCGGAT AACAATGCAC TG C G ACT ATGGTGA G
-ATGCCGGAT AACAATGCAC TG C G ACT ATGGTGA G
-ATGCCGGAT AACAATGCAC TG C G ACT ATGGTGA GG
-ATGCCGGAT AACAATGCAC TG C G ACT ATGGTGA GG
-ATGCCGGAT AACAATGCAC TG C G ACT ATG TGA G
c o p y l GATGCCGGAT AACAATGCAC TGGCCGGACT CTGCGATGGC ATGGTGAAGG CGTGGGACAT CTATGCAAAG CCGCAGGCCG
c o p y 2 GATGCCGGAT AACAATGCAC TGGCCGGACT CTGCGATGGC ATGGTGAAGG CGTGGGACAT CTATGCAAAG CCGCAGGCCG
8 0 1 0  8 0 2 0  8 0 3 0  8 0 4 0  8 0 5 0  8 0 6 0  8 0 7 0  8 0 8 0
T1 TCATTCTGTT CATCATCGAG GATGTGTCGT ACAACATTTG CGACCAGCGG TTCCACGAGT TCTACATTCG CGAGACATAT
T2 TCATTCTGTT CATCATCGAG GATGTGTCGT ACAACATTTG CGACCAGCGG TTCCACGAGT TCTACATTCG CGAGACATAT
T3 ................................................................................................................................................................................................................................................
T4 TCATTCTGTT CATCATCGAG GATGTGTCGT ACAACATTTG CGACCAGCGG TTCCACGAGT TCTACATTCG CGAGACATAT
T5 TCATTCTGTT CATCATCGAG GATGTGTCGT ACAACATTTG CGACCAGCGG TTCCACGAGT TCTACATTCG CGAGACATAT
T6 TCATTCTGTT CATCATCGAG GATGTGTCGT ACAACATTTG CGACCAGCGG TTCCACGAGT TCTACATTCG CGAGACATAT
T7 TCATTCTGTT CATCATCGAG GATGTGTCGT ACAACATTTG CGACCAGCGG TTCCACGAGT TCTACATTCG CGAGACATAT
T8 TCATTCTGTT CATCATCGAG GATGTGTCGT ACAACATTTG CGACCAGCGG TTCCACGAGT TCTACATTCG CGAGACATAT
T9 TCATTCTGTT CATCATCGAG GATGTGTCGT ACAACATTTG CGACCAGCGG TTCCACGAGT TCTACATTCG CGAGACATAT
c o p y l  TCATTCTGTT CATCATCGAG GATGTGTCGT ACAACATTTG CGACCAGCGG TTCCACGAGT TCTACATTCG CGAGACATAT
c o p y 2 TCATTCTGTT CATCATCGAG GATGTGTCGT ACAACATTTG CGACCAGCGG TTCCACGAGT TCTACATTCG CGAGACATAT
8 0 9 0  8 1 0 0  8 1 1 0  8 1 2 0  8 1 3 0  8 1 4 0  8 1 5 0  8 1 6 0
T1 CCGCACATCA AGGTGCTGCG CCGCACCCTC ACCGAGGTCC ATCGGGAGGG CAAACTGGGC CAGTCCAAGG AGTTGCTCCT
T2 CCGCACATCA AGGTGCTGCG CCGCACCCTC ACCGAGGTCC ATCGGGAGGG CAAACTGGGC CAGTCCAAGG AGTTGCTCCT
T3 ................................................................................................................................................................................................................................................
T4 CCGCACATCA AGGTGCTGCG CCGCACCCTC ACCGAGGTCC ATCGGGAGGG CAAACTGGGC CAGTCCAAGG AGTTGCTCCT
T5 CCGCACATCA AGGTGCTGCG CCGCACCCTC ACCGAGGTCC ATCGGGAGGG CAAACTGGGC CAGTCCAAGG AGTTGCTCCT
T6 CCGCACATCA AGGTGCTGCG CCGCACCCTC ACCGAGGTCC ATCGGGAGGG CAAACTGGGC CAGTCCAAGG AGTTGCTCCT
T7 CCGCACATCA AGGTGCTGCG CCGCACCCTC ACCGAGGTCC ATCGGGAGGG CAAACTGGGC CAGTCCAAGG AGTTGCTCCT
T8 CCGCACATCA AGGTGCTGCG CCGCACCCTC ACCGAGGTCC ATCGGGAGGG CAAACTGGGC CAGTCCAAGG AGTTGCTCCT
T9 CCGCACATCA AGGTGCTGCG CCGCACCCTC ACCGAGGTCC ATCGGGAGGG CAAACTGGGC CAGTCCAAGG AGTTGCTCCT
c o p y l  CCGCACATCA AGGTGCTGCG CCGCACCCTC ACCGAGGTCC ATCGGGAGGG CAAACTGGGC CAGTCCAAGG AGTTGCTCCT
c o p y 2 CCGCACATCA AGGTGCTGCG CCGCACCCTC ACCGAGGTCC ATCGGGAGGG CAAACTGGGC CAGTCCAAGG AGTTGCTCCT
8 1 7 0  8 1 8 0  8 1 9 0  8 2 0 0  8 2 1 0  8 2 2 0  8 2 3 0  8 2 4 0
X I            TGGA
X2              TGGA
T3 ................................................................................................................................................................................................................................................
300
T4              TGGA
T5               TGGA
T6              TGGA
T7              TGGA
T6              TGGA
T9               TGGA
c o p y l  GTAAGTGTAC ATTAATACCT CTATTATCAT TCATCATTGA ACTGTGTGCT CAACTCACAC GCTTGCCGCA CCACAGTGGA
c o p y 2 GTAAGTGTAC ATTAATACCT CTATTATCAT TCATCATTGA ACTGTGTGCT CAACTCACAC GCTTGCCGCA CCACAGTGGA
8 2 5 0  8 2 6 0  8 2 7 0  8 2 8 0  8 2 9 0  8 3 0 0  8 3 1 0  8 3 2 0
T1 TCCCAAGAGG TGGCCGTCAT CTACTTCCGA GCTGGCTACG AGCCCGGACA CTATCACTCG CAGGCGGATT GGGATGCCCG
T2
T3
TCCCAAGAGG TGGCCGTCAT CTACTTCCGA GCTGGCTACG AGCCCGGACA CTATCACTCG CAGGCGGATT GGGATGCCCG
T4 TCCCAAGAGG TGGCCGTCAT CTACTTCCGA GCTGGCTACG AGCCCGGACA CTATCACTCG CAGGCGGATT GGGATGCCCG
T5 TCCCAAGAGG TGGCCGTCAT CTACTTCCGA GCTGGCTACG AGCCCGGACA CTATCACTCG CAGGCGGATT GGGATGCCCG
T6 TCCCAAGAGG TGGCCGTCAT CTACTTCCGA GCTGGCTACG AGCCCGGACA CTATCACTCG CAGGCGGATT GGGATGCCCG
T7 TCCCAAGAGG TGGCCGTCAT CTACTTCCGA GCTGGCTACG AGCCCGGACA CTATCACTCG CAGGCGGATT GGGATGCCCG
T8 TCCCAAGAGG TGGCCGTCAT CTACTTCCGA GCTGGCTACG AGCCCGGACA CTATCACTCG CAGGCGGATT GGGATGCCCG
T9 TCCCAAGAGG TGGCCGTCAT CTACTTCCGA GCTGGCTACG AGCCCGGACA CTATCACTCG CAGGCGGATT GGGATGCCCG
c o p y l TCCCAAGAGG TGGCCGTCAT CTACTTCCGA GCTGGCTACG AGCCCGGACA CTATCACTCG CAGGCGGATT GGGATGCCCG
c o p y  2 TCCCAAGAGG TGGCCGTCAT CTACTTCCGA GCTGGCTACG AGCCCGGACA CTATCACTCG CAGGCGGATT GGGATGCCCG
8 3 3 0  8 3 4 0  8 3 5 0  8 3 6 0  8 3 7 0  8 3 8 0  8 3 9 0  8 4 0 0
T1 CTATCTGATG GAGACCTCGC TGGCCATCAA GTGCCCGTCG ATTCACTACC ATTTGGCGGG CACCAAGAAG GTGCAGCAGG
T2
T3
CTATCTGATG GAGACCTCGC TGGCCATCAA GTGCCCGTCG ATTCACTACC ATTTGGCGGG CACCAAGAAG GTGCAGCAGG
T4 CTATCTGATG GAGACCTCGC TGGCCATCAA GTGCCCGTCG ATTCACTACC ATTTGGCGGG CACCAAGAAG GTGCAGCAGG
T5 CTATCTGATG GAGACCTCGC TGGCCATCAA GTGCCCGTCG ATTCACTACC ATTTGGCGGG CACCAAGAAG GTGCAGCAGG
T6 CTATCTGATG GAGACCTCGC TGGCCATCAA GTGCCCGTCG ATTCACTACC ATTTGGCGGG CACCAAGAAG GTGCAGCAGG
T7 CTATCTGATG GAGACCTCGC TGGCCATCAA GTGCCCGTCG ATTCACTACC ATTTGGCGGG CACCAAGAAG GTGCAGCAGG
T8 CTATCTGATG GAGACCTCGC TGGCCATCAA GTGCCCGTCG ATTCACTACC ATTTGGCGGG CACCAAGAAG GTGCAGCAGG
T9 CTATCTGATG GAGACCTCGC TGGCCATCAA GTGCCCGTCG ATTCACTACC ATTTGGCGGG CACCAAGAAG GTGCAGCAGG
c o p y l CTATCTGATG GAGACCTCGC TGGCCATCAA GTGCCCGTCG ATTCACTACC ATTTGGCGGG CACCAAGAAG GTGCAGCAGG
c o p y 2 CTATCTGATG GAGACCTCGC TGGCCATCAA GTGCCCGTCG ATTCACTACC ATTTGGCGGG CACCAAGAAG GTGCAGCAGG
8 4 1 0  8 4 2 0  8 4 3 0  8 4 4 0  8 4 5 0  8 4 6 0  8 4 7 0  8 4 8 0
T1 CATTGGCGCA GCCGGCGGTG CTCGAGCGTT TCATCAACGA TCCGGAGGAG ATCAAGGCGG TGGGCAAGAT CTTCACGGGT
T2 CATTGGCGCA GCCGGCGGTG CTCGAGCGTT TCATCAACGA TCCGGAGGAG ATCAAGGCGG TGGGCAAGAT CTTCACGGGT
T3 ................................................................................................................................................................................................................................................
T4 CATTGGCGCA GCCGGCGGTG CTCGAGCGTT TCATCAACGA TCCGGAGGAG ATCAAGGCGG TGGGCAAGAT CTTCACGGGT
T5 CATTGGCGCA GCCGGCGGTG CTCGAGCGTT TCATCAACGA TCCGGAGGAG ATCAAGGCGG TGGGCAAGAT CTTCACGGGT
T6 CATTGGCGCA GCCGGCGGTG CTCGAGCGTT TCATCAACGA TCCGGAGGAG ATCAAGGCGG TGGGCAAGAT CTTCACGGGT
T7 CATTGGCGCA GCCGGCGGTG CTCGAGCGTT TCATCAACGA TCCGGAGGAG ATCAAGGCGG TGGGCAAGAT CTTCACGGGT
T8 CATTGGCGCA GCCGGCGGTG CTCGAGCGTT TCATCAACGA TCCGGAGGAG ATCAAGGCGG TGGGCAAGAT CTTCACGGGT
T9 CATTGGCGCA GCCGGCGGTG CTCGAGCGTT TCATCAACGA TCCGGAGGAG ATCAAGGCGG TGGGCAAGAT CTTCACGGGT
c o p y l  CATTGGCGCA GCCGGCGGTG CTCGAGCGTT TCATCAACGA TCCGGAGGAG ATCAAGGCGG TGGGCAAGAT CTTCACGGGT
c o p y 2 CATTGGCGCA GCCGGCGGTG CTCGAGCGTT TCATCAACGA TCCGGAGGAG ATCAAGGCGG TGGGCAAGAT CTTCACGGGT
CATTGGCGCA GCCGGCGGTG CTCGAGCGT TCATCAACGA TC GGAGGAG ATCAAGGCGG TG CA GAT
CATTGGCGCA GCCGGCGGTG CTCGAGCGT TCATCAACGA TC GGAGGAG ATCAAGGCGG TG CA GAT
CATTGGCGCA GCCGGCGGTG CTCGAGCGT TCATCAACGA TC GGAG AG ATCA G CG TG CA GAT
CATTGGCGCA GCCGGCGGTG CTCGAGCGT TCATCAACGA TC G AG AG ATCA G CG TG CA GAT
CATTGGCGCA GCCGGCGGTG CTCGAGCGT TCATCAACGA TC GGAG AG ATCA G CG TG CA GAT
CATTGGCGCA GCCGGCGGTG CTCGAGCGT TCATCAACGA TC G AG AG ATCA G CG TG CA GAT
CATTGGCGCA GCCGGCGGTG CTCGAGCGT TCATCAACGA TC G AG AG ATCA G CG TG CA GAT
CATTGGCGCA GCCGGCGGTG CTCGAGCGT TCATCAACGA TC G AG AG ATCA G CG TG CA GAT
CATTGGCGCA GCCGGCGGTG CTCGAGCGT TCATCAACGA TC G AG AG ATCA G CG TG CA GAT
 CATTGGCGCA GCCGGCGGTG CTCGAGCGT TCATCAACGA TC G AG AG ATCA G CG TG CA GAT
8 4 9 0  8 5 0 0  8 5 1 0  8 5 2 0  8 5 3 0  8 5 4 0  8 5 5 0  8 5 6 0
T1 CTCTACTCGC TGGACGACAA CGAGGCGGGC AATGCCAGCT ACGAGATGGC GCTGCGCACT CCGGAGAGAT TCGTGCTGAA
T2 CTCTACTCGC TGGACGACAA CGAGGCGGGC AATGCCAGCT ACGAGATGGC GCTGCGCACT CCGGAGAGAT TCGTGCTGAA
T3 ................................................................................................................................................................................................................................................
T4 CTCTACTCGC TGGACGACAA CGAGGCGGGC AATGCCAGCT ACGAGATGGC GCTGCGCACT CCGGAGAGAT TCGTGCTGAA
T5 CTCTACTCGC TGGACGATAA CGAGGCGGGC AATGCCAGCT ACGAGATGGC GCTGCGCACT CCGGAGAGAT TCGTGCTGAA
T6 CTCTACTCGC TGGACGACAA CGAGGCGGGC AATGCCAGCT ACGAGATGGC GCTGCGCACT CCGGAGAGAT TCGTGCTGAA
T7 CTCTACTCGC TGGACGACAA CGAGGCGGGC AATGCCAGCT ACGAGATGGC GCTGCGCACT CCGGAGAGAT TCGTGCTGAA
T8 CTCTACTCGC TGGACGACAA CGAGGCGGGC AATGCCAGCT ACGAGATGGC GCTGCGCACT CCGGAGAGAT TCGTGCTGAA
T9 CTCTACTCGC TGGACGACAA CGAGGCGGGC AATGCCAGCT ACGAGATGGC GCTGCGCACT CCGGAGAGAT TCGTGCTGAA
c o p y l  CTCTACTCGC TGGACGACAA CGAGGCGGGC AATGCCAGCT ACGAGATGGC GCTGCGCACT CCGGAGAGAT TCGTGCTGAA
c o p y 2 CTCTACTCGC TGGACGACAA CGAGGCGGGC AATGCCAGCT ACGAGATGGC GCTGCGCACT CCGGAGAGAT TCGTGCTGAA
8 5 7 0  8 5 8 0  8 5 9 0  8 6 0 0  8 6 1 0  8 6 2 0  8 6 3 0  8 6 4 0
T1 GCCGCAGCGC GAGGGAGGCG GCAATAAT---- --------------------  --------------------  --------------------  --------------------  --------------------
T2 GCCGCAGCGC GAGGGAGGCG GCAATAAT------------------------  --------------------  --------------------  --------------------  --------------------
T3 ................................................................................................................................................................................................................................................
T4 GCCGCAGCGC GAGGGAGGCG GCAATAATGT CTACGGCGTG GATATACCAA ATGCACTAGA G------------------  --------------------
T5 GCCGCAGCGC GAGGGAGGCG GCAATAATGT CTACGGCGTG GATATACCAN ATGCACTAAA-G------------------  --------------------
T6 GCCGCAGCGC GAGGGAGGCG GCAATAATGT CTACGGCGTG GATATACCAG ATGCACTAAA-G------------------  --------------------
T7 GCCGCAGCGC GAGGGAGGCG GCAATAATGT CTACGGCGTG GATATACCAG ATGCACTAAA-G------------------  --------------------
T8 GCCGCAGCGC GAGGGAGGCG GCAATAATGT CTACGGCGTG GATATACCAG ATGCACTAAA-G------------------  --------------------
T9 GCCGCAGCGC GAGGGAGGCG GCAATAATGT CTACGGCGTG GATATACCAG ATGCACTAAA-G------------------  --------------------
301
\c o p y l  GCCGCAGCGC GAGGGAGGCG GCAATAATGT CTACGGCGTG GATATACCAG ATGCACTAAA GGTGAGTTAT TCCACTTTGA
c o p y 2 GCCGCAGCGC GAGGGAGGCG GCAATAATGT CTACGGCGTG GATATACCAG ATGCACTAAA GGTGAGTTAT TCCACTTTGA
8 6 5 0  8 6 6 0  8 6 7 0  8 6 8 0  8 6 9 0  8 7 0 0  8 7 1 0  8 7 2 0
T1          CG CATGTCACGC GTGGAGCGCT
T2           CG CATGTCACGC GTGGAGCGCT
T3 ................................................................................................................................................................................................................................................
T4           CG CATGTCACGC GTGGAGCGCT
T5           CG CATGTCACGC GTGGAGCGCT
T6           CG CATGTCACGC GTGGAGCGCT
T7           CG CATGTCACGC GTGGAGCGCT
T8          CG CATGTCACGC GTGGAGCGCT
T9           CG CATGTCACGC GTGGAGCGCT
c o p y l  TGATTATTTG AATTGTGAAC AGTTTTGTAA CAAATCCTTC TCCTTCTTTA TCCATCAGCG CATGTCACGC GTGGAGCGCT
c o p y 2 TGATTATTTG AATTGTGAAC AGTTTTGTAA CAAATCCTTC TCCTTCTTTA TCCATCAGCG CATGTCACGC GTGGAGCGCT
8 7 3 0  8 7 4 0  8 7 5 0  8 7 6 0  8 7 7 0  8 7 8 0  8 7 9 0  8 8 0 0
T1 CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA TATGCCGCCC
T2 CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA TATGCCGCCC
T3 ................................................................................................................................................................................................................................................
T4 CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA TATGCCGCCC
T5 CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA TATGCCGCCC
T6 CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA TATGCCGCCC
T7 CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA TATGCCGCCC
T8 CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA TATGCCGCCC
T9 CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA TATGCCGCCC
c o p y l  CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA TATGCCGCCC
c o p y 2  CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA TATGCCGCCC
CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA
CCGCCTGGAT TCTGATGGAT CTGAT CATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA
CCGCCTGGAT TCTGATGGAT CTGAT CATC CGC GCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA
CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA
CCGCCTGGAT TCTGATGGAT CTGAT CATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA
CCGCCTGGAT TCTGATGGAT CTGAT CATC CGC GCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA
CCGCCTGGAT TCTGATGGAT CTGAT CATC CGC GCTGAC CAAGGGCTAT ATGGTGCG C CCGGTGGCGA
CCGCCTGGAT TCTGATGGAT CTGATTCATC CGCCGCTGAC CAAGGGCTAT ATGGTGCG C CCGGTGGCGA
TCTGATGGAT CTGAT CATC CGCCGCTGAC CAAGGGCTAT ATGGTGCGGC CCGGTGGCGA
TCTGATGGAT CTGAT CATC CGCCGCTGAC CAAGGGCTAT ATGGTGCG C CCGGTGGCGA
8 8 1 0  8 8 2 0  8 8 3 0  8 8 4 0  8 8 5 0  8 8 6 0  8 8 7 0  8 8 8 0
T1 CAGATCGTGG ACATGGTCTC CGAGCTGGGC ATCTTCGGTG TGGTGATCGG AGATGCGGAG CACATTGTGC ACAACTACCA
T2 CAGATCGTGG ACATGGTCTC CGAGCTGGGC ATCTTCGGTG TGGTGATCGG AGATGCGGAG CACATTGTGC ACAACTACCA
T3 ................................................................................................................................................................................................................................................
T4 CAGATCGTGG ACATGGTCTC CGAGCTGGGC ATCTTCGGTG TGGTGATCGG AGATGCGGAG CACATTGTGC ACAACTACCA
T5 CAGATCGTGG ACATGGTCTC CGAGCTGGGC ATCTTCGGTG TGGTGATCGG AGATGCGGAG CACATTGTGC ACAACTACCA
T6 CAGATCGTGG ACATGGTCTC CGAGCTGGGC ATCTTCGGTG TGGTGATCGG AGATGCGGAG CACATTGTGC ACAACTACCA
T7 CAGATCGTGG ACATGGTCTC CGAGCTGGGC ATCTTCGGTG TGGTGATCGG AGATGCGGAG CACATTGTGC ACAACTACCA
T8 CAGATCGTGG ACATGGTCTC CGAGCTGGGC ATCTTCGGTG TGGTGATCGG AGATGCGGAG CACATTGTGC ACAACTACCA
T9 CAGATCGTGG ACATGGTCTC CGAGCTGGGC ATCTTCGGTG TGGTGATCGG AGATGCGGAG CACATTGTGC ACAACTACCA
c o p y l  CAGATCGTGG ACATGGTCTC CGAGCTGGGC ATCTTCGGTG TGGTGATCGG AGATGCGGAG CACATTGTGC ACAACTACCA
c o p y 2 CAGATCGTGG ACATGGTCTC CGAGCTGGGC ATCTTCGGTG TGGTGATCGG AGATGCGGAG CACATTGTGC ACAACTACCA
8 8 9 0  8 9 0 0  8 9 1 0  8 9 2 0  8 9 3 0  8 9 4 0  8 9 5 0  8 9 6 0
T1 GGCGGGACAC ATGCTGCGCA CAAAGCTCTC AACCGCCAAC GAAGGAGGCG TGGCAGCCGG TCTGGGCGCC CTGGACAGTC
T2 GGCGGGACAC ATGCTGCGCA CAAAGCTCTC AACCGCCAAC GAAGGAGGCG TGGCAGCCGG TCTGGGCGCC CTGGACAGTC
T3 ................................................................................................................................................................................................................................................
T4 GGCGGGACAC ATGCTGCGCA CAAAGCTCTC AACCGCCAAC GAAGGAGGCG TGGCAGCCGG TCTGGGCGCC CTGGACAGTC
T5 GGCGGGACAC ATGCTGCGCA CAAAGCTCTC AACCGCCAAC GAAGGAGGCG TGGCAGCCGG TCTGGGCGCC CTGGACAGTC
T6 GGCGGGACAC ATGCTGCGCA CAAAGCTCTC AACCGCCAAC GAAGGAGGCG TGGCAGCCGG TCTGGGCGCC CTGGACAGTC
T7 GGCGGGACAC ATGCTGCGCA CAAAGCTCTC AACCGCCAAC GAAGGAGGCG TGGCAGCCGG TCTGGGCGCC CTGGACAGTC
T8 GGCGGGACAC ATGCTGCGCA CAAAGCTCTC AACCGCCAAC GAAGGAGGCG TGGCAGCCGG TCTGGGCGCC CTGGACAGTC
T9 GGCGGGACAC ATGCTGCGCA CAAAGCTCTC AACCGCCAAC GAAGGAGGCG TGGCAGCCGG TCTGGGCGCC CTGGACAGTC
c o p y l  GGCGGGACAC ATGCTGCGCA CAAAGCTCTC AACCGCCAAC GAAGGAGGCG TGGCAGCCGG TCTGGGCGCC CTGGACAGTC
c o p y 2 GGCGGGACAC ATGCTGCGCA CAAAGCTCTC AACCGCCAAC GAAGGAGGCG TGGCAGCCGG TCTGGGCGCC CTGGACAGTC
8 9 7 0  8 9 8 0  8 9 9 0  9 0 0 0  9 0 1 0  9 0 2 0  9 0 3 0  9 0 4 0
T1 CATATCTGAT CGATAGCGAT GACGAGGATG AGCAGAAGTA GG................................................................................................................
T2 CATATCTGAT CGATAGCGAT GACGAGGATG AGCAGAAGTA GG.....................  .......................................................................................
T3 ................................................................................................................................................................................................................................................
T4 CATATCTGAT CGATAGCGAT GACGAGGATG AGCAGAAGTA GGATCCTTTA ACGAGATAAA GGCTTCGAAC GCCGGCATTC
T5 CATATCTGAT CGATAGCGAT GACGAGGATG AGCAGAAGTA GGATCCTTTA ACGAGATAAA GGCTTCGAAC GCCGGCATTC
T6 CATATCTGAT CGATAGCGAT GACGAGGATG AGCAGAAGTA G ...................................................................................................................
T7 CATATCTGAT CGATAGCGAT GACGAGGATG AGCAGAAGTA G ...................................................................................................................
T8 CATATCTGAT CGATAGCGAT GACGAGGATG AGCAGAAGTA G ...................................................................................................................
T9 CATATCTGAT CGATAGCGAT GACGAGGATG AGCAGAAGTA G ...................................................................................................................
c o p y l  CATATCTGAT CGATAGCGAT GACGAGGATG AGCAGAAGTA GGATCCTTTA ACGAGATAAA GGCTTCGAAC GCCGGCATTC
c o p y 2 CATATCTGAT CGATAGCGAT GACGAGGATG AGCAGAAGTA GGATCCTTTA ACGAGATAAA GGCTTCGAAC GCCGGCATTC
9 0 5 0  9 0 6 0  9 0 7 0  9 0 8 0  9 0 9 0  9 1 0 0  9 1 1 0  9 1 2 0
302
T1
T2
T3
T4
T5
T6
T7
T8
T9
copyl
copy2
T1
T2
T3
T4
T5
T6
T7
T8
T9
copyl 
copy 2
T1
T2
T3
T4
T5
T6
T7
T8
T9
copyl 
copy 2
CACCTGTTGC CTCAGTCTTG TATAAATGAT TATTTTTTGT AAAGCGTATT GTAAATTTTT TGCACTATTT TTTCCCCGTC 
CACCTGTTGC CTCAGTCTTG TATAAATGAT TATTTTTTGT AAAGCGTATT GTAAATTTTT TGCACTATTT TTTCCCCGTC
CACCTGTTGC CTCAGTCTTG TATAAATGAT TATTTTT-GT AAAGCGTATT GTAAATTTTT TGCACTATTT TTTCCCCGTC 
CACCTGTTGC CTCAGTCTTG TATAAATGAT TATTTTT-GT AAAGCGTATT GTAAATTTTT TGCACTATTT TTTCCCCGTC
9 1 3 0  9 1 4 0  9 1 5 0  9 1 6 0  9 1 7 0  9 1 8 0  9 1 9 0  9 2 0 0
CCAATGTCAA TAAATAAAAT GTTAA-CTAG AAAAAAAAAA AAAAAAAACT CGAGGGGGGG CCCGGCCCCA ATTCCCCCTT 
CCAATGTCAA TAAATAAAAT GTTAA-CTAG AAAAAAAAAA AAAAAAA-CT CNAGGGGGGG CCCGGNCCCA ATTCCCCCTT
CCAATGTCAA TAAATAAAAT GTTAAACTAG AAATTCTGGT CAATATGCAA ACTATGCAAA ATATGCCAGG 
CCAATGTCAA TAAATAAAAT GTTAAACTAG AAATTCTGGT CAATATGCAA ACTGGAT  --------------------
9 2 1 0
TATGGAGTAT - -  
TANGGAGTNT GT
303
9.3 Appendix C: Sequence of human GS cDNA cloned into 
pUAST
10  2 0  3 0  4 0  50  60  70  80 90
GGCGAACTAG TGTTGGGATG GCCACCAACT GGGGGAGCCT CTTGCAGGAT AAACAGCAGC TAGAGGAGCT GGCACGGCAG GCCGTGGACC
1 0 0  11 0  1 2 0  1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  18 0
GGGCCCTGGC TGAGGGAGTA TTGCTGAGGA CCTCACAGGA GCCCACTTCC TCGGAGGTGG TGAGCTATGC CCCATTCACG CTCTTCCCCT
1 90  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0  2 5 0  2 6 0  2 7 0
CACTGGTCCC CAGTGCCCTG CTGGAGCAAG CCTATGCTGT GCAGATGGAC TTCAACCTGC TAGTGGATGC TGTCAGCCAG AACGCTGCCT
2 8 0  2 9 0  3 0 0  3 1 0  3 2 0  3 3 0  3 4 0  3 5 0  3 6 0
TCCTGGAGCA AACTCTTTCC AGCACCATCA AACAGGATGA CTTTACCGCT CGTCTCTTTG ACATCCACAA GCAAGTCCTA AAAGAGGGCA
3 7 0  3 8 0  3 9 0  4 0 0  4 1 0  4 2 0  4 3 0  4 4 0  4 5 0
TTGCCCAGAC TGTGTTCCTG GGCCTGAATC GCTCAGACTA CATGTTCCAG CGCAGCGCAG ATGGCTCCCC AGCCCTGAAA CAGATCGAAA
4 6 0  4 7 0  4 8 0  4 9 0  5 0 0  5 1 0  5 2 0  5 3 0  5 4 0
TCAACACCAT CTCTGCCAGC TTTGGGGGCC TGGCCTCCCG GACCCCAGCT GTGCACCGAC ATGTTCTCAG TGTCCTGAGT AAGACCAAAG
5 5 0  5 6 0  5 7 0  5 8 0  5 9 0  6 0 0  6 1 0  6 2 0  6 30
AAGCTGGCAA GATCCTCTCT AATAATCCCA GCAAGGGACT GGCCCTGGGA ATTGCCAAAG CCTGGGAGCT CTACGGCTCA CCCAATGCTC
6 4 0  6 5 0  6 6 0  6 7 0  6 8 0  6 9 0  7 0 0  7 1 0  7 2 0
TGGTGCTACT GATTGCTCAA GAGAAGGAAA GAAACATATT TGACCAGCGT GCCATAGAGA ATGAGCTACT GGCCAGGAAC ATCCATGTGA
7 3 0  7 4 0  7 5 0  7 6 0  7 7 0  7 8 0  7 9 0  8 0 0  8 1 0
TCCGACGAAC ATTTGAAGAT ATCTCTGAAA AGGGGTCTCT GGACCAAGAC CGAAGGCTGT TTGTGGATGG CCAGGAAATT GCTGTGGTTT
8 2 0  83 0  84 0  8 5 0  8 6 0  8 7 0  8 8 0  8 9 0  9 00
ACTTCCGGGA TGGCTACATG CCTCGTCAGT ACAGTCTACA GAATTGGGAA GCACGTCTAC TGCTGGAGAG GTCACATGCT GCCAAGTGCC
9 1 0  92 0  9 3 0  94 0  9 5 0  9 6 0  9 7 0  9 8 0  9 90
CAGACATTGC CACCCAGCTG GCTGGGACTA AGAAGGTGCA GCAGGAGCTA AGCAGGCCGG GCATGCTGGA GATGTTGCTC CCTGGCCAGC
1 0 0 0  1 0 1 0  1 0 2 0  1 0 3 0  1 0 4 0  1 0 5 0  1 0 6 0  1 0 7 0  1 0 8 0
CTGAGGCTGT GGCCCGCCTC CGCGCCACCT TTGCTGGCCT CTACTCACTG GATGTGGGTG AAGAAGGGGA CCAGGCCATC GCCGAGGCCC
1 0 9 0  1 1 0 0  1 1 1 0  1 1 2 0  1 1 3 0  1 1 4 0  1 1 5 0  1 1 6 0  1 1 7 0
TTGCTGCCCC TAGCCGGTTT GTGCTAAAGC CCCAGAGAGA GGGTGGAGGT AACAACCTAT ATGGGGAGGA AATGGTACAG GCCCTGAAAC
1 1 8 0  1 1 9 0  1 2 0 0  1 2 1 0  1 2 2 0  1 2 3 0  1 2 4 0  1 2 5 0  1 2 6 0
AGCTGAAGGA CAGTGAGGAG AGGGCCTCCT ACATCCTCAT GGAGAAGATC GAACCTGAGC CTTTTGAGAA TTGCCTGCTA CGGCCTGGCA
1 2 7 0  1 2 8 0  1 2 9 0  1 3 0 0  1 3 1 0  1 3 2 0  1 3 3 0  1 3 4 0  1 3 5 0
GCCCTGCCCG AGTGGTCCAG TGCATTTCAG AGCTGGGCAT CTTTGGGGTC TATGTCAGGC AGGAAAAGAC ACTCGTGATG AACAAGCACG
1 3 6 0  1 3 7 0  1 3 8 0  1 3 9 0  1 4 0 0  1 4 1 0  1 4 2 0  1 4 3 0  1 4 4 0
TGGGGCATCT ACTTCGAACC AAAGCCATCG AGCATGCAGA TGGTGGTGTG GCAGCGGGAG TGGCAGTCCT GGACAACCCA TACCCTGTGT
1 4 5 0  1 4 6 0  1 4 7 0  1 4 8 0  1 4 9 0  1 5 0 0  1 5 1 0  1 5 2 0  1 5 3 0
GAGGGCACAA CCAGGCCACG GGACCTTCTA TCCTCTGTAT TTGTCATTCC TCTCCTAGCC CTCCTGAGGG GTATCCTCCT AAAGACCTCC
1 5 4 0  1 5 5 0  1 5 6 0  1 5 7 0  1 5 8 0  1 5 9 0  1 6 0 0  1 6 1 0  1 6 2 0
AAAGTTTTTA TGGAAGGGTA AATACTGGTA CCTTCCCCCA GCTTTCCATC TGAGGACCAG AAAAGTTGTG TCTCCCTTAG ATGAGATCTA
1 6 3 0  1 6 4 0  1 6 5 0  1 6 6 0  1 6 7 0  1 6 8 0  1 6 9 0  1 7 0 0  1 7 1 0
GACGCCCCCA AATCCTTGAG ATGTGGGTAT AGCTCAGGGT AAGCTGCTCT GAGGTAAAGG TCCATGAACC CTGCCCCACT CCTGTCAGCC
304
1 7 2 0  1 7 3 0  1 7 4 0  1 7 5 0  1 7 6 0  1 7 7 0  1 7 8 0  1 7 9 0  1 8 0 0
CCTCATCAGC CTTTTCAGCA GGTTCCAGTG CCTGACTTGG ATAGACTGAG TGGTAGGAGG AGGGGGAGTG GAGGGATAGC CTTTCCCTAA
1 8 1 0  1 8 2 0  1 8 3 0  1 8 4 0  1 8 5 0
TTCTGCCTTA AATAAAACTG CATTGCTGAT TCAAAAAAAA AAAAAAAAAA
9.4 Appendix D: Sequence of GFP gene cloned into pQBI25-f
The sequence of the portion of plasmid pQBI25-f containing the GFP gene used to create 
GFP dsRNA for RNAi control experiments, with the primer positions highlighted.
841 gtaggcgtgt acggtgggag gtctatataa gcagagctcg tttagtgaac cgtcagatcg
901 cctggagacg ccatccacgc tgttttgacc tccatagaag acaccgggac cgatccagcc
961 tccgcgggcg cgcaagaaSt_ggctagcaaa ggagaagaac tcttcactgg agttgtccca 
1021 attcttgttg aattagatgg tgatgttaac ggccacaagt tctctgtcag tggagagggt
1081 gaaggtgatg caacatacgg aaaacttacc ctgaagttca tctgcactac tggcaaactg
1141 cctgttccat ggccaacact agtcactact ctgtgctatg gtgttcaatg cttttcaaga
1201 tacccggatc atatgaaacg gcatgacttt ttcaagagtg ccatgcccga aggttatgta
1261 caggaaagga ccatcttctt caaagatgac ggcaactaca agacacgtgc tgaagtcaag
1321 tttgaaggtg atacccttgt taatagaatc gagttaaaag gtattgactt caaggaagat
13 81 ggcaacattc tgggacacaa attggaatac aactataact cacacaatgt atacatcatg
1441 gcagacaaac aaaagaatgg aatcaaagtg aacttcaaga cccgccacaa cattgaagat
1501 ggaagcgttc aactagcaga ccattatcaa caaaatactc caattggcga tggccctgtc
1561 cttttaccag acaaccatta cctgtccaca caatctgccc tttcgaaaga tcccaacgaa
1621 aagagagacc acatggtcct tcttgagttt gtaacagctg ctgggattac acatggcatg
1681 gatgaactgt acaacatcga ttccactagt aacggccgcc agtgtgctgg aattctgcag
1741 atatccatca cactggcggc cgctcgagca tgcatctaga gggccctatt ctatagtgtc
1801 acctaaatgc tagagctcgc tgatcagcct cgactgtgcc ttctagttgc cagccatctg
1861 ttgtttgccc ctcccccgtg ccttccttga ccctggaagg tgccactccc actgtccttt
1921 cctaataaaa tgaggaaatt gcatcgcatt gtctgagtag gtgtcattct attctggggg
9.5 Appendix E: GenBank accession numbers of cDNA clones 
sequenced in Chapter 5
GenBank Accession number Transcript Source of cDNA
EF419254 T1 (CG6835-RC) y  sn3 v (double GS) adult fly
EF419255 T2 (CG6835-RD) y  sn3 v (double GS) adult fly
EF419256 T4 y sn3 v (double GS) adult fly
EF419257 T6 (CG32495-RA) S2 cells
EF419258 T8 (CG32495-RB) S2 cells
EF419259 T8 (CG32495-RB) w sn3 (single GS) adult fly
EF419260 T8 (CG32495-RB) y  sn3 v (double GS) adult fly
EF419261 T10 y  sn3 v (double GS) adult fly
EF419262 T10 w sn3 (single GS) adult fly
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